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vAbstract 
 
Salvinorin A [(2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(3-furanyl)-dodecahydro-6a,10b-
dimethyl-4,10-dioxo-2H-naptho[2,1-c]pyran-7-carboxylic acid methyl ester] is a trans-neoclerodane 
diterpene from the leaves of the hallucinogenic Mexican sage Salvia divinorum and has been identified 
as the principal psychoactive component in this plant of traditional spiritual importance. Salvinorin A is 
the most potent naturally occurring hallucinogen found so far, and is reported to act selectively as a -
opioid receptor agonist. Synthetic modification of the natural product has contributed to a number of 
proposed pharmacophores to identify the key structural features necessary for biological activity and a 
direct strategy for the asymmetric synthesis of the natural product is desirable since it allows access to a 
more flexible range of analogues. A recent synthesis of salvinorin A and effort towards many other 
clerodane diterpenoid natural products have followed a linear methodology. A convergent approach for 
the synthesis of neo-clerodane natural products is not yet reported in literature and would be of value for 
the facile preparation of salvinorin A. 
 
An ambitious retrosynthetic study of salvinorin A indicated the C(3)-heterosubstituted furan as 
an appropriate starting material for a Diels-Alder approach towards the ketone ring of the natural 
product. An expedient and high yielding methodology for the preparation of 3-furylamines is described, 
allowing the flexible introduction of alkyl substituents in the C(5) position. A variety of non-chiral aza 
heterosubstituents were incorporated at C(3) of the furan ring including amine and amide functionalities, 
facilitating the examination of the chemical stability of these previously unreported compounds. 
Optically pure ephedrine isomers have been explored as chiral amine auxiliaries and have been 
successfully attached as 3-furylamine substituents using the general methodology described.  
 
The 3-furylamines are electron rich dienes that are highly reactive towards Diels-Alder 
cycloaddition reactions. By reacting a selection of non-chiral 3-furylamines with methyl acrylate, the 
Diels-Alder cycloaddition products were prepared in high yield and diastereomeric outcomes were 
partially controlled using amine substituents of increased size and changes in reaction media polarity. A 
study involving Diels-Alder reactions in a range of solvents identified water as a general and optimum 
reaction medium for [4+2] electron cycloadditon reactions involving 3-furylamines, due to kinetic 
enhancement experienced in heterogeneous conditions and the potential for hydrolysis of reactive 
enamine cycloadduct intermediates. Diastereoisomers of the 7-oxanorbornane species methyl 1-methyl-
5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate were prepared as new compounds from the hydrolysis 
of Diels-Alder cycloadducts and are functionalised bicyclic intermediates to access the ketone of the 
natural product. Diels-Alder reactions between the non-racemic (1S,2S)-pseudoephedrine-derived furan 
vi 
and methyl acrylate gave solely the endo diatereoisomeric adduct as a spiro-oxazolidine system that 
underwent hydrolysis at pH = 5.5 to give the desired ketone. Reduction of the Diels-Alder spiro adduct 
to the bicyclic amine allowed for purification of the major diastereoisomer by crystallization as the 
perchlorate salt and the single product was identified by X-ray crystallography as the (1S,2S,4S,5S)-
diastereoisomer. In Diels-Alder reactions involving the (2S)-ephedrine derived furans, face selectivity 
was established to favor the (1S,4S)-enantiomer as desired for the asymmetric natural product synthesis.  
 
A procedure for the ether cleavage of methyl 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-
carboxylate was required to access the convergent precursor methyl 5-acetoxy-2-methyl-4-oxocyclohex-
2-enecarboxylate. Base mediated ether ring opening was discovered to yield C-C cleavage products as a 
consequence of anionic rearrangement. Successful C-O cleavage was achieved using Lewis-acid 
catalysis with BBr3 followed by mixing with the hindered base 2,4,6-collidine to yield methyl 5-
hydroxy-2-methyl-4-oxocyclohex-2-enecarboxylate albeit only at high dilution. Acetylation proceeded in 
excellent yield in the same reaction vessel to give methyl 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-
carboxylate in excellent yield. Both cyclohexenone containing ether cleavage products required isolation 
by HPLC and found to be facile towards epimerization at C(5) under non-neutral conditions. The devised 
synthetic pathway is shown to successfully construct the ketone ring of salvinorin A and stereoselectivity 
for the (1S,4S)-enantiomer can be achieved using the ephedrine derived furans as desired for the 
asymmetric natural product synthesis. This molecule can be used directly as a precursor to salvinorin A 
by enolate trapping of the vinyl Gilman 1,4-addition product followed by reaction with a second 
molecule with the desired -lactone structure.  
 
The -lactone ring 6-(furan-3-yl)-5,6-dihydro-4-methyl-3-vinylpyran-2-one was derived from 
rudimentary precursors as a convergent reagent to introduce the lactone ring of salvinorin A, as 
hypothesized from retrosynthetic analysis. A short synthesis for the racemic compound is described 
starting from the aldol reaction between 3-furaldehyde and acetone to give the 3-furfurol, 4-(furan-3-yl)-
4-hydroxybutan-2-one in quantitative yield. The 3-furfurol was reacted to form the -bromovinyl ester, 
1-(furan-3-yl)-3-oxobutyl 2-bromobut-3-enoate using a deconjugation/esterification protocol with 2-
bromobut-3-enoyl chloride. Intramolecular ring closure to the -lactone was achieved using a 
Reformatsky reaction and dehydration under acidic conditions yielded the racemic convergent precursor 
6-(furan-3-yl)-5,6-dihydro-4-methyl-3-vinylpyran-2-one in high yield. A possible strategy for joining the 
ketone and lactone fragments for the total synthesis of salvinorin A is proposed.  
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also shown. 
18 
1.17 Left; Proposed binding mode with important amino acid residues and Right; a current 
pharmacophore model for salvinorin A (1) reported by Singh et al., constructed using ‘Catalyst 
4.8’ computational software. 
19 
1.18 The Chem3D MM2 energy minimized structure of salvinorin A (left), the ABC ring system 
with stereocentres indicated* (middle) and the numbering system for the salvinorin A carbon 
framework (right). 
23 
1.19 The antibacterial lupulin A and the immunomodulatory cis-clerodane casearinol A. The 
Chem3D MM2 energy minimized structure of polystachyne D is also shown. 
25 
1.20 An MM2 minimised Chem3D structure of the cis-ent-neoclerodane diterpene 6-
hydroxyarcangelisin. The trans-neoclerodane insect antifeedant Bacchotricuneatin A and 
hemostatic Lagochilin are also shown. 
26 
1.21 Chiral stationary phases cellulose triacetate and 	-cyclodextrin. 29 
1.22 The proline derived oxazaborolidine chiral hydride reagent, (-)-norpehedrine borane reducing 
complex (top), and Jacobsens manganese(II)salen catalyst for enantioselective epoxidation 
(bottom). 
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2.1 Energy level diagram demonstrating the molecular orbitals resulting from the combination of p-
atomic orbitals in ethylene and 1,3-butadiene. 
62 
2.2 Canonical forms of benzene and a Chemdraw representation of the - cloud in the benzene ring. 63 
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2.3 Canonical forms of furan and a Chemdraw representation of the - cloud in the furan ring. 63 
2.4 Left; GC-MS of the reaction mixture for the bromination of 2-furaldehyde at 50°C in the 
presence of AlCl3 to form 8 in 20% yield. Right; GC-MS of the crude Wolff-Kishner reduction 
product, indicating the successful formation of 10 in low yields. 
72 
2.5 GC-MS analysis for the bromination of 13 in CCl4. Tetrabrominated peaks at tR = 18 min have 
the characteristic isotope pattern for four bromine atoms. 
74 
2.6 GC-MS of the Pd(0)[P(t-Bu)2-o-biphenyl]2 coupling of 10 to morpholine to produce 5a in 30% 
yield relative to 10.
78 
2.7 200 MHz 1H and 50 MHz 13C NMR analysis of 18a and EIMS fragmentation. 87 
2.8 MM2 Energy minimized Chem3D models of E- and Z- geometric isomers of 19a. The 
proximity of the carbonyl in the E-isomer has an influence on the C(5) hydrogens in 1H NMR 
studies. 
89 
2.9 200 MHz 1H and 50 MHz 13C NMR analysis of 19a and EIMS fragmentation. 90 
2.10 200 MHz 1H NMR for the Z-isomer of 19l and the mixture of E- and Z- isomers of 19n. 93 
2.11 EIMS and 200MHz 1H/50 MHz 13C HETCOR analysis of 19a. 13C DEPT 135 data is on the 
right margin. CH and CH3 groups are positive, CH2 groups are negative. 
96 
2.12 200MHz 1H NMR spectra of 19i with peak assignments. 98 
2.13 Top; 200 MHz 1H NMR spectrum of 19i with TFA in CDCl3 to give the proposed compound 
19i-int. Middle; CDCl3 solution after extraction with D2O. Bottom; 1H NMR of the D2O extract 
and assignments for the proposed intermediates 19i-int2 and 19i-int3.
99 
2.14 Top; 200 MHz 1H NMR of the C(2’)-deuterated furan D(2’)-5i in CDCl3 obtained from 
basification of the D2O extract with NaOD and extraction into CDCl3. Bottom; 200 MHz 
spectra 1H spectrum of the non-deuterated furan 5i.
100 
2.15 Structures of (1S,2S)-(+)-pseudoephedrine 23 and (1R,2S)-(-)-ephedrine 24 differ in 
stereochemistry at the C(1) carbon. 
104 
2.16 Left; GC trace of product mixture 19p starting at 70ºC followed by 10ºC/min  temperature 
ramp. Right; GC trace of product mixture 19q starting at 70ºC followed by 8ºC/min  
temperature ramp. Bottom; The electron impact mass spectra for 19p and 19q contain the same 
major mass fragment ions and a spectrum of 19q is shown. 
105 
2.17 300 MHz 1H/75 MHz 13C HMQC NMR of 19p. 1H and 13C correlations are drawn for the major 
oxazolidine isomer. 
107 
2.18 300 MHz 1H and 75 MHz 13C NMR data for (1S,2S)-2-(N-methyl-N-(5-methylfuran-3-
yl)amino)-1-phenylpropan-1-ol 5p. Mass spectrum of 5p shows a molecular ion at 245 m/z.
109 
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3.1 Diene and dienophile undergo a [4+2] electron cycloaddition reaction, during which orbital 
symmetry is conserved with respect to the mirror plane m.
116 
3.2 Interaction diagram of ethylene and 1,3-butadiene to form cyclohexene using SHMO energy 
level approximations. 
120 
3.3 Differences in FMO energy levels between neutral and activated dienes and dienophiles are 
exemplified by SHMO energy diagrams of reactants incorporating an amine EDG (Rx = NH2)
and carboxyl EWG (Rx = COOH). Magnitudes of orbital coefficients are represented by the 
shaded and un-shaded circles. 
121 
3.4 Magnitudes of FMO coefficients indicate that the para product is favoured in the reaction 
between the C(2) aminobuta-1,3-diene and acrylic acid. The ortho product is favoured in the 
reaction between C(1) aminobuta-1,3-diene and acrylic acid. 
122 
3.5 Simple Huckel orbital diagram for furan, and model reagents 3-aminofuran and acrylic acid. 
The energy gap between FMOs involved in the concerted pericyclic D-A pathway is indicated. 
122 
3.6 Regioprediction by comparison of FMO orbital overlap using simple Hückel coefficients 
indicates the para isomer as the favoured product for the reaction between 3-aminofuran and 
methyl acrylate. 
123 
3.7 GC-MS spectra for the reaction of 5a with MAC at 40, 50 and 70ºC show increasing yields for 
4 (M+· 184 m/z) and the hydrolysed morpholine group was observed to react with the dienophile 
via 1,4-addition to give the amine by-product (M+· 173 m/z) observed as an earlier eluting 
component than 4 at tR = 12:06 min. A major by-product is formed at high temperatures with a 
fragment ion of 247 m/z. GC analysis conditions are listed in Section 6.10, Instrument 1. 
147 
3.8 500 MHz 1H and COSY NMR analysis of endo 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-
carboxylic acid methyl ester (4a). The 300 MHz 1H NMR for the overlapping H(3A)/H(3B) and 
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H(6A)/H(6B) signals is shown on the same scale.   
3.9 500 MHz HMQC spectrum of 4a, 125 MHz 13C and DEPT 135 NMR analysis is also shown 
with 1H and 13C assignments. 13C data for 4a is also included in Appendix 3.2. 
150 
3.10 GC-MS analysis of the crude D-A reaction of 5a with MAC in DCM at 25ºC indicates clean 
conversion to the cycloadduct 25 with significant in situ hydrolysis to 4 due to atmospheric 
moisture. Hydrolysis in 0.5 M HCl gave 4a and 4b in a 4:1 ratio. 
151 
3.11 1H 300 MHz/13C 75 MHz HMBC and 300 MHz COSY spectra of 4b with correlations. 152 
3.12 ORTEP drawing of exo-methyl 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate 4b.
Crystal Data. C9H12O4, MW = 184.19, T = 293(2) K,  = 0.71073 Å, triclinic, space group P-1, 
a = 7.2235(10), b = 8.1158(11), c = 8.3058(12) Å,  = 75.273(2)o, 	 = 74.540(3)o,
 = 86.114(2)o, V = 453.89(11) Å3, Z = 2, Dc = 1.348 Mg/m3, µ(Mo K) = 0.106 mm-1, F(000) 
= 196, crystal size 0.50 x 0.15 x 0.10 mm3, 2428 reflections measured, 1583 independent 
reflections (Rint = 0.0587); the final wR(F2) was 0.1414 (all data) and final R was 0.0529 for 
1311 unique data [I > 2(I)]. Goodness of fit on F2 = 1.029. Crystallographic data for the 
structure reported has been deposited with the Cambridge Crystallographic Data Centre as 
deposition No. 288600. 
153 
3.13 GC-MS analysis of the crude extract from the D-A reaction between 5a with MAC in water at 
45ºC indicated the clean formation of cycloadducts 25 and 4 and the enamine 25 was 
predominately hydrolysed to 4 after a 2 h reaction time. The MS of the starting furan 5a could 
be detected in the tailing edge of 4b, suggesting the D-A reaction is in equilibrium with 5a with 
strong preference for the cycloadduct. 
156 
3.14 Chem3D generated MM2 energy minimised structures and calculated HOMO energy levels are 
shown, indicating changes in configuration of the isopropyl substituent and an increase in 
HOMO energy levels. 
159 
3.15 Left; Chromatogram of a mixture of 4a and 4b on J&W Cyclosil-	 column showing the 
separation of (1R/1S)-4b only. Midddle; Chromatogram of 4b after crystallization from Et2O. 
Right; Chromatogram of Et2O crystallization mother liquor consisting of 4a:4b (11:1). 
161 
3.16 300 MHz 1H/75 MHz 13C HMQC NMR of 28-endo with structure assignments is shown and 
the quaternary C(2’)/(2) carbon is confirmed by DEPT 135 NMR. 
163 
3.17 300 MHz 1H/75 MHz 13C HMQC spectrum of a mixture of (1S,2S,4S,5S)-29 and 
(1R,2R,4R,5R)-29 and DEPT 135 data. 
165 
3.18 300 MHz 1H NMR and 75 MHz 13C NMR spectra of (1S,2S,4S,5S)-29.HClO4, obtained by 
crystallization from ACN using vapour diffusion with Et2O, indicates a single diasteroisomer. 
167 
3.19 ORTEP drawing of (1S,2S,4S,5S)-methyl 5-(N-((1S,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-
methylamino)-1-methyl-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate perchlorate salt 
(1S,2S,4S,5S)-29.HClO4. Crystal Data. C19H28ClNO8, MW = 433.87, T = 293(2) K,  =
1.54180 Å, orthorhombic, space group P-212121, a = 8.511(2), b = 15.356(5), c = 15.839(3) Å, 
 = 90.00o, 	 = 90.00o,  = 90.00o, V = 2070.1(9) Å3, Z = 4, Dc = 1.392 mg/m3, µ(Cu K) =
2.025 mm-1, F(000) = 920, crystal size 0.20 x 0.10 x 0.02, 2462 reflections measured, 2365 
independent reflections (Rint = 0.0230); the final wR(F2) was 0.1371 (all data) and final R was 
0.0496 for 2006 unique data [I > 2(I)]. Goodness of fit on F2 = 1.071. Crystallographic data 
for the structure reported has been deposited with the Cambridge Crystallographic Data Centre 
as deposition No. 288601. 
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3.20 Chiral GC analysis of optically enriched mixtures of 4 prepared using the chiral dienes 5p and 
5q in D-A reactions with MAC. Calculated enantioselectivities for 4a and 4b are listed in Table 
3.2 and represent the average reproducible values. Top left; The 7-oxanorbornane 4a is 
prepared in >99% diastereoselectivity using 5p in DCM, starting at –50ºC with warming to –
10ºC for 2 h and reaching 25ºC over an 8 h period. Bottom left; Reaction of 5q in DCM under 
the same conditions as for 5p produced a 1:3 ratio of 4a:4b. Top right; Reaction of 5p in H2O
produced a 9:1 ratio of 4a:4b after 1.5 h at temperatures between 10 to 20ºC under ultrasonic 
irradiation. Bottom right; Reaction of 5q in H2O produced ratio of 4a:4b varying between 1.3:1 
to 1:1 after 1.5 h at temperatures between 10 to 20ºC under ultrasonic irradiation. 
170 
3.21 Top; An enantioenriched mixture of the exo isomer was prepared on a 2 g (8.2 mmol) scale 
from the reaction between 5q and MAC in H2O to provide 4b in 48% ee as determined by 
chiral GC analysis. Middle and Bottom; Two recrystallization from Et2O at –18ºC provided the 
single (1S,2R,4S)-4b enantiomer in optical purity as indicated by chiral GC analyses. 
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3.22 The (+)-(1S,2R,4S)-4b enantiomer has the same absolute stereochemistry as observed in Ring A
of the natural product 1.
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4.1 The crude GC-MS analysis for the reaction of 4a with TBDMSOTf/TEA is shown with EI-MS 
spectra. Base peak ions for the 3’-siloxy-2’,5’-dimethylfuran fragment at 225 m/z indicate 
major product as 3-[(3-tert-butyl-dimethyl-silanyloxy)-5-methyl-furan-2-yl]-propionic acid 
methyl ester 31, corroborated by a 298 m/z molecular ion. 
185 
4.2 300 MHz 1H COSY NMR and 13C NMR spectrum of 31. 186 
4.3 1H 300 MHz/13C 75 MHz HMBC analysis of 32 with DEPT 135 and heteronuclear 13C-1H
coupled NMR data also shown. 
191 
4.4 GC-MS of the crude ether cleavage reaction of 4b with BF3.(Et2O) in the presence of Ac2O to 
give 68% conversion to the acylal derivative 33. The molecular ion M+· 286 m/z is not seen and 
the largest fragment ion 243 m/z and corresponds to the loss of an acetyl group (43 m/z). 
195 
4.5 Top; GC-MS analysis of the BBr3 ether cleavage of 4b conducted at 5ºC, followed by 
quenching and workup using the described procedures gave a mixture of products amongst 
which the peaks at tR = 13:06 min and tR = 13:08 min show a molecular ion corresponding to 
the ring opened brominated product 34. Bottom; GC-MS of the ether cleavage of 4b conducted 
at –1ºC shows a single major product at tR = 12:15 min in 61% with fragments 97, 55, 41 m/z 
characteristic of a cyclic ketone and a molecular ion at 184 m/z in agreement with the structure 
of 3.
203 
4.6 GC traces for the purification of crude BBr3/collidine ether cleavage mixtures. Left; Isolation 
by FCC on silica gel shows a mixture of the ether cleavage product 3 and the C(5) 
diastereoisomer C(5)-epi-3 as a result of on-column keto-enol tautomerisation of the carbonyl. 
Right; Purification of 3 by semi-preparative HPLC separation shows the isolated product in 
>99% purity without epimerization. 
205 
4.7 300 MHz 1H COSY NMR of 3 with structural correlations and coupling constants shown. 207 
4.8 300 MHz 1H/ 75 MHz 13C HMQC NMR of 3 with structural assignments and DEPT 135 NMR 
data. 
209 
4.9 Left; Energy minimized models of the pseudo-chair and pseudo-boat conformers for 3
calculated using Chem3D (MM2). Right; 500 MHz 1H-1H NOESY analysis of 3 with cross-
peaks shown. 
210 
4.10 500 MHz 1H-1H NOESY analysis of a 1:1 mixture of 3 and C(5)-epi-3 with 1H assignments for 
the C(5)-epi-3. The absence of NOE between epi-H(5)/epi-H(1) in C(5)-epi-3 unambiguously 
confirms the relative stereochemistry of H(1)/H(5) for 3.
212 
4.11 Energy minimized models of the pseudo-chair and pseudo-boat conformers for C(5)-epi-3
calculated using Chem3D (MM2) are shown and comparison of estimated heat of formation 
suggests C(5)-epi-3 to exist as the pseudo-boat conformer in support of NOESY NMR data. 
213 
4.12 GC-MS analysis of the BBr3 cleavage of 4a conducted under optimised conditions shows a 
55:45 mixture of 3:C(5)-epi-3 and the products were verified by comparison of GC retention 
times and MS fragmentation. 
214 
4.13 Top; Middle; GC-MS analysis of the crude acetylation mixture indicating the complete 
acetylation of the alcohol 3 in 35 min to produce a high yield of 2 with a small amount of by-
product. Bottom; EI-MS of the acetylated product shows an M+· ion at 226 m/z in agreement 
with 2.
217 
4.14 300 MHz 1H/75 MHz 13C HMQC and DEPT 135 NMR of 2 with structural assignments. 218 
4.15 GC-MS spectra for the partial acetylation of 3 prepared using 40 equivalents of AcCl to 
produce a mixture of 4b, 3, 2 and 34. The mixture shown was used to optimise the mobile 
phase for HPLC separation to avoid the co-elution of 34 with 2 or 3.
220 
4.16 Left; The HPLC UV-Vis trace (254 nm) for the separation of the ether cleavage mixture shown 
in Figure 4.15, using the optimized mobile phase 55:45 ACN:H2O. Baseline separation of 3 at 
tR = 5:04 and 2 at tR = 7.24 min from 34 at tR 6.24 min was achieved as shown. Right; UV-Vis 
spectra (200 to 325 nm) for 3 and 2 are similar since both contain the ,	-unsaturated enone 
chromaphore and a common max = 235 nm. The C(2)-bromo compound 34 shows a broad 
absorbance with max = 235 nm. 
221 
4.17 300 MHz COSY analysis of the isolated HPLC peak at 6:24 min (Figure 4.16) shows a 1.0:0.3 
mixture of cis-34 and trans-34 isomers and the structure of cis-34 was confirmed using 1H-1H
coupling constants. 
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4.18 The addition of HBr to 3 forms a mixture of cis- and tras-34. Energy minimized models of the 
chair conformations for both isomers calculated using Chem3D (MM2) are shown with 
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estimated heats of formation. 
4.19 Top left; The addition of 48% HBr (10 equiv.) to 3 followed by stirring at 22ºC for 10 min led 
to the formation of 34 in 51% yield in a 14:37 cis:trans ratio. Bottom left; An aromatised 
product was identified at tR = 12:44, showing a molecular ion M+· = 166 m/z corresponding to 
the substituted phenol and a 77 m/z fragment ion characteristic of a benzene ring. Top right; 
Isomers of 34 formed during the reaction of 4b with BBr3/collidine at 0ºC shows a 77:23 
cis:trans ratio with a predominance of cis-34 (tR = 13:08 min). Bottom right; Isomers of 34 
formed upon reaction of 4b with BBr3/collidine at 5ºC shows a 35:65 cis:trans ratio with a 
predominance of the trans-34 isomer (tR = 13:06 min). 
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4.20 GC trace of the product mixture obtained from the reaction of 2 with the divinyl homocuprate 
in THF at –50ºC showing a mixture of 2 and C(5)-epi-2.
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Chapter 5 
 
5.1 Top; The aldol condensation product at (M+· = 136 m/z, tR = 16:61 min) formed predominately 
upon the reaction of acetone with 2-furalehyde at 5 to 10ºC over 30 min, in the presence of a 
catalytic amount of NaOH. Bottom; Reaction from -10 to -5ºC over 30 min gave the desired 
alcohol 35 in 92% yield and the identity was confirmed by a 154 m/z molecular ion at tR =
16:75 min. 
246 
5.2 200 MHz 1H NMR analysis is shown for 36 with structural assignments and integral regions. 
The 50 MHz 13C NMR spectrum is also shown indicating the expected resonances for 36 in 
agreement with Chemdraw predictions. The assigned structure is also shown. 
248 
5.3 300 MHz 1H COSY NMR analysis of 8 with structural assignments. 252 
5.4 GC-MS analysis of the crude esterification of 8 using (Z)-2-bromobut-2-enoyl chloride and 
TEA in Et2O at -78ºC showing the formation of 7 as the major product at tR = 13:95 min. 
253 
5.5 300 MHz 1H/75 MHz 13C HMQC NMR analysis of 7 with structural assignments. The DEPT 
135 NMR spectrum of 7 is also shown. 
254 
5.6 300 MHz 1H COSY NMR of the conjugated ester 37. 256 
5.7 GC-MS analysis of the crude Reformatsky product mixture shows the formation of the target 
dihydro-pyranone 6 as the major product at tR = 14:17 min in 92% yield, as identified by a M+· 
ion at 204 m/z.
260 
5.8 300 MHz 1H/75 MHz 13C HMQC analysis of 6 with structural assignments shown. DEPT 135 
NMR data is also included. 
261 
5.9 GC-MS analysis for the Reformatsky reaction of 7 shows two diastereoisomers of the alcohol 
38.
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the preparation of 5 from 10.
71 
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phosphines BINAP and P-(tBu)2-o-biphenyl. 
76 
2.17 The palladium coupling cycle involves oxidative addition across the Pd(0)(BINAP) catalyst, 
followed by complexation of the amine and reductive elimination under basic conditions to 
produce the arylated amine Ar-NR1R2.
77 
2.18 Palladium coupling of 10 with morpholine under conditions described by Harris et al. provided 
4-(5-methylfuran-3-yl)morpholine (5a) in 30% yield. 
77 
2.19 Pathways towards carboxylate substituted 3-aminofurans. 79 
2.20 Novel pathways towards the 2,4-diphenyl substituted 3-aminofurans. 80 
2.21 The hydrolysis of dimethyl-(5-methyl-2,4-diphenyl-furan-3-yl)-amine was reported under 
aqueous acidic conditions to the produce corresponding 5-methyl-2,4-diphenyl-furan-3-one. 
Conversely, the 5-methyl-furan-3-one 16 may provide 5a by a condensation reaction with 
pyrrolidine. 
81 
2.22 Preparation of 4-methyl-3(2H)-furanone 16 from the Claisen reaction between acetone and 
chloroacetic acid ethyl ester, followed by base catalyzed cyclization. 
81 
2.23 The condensation of 16 and pyrrolidine failed to give the furan 5a or the 1,4-addition product 
and instead led to decomposition products. 
82 
2.24 Reaction of dodeca-5,7-diyne-4,9-diol with aqueous diethylamine at 100ºC provides moderate 
yields of dimethyl-(5-methyl-2-propyl-furan-3-yl)-amine via a retro-aldol pathway. 
83 
2.25 Top; Addition of amines to ethynyl ketones provides stable 	-enaminones. Upon purification by 
sublimation, the imine tautomer 4-phenylimino-butan-2-one was formed for the aniline addition 
product. Bottom; the Michael addition of piperidine to 7-hydroxy-dec-5-yn-4-one resulted in the 
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formation of the 1-(2,5-dipropyl-furan-3-yl)-piperidine via the enaminone intermediate. 
2.26 Studies by Heilbron on the preparation of 2,5-dimethyl-furan via an anionotropic rearrangement 
of 5-hydroxy-hex-3-en-2-one. 
84 
2.27 Retrosynthesis for the preparation of 3-aminofuran heterocycles 5 from the hydroxy protected 
alkynone 18 via the enaminone. 
85 
2.28 Acid catalyzed THP protection of prop-2-yn-1-ol in 3,4-dihydro-2H-pyran to produce 17. The 
sodium acetylide salt of 17 was acylated with Ac2O (R1 = Me) to provide 18a and propanoic 
anhydride (R1 = Et) to produce 18b.
86 
2.29 Formylation of the terminal acetylene of 17 using DMF with acidic quenching to provide 18c. 87 
2.30 Nucleophilic addition to 18 can result in E- or Z- isomers dependant on the acyl substituent R1. 88 
2.31 Possible mechanism for the Michael addition to the alkynone. The morpholine addition product 
of 18a (R1 = Me) can be expected to provided 19b as the E-isomer.  
89 
2.32 1,4 Addition to 18c to prepare 19l-n. 92 
2.33 Acid catalyzed THP deprotection to form the 	-acyl enaminium ion. 94 
2.34 Preparation of tertiary 3-aminofurans 5a-e, i-j, l-m  from the corresponding enaminones in 
Table 2.4. 
95 
2.35 Preparation of 3-furylamides 21. 97 
2.36 Proposed reaction pathway for the cyclization of the enaminone 19 to the furan 5. 101 
2.37 Synthesis of 2-((S)-1-methyl-1-methoxy-propyl)-1-(2-triisopropylsilanyloxy-furan-3-yl)-
pyrrolidine from the L-proline derivative (S)-2-(1-methyl-1-methoxy-propyl)-pyrrolidine. 
103 
2.38 Low yields of (+)-(S)-2-(hydroxymethyl)-pyrrolidine were obtained from the reduction of L-
proline. Preparation of 5o was achieved in low yields using the L-proline methyl ester 22.
103 
2.39 Addition products of 23 and 24 with 18a produce the enaminone intermediate that rapidly 
undergoes isomerization to the 5 membered oxazolidine structure. 
106 
2.40 Cyclization of the oxazolidines 19p-q using TFA, followed by THP deprotection in EtOH 
provided the ephedrine and pseudoephedrine substituted furans 5q and 5p in high yields. 
108 
 
Chapter 3 
 
3.1 The [4 + 2] electron cycloaddition is reversible and proceeds in a disrotatory manner with 
respect to substituents on the reactive carbons. Often the kinetically favoured endo diastereomer 
predominates due to secondary -orbital interactions in which case the exo form is 
thermodynamically more stable due to steric considerations. 
124 
3.2 2-Methyl furan undergoes facile cycloaddition in DCM at 13.5 kbar and mono activated 
dienophiles provide ortho- orientation of substituents in the cycloadduct. 
126 
3.3 Cr3+ exchanged clays prepared by Adams catalyze the room temperature D-A reaction of furan 
and pyrrole with MAC in low yield. 
127 
3.4 Second order rate constants reported by Breslow et al. indicates an increase in reaction kinetics 
in aqueous media and in the presence of antichaotropic salt (LiCl). Increases in selectivity for 
the endo product are reported upon increase in solvent polarity. 
128 
3.5 D-A methodology towards quassinoid natural products by Greco et al. involves the preparation 
of a functionalized tricyclic skeleton as a mixture of C(14) diastereoisomers. Changes in 
proportions of  and 	 isomers where observed upon changes in solvent polarity. 
129 
3.6 Vogel et al. have used the (-)-camphoryl auxiliary in the optical pure dienophile (-)-1-
cyanovinyl camphanate to provide the optically pure (1R,4R)-7-oxabicyclo[2.2.1]hept-5-en-2-
one via the separation and hydrolysis of the cyanohydrin intermediate. 
130 
3.7 D-A reaction of the complex prepared from acrylyloxazolidinone and a chiral sulfonamide 
catalyst with 5-benzyloxymethyl-1,3-cyclopentadiene has been reported by Corey to proceed in 
excellent yield and selectivity at low temperatures. 
131 
3.8 Top; D-A reactions with (+)-(2S)-2-(methoxymethyl)pyrollidine substituted (E)-dienes have 
been reported by Barluenga et al. to give endo cycloadducts in high enantioselectivity and 
hydrolysis in mildly acidic (pH = 4.6) buffer provided the functionalized cyclohexanone. 
Bottom; Reaction of (Z)-dienes are reported to give the Michael addition product and hydrolysis 
in acid gave the chiral C(2) substituted furan. 
132 
3.9 Kozmin et al. have incorporated the (2R,5R)-2,5-diphenylpyrrolidine auxiliary into 1-amino-3-
siloxy-1,3-butadiene to achieve good enantioselectivity in D-A reactions with methacrolein. 
This provides a direct pathway to the functionalized cyclohexenone in high yield which was 
transformed in four steps to (-)--elemene. 
133 
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3.10 The 7-oxanorbornanes prepared via the D-A reaction of furan and 2-methyl furan with maleic 
anhydride, undergo facile bromination across the olefin and dehydrohalogenation followed by 
retro-D-A reaction to the furan has been reported upon heating in quinoline. 
135 
3.11 Top; 2-p-Tolyloxy-furan has been prepared by Cella by decarboxylation of the furan carboxylic 
acid and reported to undergo D-A reaction with maleic anhydride followed by hydrolysis of the 
ketal ether bridge and aromatization. Bottom; D-A reaction between MAC and 5-aminofuran-2-
carboxylic acid methyl ester followed by aromatization using BF3.Et2O has been reported to 
give the substituted amine and phenol products in high yields. 
136 
3.12 Intramolecular D-A reaction of 2-furylamides has been reported by Padwa et al. to proceed in 
good yield to produce the functionalized hexahydroindolinone skeleton for use in natural 
product synthesis. 
136 
3.13 Koreeda et al. have investigated the reactivity of the diactivated 3,4-dimethoxyfuran (R = Me) 
and 3,4-bis-benzyloxyfuran (R = Bn) at atmospheric pressure. Top; When R = Me, reaction with 
an excess of cyclohex-2-enone in benzene with ZnI2 catalysis was reported to give the di-1,4-
addition product in moderate yield. Bottom; When R = Bn, neat reaction with ZnI2 catalysis was 
reported to proceed in qualitative yield in 15.3:1 selectivity for the endo product and the product 
was transformed to the racemic oxygenated core of (+)-methyl triacetylshikimate. 
138 
3.14 High face selectivity has been reported by Takahashi et al. in the D-A reaction between the 
chiral dienophile (S)s-3-(2-pyridylsulfinyl)acrylate and 3,4-bis–benzyloxy-furan. Reduction of 
the optically enriched cycloadducts to the saturated bicyclic alcohol provided the key precursor 
for the steroselective synthesis of (-)-methyl triacetylshikimate in 5 steps using known reactions. 
138 
3.15 Studies by Bridson on the D-A reactivity of N-3’-furylbenzamide with maleic acid in Et2O and 
dimethyl maleate in iPrOH revealed good yields of D-A cycloadduct and hydrolysis of the 
enamide was reported to be successful by stirring in water. 
139 
3.16 Top; Bridson reports that D-A reaction of N-3’furylbenzamide with dimethyl maleate in MeOH 
proceeds in low yield followed by the addition of water to give the endo hydrogen bond 
stabilized hydroxylamine cycloadduct. Bottom; D-A of a 2:1 mixture of N-3’-furylbenzamide 
with MAC in toluene was reported to produce the C(5) furan adduct of the D-A product in a 
non-reversible reaction. 
140 
3.17 Campbell et al. have reported the D-A reaction of 3-(tbutoxycarbonylamino)furan with DMAD 
to proceed in 24% yield, however reaction with methyl 3-nitroacrylate predominately formed 
the Michael-type addition product in 9.6% yield, as well as the D-A cycloadduct in small 
amounts (3%). 
141 
3.18 Yamamoto et al. have reported on the D-A reactivity of 3-methylthiofuran with a range of mono 
and di-activated dienophiles and good yields of cycloadduct were prepared upon prolonged 
stirring at ambient temperature. 
141 
3.19 Yamamoto et al. have reported the enantioselective D-A reaction of 3-methyl thiofuran using a 
tartaric acid derived titanium catalyst to provide the endo isomer as the major product in 87% 
ee.
142 
3.20 Top; Schlessinger et al. have reported the D-A reaction between 2-((S)-1-ethyl-1-methoxy-
propyl)-1-(2-triisopropylsilanyloxy-furan-3-yl)-pyrrolidine and MAC to yield the endo product 
as the major isomer in >99% ee. Bottom; D-A reaction of MAC with 1-(4-bromo-2-methyl-5-
triisopropylsilanyloxy-furan-3-yl)-2-((S)-1-methyl-1-methoxy-ethyl)-pyrrolidine has been 
reported to produce the endo cycloadduct in 99% ee in DCM at 22ºC. 
143 
3.21 Schlessinger et al. have used the D-A reaction of the proline derived 3-furylamine with dimethyl 
2,3-pentadiendioate allene to produce the endo cycloadduct in >99%ee. Hydrolysis in aqueous 
acidic ACN gave clean hydrolysis to the ketone that was reduced using NaBH4, followed by 
isomerization using DMAP and ozolonysis. Stereoselective transformation to (+)-Cyclophellitol 
was achieved in a further six steps. 
144 
3.22 D-A reaction of non-chiral 3-aza-5-methylfurans with MAC should produce a racemic mixture 
of endo and exo enamines 25 which can undergo hydrolysis in aqueous acidic conditions to form 
endo (4a) and exo (4b) diastereoisomers of 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-
carboxylic acid methyl ester. The (1S,2R,4S)-4b and (1R,2R,4R)-4a antipodes can be used in the 
synthesis of the natural product 1.
145 
3.23 D-A reaction of 5a with MAC in n-hexane produced increasing yield of 4 at higher 
temperatures. The facile 1,4-addition reaction of morpholine to MAC occurred at 70ºC, 
indicated by a parent ion at 173 m/z in GC-MS analysis. 
146 
3.24 Reaction of 5a with MAC in toluene at 111ºC gave 26 via formation of the D-A cycloadduct 25 154 
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followed by addition to the C(5) enamine olefin with a second equivalent of 5a which reacts at 
the C(2’) furan carbon. 
3.25 D-A reaction of 5a with MAC in water (25ºC) gave rapid conversion to 25 and the hydrolysis of 
25-exo to 4b appeared to be more facile than the hydrolysis of 25-endo to 4a (Appendix 3.7). 
Aqueous reaction at 45ºC gave a predominately hydrolyzed 2:1 mixture of 4a and 4b whereas 
reaction at 25ºC gave a 4:1 mixture. 
155 
3.26 The D-A reaction of 5b with MAC in H2O or 3.0 M LiCl produced the cycloadduct 27 in 
quantitative yield followed by hydrolysis upon continued stirring to produce the ketone in a 1:2 
ratio of 4a:4b.
159 
3.27 D-A reaction of 5p with MAC in cold DCM with warming to ambient temperature gave the 
enamine cycloadduct 28-int as a single isomer in >95% which spontaneously underwent 
intramolecular cyclization to the spiro oxazolidine heterocycle 28-endo. Partial hydrolysis in 0.5 
M HCl indicated the endo 7-oxanorbornane 4a as a single diastereoisomer in an enriched 
mixture of enantiomers. 
162 
3.28 The oxazolidine 28-endo was equilibrated with the enamine 28-int in glacial acetic acid 
followed by reduction to the tertiary amine using NaBH(OAc)3 to produce a 10:1 mixture of 
diastereoisomers of 29.
164 
3.29 Precipitation of 29 as the hydrochloride salt followed by counter-ion exchange using AgClO4 in 
MeCN allowed the purification of (1S,2S,4S,5S)-29.HClO4 by crystallization using vapour 
diffusion with Et2O. 
166 
3.30 D-A reaction of 5q with MAC in cold DCM with warming to ambient temperature gave the 
enamine cycloadduct 30-int which underwent intramolecular cyclization to the spiro oxazolidine 
heterocycle 30. Hydrolysis in NaOAc/CH3COOH solution produced an optically enriched 3:1 
mixture of 4a and 4b.
169 
 
Chapter 4 
 
4.1 Ether ring openings of 7-oxabicyclo[2.2.1]hept-2-enes. Top; Lautens et al. have reported the 
Ni(COD)2/(R)-BINAP catalyzed stereoselective hydrogenation of 5,6-bis(methoxymethyl)-7-
oxa-bicyclo[2.2.1]hept-2-ene using DIBAL-H. Middle; Forsey et al. have used Raney nickel 
hydrogenolysis for the cleavage of aryl substituted cyclic ether rings in the preparation of 
Podophyllum lignans. Bottom; Ring cleavage with organolithium nucleophiles has also been 
used by Lautens et al. to prepare the functionalized cyclohexenol in excellent yield. 
182 
4.2 Top; Ogawa et al. have reported the acid mediated hydrolysis of the 7-oxanorbornane ring using 
AcOH/Ac2O/H2SO4 to produce the 1,4-diacetoxy isomers in a 1:1 mixture. Bottom; Luo et al. 
report the acid mediated dehydration of aryl bicyclic ethers using HCl/Ac2O to yield the 
aromatised product, as shown in the preparation of 5,12-dihydronapthacene. 
183 
4.3 Ether cleavage pathways for the transformation of 4a and 4b to 2 183 
4.4 Top; The facile base mediated rearrangement of the 7-oxa-bicyclo[2.2.1]heptan-2-one ring using 
TBDMSOTf/TEA has been used by Vogel et al. to prepare the natural product (+)-Corduritol F 
in moderate yield. Bottom; Arjorna et al. have prepared the glycoside containing cyclohex-5-
ene-1,2,3,4-tetrol using similar conditions, allowing access to the glycosyl-myo-inositol 
analogues in a further three steps. 
184 
4.5 The TfOH catalysed C-O opening reported by Pasquarello et al. who theorise the reaction to 
proceed via the vinylic carbocation intermediate followed by Ritter reaction with MeCN. 
Bottom; Vogel et al. report the cleavage of substituted epoxy-7-oxa-norbonyl derivatives with 
HSO3F/ Ac2O to produce the furan product (41%) as a result of C(1)-C(2) cleavage, as well as 
the Wagner-Meerwein rearrangement product (24%). 
187 
4.6 Proposed mechanisms for the reaction between 4a and TBDMSOTf in the presence of TEA to 
give the furan 31. Top; The acid catalyzed pathway can proceed via silylation of the enolate 
followed by protonation of the ether oxygen. Bottom; The base catalyzed pathway can proceed 
from the enolate ion via a retro 1,4-conjugate addition followed by ester enolate trapping with 
TBDMSOTf. 
188 
4.7 Top; Base mediated bicyclic ether cleavage has been reported by Morris et al. to proceed in 
good yields using K2CO3 to give the ,	-unsaturated ketone. Bottom; Takahashi et al. have 
utilized LiN(TMS)2 at low temperatures to facilitate the base mediated ether cleavage of the 
oxygenated bicyclic ether to produce the ,	-unsaturated ester. 
189 
4.8 Treatment of 4a with LHMDS or K2CO3 did not give the expected -ketol product and instead 
underwent C(1)-C(2) cleavage to produce methyl 3-(2,3-dihydro-5-methyl-3-oxofuran-2-
190 
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yl)propanoate 32. The structure of 32 was also confirmed by desilylation of 31 with TBAF. 
4.9 Rainer et al. describe the C-C cleavage in some bicyclic structures using NaH and suggest a 
four-membered hemiacetal intermediate formed from the 1,3-keto-alcohol system. The 7-
oxanorbornanone (top) and norbornanone (bottom) skeletons behaved similarly to produce the 
five membered cyclic olefins. 
192 
4.10 Research conducted by Vidari et al. involves the Lewis-acid mediated rearrangement of geraniol 
epoxide. Top; FeCl3.6H2O was reported to produce the cyclohexenol via the 7-oxanorbornane 
intermediate. Bottom; ZrCl4 was reported to give improved results for both the 7-oxanorbornane 
and geraniol epoxide rearrangements. 
193 
4.11 Top; Research conducted by Mehta et al. involves 7-oxanorbornane cleavage using 
BF3.(Et2O)/TBAI to produce the iodinated product with inversion of stereochemistry, followed 
by conversion to the neo-inositol derivative in two steps. Bottom; Research conducted by 
Gschwend et al. involved 7-oxanorbornane ether cleavage using BF3.(Et2O)/Ac2O to produce 
the acetoxy substituted product as a 1:1 mixture of olefin isomers. 
194 
4.12 Reaction of 4b with BF3.(Et2O) produced the C(5) acylal derivative methyl 5,5-diacetoxy-1-
methyl-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate 33 in moderate yield (68%). The desired 
methyl 5-acetoxy-2-methyl-4-oxocyclohex-2-enecarboxylate 2 was not seen. 
196 
4.13 Koreeda et al. have conducted studies on the stereo- and regioselective ether opening of 1,2,3,4-
tetrahydro-1	,4	-epoxy-2,3-carbonyldioxyl arenes using BBr3. The authors have rationalized 
the reaction to proceed via a stabilized carbocation intermediate based on AM1 calculations in 
support of experimental findings. 
197 
4.14 Mosimann et al. have described the stereo- and chemo-selective cleavage of the 7-
oxanorbornane ether ring. Top; Reaction with HBr was reported to undergo an SN-2 type 
inversion with the bromide ion. Cleavage with BBr3 provided retention of stereochemistry at 
C(4) but inversion at C(1) via an intermediate involving the adjacent C(2) acetoxy group. 
Bottom; The chemoselective BBr3 cleavage of carbocycles containing two 7-oxanorbornane 
functionalities using controlled temperatures to produce the anisoate (An) substituted 
tetradecahydrophenanthrene structures. 
198 
4.15 Jotterand et al. report the BBr3-mediated cleavage of the pentapivaloate derived 7-
oxanorbornanes to yield the 1,4-dihydroxy hydrolysis products with retention of 
stereochemistry. The authors propose that the reaction intermediates the pivaloate group and 
equilibration followed by quenching in NaHCO3 leads to cis-oriented hydroxyl groups in the 
cleavage product. 
199 
4.16 Research presented by Pasquarello et al. involves BBr3-mediated ether cleavage of the 7-
oxanorbornenes and the authors suggest a vinylic carbocation intermediate followed by reaction 
with the bromide ion at C(5) on the same face as the bromoborane ether, followed by quenching 
in saturated NaHCO3 to give the C(2) alcohol in good yield (72%) with retention of 
stereochemistry. 
200 
4.17 Research presented by Barrero et al. describes the ether cleavage of 7-oxanorbornanes using 
BBr3 followed by quenching in 1 M collidine. Top; 4-(2',5'-Epoxy-2',6',6'-trimethyl)cyclohexyl-
2-butylacetate underwent rearrangement to give a mixture of olefin isomers with retention of 
stereochemistry at the C(1) hydroxyl group. Bottom; Treatment of 4-(2',5'-Epoxy-2',6',6'-
trimethyl)cyclohexyl-2-butylacetate with BBr3/collidine was reported to give chemoselective 
cleavage to 3-(3'-acetoxybutyl)-2,2,4-trimethylcyclohex-3-enol in 89% yield. 
201 
4.18 Reaction of 4b with BBr3 followed by quenching in aqueous NaHCO3 returned the starting ether 
with no detectable formation of 3. Reactions involving quenching in 1 M collidine/DCM gave 
the desired ,	-unsaturated ketone (1S,5R)/(1R,5S)-methyl 5-hydroxy-2-methyl-4-oxocyclohex-
2-enecarboxylate 3 and small quantities of the C(2) bromo isomers (1S,2RS,5S)/(1R,2RS,5R)-
methyl 2-bromo-5-hydroxy-2-methyl-4-oxocyclohexanecarboxylate 34.
202 
4.19 The purification of 3 by FCC methods led to C(5) racemization likely via the conjugated enol 
tautmer to provide a mixture of 3 and C(5)-epi-3.
204 
4.20 Tanyeli et al. have reported the preparation of racemic (R,S)-2-oxocyclohex-3-enyl acetate via 
the Mn(OAc)3 oxidation of cyclohex-2-enone. Chemo-enzymatic resolution of (S)-2-
oxocyclohex-3-enyl acetate was achieved using Pig Liver Esterase and the ’-acetoxylated 
compound was purified by FCC, also providing the racemic alcohol (R,S)-6-hydroxycyclohex-2-
enone. 
206 
4.21 The ether cleavage of 4a using BBr3 formed a mixture of 3 and C(5)-epi-3 in 55:45 ratio, 
indicating racemization during the ring opening process to yield a small excess of 3 as the C(5) 
214 
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stereochemically inverted product. 
4.22 The proposed mechanism for the BBr3/collidine ether cleavage of 4a and 4b is based on ratios of 
3:C(5)-epi-3 obtained from reaction at –1ºC, and involves co-ordination of BBr3 with the ether 
oxygen as described by Gopalaswamy et al. followed by abstraction of H(6) during quenching 
in collidine. The observed C(5) epimerization during the cleavage of 4a can be rationalized as 
the result of enolization and intramolecular interaction with the ester carbonyl leading to 
equilibration to give 3 in a small excess upon work-up. The 2,5-diol was not formed upon 
quenching in aqueous media, indicating that a carbocation intermediate is unlikely. 
215 
4.23 Acetoxylation of the C(5) hydroxyl group was most conveniently achieved by the addition of 
AcCl to 3 in the 1 M collidine/DCM quenching mixture and led to the complete consumption of 
3 in 35 min as indicated by GC-MS monitoring. The separation of 2 was achieved by semi-
preperative HPLC to give 2 in 40% isolated yield. 
217 
4.24 The BBr3 ether cleavage of 4b at 5ºC was found to give a 15% yield of the brominated isomers 
34 in a 35:65 cis:trans ratio. A proposed mechanism to account for the predominace of trans-34 
involves the formation of a carbocation intermediate at C(1) followed by reaction of the bromide 
ion at the same face as the boron ether intermediate. At the same time a mixture of cis- and 
trans-34 can form due to the in situ reaction of 3 with HBr. 
225 
4.25 Top; Koreeda et al. have discussed the BCl3 mediated cleavage of the 7-oxanorbornante moiety 
in high yield and mild under conditions (-20ºC) to produce the cis-chloro alcohol in a 3.5:1 ratio 
with the 1-epimer. Bottom; Further work towards the ether cleavage of 4 may involve reaction 
with BCl3 to produce either the chloro-alcohol or ,	-unsaturated alcohol 3.
226 
4.26 The final transformation in the synthesis of Ring A involves the Michael-type addition reaction 
of a vinyl copper reagent to the 	-olefinic carbon of (1R,5S)-2. The S- configuration can be 
expected at C(2) as a result of 1,4-addition to the least Si hindered face. 
227 
4.27 Left; The reaction of one equivalent of MeLi or MeMgCl with cuprous iodide (CuI) in Et2O was 
reported by Gilman et al. to give the mono-organocopper compound as a yellow precipitate. 
Reaction with a second equivalent of MeLi gives the homocuprate, which is soluble in Et2O and 
gives a clear solution. Right; The mechanism for the 1,4-cuprate addition to enones has been 
reviewed by Woodward and is shown using acrolein as an example. Complexation of the -
system followed by alkylation to produce the enolate, and can be ‘trapped’ at this stage by 
reaction with TMSCl, accompanied by enhanced reaction rate and yields. 
228 
4.28 Top; Formation of the divinyl homocuprate was achieved by the reaction of vinyl magnesium 
bromide with Cu(I)I in THF at –30ºC. Bottom; Reaction of 2 with the divinyl homocuprate was 
conducted at –50ºC but alkylation at C(2) did not occur. The product mixture returned a mixture 
of 2 and C(5)-epi-2 due resulting from C(5) racemization. 
229 
4.29 Improvements in the 1,4-addition of vinyl Gilman organocuprates to 3,5,5-trimethylcyclohex-2-
enone have been reported by Lipshutz et al. using BF3.Et2O catalysis. 
231 
4.30 Top; Corey et al. have published the 1,4-addition of lithium divinylcuprate to a -ether 
substituted cyclohexenone and report enhanced rate and selectivity in the presence of TMSCl. 
The authors propose silylation to occur in the transition state. Bottom; Smith et al. describe yield 
and selectivity improvements in the conjugate addition of Gilman reagents to a’-acetoxy 
substituted cyclopentenones upon the addition of TMSCl. 
231 
4.31 The chiral furylamine 5q prepared from the commercially available 24 has been shown to 
undergo D-A reaction with MAC in H2O to give the exo- cycloadduct (1S,2R,4S)-4b in 60% ee 
as a 1:1 mixture with the endo isomer. Ether cleavage using BBr3 at -1ºC followed by quenching 
in collidine provides (1R,2S)-3 with retention of stereochemistry and in situ acetyl with AcCl 
provides (1R,2S)-2 in 40% overall from (1S,2R,4S)-4b. Ring A can be accessed in a 
stereoselective manner by reaction of (1R,2S)-2 with vinyl Gilman reagent. 
233 
 
Chapter 5 
 
5.1 Top; Disconnection of ring B gave the ,	-unsaturated lactone (S)-6 as a convergent precursor 
for the synthesis of 1. Bottom; Cleavage of the C(3)/C(4) olefin shows (S)-7 with X = H or Br as 
a possible synthons for a retro-aldol type condensation and cleavage of the ester indicates the 
furyl alcohol (S)-8 and a vinylacetic acid derivative as potential starting materials for the 
preparation of 7.
239 
5.2 Top; Hagiwara et al. incorporate the 3-furyl group on the bicyclic aldehyde at C(12) using 3-
furyl lithium followed by deoxygenation in two steps. Oxidation of furan to the -hydroxyfuran-
241 
List of Schemes 
xxv 
2(5H)-one was achieved using photochemical methods to give the clerodane 16-hydroxycleroda-
3,13(14)Z-dien-15,16-olide. Bottom; De Rosa et al. have prepared 6-(furan-3-yl)-5,6-dihydro-
pyran-2-ones as a means of accessing the bioactive pyranofuranone unit of manoalide. 
5.3 Preparation of the CD ring system of mexicanolide was achieved by Liu et al. using HIO4 diol 
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Introduction 
1.1 Salvia divinorum, a Brief Background of the Unique Mexican Sage 
 
Salvia divinorum is a perennial herb which grows best in humid, shaded areas, and struggles to 
survive in intense direct sunlight or heavy frost. Although wild and cultivated populations have been 
found in elevated areas (300 – 1800 m) in the highlands of northern Mexico, it is not known whether the 
species is native to the area or was introduced. S. divinorum thrives in tropical evergreen forests and 
ravines and reproduces vegetatively, with roots striking from the fresh or dried nodes [1]. Distinct 
physical features of the plant include a hollow quadrangular stem, with serrated elliptic leaves as long as 
30 cm on a mature plant, growing in an opposite arrangement on the stem. A slight ‘musty’ odour can be 
noticed from the large green leaves, which vary in shape and shade in different climates. Rarely does the 
plant set seed or flower, and those grown from seeds are reported to sometimes lack vigour [2]. The mint 
grows to over 1 m in height and blossoms with white flowers and purple calyces [3]. Reports on 
cultivated populations of the ‘sacred’ plant, carefully hidden by the Mazatec Indians of Oaxca, suggest 
that many populations of the plant are clonal, hence inbreeding depression may account for the low 
number of successfully developed seedlings in cross-pollination studies [3]. 
 
Figure 1.1: Salvia divinorum growing in Melbourne (Photo; J. Lingham 2001) 
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Historically, S. divinorum (known as hojas de la Pastora – ‘Leaves of the Shepherdess’ and 
variations thereof) has been used in traditional societies of the Mazatec Indians for healing and 
divinatory rituals [4], and as the weakest of three hallucinogens used in shamanic training. The leaves are 
prepared for ingestion as an infusion or alternately chewed as a ‘quid’ and held under the tongue, 
although the fresh leaf material is extremely bitter in taste. Dried leaf material is popular amongst 
younger indigenous people and in this case is more commonly smoked. Common dosage is in the range 
of 20 to 100 leaves, sometimes mentioned as 10 to 50 ‘pairs’ of leaves, and is dependant on the method 
of ingestion [5]. A detailed description of the bioactive effects and botanical history of S. divinorum is 
found in research by Siebert et al. [6] and identification of the active components relative to the periodic 
discovery of other naturally occurring hallucinogens from Mexican plant of traditional and sacramental 
use is summarised. 
 
The first of the psychoactive Mexican plants to be studied in detail was the péyotl cactus 
Lophophora williamsii from which Heffter (1897) isolated the hallucinogenic phenethylamine mescaline 
(Figure 1.2), a comprehensive list of bioactive cactus alkaloids is found in more recent literature by 
Shulgin et al. [7]. The indole ethylamine, N,N-dimethyltryptamine (DMT) has been found as an active 
component in Psychotria viridis or ‘Chacruna’ used in an admixure of plants to prepare ‘ayahuasca’, a 
south American drink used in the Amazon Basin. -Carboline alkaloids present in Banisteropsis caapi 
act to inhibit DMT metabolism via monoamine oxidase in the gut and liver, allowing the DMT to be 
orally active [8]. DMT had been synthesised in 1931 by Richard Manske before being uncovered as a 
bioactive natural product and has since been identified in many plant species including Phalaris grasses 
such as Phalaris tuberosa, and various acacias [9]. S. divinorum was first referenced in botanical 
literature by Jean B. Johnson in 1939 along with other Mexican plants of traditional Aztec use [10] 
during an expedition to establish the existence of traditional ceremonies involving ‘sacred’ mushrooms. 
An ethnobotanist, R. Gordon Wasson obtained samples of mushrooms, referred to as ‘Teonanácatl’ in 
the language native to the Mazatecs (Nahuatl), for identification and analysis [5, 6]. The hallucinogenic 
mushroom was identified as a new species Psilocybe mexicana (Strophariaceae family) by mycologist 
Roger Heim [11]. The psilocybian mushrooms are the more potent of ceremonial inebriants and 
investigations into the mushrooms psychoactive components by Albert Hofmann in 1958, revealed the 
indole ethylamines psilocibin and psilocin (Figure 1.2)[12]. It has since been suggested that psilocibin 
metabolises in the gut to psilocin, so the latter may actually be the active drug [13]. In 1959 Wasson and 
Hofmann had collaborative success in the isolation of psychoactive lysergic acid amides from 
‘Ololiuhqui’, seeds of the morning glory Turbina corymbosa, many of which had already been 
synthesised by Hofmann from naturally occurring rye ergot alkaloids leading to the discovery of the 
prototype hallucinogen LSD-25 (Figure 1.2) in 1943 [14]. The samples of S. divinorum obtained by 
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Wasson and Hofmann were later identified by Epling & Játiva (1962) [15] as a new species of salvia 
from the Labiatae family (now the Lamiaceae family). Leaf extract of S. divinorum was retrieved and 
preserved in alcohol, upon storage the extract decreased in potency and it was concluded that the 
psychoactive component was unstable. The role of S. divinorum in ritualistic use as compared to the 
other inebriants mentioned is discussed by Valdés et al. [16] in an account of the plants effects and 
significance to indigenous culture. 
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Figure 1.2: Hallucinogenic natural products: Salvinorin A (1), Mescaline, N,N-Dimethyltryptamine (DMT), 
Psilocybin, Psilocin, Lysergic acid and the semi-synthetic prototypical hallucinogen LSD-25. 
 
It was not until 1982 that a research group led by Alfredo Ortega reported the isolation of a 
secondary metabolite from S. divinorum, present in high concentration in the leaf, and elucidated its 
structure as (2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(3-furanyl)-dodecahydro-6a,10b-dimethyl-
4,10-dioxo-2H-naptho[2,1-c]pyran-7-carboxylic acid methyl ester using 1H and 13C nuclear magnetic 
resonance (NMR) studies as well as single crystal X-ray crystallography [17]. The newly discovered 
trans-neoclerodane diterpene was called salvinorin (Figure 1.2). Valdés et al. [18] independently isolated 
the same compound in 1984 along with its deacetyl derivative and allocated the names divinorin A and 
divinorin B, respectively. Although both names are used interchangeably in the literature, salvinorin 
remains the more common name to describe the compound and its analogues. Through in vivo studies in 
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mice, Valdés and co-workers confirmed that salvinorin A (1) was indeed a main psychoactive component 
of the leaves with high potency, and concentrations of 1 have since been reported to range between 0.89-
3.70 mg/g (dry weight leaf) [19]. The absolute stereochemistry of 1 was first postulated using circular 
dichroism (CD) spectroscopy and based on the observed negative n J * Cotton effect of the ketone 
around 295 nm by comparison to the effect of isofructtcolone [17], then was later verified by Koreeda et 
al. [20] using the non-empirical exciton chirality CD method. Dedicated study to describe unambiguous 
NMR spectral assignments of 1 was published by Giner et al. [21] at the time of this thesis. Salvinorin A 
presents itself as an attractive synthetic target for natural product synthesis as it is the first reported non-
nitrogenous hallucinogen and is also dissimilar in structure to the psychoactive alkaloids shown in Figure 
1.2. 
 
The location of 1 and related diterpenes in S. divinorum has been reported by Siebert [22] in 
resinous secretion accumulating in the subcuticular space of peltate glandular trichomes, which are 
present in highest levels in the leaves but also present most other parts of the plant in lower 
concentration. Elucidation of the pathway for the biosynthesis of 1 in S. divinorum has been studied by 
Kutrzeba et al. [23] and is discussed in Section 1.4.3. The search for other biologically active compounds 
from S. divinorum has produced improvements in the isolation of secondary metabolites from the leaves, 
leading Munro et al. [24] to report the isolation of commonly encountered plant metabolites such as 
presqualene alcohol, (E)-phytol and peplusol [24]. The structurally related metabolites salvinorin C [25], 
D-F [24], G [26] and divinatorins A-C [27], D-E [26] have been isolated in low concentrations (Figure 
1.3) along with the tetrahydrofuran analogues salvinicin A and B [28]. Recent studies by Shirota et al. 
[29] have identified salvinorins H-I, divinorin F as well as a range of metabolites Salvidivin A-D 
featuring an oxidised furan moiety (Figure 1.3). Known terpenoids hardwickiic acid [27] and loliolide 
[30] have also been isolated.  So far no other isolated metabolites have shown the same potency as 1.
When thus research was commenced no synthetic studies addressing the stereoselective synthesis 
of salvinorin A had been reported in the literature. During revisions of this thesis, Scheerer et al. [31] 
published the first asymmetric synthesis of the target compound 1 and their approach is discussed in 
Section 1.6.4. 
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Figure 1.3: Compounds isolated and characterised from Salvia divinorum [22-28]. 
 
The aim of this thesis is to design a novel stereoselective approach to 1 and its analogues for 
further research into these newly recognised bioactive diterpenoids. In the remainder of this introduction, 
the implication of chirality in biological systems and organic synthesis of the trans-neoclerodane 1 are 
discussed. The importance of bioactive natural products to ongoing pharmacological research is 
mentioned followed by a short review of clerodanes isolated from bioactive plants that feature similar 
trans-neoclerodane connectivity to 1. Publications related to the mode of action of 1 are reviewed and 
descriptions of bioactive analogues prepared by synthetic transformation on the natural product 1 are 
included. Relevant synthetic principals used throughout later chapters are described and previously 
established chemistry for the asymmetric synthesis of clerodane diterpenes is also outlined.  
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1.2 Chirality and Neurotransmission 
 
1.2.1 Chirality 
 
In 1874, both Van’t Hoff and Le Bel proposed that when four different groups are connected to a 
non-planar central carbon the molecule can exist in two non-superimposable forms [34]. These two 
forms are mirror images of each other and are called enantiomers or ‘optical isomers’ (Figure 1.4) [35]. 
In likeness to the symmetry of two hands when held side by side, the phenomena as a whole is called 
chirality, from the greek term ‘Cheiros’ meaning handedness. In 1913, Bragg demonstrated through the 
use of X-ray analysis that these four groups are distributed in a tetrahedral arrangement, hence giving 
chemists a visual model to represent chiral compounds. The central carbon in the tetrahedron is referred 
to as a stereogenic or chiral center, from which the four different atoms are arranged at or near the 
tetrahedral angle of 1090 28’. 
 
Figure 1.4: Enantiomers 
Years before the quadrivalency of carbon had been conceived and the tetrahedral arrangement 
confirmed, extensive investigation into the properties of chiral compounds had already commenced. In 
1848, after slowly crystallizing a racemic mixture of the tartaric acid salts, Louis Pasteur physically 
separated enantiomers of individual crystals according to their hemihedral shapes [34]. The separated 
tartrate salts were found to possess identical physical and chemical properties but were metabolised at 
different rates by the mould Penicillium glaucum [35]. For the first time the importance of chirality in 
biochemical processes was realised. In 1860, Pasteur concluded that the asymmetric arrangement of 
groups within a molecule is responsible for optical activity, whereby mirror images of the same molecule 
can rotate the plane of polarised light in opposite directions when viewed through a polarimeter [35] 
(Figure 1.5).  
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Figure 1.5: Diagram of a polarimeter adapted from McMurry [36]. Incident light is polarised through a slotted lens 
before being passed through a solution of optically active compound. The analysis lens is also slotted and is rotated 
to find the maximum intensity of light passing from the light source.  The rotation of the analysis lens provides the 
angle of rotation .
The optical activity of a pure enantiomer is unique to the compound and the opposite enantiomer 
will give an equal but opposite angle of rotation. The observed optical rotation is dependent on the cell 
length (l in dm.), sample concentration (c) expressed in g/100 mL and temperature [35].  Results for pure 
compounds are reported as their specific rotation TD][ calculated as shown in Equation 1.1; 
 
cl
T
D ×
=
 100][ (1.1) 
 
To distinguish between enantiomers in chemical nomenclature, those rotating the plane of 
polarised light to the left are called laevorotatory and are given the prefix L or (-), and to the right are 
called dextrorotatory and are given the prefix D or (+). However this convention is not always strictly 
used; in carbohydrates the D, L prefixes describe the configuration relative to that in (D)-(+)-
glyceraldehyde. Alternately the Cahn Ingold Prelog rules [36] determine by substituent ranking whether 
a compound is right handed or rectus thus given the prefix (R), or left handed (sinister) and given the 
prefix (S). L and D do not indicate absolute stereochemistry of the compound whereas the Cahn-Ingold-
Prelog convention does. 
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The presence of multiple stereocentres introduces the concept of diastereoisomers, or 
diastereomers, whereby geometric isomers no longer have a mirror image relationship and posses 
different physical and chemical properties. A good example of this can be seen in saturated ring 
structures. The trans- isomer of 1,2-cyclohexanediol has a non-superimposable mirror image and hence 
enantiomers exist as the (R,R) and (S,S) forms. The cis- diastereomer (R,S) has C-2 plane of symmetry 
whereby mirror images are identical. This is referred to as the meso-form and in the case of 1,2-
cyclohexanediol the meso-cis-isomer has a lower melting point to the trans- isomer (Figure 1.6). It is also 
of interest to note that the racemic trans- mixture of 1,2-cyclohexanediol, consisting of an equal ratio of 
both (R,R) and (S,S)-enantiomers, has a lower melting point compared to the enantiomerically pure 
products. 
 
HO OHHO OH HO OH
(1S,2S)-(+) (1R,2R)-(-)
trans-1,2-Cyclohexanediol
m.p. 107-109oC m.p. 107-109oC
equal mixture
m.p. 101-104oC
cis-1,2-Cyclohexanediol
m.p. 99-101oC
S S RR S R
Figure 1.6: Mixtures of trans-1,2-cyclohexanol enantiomers possess lower melting points than their optically pure 
counterparts. The cis-diastereomer is in fact a different compound and possesses different chemical and physical 
properties from the trans- isomer. 
 
Attempts to chemically differentiate, separate or form one optical isomer preferentially often 
involve the interaction with another optically active compound. It is the diastereo-interaction between 
enantiomers and an optically pure molecule or substrate that allows them to be distinguished (Section 
1.5.2). To describe the purity of an enantiomer with respect to the abundance of its antipode the percent 
enantiomeric excess (% ee) is calculated as shown below in Equation 1.2:  
 
100% ×
+

=
BenantiomerAenantiomer
BenantiomerAenantiomerAenantiomeree (1.2) 
 
It follows, a 70:30 mixture of enantiomers A and B, respectively would be expressed as 40% excess of 
enantiomer A (or 40% ee).  
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1.2.2  Chirality in Biological Systems 
 
As suggested in early experiments conducted by Pasteur, the biology of individual enantiomers 
are often significantly different. When taken into consideration that natural amino acids exist as the L-
enantiomer and carbohydrates are found as D-carbohydrates, it is evident that biological systems provide 
a chiral environment for chemical processes. Asymmetry in the essential building blocks for life puts into 
effect the crucial role of chirality in metabolic pathways, enzyme-substrate binding, neural receptor 
binding and the structure and function of the DNA chiral helix, to name but a few. Olfactory receptors 
are an everyday example of this, (R) and (S)-limonene, although differing only at their chiral center, 
smell like orange and lemon, respectively (Figure 1.7) [37]. 
 
(S)-Limonene(R)-Limonene
Orange fragrance Lemon fragrance  
Figure 1.7: (R) and (S) enantiomers of limonene have orange and lemon fragrances demonstrating the importance 
of chirality in the olfactory system. 
 
Optical isomers of some medicinal drugs have been shown to have distinctly different 
physiological effects in the body. Thalidomide (Figure 1.8) was prescribed as a racemic mixture in the 
1960s to treat nausea associated with morning sickness. After a high occurrence of birth defects was 
linked to the use of thalidomide, biological evaluations on individual enantiomers identified (R)-(+)-
thalidomide as responsible for therapeutic action, however the (S)-(-)-enantiomer proved to cause the 
teratogenic side effects. Incidentally, racemisation between enantiomers has been demonstrated in in vivo 
studies indicating that the drug cannot be reliably administered [38].  
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Figure 1.8: Chiral drugs (S)/(R)-Thalidomide and (S)/(R)-Propranolol. 
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Not all racemic drugs have ended with such detrimental effects. Propranolol (Figure 1.8) is a -
adrenergic drug that blocks or ‘antagonises’ the action of epinephrine and nor-epinephrine, which are 
neurotransmitters released when the body is under physical or emotional stress [39], to prevent increased 
heart rate and blood pressure. The -blocking activity has been found to reside in the (S)-enantiomer, 
however the (R)-enantiomer has a reduced capability to produce these effects but exhibits potent 
antioxidative activity [40]. Activity testing on individual drug enantiomers is now mandatory.   
 
Chirality has a crucial role in biological functions, of which signal transmission and reception are 
relevant examples, and is regularly discussed throughout the following chapters of this thesis from an 
organic chemistry perspective.  
 
1.2.3  Neurotransmitters and Psychoactive Ligands 
 
Signal processes of the central nervous system (CNS), which includes the spinal cord and brain, 
and the peripheral nervous system, rely on nerve cells called neurons. Nerve cells pass an electric signal 
down the length of the cell and transmission between neurons occurs by the release of neurotransmitters 
in the junction or ‘synapse’ between neural cells. Exogenous psychoactive ligands act on the CNS by 
mimicking the endogenous neurotransmitters responsible for homeostasis, signal transduction and the 
regulation of emotional and physiological states. Although some ligands directly affect cell wall ion 
channels, others can bind to G-protein coupled receptors (GPCRs), which consist of seven 
transmembrane-spanning helices with intra and extra cellular loops of varying lengths. These receptors 
are coupled to the release of “secondary messengers”, which in turn act at ion gates (Appendix 1.1). 
Endogenous neurotransmitters are synthesised within the body and can be separated into four categories: 
 
Amino acid neurotransmitters.  
- Glycine, aspartate, glutamate, 	-aminobutyrate (GABA). 
Monoamine neurotransmitters.  
- Serotonin (5-HT), dopamine, norepinephrine, epinephrine. 
Acetylcholine.  
- Acetylcholine (ACh). 
Peptides neurotransmitters (neuropeptides). 
- Substance P, leu- and met-enkephalin, dynorphin. 
 
The nitrogen containing or ‘alkaloid’ hallucinogens LSD, DMT, psilocybin and psilocin possess 
an indole ethylamine backbone and closely resemble the monoamine neurotransmitter serotonin (Figure 
1.9). Serotonin (5-HT) governs body temperature, sleep and feeding and acts at an array of receptors that 
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are found in both the central and peripheral nervous systems [41]. 5-HT imbalances has been implicated 
in depression, anxiety, social phobia and obsessive-compulsive disorders. The other effects of 5-HT are 
felt most predominately in the cardiovascular system, with additional activity in the respiratory system 
and the intestines [42]. Dopamine (Figure 1.9) is involved in mood, motor activity and cognitive 
functions (learning and memory). It also plays a crucial role in reward-reinforcement, and reward-related 
incentive learning. Dopamine receptors modulate hippocampal ACh release [43] and receptor signaling 
pathways in the nucleus accumbens (brain) caused by cumulative drug abuse, are hypothesised to 
produce tolerance to the rewarding effects of receptor stimulation, leading to increased drug intake to 
satisfy the reward-reinforcement pathway [43]. Dopamine, norepinephrine and ephinephrine share a 
phenylethylamine backbone similar to the psychoactive natural product mescaline (Figure 1.2).  
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Figure 1.9: The monoamine neurotransmitters serotonin (5-HT), dopamine, norepinephrine and epinephrine. 
 
Extensive research on the preparation of bioactive compounds that mimic the function of 
neurotransmitters has been achieved through structural modification on the indole ethylamine and 
phenylethylamine backbones. Hundreds of compounds with unique CNS activity [44, 45] (Figure 1.10) 
have been prepared, allowing for successful studies of computer generated pharmacophore assessment 
and receptor mapping through the conformational analysis of a range of structurally related agonists of 
differing potency [45, 46, 47].  
NH2OI
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N
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O N
N
Cl
HO
HO
2,5-Dimethoxy-4-
iodo-phenylethylamine
N-Isopropyl-5-methoxy-
N-methyl-tryptamine SKF82958
1-(7-Bromobenzodifuran-4,10-yl)
propan-2-amine (twice LSD potency)  
Figure 1.10: Psychotomimetic structures based on endogenous neurotransmitter skeletons. Potent 5-HT agonists 
2,5-dimethoxy-4-iodo-phenylethylamine (DOI) [44] and 1-(7-Bromobenzodifuran-4,10-yl) propan-2-amine [45], 
serotonin type 5-HT agonist N-isopropyl-5-methoxy-N-methyl-tryptamine [7] and the potent dopamine agonist 
SKF82958 [46]. 
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Neuropeptides consist of amino acids, the majority of which contain stereogenic centers. Almost 
all of the neuropeptide receptors belong to the rhodopsin or glucagon-vasoactive calcitonin GPCR 
family. Neuropeptides are far more potent than other neurotransmitters and are responsible for mediating 
sensory and emotional responses including hunger, thirst, sex drive, pleasure and pain and can be 
predominately found in the brain and gut. The earliest neuropeptide to be studied was substance P, which 
is a sensory neurotransmitter in the spinal chord involved in the perception of pain [48]. Opioid 
neuropeptides include endorphins, enkephalins and dynorphins (Figure 1.11) and are so called since they 
bind to the same postsynaptic receptors as opium derivatives (Section 1.3.1). The release of substance P 
is inhibited by opioid peptides, which hyperpolarise the postsynaptic membrane and prevent transmission 
of pain signals back to the brain, resulting in analgesia [42].  
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Figure 1.11: The peptide neurotransmitters are constructed from amino acids as shown [48, 49]. 
 
1.3  Investigation into the Mode of Action of Salvinorin A 
In 1994-1995, Siebert and Ott both reported the effects of the S. divinorum leaf material to be 
subjectively identical to those experienced from salvinorin A (1) [4, 50]. A sample of the purified 
diterpene was submitted to a commercial bio-receptor screening service, NovaScreenTM to screen for 
binding activity at a range of known receptors [51]. Curiously although the drug had no affinity for all 
screened receptors, including 5-HT2A, the main molecular target for LSD, N,N’-dimethyltryptamine, 
mescaline, psilocybin, and DOI [52, 53], it was apparent that the documented activity profile reported 
effects had a distinctive profile compared to the prototypical hallucinogens. An increase in the interest of 
the pharmacology occurred in the new millennium and in 2002 Roth et al. [54] published their findings 
on the pharmacology of 1, revealing inactivity at a range of 50 receptors, transporters and ion channels. 
Functional studies on cloned 
-opioid receptors expressed in human embryonic kidney-293 cells and at 
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native 
-opioid receptors (KOR) expressed in guinea pig brain indicated that 1 was a KOR agonist with 
extremely high potency and efficacy. High selectivity for the KOR was demonstrated by in situ 
radioligand binding assays at µ- and -opioid receptors that show negligible activity [54], proving 1 to be 
unique diterpene KOR agonist and a new template for ligand-based drug development. A short review 
covering the many years of trial and error based receptor assays involved for establishing 1 as a potent 
KOR agonist can be found in studies by Sheffler et al. [55].  
 
1.3.1 The Role and Function of the Opioid Receptors 
 
Opioid receptors belong to the superfamily of GPCRs known to mediate many of the actions of 
hormones and neurotransmitters responsible for psychological states and an excellent review covering 
the general biology of opioid receptors is in the literature by Waldhoer et al. [56]. The 
- receptor is one 
of three major subclasses of opioid receptors that have been identified to act on endogenous and synthetic 
ligands. 
 
The three major subclasses of opioid receptors, types µ-, - and 
-, are widely expressed in the 
central nervous system. The µ-opioid receptors (MOR) are located throughout the central nervous system 
in areas involved with sensory and motor function, such as the cerebral cortex and amygdala, and are 
located in high density in the caudate putamen of the basal ganglia also in the brain [49]. MOR agonists 
derive their name from the prototype morphine for which the affinities for 
- and - receptors are 
substantially lower [57]. µ-Agonists display analgesic effects and are of high importance in clinical 
medicine for the treatment of severe pain, especially that experienced by terminally ill patients. Morphine 
and codeine are MOR agonists from the biological extracts of the opium poppy Papaver somniferum.
Heroin, the 3,6-diacetylmorphine derivative of morphine, has greater potency due to increased lipid 
solubility, facilitating more rapid penetration through the blood-brain barrier and into the CNS. A 
number of synthetic MOR agonists have been prepared for clinical use and are structurally dissimilar to 
the opiate MOR agonists, one example is fentanyl shown in Figure 1.12. MOR agonists often 
demonstrate physical and psychological dependence and side effects such as respiratory depression, 
nausea and euphoria [58]. -Endorphin is the most potent endogenous MOR ligand, although it is not 
selective and exhibits agonist activity at all µ-, - and 
-, opioid receptor sites. 
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Figure 1.12: MOR agonists morphine, codeine, heroin and fentanyl. 
 
Distribution of the -opioid receptor (DOR) is less extensive than the MOR. It is present in high 
density in the olfactory bulb, cerebral cortex, nucleus accumbens and caudate putamen at the brains 
cortices. The term - is derived from vas deferens since the DOR was first identified in the vas deferens 
of mice. DORs play a functional role in the autonomic nervous system, neuroendocrine system as well as 
mood regulation and olfaction [49]. -Receptor agonists mediate analgesia and potentiate the analgesic 
and euphoric effects produced by MOR ligands [59]. The -opioid binding site is also involved in the 
development of opiate tolerance, dependence and co-administration of morphine and a -opioid 
antagonist has been shown to attenuate the development of tolerances [60]. The endogenous ligands for 
the DOR are the met-enkephalin and leu-enkephalin peptides, and prototypical agonists include DPDPE 
and (-)-TAN67 [60] (Figure 1.13).  
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Figure 1.13: DOR agonists DPDPE and the non-peptide agonist (-)-TAN67. 
 
The benzomorphan, ketocyclazocine (Figure 1.14), is the prototype for the 
-opioid receptor 
(KOR), although many 
- agonists also possess activity at either µ- or - receptors. In studies requiring a 
selective KOR agonist, U50,488H [61] or U69593 [62] are often used (Figure 1.14). Activation of the 
KORs has been reported to produce analgesia [63] without respiratory depression, however dysphoria 
[64] and sedation occur at lower doses than those needed for analgesic effects and this is also the case 
Introduction 
15 
with 1 [65]. The administration of KOR agonists has been reported to block or decrease the effects of 
cocaine in rodents [66] and squirrel monkeys [67] and findings suggest that this occurs by attenuating 
cocaine-induced increases in dopamine levels [68]. KOR agonists that are also partial MOR antagonists 
have been investigated as therapeutics for cocaine dependence [69]. The KOR participates in the 
symptoms of chronic morphine induced withdrawal [70] and mediates the adverse affects of 9-
tetrahydrocannabinol [71]. The most probable endogenous ligands for the KOR are dynorphins (Figure 
1.11), and three receptor subclasses: 
1, 
2 and 
3 are hypothesised to exist [49] but are still the topic of 
intense investigation. 
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Figure 1.14: Prototypical KOR agonists ketocyclazocine U50,488H and U69593. 
 
1.3.2  Studies on the Bioactivity of Salvinorin A 
 
In comparison to the aforementioned opioid agonists, salvinorin A (1) is structurally unique since 
it lacks the characteristic aromatic rings and amine functionalities common of both synthetic and 
classical alkaloid agonists, previously believed essential for psychoactivity. It is the most potent natural 
product discovered to date and the only terpenoid structure that has demonstrated selective activity at 
opioid receptors. Gruber et al. report that the drug is barely active through ingestion, can be partially 
absorbed sublingually through the oral mucosa, and most effectively through vaporization and inhalation, 
whereby the active dose is 200 – 500 µg [72]. 
 
Other isolated products from the leaves of S. divinorum have since been screened for binding 
affinity and functional activity at opioid receptors. Salvinorin B is shown to posses much lower activity 
at the 
-receptor than 1 [73] and metabolism of the C(2) acetoxy substituent of 1 to give the inactive 
salvinorin B has been suggested as a major pathway for metabolic deactivation throughout the 
gastrointestinal tract [74, 75]. Salvinorin C, D and F have been tested for bioactivity by Munroe et al. and 
found to be barely active [76] at the KOR, Harding et al. [28] have reported partial KOR agonist activity 
for salvinicin A and low MOR antagonist activity for salvinicin B (Figure 1.3), revealing the first 
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diterpene with activity at the MOR. Bioassays by Simpson et al. [77] describe salvidivin A (Figure 1.3) 
as a KOR antagonist with some activity at MOR and DOR, further reaffirming the significance of the 
neoclerodane core as a new template for bioactive ligands. 
 
Studies towards chemical transformations on salvinorin A are a subject of heavy investigation 
and over 100 salvinorin A analogues with measured biochemical activity are in the current literature, all 
of which have been prepared by semi-synthesis on the parent 1. New analogues of 1 reported in chemical 
and pharmacological research literature are commonly analysed using binding assays at cloned receptors, 
and the accumulated data used to further insight into the structural requirements necessary for selectivity, 
binding efficacy and activity. Several research groups have concentrated on modification of the C(2) 
substituent and consistent findings show a general decrease in 
-agonist activity with larger ester groups. 
A number of semi-synthesised analogues containing C(2) propionate ester, carbamate and ethyl ether 
substituents have been prepared by Bégiun et al. [78] with reported KOR activity similar to 1 (Figure 
1.15). Preparation of the methoxymethyl C(2) substituted analogue by Lee et al. [79] revealed a KOR 
agonist with approximately seven times greater potency than salvinorin A and is the first reported 
synthetic derivative of 1 with greater potency than the natural product. Some bioactive C(2) functional 
group analogues are listed in Figure 1.15 but is by no means extensive as the number of tested analogues 
continues to expand and most inactive analogues have been omitted.  
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Figure 1.15: The measured binding affinity (Ki), functional activity (EC50) and efficacy (%) values of C(2) 
modified Salvinorin A analogues [78-80, 82-84]. Efficacy determined as the percentage of maximal response 
produced by U50,488H [78-79, 82-84] and U69593 [83]. 
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The C(2) thioester analogue of 1 has been prepared by Bikbulatov et al. [80] who report 
moderate KOR affinity with reduced activity for the C(2) epimer, a trend also reported for 1 [81]. Later 
studies by Béguin et al. [82] focus on the activity of C(2) epimers of a number of analogues and 
demonstrate diminished activity in all cases except the isopropyl amino product, which proved more 
active as the unnatural C(2)-epimer. Interestingly, the C(2) epimer of 1 has been reported to act as a DOR 
antagonist [81] and is the first synthesised diterpinoid derivative with DOR activity. Harding et al. [83] 
report the C(2) methanesulfonyloxy (Figure 1.15) derivative to possess similar KOR potency to 1 [83] 
and have demonstrated that analogues possessing aromatic C(2) ester substituents are only moderately 
active at KORs, but show increased affinity for MORs. The C(2) benzoate derivative herkinorin 
represents the first non-nitrogenous µ-agonist synthesised from 1 (Figure 1.15) and further studies by 
Tidgewell et al. [84] have shown that MOR/KOR selectivity decreases upon increased chain length or 
steric size of the C(2) ester group, with a large increase in MOR activity for the aromatic esters. The 
semi-synthesised 4-bromobenzoate and thiophene-2-carboxylate C(2) esters were reported to have high 
MOR activity with approximately two and five times MOR/KOR selectivity [84].  
 
Lee et al. [85] have prepared a series of analogues containing various C(18) substituents were 
prepared and in general, longer or bulkier ester substituents decreased KOR binding affinity. Although 
potency was demonstrated to be lower for the C(8) epimer of 1 and its analogues, the C(18) carboxylic 
acid measured more potent as the C(8) epimer than in the natural configuration [85] (Figure 1.16). 
Studies addressing the KOR activity of the C(8) epimer of salvinorin B have also been published [86]. 
Further reports on the biological assessment for synthetic analogues of 1 have involved modified furan 
structures. Munroe et al. report that the reduction of the lactone ring to the pyran or the dihydropyran 
gave agonist compounds with high KOR affinity (Figure 1.16), inferring that the lactone carbonyl may 
not be crucial for receptor binding [86]. Remarkably, reduction of the ketone at C(1) gave a compound 
that retained considerable activity as a KOR agonist, whereas the C(1) alcohol and acetoxy compound 
produced no significant activity. Analogues prepared by hydrogenation of the furan ring gave compounds 
of lesser affinity and potency than the parent compound 1 [86].  
 
Simpson et al. have recently reported on a semi-synthesis of salvinicin A and B from 1 [77] 
along with other selective modifications of the furan ring of 1. Replacement of the 3-furyl group with a 
nitrogenous heterocycle was reported to decrease in KOR activity [77], as was removal of the furan 
altogether. The 2-bromofuran analogue was reported to be a potent KOR agonist and the incorporation of 
an oxadiazole group gave a synthetic analogue of 1 with KOR antagonist activity (Figure 1.16) [77]. 
Further work by the same group involved the preparation of a range of modified furan KOR agonists, 
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amongst which the N-sulfonylpyrrole derivative was mentioned to have low agonistic activity at KOR 
[87]. 
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Figure 1.16: The measured binding affinity (Ki), functional activity (EC50) and efficacy (%) values of C(18) 
modified Salvinorin A analogues reported by Lee et al. [85]. Furan modified bioactive analogues are also shown 
[86, 77, 87]. 
 
Prior to the publication of numerous salvinorin A analogues in the scientific literature with reported 
opioid receptor binding data, studies by Roth et al. [54] proposed a binding model for 1 based solely on 
hydrogen bonding interactions using an established model for the KOR bound to the agonist U69593, 
followed by atom overlap comparison with 1. Computer modeled conformations for KOR docked 
salvinorin A predicted residues for H-bond acceptor interactions at the lactone (Tyr139), acetoxy 
(Tyr313) and ester (Tyr312) carbonyls and also at the furan oxygen (Gln115). A later model by Yan et 
al. [88] is based on a Rhodopsin template, and energy minimised by computer modeled docking with an 
ensemble of known agonists (bremazocaine, morphine, MPCB, U69593 and 6’-GNTI) according to 
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suggested structure activity relationships. Site-directed mutagenesis studies were performed to test their 
hypotheses via radioligand binding and functional assays, and suggest involvement from residues Tyr119 
and Tyr320. New and more accurate models have since been proposed using the guidance of bioactivity 
measurements for known analogues and a refined qualitative model has been published by Kane et al. 
[60] and explores binding site interaction using wild-type and chimeric receptor studies to probe for 
changes in receptor function upon alteration of significant binding regions. Their results suggest that 
salvinorin A binds at transmembrane residues in TMII, TMVII and ELII of the KOR receptor protein and 
single point mutagenesis studies suggest involvement from Q115, Y119 (TMII) and Y312, Y313, Y320 
(TMVII) residues, in near corroboration with studies by Roth et al. [54, 88]. A publication by Singh et al. 
[89] from the same laboratories has incorporated a combined ligand-based target-based approach for 
GPCR modeling using salvinorin A as a computational case study. The amino acid residues inferred 
necessary for KOR binding from earlier studies were considered in a computer docking simulation study 
to hypothesise an energy minimised binding mode for 1 (Figure 1.17, left).   
 
Figure 1.17: Left; Proposed binding mode with important amino acid residues [89] and Right; a current 
pharmacophore model for salvinorin A (1) reported by Singh et al. [89], constructed using ‘Catalyst 4.8’ 
computational software. 
 
Compounds including 1 and analogues with reported potency as KOR agonists were used to 
construct a hypothetical computer generated pharmacophore model using ‘Catalyst 4.8’ software as 
shown in Figure 1.17 (right) [89]. The ‘best-fit’ pharmacophore was validated using an additional 12 
analogues of 1 and also compared favorably in the prediction of known non-terpene KOR agonists. This 
approach aims to improve the identification of new lead compounds for the process of drug development 
based on the bioactive neoclerodane scaffold.  
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Studies by Vortherms et al. [90] follow a similar trend during studies to further the elucidation of the 
binding mechanisms through which 1 can act at the KORs and use the natural product to probe 
morphological differences between MOR, DOR and KOR opioid receptor classes. Using a combination 
of site-directed mutagenesis studies and computational modeling/dynamics analysis of the protein 
receptor, the authors support the current theory that differential helical orientations amongst GCPRs 
attribute ligand or neurotransmitter selectivity. The topology of binding amino acid residues at the 
extracellular segment in DOR and MOR receptors is suggested to disrupt binding of 1, offering a 
rationale for KOR selectivity.  
Further interest from the pharmacology and neuroscience community has led to a number of 
significant findings related to the activity of 1 and analogues with potential therapeutic value. Ansonoff 
et al. [91] have demonstrated using radioligand binding assays that 1 is a selective agonist at the 
1
receptor subclass (Section 1.3.1) whereas the synthetic KOR agonists U50,488H and U69593 (Figure 
1.14) show affinity for both 
1 and 
2 receptor subclasses. Groer et al. [92] have furthered 
characterization of the MOR bioactivity of herkinorin (Figure 1.15), the C(2) benzoate analogue of 1 and 
in vivo studies in mice have shown that the µ-activity of herkinorin does not involve interactions with -
arrestin proteins, which are currently accepted to play a role in mediating the side effects (tolerance, 
constipation, respiratory depression) associated with morphine based MOR agonists [92]. Studies by 
Rothman et al. [93] report allosteric modulation of µ-receptors upon interaction of 1 with KORs and 
Butelman et al. [94] have used 1 in a neuroendocrine biomarker assay. Braida et al. [95] have also 
reported the effect of 1 in zebrafish and tentitatively propose CB1-cannabinoid receptor involvement 
based on known interactions between the KORs and cannabinoid system in self-administration studies. 
 
1.4 Clerodane Diterpenes 
 
The trans-neoclerodane structure of salvinorin A from S. divinorum contains a carbon skeleton 
common to the clerodane diterpene family of natural products, although it is the first diterpene to exhibit 
potent neuroactivity. Clerodane structures are commonly isolated metabolites from the Salvia species and 
attract significant interest due to their unique structures and bioactivity. The clerodane metabolites are 
often oxygenated and involve complex stereochemistry as a consequence of multiple metabolic steps. In 
order to further discuss the bioactivity and stereochemistry of clerodane compounds it is helpful to 
briefly describe the biogenesis through which terpenes are derived.  
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1.4.1  The Origin of Chirality in Terpenoid Natural Products 
 
Biosynthesis and biotransformation processes within living organisms frequently produce 
complex organic structures, many of which contain intricate stereochemistry. The in vivo pathways by 
which these compounds are produced are of enormous interest to chemists and biochemists and over the 
past decade advances in this field have been very significant. Included in the terpene family are 
hormones, vitamins, drugs, as well as rubber. It was originally thought that all terpenes were 
biosynthesised via the ‘mevalonate’ pathway, however through 13C labeling it has been uncovered that in 
plants a mevalonate independent pathway also exists, which is absent in mammals [96]. This non-
mevalonate biosynthetic route is known as the methylerythritol phosphate (MEP) or 1-deoxy-D-xylulose-
5-phosphate (DOXP) pathway. By either pathway, all terpenes are assembled from ‘isoprene’ (2-methyl-
1,3-butadiene) units with two universal precursors, isopentenyl diphosphate and dimethylallyl 
pyrophosphate. Metabolites formed in the growth stage are referred to as primary metabolites and those 
formed thereafter are secondary metabolites. In some organisms, during various stages of growth, 
different pathways have been suggested to predominate. During these processes, one or more stereogenic 
centers are often introduced and transformations executed by enzymatic processes typically produce 
species in optically enhanced or optically pure form. A simple example of this is the production of (-)-
limonene from geranyl diphosphate (GPP) [97] (Scheme 1.1). 
 
OPP
GPP
OPP
(+)-(3S)-Linalyl diphosphate
H
OPP
(-)-(4S)-Limonene
Scheme 1.1: The isomerization and cyclization of GPP to (-)-(4S)-limonene catalysed by limonene synthase [97]. 
 
Natural products contain substructures and stereogenic centers, which may be indicative of the 
biosynthetic pathways or even the subcellular location of its production. In higher plants and certain 
eubacteria, triterpenes are often made via the mevalonate pathway in the cytoplasmic compartment of a 
cell, whereas mono and diterpenes are biosynthesised in plant organelles (plastids) via the MEP pathway 
[97]. Metabolites have been known to switch pathways at intermediate stages of the metabolic process. 
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1.4.2 Biosynthesis and Nomenclature of Clerodane Diterpenes 
 
Diterpenoids that feature the clerodane carbon skeleton are very common, the majority of which 
have been isolated from the Lamiacae and Compositae families. Clerodane diterpenoids have been 
shown to commonly occur via the MEP pathway, through the enzymatic cyclization of geranylgeranyl 
diphosphate (GGPP) [99] and appear to be related to labdane structures through a series of methyl and 
hydride shifts [100] (Scheme 1.2). The genes responsible for encoding terpene cyclase-like proteins 
involved in the biosynthesis of the antibiotic terpentecin (Section 1.6.1) have been isolated and the 
mechanism for the production of the trans-clerodane structure concluded by deuterium labeling in NMR 
studies [99]. The biogenic pathway for the synthesis of 1 in S. divinorum has been addressed in studies 
by Kutrzeba et al. [23] using the in vitro incorporation of [1-13C]-glucose, [Me-13C]-methionine and [1-
13C, 3,4-2H2]-1-deoxy-D-xyulose substrates followed by retro-biosynthetic NMR spectroscopic analysis. 
The authors suggest that the biosynthesis from clerodane pyrophosphate proceeds via the DOXP pathway 
based on 13C NMR isotope patterns observed in the radiolabeled metabolic analogue of 1 (Scheme 1.2). 
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Scheme 1.2: The enzymatic cyclization of geranylgeranyl diphosphate (GGPP) to produce labdane and clerodane 
skeletons [100]. Biooxidation to give 1 has been reported to occur via the DOXP pathway [23]. 
 
The absolute stereochemistry of the insect antifeedant clerodin [101], the first member of the 
clerodane products to be isolated, has been revised [102] and is used as a template to describe 
stereochemistry in other clerodane metabolites. Those possessing identical absolute stereochemistry to 
clerodin are termed neo-clerodanes and those enantiomeric to clerodin are termed ent-neo-clerodanes. A 
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further cis and trans division of clerodanes based on the relationship of substituents at the C(5)/C(10) 
ring junction also exists. This system of naming clerodane diterpenes only describes the stereochemical 
aspects and ignores functionality and the connectivity of additional ring systems. 
 
Based on the nomenclature described above, salvinorin A (1) is a trans-neo-clerodane structure 
and the three fused saturated six-membered ring systems will be referred to as rings A, B, and C (Figure 
1.18) throughout the discussion section of this thesis. Ring C is a -lactone connected to a -substituted 
furan and although common amongst clerodane terpenes only few examples exist of compounds which 
also possess the trans-neo- stereochemistry. The methyl and hydrogen bridge-head atoms at the A/B ring 
junction C(5)/C(10) are in the trans- configuration with respect to each other and the same relationship 
exists at the B/C ring junction C(8)/C(9) and along the adjoining A/C bond C(9)/C(10). Since the trans 
stereochemistry relationship exits between consecutive C(5)/C(10)/C(9)/C(8) bridge-head substituents, 
the tricyclic ring structure sits in a planar orientation and each fused saturated cyclohexane ring exists in 
the most stable chair conformation. 
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Figure 1.18: The Chem3D MM2 energy minimised structure of salvinorin A (left), the ABC ring system with 
stereocentres indicated* (middle) and the numbering system for the salvinorin A carbon framework (right). 
 
Salvinorin A contains seven stereocentres as indicated in Figure 1.18. The number of possible 
stereoisomers is calculated by considering that each stereocentre has two possible configurations, hence a 
compound with seven stereocentres has: (2)7 = 128 possible stereoisomers. The C(2)-epimer and C(8)-
epimer of 1 have been prepared from the natural compound as discussed in Section 1.3.2, although the 
inversion of stereochemistry at C(4), C(5), C(9) might be more challenging, requiring the synthetic 
preparation of these diastereoisomers. It can be rationalised that inversion of stereochemistry at the 
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bridge-head atoms of 1 will change the stable trans chair conformation and a number of examples 
presented in section 1.4.3 demonstrate how the three-dimensional shape of the ABC ring system is 
determined by the stereocentres at the C(5)/C(10) and C(8)/C(9) ring junctions. Other clerodanes 
identified from biological plant extracts are also discussed in the following section. 
 
1.4.3  Clerodane Diterpenes from Bioactive Plants 
 
The clerodane diterpinoids are classified as secondary metabolites and are an important class of 
natural products due to their ubiquitous distribution and extensive structural variation [4]. Many 
clerodanes isolated from bioactive plant extracts have been comprehensively characterised, however 
bioassay data on the identified constituents is lacking. Existing bioassays on isolated terpenes from the 
clerodane family have revealed their unique biological activities.  
 
The accumulation of secondary metabolites in plants may be the result of an evolutionary 
adaptation to defend against insects. Genus Scutellaria (Lamiacae) has provided some of the most potent 
neoclerodane insect antifeedants currently known. trans-Neoclerodanes Jodrellin A & B, isolated from S.
woronowii [103] and Scutegalin B from S. galericulata [104] have been found to possess phagostimulant 
activity against larvae of lepidopteran Spodoptera littoralis (Egyptian cotton worm). Jodrellin B has also 
proven active against plant pathogenic fungi Fusarium oxysporum [105]. The significance of the 
Jodrellin structure as a means of chemical defence against botanical pests has made it an attractive target 
for total synthesis and to date there have been two successful total syntheses of Jodrellin A [106, 107] 
(Section 1.6.3). 
 
As described in earlier discussion, clerodane diterpenoids identified from medicinal plants 
provide important new lead compound for furthering the understanding receptor systems in humans and 
the development of novel pharmaceuticals. Casearinol A (Figure 1.19), a cis-clerodane diterpene from 
the leaves of Casearia guianensis has been found to have immunomodulatory effects and may be useful 
in the search for immunosupressant compounds for the prevention of organ rejection in transplant 
patients [108]. The trans-neoclerodane lupulin A (Figure 1.19) from Ajuga lupulina has been shown to 
possess antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia 
coli. [109]. Saliva polystachya has been traditionally used in Mexican folk medicine as an anti-gastralgic, 
anti-dysentric, purgative and emollient and Maldonado and Ortega have shown the aerial parts to be rich 
in clerodane diterpenoids [110]. One example is Polystachyne D [110] which contains similar 
connectivity and functionality to 1 however the cis- relationship at the A/B and B/C ring junctions 
creates a twisted u-shaped conformation in the skeleton (Figure 1.19).  
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Figure 1.19: The antibacterial lupulin A and the immunomodulatory cis-clerodane casearinol A. The Chem3D 
MM2 energy minimised structure of polystachyne D is also shown.  
cis-Clerodane diterpenes bearing similar chemical functionalities to salvinorin A have been 
isolated from bioactive fractions of the Tinospora genus (Menispermaceae family) (Figure 1.19). Leaf 
extracts from Tinospora rumphii are rich in clerodane diterpenes [111] and extracts are used medicinally 
in south-east Asia for the treatment of stomach disorders, ulcers and fevers with bioassays on methanolic 
stem extracts revealing significant stimulation glucose transport activity. Interestingly, isolated products 
from the stem extract have revealed several clerodane glycosides [112] similar to those found in stem 
extracts of Tinospora cordifolia, an Ayurvedic medicinal plant of India locally known as ‘Guduchi’, a 
herb is traditionally used for the treatment of urinary [113], liver and intestinal disorders [114] but also 
found to possesses immunostimulant activity [115]. Many isolated compounds from the Tinospora genus 
contain the fused –lactone ring at C(8)/C(9), incorporating the C(11)-C(16) side chain, and have cis-
geometry at the A/B ring system. Highly oxygenated cis-ent-neo-clerodane diterpenes featuring the 
opposite stereochemistry to clerodin in the B/C ring junction, such as 6-hydroxyarcangelisin (Figure 
1.20), have been isolated from the stem of Tinospora cordifolia [113] but no bioactivity studies on 
isolated compounds have been reported as yet. 
 
A few other trans-neoclerodane metabolites of scientific interest include Bacchotricuneatin A 
[116] (Figure 1.20) isolated Baccharis crispa, that shows insect antifeedant activity against Tenebrio 
molitor L. larvae [117]. Structure-antifeedant activity relationships suggest that stereoelectronic factors 
are more important than hydrophobic effects [118] for antifeedant activity, which was significantly 
diminished upon hydrogenation of the furan substituent. Diterpenoids isolated from the genus Lagochilus 
(Lamiaceae) have provided trans-labdane diterpenes with strong bioactivity as hemostatic compounds. 
Lagochilin (Figure 1.20) from Lagochilus inebrians has been identified as the major bioactive 
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component and synthetic derivitization of the lagochilin structure has provided compounds of enhanced 
potency [119]. 
Figure 1.20: An MM2 minimised Chem3D structure of the cis-ent-neoclerodane diterpene 6-hydroxyarcangelisin. 
The trans-neoclerodane insect antifeedant Bacchotricuneatin A and hemostatic Lagochilin are also shown. 
1.5 Introduction to Synthesis 
 
Considerable research efforts from academic and industrial laboratories have resulted in the 
development of general methodologies for the preparation of chiral molecules with high enantiomeric 
purity. A number of these methods predominate in the area of natural product synthesis and will be 
explained.   
 
1.5.1 The Chiral Pool  
 
Both abundant and accessible, the chiral materials that are found in nature are referred to as the 
‘Chiral Pool’. Chiral pool materials have now been used as building blocks for chemists for over a 
century and include sugars, terpenes, amino acids and carbohydrates (Scheme 1.3, top). The oldest and 
most classic approach towards asymmetric synthesis is to design around chiral pool reagents, and many 
successful natural product syntheses have been accomplished in this manner [120]. 
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Scheme 1.3: Top; Chiral pool compounds -D-glucose, L-proline and D-camphor. Bottom; L-Proline uses both 
acidic and basic functionalities to stereoselectively catalyse the Robinson annulation. 
 
Optically pure amino acids and simple derivatives thereof have proven effective as chiral 
auxiliaries and ligands for metal complex based asymmetric catalysts. Proline itself has been used as an 
amphoteric chiral catalyst for aldol reactions, and Robinson annulations [121] (Scheme 1.3, bottom).  
 
Chiral terpenes are isolated with varying degrees of enantioenrichment and monoterpenes such 
as pinenes, menthones, menthols, carvones, camphor and limonene (Scheme 1.4, top) are especially 
important and abundant compounds useful for synthetic manipulation. Monoterpenes are widely 
distributed in nature [122] and are obtained from plants in high yields. Terpenes are frequently used in 
asymmetric synthesis both as building blocks for the preparation of natural products and as ligands for 
stereoselective transformations.  
 
-(+)-Pinene
O
(1R,4S)-(-)-Menthone
O
L-(-)-Carvone
-(+)-Pinene
BH3
THF
(-)-Ipc2BH
)2BH
H
Ipc2B
H
HOH2O2
-OH
(R)-(-)-2-Butanol
98% ee
Scheme 1.4: Top; Chiral terpenes (+)-pinene, (-)-menthone and (-)-carvone from the chiral pool Bottom; (-)-Ipc2BH 
prepared from (+)-pinene can be used in the asymmetric hydroboration of cis-but-2-ene to produce (R)-(-)-2-
butanol in 98% ee [123]. 
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Chiral reagents can be easily prepared through chemical or biological transformations of 
optically active terpenes. Hydroboration of -pinene produces diisopinocampheylborane ((-)-Ipc2BH), an 
effective reagent for the asymmetric hydroboration of cis-substituted alkenes [123]. Chiral reagents and 
ligands allow for the transfer of chirality into the desired target molecule, in this case, the product after 
hydrolysis is a chiral alcohol in high optical purity (Scheme 1.4, bottom). Unlike amino acids, which 
almost exclusively have the (S) configuration, many monoterpenes exist in Nature as both enantiomers 
variously distributed in different plant species. They are “scalemic” which means that both antipodes are 
produced by a single source, although one usually predominates [122].  
 
Chiral pool reagents can be extremely useful if the diastereo- or enantio-selectivity is induced to 
give the desired isomer for synthesis. If the stereogenic center produced is the opposite to that wanted, 
asymmetric catalysis is often the most attractive alternative. Purification of a single enantiomer from a 
racemic mixture can provide both enantiomers in pure form. This process is known as racemic resolution 
and is almost always necessary when chiral products are obtained or formed in less than 100% optical 
purity.  
 
1.5.2 Racemic Resolution 
 
Racemic resolution is an approach that still dominates the pharmaceutical industry and many of 
the research institutions as the most reliable and economically attractive method of obtaining pure 
enantiomorphs [124]. Racemates can be resolved by two methods; 
 
1. Formation of a diastereomeric derivative by reacting the racemate with an optically        
pure compound termed a ‘resolving agent’. 
 
The racemate can be reacted with a resolving agent to form a covalent bond, a diastereomeric 
complex, or a diastereomeric salt. The diastereomeric derivatives can then be purified by differences in 
chemical properties before the resolving agent is detached to yield a pure enantiomer. Typically, 
differences in solubility between diastereomeric pairs are used to separate enantiomers since the less 
soluble species tends to crystallise with increased optical purity. An example of this is shown in the 
resolution of racemic 2-chloro-3-phenyl-propionic acid using L-phenylalanine as the resolving reagent 
(Scheme 1.5). The racemic -halo acid is recrystallised with L-phenylalanine to produce diastereomeric 
salts. The (R) salt of the -halo acid has a lower solubility than its enantiomer and is separated as a solid, 
leaving the (S) salt in solution [124]. 
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Scheme 1.5: Racemic resolution of 2-chloro-3-phenyl-propionic acid by formation of diastereomeric salts. 
 
The number of resolutions achieved using diastereomeric salt formation alone is over 10,000 [124], 
however finding the most suitable resolving agent and crystallization conditions during development of 
chiral separation procedures for novel compounds often demands a high level of perseverance. 
 
2. Chiral Separation by Chromatography. 
Enantioselective separations based on the formation of transient diastereomer complexes are 
commonly rationalised using a three-point interaction model [125] that assumes a minimum of three 
simultaneous interactions between the optically pure ‘chiral selector’ and an enantiomer, where at least 
one interaction is stereochemically dependent. Enantioseparation by chromatography can be achieved by 
using either chiral mobile phase additives or a chiral stationary phase. A chiral stationary phase is 
composed of a chiral selector that is chemically bound or coated onto a polymer support. Chiral 
separation by Gas-Chromatography (GC) uses capillary columns with a stationary film of polysiloxanes 
bound to amino acid or -cyclodextrin (Figure 1.21) derivatives and the chiral selector can constitute up 
to 30% of the stationary phase.  
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Figure 1.21: Chiral stationary phases cellulose triacetate and -cyclodextrin. 
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Enantiomer separation by chromatography on a chiral GC column is an efficient method for 
analytical purposes and to separate small quantities of racemate, discussed in more detail in Section 
3.3.2. Liquid chromatography using chiral stationary phases can successfully purifiy enantiomers on 
multigram scales, but it is expensive for larger scale production due to the price of solvents and 
consumables. Cellulose and modified cellulose columns such as cellulose triacetate (Figure 1.21) are an 
efficient stationary phase for liquid chromatography [126].  
 
Chiral separation by capillary electrophoresis can be achieved by adding a chiral selector to the 
mobile phase and works by interacting with analytes in solution during the separation process [124]. -
Cyclodextrin works well for this process since it is water soluble and forms a bucket shape that can hold 
an organic molecule in the center. The retention differences due to variable interaction of each 
enantiomer with the cyclodextrin cavity discriminates each enantiomer during chromatography.   
 
1.5.3 Asymmetric Synthesis  
 
Asymmetric syntheses are designed to facilitate the synthesis of a single enantiomer as the major 
product, hence increasing the yield of the reaction and hopefully shortening the length of the synthetic 
route. Generally speaking, asymmetric synthesis involves the generation of chiral centers from prochiral 
materials during which process chirality is transferred from the reagent, catalyst, or auxiliary to the 
newly introduced asymmetric center. Often the degree of purity of the new enantiomer is less than 100% 
ee and further purification by racemic resolution is performed to provide the pure isomer. The differences 
entailed between the asymmetric techniques will be outlined under the categories asymmetric catalysis, 
chiral reagents, and chiral auxiliaries and discussed.  
 
1.5.3.1   Chiral Auxiliaries  
 
A chiral auxiliary modifies the substrate molecule by introducing a stereogenic center that will 
influence the reaction outcome in an asymmetric manner. After the key reaction steps, it must be 
removed unless it is to become part of the target compound. An efficient practice is to incorporate the 
chiral auxiliary as both a protecting group for sensitive functional groups as well as to transfer chirality 
to the substrate. If the auxiliary is removed intact after the asymmetric transformation it has the potential 
to be recycled.  
 
The ephedrine derivatives serve as practical chiral auxiliaries for the preparation of most 
functional groups in highly enantioenriched forms including acids, alcohols, carbonyl and carboxylic 
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acids [127], amines [128] and sulfinates [129]. An asymmetric preparation of -phenethylamine using a 
norephedrine chiral auxiliary is shown in Scheme 1.6. Hydrogenation of the imine prepared from 
acetophenone and (-)-norephedrine gives selectivity for the Re face. The (-)-norephedrine auxiliary 
provides a chiral intermediate for the reduction to take place, then oxidative removal of the remaining 
auxiliary provides the (R)--phenethylamine and the nitrogen from the auxiliary is incorporated into the 
product [128] In this example, (-)-norephedrine acts as a self-immolative (non-recoverable) chiral 
auxiliary and ephedrine derivatives are often used in this manner since they are inexpensive and often not 
easily recovered.  
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Scheme 1.6: Norephedrine as a chiral auxiliary in the preparation of (R)--phenethylamine from acetophenone 
[128]. 
 
1.5.3.2   Asymmetric Catalysis 
 
An ionic complex prepared using an optically pure ligand with a reactive inorganic center can be 
used as a chiral reagent to prepare non-racemic compounds from planar sp2 hybridised prochiral 
substrates. If the reactive complex can be reformed in situ or remains unchanged after the reaction, this is 
now referred to as an enantioselective catalyst. Chiral catalysis is one of the most popular and efficient 
methods for asymmetric synthesis and some commonly used reagents are described below.  
 
Proline [130] and (-)-norephedrine [131] derived ligands that contain the 1,2-amino alcohol 
functional group system have been used to prepare asymmetric oxazaborolidine hydride complexes 
(Figure 1.22, top). The chiral borohydride complex facilitates enantioselective reduction of carbonyl, 
ketoxime [132] and imine [131] functionalities to give the corresponding alcohol or amine (Figure 1.22, 
top) products. A diastereomeric interaction takes place between the prochiral center being reduced and 
the ligand hydride complex, leading to optical enrichment of the reduced products.  
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Figure 1.22: Top; The proline and (-)-norpehedrine borohydride complexes give enantioselective reduction of 
carbonyls and imines. Bottom; Jacobsens manganese(II)salen catalyst for enantioselective epoxidation of olefins 
[133]. 
 
Jacobsens catalyst, a manganene(II)salen complex, catalyses the stereoselective epoxidation of 
activated and unactivated double bonds using 4% hypochlorite solution [133] (Figure 1.22). The 
Jacobsens catalyst ligand is an imine dimer prepared by the reaction of a chiral diamine and two 
substituted salicylaldehyde molecules. Complexation to the redox active manganese cation provides a 
very efficient and scaleable chiral epoxidation catalyst. Sharpless catalytic asymmetric epoxidation 
conditions involve a Ti(IV) complex with the (+)-diisopropyl L-tartrate ligand to epoxidise a similar 
range of olefins as Jacobsens catalyst under mild conditions and has found use in the synthesis of 
complex natural products [134].  
 
1.5.3.3  Biotransformation and Enzymatic Resolution 
 
Asymmetric transformations using biological catalysts is an area often overlooked by synthetic 
research chemists, however the industrial synthesis of chiral amines relies on enzymatic processes for the 
production of commercial quantities of amino acids. The biological function of aminotransferase or 
transaminase enzymes is to take the amino groups of a donor amine and exchange it with a keto group of 
another molecule [135]. This consumed amine product of the enzymatic transformation is in a reversible 
equilibrium with the starting amine which is optically pure. The use of L-aspartic acid as an ‘amine 
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donor’ allows the reaction to proceed to 90% completion due to the removal of oxaloacetic acid via 
further metabolism or decomposition to pyruvic acid (Scheme 1.7). Alternately, enzymatic resolution 
may be carried out on a racemic mixture of amides or esters through enantioselective hydrolysis. 
Purification of the unnatural D-isomer of amino acids is made accessible by this process. [124]. 
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+
Scheme 1.7: Conversion of ketone to amine functionalities through the action of aminotransferase and the L-
aspartic acid donor amine. 
 
1.6 Asymmetric Approaches Towards Clerodane Natural Products 
1.6.1  Synthesis via ‘Wieland-Miescher’ Ketone  
 
Studies towards the synthesis of clerodane terpenes are not common in the literature. The most 
popular approach towards the diterpene backbone of clerodane and neo-clerodane structures is to 
synthesise the fused A/B ring system via a stereoselective Robinson annulation procedure.  
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Scheme 1.8: Asymmetric Robinson annulation synthesis of the Wieland-Miescher ketone using (+)-CSA acid and 
phenylalanine [136]. 
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The Michael-addition of 2-methyl-cyclohexane-1,3-dione to pent-1-en-3-one under basic 
conditions gives symmetrical triketone. Asymmetric cyclisation of the triketone in the presence of L or 
D--phenylalanine and D-10-camphorsulfonic acid ((+)-CSA) [136] provides optically active (S) and (R)
isomers respectively of the bicyclic 1,4a-dimethyl-4,4a,7,8-tetrahydronaphthalene-2,5(3H,6H)-dione, 
known as the Wieland-Miescher ketone (I) (Scheme 1.8) [136].  
 
A linear synthesis of the core of terpentecin has been reported by Ling et al. [137] using the (S)-
(+)-Wieland-Miescher ketone Robinson annulation product (+)-(I) as a starting point for the bicyclic 
decalin ring system and provides a good example of the general synthetic methodology involved in 
creating additional stereocentres. Protection of the C(4) carbonyl as the cyclic acetal leaves the 
conjugated ,-unsaturated carbonyl as the most reactive functionality. A stereoselective reductive 
alkylation reaction was then performed using lithium metal in ammonia, followed by heating with the 
alkylating agent vinyl bromide. This gives the 1,3-alkyl addition product with selectivity for the trans-
C(5)/C(10) ring system relative to the starting ketone.  
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Scheme 1.9: Reductive alkylation methodology of (S)-(+)-Wieland-Miescher ketone to give the trans-C(5)/C(10) 
bicyclic ketone (-)-(II) [137]. 
The C(9) alkyl substituent favors a cis- geometry with the adjacent C(10) bridge-head hydrogen, 
both of which are on the exo-face (Scheme 1.9). Ozonolysis of the terminal olefin, followed by reduction 
of the resulting aldehyde provides the C(5) hydroxy-ethyl side chain and protection as the trisopropylsilyl 
ether (TIPSO) allows access to the flexible clerodane starting material (-)-(II).   
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Oxidation of the C(6) carbon was achieved in a further 6 steps using literature procedures. 
Methylenation of the C(8) carbonyl using the Peterson olefination conditions involving 
trimethylsilylmethyl-magnesium chloride (TMSCH2MgCl)  [137] gave an exo-cyclic double bond that 
upon hydrogenation with Wilkinsons catalyst ((Ph3P)3RhCl) underwent face selective reduction of 20:1 
in favour of the cis- orientation of substituents at C(8)/C(9) (Scheme 1.10).  
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Scheme 1.10: Peterson olefination followed by hydrogenation with Wilkinsons catalyst [137]. 
 
Oxidation of the C(6) and C(7) positions was performed in 6 steps to provide the hydroxy ketone 
core of terpentecin as a single isomer in a total synthesis of 20 steps from (+)-(I) [137] (Scheme 1.11). 
Almstead et al. [138] have prepared the core of clerocidin (Scheme 1.11) using the same approach. 
Clerocidin and terpentecin have measured antibacterial and antitumor properties and have also been 
found to induce topoisomerase II-mediated DNA damage [139]. This mode of ‘topoisomerase poisoning’ 
has been suggested as a novel approach to new anticancer drugs [140]. 
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Scheme 1.11: Oxidation of C(6) and C(7) provides the core skeleton of terpentecin [137]. Both terpentecin and 
clerocidin have measured antibacterial and antitumor properties [139, 140].  
 
A Japanese research group led by Hisahiro Hagiwara, have conducted a number of studies 
towards construction of the trans-neo-clerodane skeleton. In 1995, research towards the total synthesis of 
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an antibacterial clerodane from Acritopappus longifolia [141], 16-hydroxycleroda-3,13(14)Z-dien-15,16-
olide was reported, starting from the (R)-(-)-Wieland-Miescher ketone (-)-(I). The C(10)/C(5) trans-
selective reductive alkylation was used as in Scheme 1.9 to stereoselectively introduce the C(9) alkyl 
chain in six steps to produce (+)-(II). The conjugated ,- unsaturated ketone was then introduced in five 
steps by functional group interconversion using known procedures [141] .  
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Scheme 1.12: Stereoselective construction of the trans-neo-clerodane skeleton from (-)-(I) as reported by Hagiwara 
et al. [141]. 
 
Reduction of the ,-unsaturated olefin C(7)/C(8) using lithium metal in mixture of liquid 
ammonia and tetrahydrofuran (THF), followed by quenching in ethanol, was reported to produce the 
trans-neoclerodane stereochemistry [141]. A further seven steps were then required to produce the core 
of the target skeleton (Scheme 1.12).  
 
The first total synthesis of (-)-methyl barbascoate [142], a natural product from the ethanol 
extract of Croton californicus, has been reported from the same research group in 2005. Traditionally, 
powdered leaves of this plant are used as a pain reliever for rheumatism and also used by fishermen to 
stun fish. The trans-neoclerodane was synthesised via a linear approach in 12 steps beginning with the 
chiral precursor (+)-(II) [136, 142, 143] (Schemes 1.13-1.15). Wittig olefination of the trans-decalone 
(+)-(II) produced the exo-cyclic olefin at C(8) which underwent hydroboration using borane-THF 
etherate (BH3-THF), and oxidation with hydrogen peroxide (H2O2) to give a 3.8:1 ratio of 8  and 8
alcohols in favor of the undesired stereoisomer (Scheme 1.13). 
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Scheme 1.13: Wittig methylenation of C(8) in (+)-(II) carbonyl followed by hydroboration and oxidation to the 
primary alcohol [142]. 
 
The authors report oxidation with pyridinium dichromate (PDC) under basic conditions to 
produce the aldehyde substituent at C(8) in quantitative yield [142] without deprotection. This 
intermediate was easily epimerised at C(8) using sodium methoxide (NaOMe) in methanol to give the 
desired 8 diastereoisomer as the thermodynamically favoured epimer (Scheme 1.14). 
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Scheme 1.14: Hagiwara et al. [142] report the C(8) aldehyde to epimerise to the desired isomer upon treatment with 
MeONa. Deprotection followed by oxidation of the C(9) chain to the aldehyde was achieved in three steps using 
known procedures [142]. 
 
Protection of the aldehyde as the acetal locked the C(8) stereocenter in the trans-neo-
configuration by preventing further enolization, and subsequent desilylation followed by oxidation of the 
C(9) alkyl chain was reported to give the protected aldehyde in three steps using known reactions [142] 
(Scheme 1.14). The 3-furyl group was introduced by the nucleophilic reaction of 3-furyl lithium, 
prepared from the reaction between 3-bromofuran and n-butyl lithium, with the diacetal aldehyde to give 
the racemic C(12) furfurol in high yield (Scheme 1.15). Removal of the acetal protection groups, 
oxidation to the -lactone ring and introduction of C(4) conjugated ester was performed in four steps 
using known conditions to produce a 3:2 mixture of (-)-methyl barbascoate and its C(12) epimer [142]. 
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Methyl barbascoate and salvinorin A (1) have many structural and functional group similarities as both 
share the same fused tricyclic skeletons, -lactone and 3-furanyl moieties. The 12-(R) stereochemistry of 
the 3-furyl moiety in (-)-methyl barbascoate forces the lactone ring into a boat conformation, however 
the 12-(S) isomer exists in the chair conformation as seen in 1.
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Scheme 1.15: Hagiwara et al. [142] report nucleophilic addition of the 3-furyl moiety followed by oxidation and 
functional group interconversion to provide (-)-methyl barbascoate in 18 steps overall from (+)-(II). 
 
1.6.2  Synthesis from (-)-Verbenone 
 
An approach by Kato et al. [144] provides the trans-decalone by Lewis-acid catalysed ring 
opening of a (-)-verbenone derivative. 1,4-Conjugate addition of vinyl Gilman reagent to the chiral 
terpene (-)-verbenone was performed in quantitative yield (Scheme 1.16). Methylation at the -carbonyl 
position progressed regioselectively through deprotonation with lithium diisopropylamine (LDA) in the 
presence of 1-methyl-2-pyrrolidinone (NMP), followed by alkylation with iodomethane. The chemical 
transformation of the vinyl to a 2-acetoxy group was achieved in 3 steps by conventional reactions [144].  
 
Introduction 
39 
O
O
AcO
3 steps
O O
a) b)
1
4
a) CH2=CHMgBr, CuI, THF, quantitative b) LDA, MeI, NMP, THF 
 
Scheme 1.16: Functionalization on the (-)-verbenone structure reported by Kato et al. [144]. 
 
Regioselective cleavage of the cyclobutane ring was achieved using a Lewis acid mixture of 
boron trifluoride diethyl etherate (BF3.OEt2), zinc(II)acetate (Zn(OAc)2) and acetic anhydride (Ac2O) to 
give the enol acetate (Scheme 1.17). Hydrolysis to the ketone was performed in potassium carbonate 
(K2CO3) solution and this was accompanied by concomitant epimerization of the -methyl carbonyl 
group to give the cis methyl product in quantitative yield.  
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Scheme 1.17: Regioselective lewis acid mediated ring opening of the (-)-verbenone derivative to provide a 
substituted cyclohexene structure followed by base assisted epimerization to the desired isomer. 
 
Protection of the carbonyl and oxidation of the acetoxy substituent to the corresponding aldehyde 
was performed in 3 steps using literature methods [144]. Cyclization via an ‘ene’ reaction with diethyl 
aluminium chloride (Et2AlCl) gave the trans-C(5)/C(10) decalin ring system and subsequent oxidation of 
the C(7) alcohol using Swern reaction conditions was reported to produced the ,-usaturated carbonyl  
derivative in good yield (Scheme 1.18, step f). The 1,4-conjugate addition to C(9) using vinyl Gilman 
reagent gave the cis vinyl substituent relative to the adjacent bridgehead hydrogen C(10) in an analogous 
manner to the reductive alkylation product from the Wieland-Miescher ketone. -Carbonyl methylation 
at C(8) progresses regioselectively through deprotonation with lithium hexamethyldisilazane (LHMDS), 
followed by alkylation with iodomethane to produce the trans-C(8)/C(9) dimethyl groups. Facile 
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epimerisation of the C(8) methyl group occurred using 5% KOH in methanol to provide the trans-
neoclerodane skeleton in 17 steps from (-)-verbenone (Scheme 1.18, step i) [144]. 
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Scheme 1.18: Ene-cyclization using Et2AlCl to produce the trans-C(5)/C(10) decalin system followed by 1,4- 
Gilman addition, -carbonyl methylation and finally C(8) epimerization to provide the trans-neoclerodane 
skeleteon [144]. 
 
1.6.3 Novel Clerodane Syntheses  
 
As discussed in section 1.4.4, the potent insect antifeedant Jodrellin is an attractive target for total 
synthesis due to its potential as an antifeedant in farming and agriculture. Research by Ley et al. towards 
the synthesis of Jodrellin A and B [106, 107] have followed a linear synthetic approach to provide a 
successful pathway to the rigid epoxy diacetate decalin framework of the natural product (Scheme 1.19).  
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Scheme 1.19: Synthesis of the Jodrellin A framework via a selenium mediated -coupling [106, 107]. 
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The key step in this methodology is the selenium mediated coupling of the -ketoester to the 
alkene using N-phenylselenophthalimide (NPSP) to form the tricyclic Jodrellin skeleton. The Jodrellin 
framework was found to retain some of the insect antifeedant properties of the parent compound 
(Scheme 1.19). 
 
A novel approach by Arns et al. [145] towards the trans-decalin core of Teucrolivin A was 
reported in 2006. A [4+2] cycloaddition reaction of 1,3-cyclohexadiene was performed using singlet 
oxygen, generated in situ from ozone gas under ultraviolet light in the presence of TPP, to produce the 
dioxabicyclic peroxide starting substructure. Reduction using methanolic thiourea to the cis-cyclohex-2-
ene-1,4-diol provided a suitable building block for functionalization (Scheme 1.20). Olefination and 
incorporation of the 3-furyl moiety was conducted in eight steps and followed by a thermally induced 
tandem oxy-Cope/Claisen/ene reaction under microwave irradiation. This provided not only the trans-
decalin clerodane core but also the neoclerodane geometry at C(8)/C(9). Ozonolysis of the olefins gave 
the hemiacetal system present in Teucrolivin A with relative stereochemistry identical to that in the 
natural product. 
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Scheme 1.20: Synthesis of Teucrolivin A starting from the [4+2] electron cycloadduct product of cyclohexadiene 
and singlet oxygen, published by Arns et al. [145]. 
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1.6.4 Previously Reported Asymmetric Total Synthesis of Salvinorin A 
At the time that the research presented in this manuscript was carried out, no successful or 
proposed strategies for the asymmetric total synthesis of 1 were reported in the literature. During the 
final manuscript preparation an asymmetric total synthesis of the target compound 1 was published by 
Scheerer et al. [31] who described the construction of the tricyclic trans-neoclerodane ring using a 
transannular Michael reaction cascade of an appropriate, highly substituted macrolactone. The required 
functionality for ring A was progressively introduced on an acyclic chain starting from 1-(2-
thioxothiazolidin-3-yl)pent-4-en-1-one (Scheme 1.21). The stereochemistry at the C(4) ester of 1 was 
established by orthoester alkylation using Ni(II)-(R)-BINAP catalysis to give the -ketoester in excellent 
enantioselectivity (94% ee) and interconversion to the ,-unsaturated aldehyde was achieved in a 
further four steps using known methods. Selective aldol-type addition was reported in 9:1 d.r. using the 
acetate of the (S)-4-isopropyl-2-thioxothiazolidin-3-yl auxiliary in the presence of Sn(OTf)2, followed by 
protection as the C(7) TBS ether. Mentioned by the authors as a footnote, the C(7) stereocenter was 
predicted to promote the convergence of macrocyclic precursors.  
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a) Ni-(R)-BINAP(OTf)2, 2,6-lutadine, BF3.Et2O, HC(OMe)3 b) HO2CCH2CO2Et, i-PrMgCl, 65ºC c) Sn(OTf)2, N-
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Scheme 1.21: Scheerer et al. [31] have prepared the highly functionalised aldehyde using a combination of chiral 
catalysts and auxiliaries, as a major fragment for the convergent synthesis of 1.
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Transesterification to the methyl-ester followed by conversion to the terminal aldehyde was 
reported in two steps and (-)-N-methyl-ephedrine-mediated zinc acetylide addition was reported to give 
the propargylic alcohol in high yield with 6:1 preference for the desired stereochemistry in the 
corresponding C(2) acetoxy position in 1. Protection of the alcohol and oxidative cleavage was carried 
out in three steps to provide the terminal aldehyde in 70% as a major convergent fragment to 1 [31] 
(Scheme 1.21).  
 
Stereochemistry at the C(12) 3-furyl position was established using the (R)-B-Me-
oxazaborolidene catalysed asymmetric reduction of 1-(furan-3-yl)but-2-yn-1-one and transformation to 
the vinyl iodide using known methods was reported to yield the second convergent fragment in three 
steps and high enantioselectivity (97%  ee) [31] (Scheme 1.22).  
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f) (R)- B-Me-oxazaborolidene, BH3.Me2S, -30ºC g) n-BuLi, MgBr2.OEt2, -78ºC, aldehyde, then MgBr2.OEt2, DCM, 
-78 to 0ºC h) TBAF, –78 to 5ºC i) K2CO3, MeOH, quantitative j) Ac2O, Pyridine, DMAP. 
 
Scheme 1.22: Scheerer et al. [31] report coupling of the furan fragment using the Grignard reaction of the vinyl 
iodide functionality with the aldehyde fragment in a convergent approach. Transformation to the bisenone followed 
by Michael reaction cascade gave the desired stereochemistry at C(5), C(9) and C(10) and as featured in 1, which 
was obtained upon further synthetic manipulation.  
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The vinyl Grignard was generated using n-BuLi/MgBr2.OEt2 which was reacted with the 
aldehyde fragment, yielding the alcohol in 86%, and macrolactonization followed by oxidation to the 
bisenone system was reported in a further six steps (64%).  The Michael reaction cascade was effected 
under very mild conditions (TBAF, -78 to 5ºC), resulting in a single tricyclic isomer in an impressive 
99% yield. In this key step, diastereocontrol was achieved for the cis-oriented C(5) and C(9) methyl 
groups, both of which are positioned trans to the C(10) proton is in agreement with in the  
stereochemistry of 1. The authors credit this result to the reinforcement from C(4) and C(12) 
stereocentres based on their experimental data on model compounds, and transformation to a mixture of 
C(8)-epi-salvinorin B and salvinorin B followed in a further five steps. C(8)-Epimerization followed by 
acetylation was accomplished (78%) to give 1 in thirty four steps overall from commercially available 
reagents.  
 
This example represents the first reported synthesis of salvinorin A (1) and validates the 
significance of 1 as an important synthetic target. The synthesis described in this manuscript aims at 
achieving the same target product 1 and follows a different pathway to all examples described in section 
1.6. The retrosynthetic analysis of 1 is outlined in section 1.7.  
 
1.7 Retrosynthesis of Salvinorin A  
 
The clerodane syntheses reviewed in section 1.6 all follow a linear synthetic methodology, 
starting from a chiral starting material and building on it in sequential sections to the original chiral core 
fragment. As has been hopefully observed from the examples shown, when choosing a chiral starting 
structure, the stereochemical outcomes required of the target product determine which products are most 
appropriate to initiate the synthesis. The starting material is required not only to possess as many chiral 
centers as possible in common with the desired target product, but also should direct sequential reactions 
in a stereoselectivly favourable manner. The highly oxygenated ketone ring present in salvinorin A 
appeared to have more functionality than could be introduced conveniently through linear modification 
of the Wieland-Miescher ketone (Section 1.6.1). Furthermore, studies by Hagiwara [142] (Figure 1.14) 
and chemical transformations on salvinorin A [86, 146] demonstrate that the carbon center C(8) is easily 
epimerised when adjacent to carbonyl functionalities. This led us to investigate a convergent synthesis 
and commence separate studies towards the synthesis of either end ring of the salvinorin A molecule and 
attempt to create the central ring during the junction of the two. An attractive feature of this synthesis is 
that both convergent halves contain definite pharmacophores that can be studied individually.  
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Scheme 1.23: Disconnection of salvinorin A (1) at ring B to produce convergent precursors rings A and C.
Ring B dissection of the tricyclic structure at C(9)/C(10) and C(6)/C(7) presents a functionalised 
cyclohexanone (ring A) and an ,-unsaturated lactone (ring C) as precursors in a convergent synthesis 
(Scheme 1.23). Stereocentres adjacent to ketone and ester functionalities contain acidic protons and were 
identified as potential sites for racemization during preparation and purification.   
 
Introduction of the vinyl substituent can be retrosynthetically derived from the reaction between 
a ,-unsaturated ketone (2) and a vinyl Gilman nucleophile. Cleavage of the easily modified acetyl 
group leaves an ,-unstaurated vinylogous acid (3) (Scheme 1.24). If this intermediate were prepared 
through rigorous reaction conditions involving heat or strongly acidic or basic conditions, dehydration of 
the alcohol would be likely and subsequent isomerization would produce an aromatic phenol.  
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Scheme 1.24: Disconnection of ring A using a vinyl Gilman reagent and acetyl action using acetyl chloride. 
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For this reason we decided to prepare the alcohol (3) by the ether bridge cleavage of a 7-
oxanorbornane or 7-oxabicyclo[2.2.1]heptane species (4).  Ring opening of the bicyclic ether provides 
the stereochemistry of the ketone ring present in both salvinorin A and B. The enol of the ketone can then 
be retrosynthetically disconnected as the [4+2] electron Diels-Alder cycloaddition product between a 
substituted furan (5) and methyl acrylate (MAC) (Scheme 1.25). 
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Scheme 1.25: The oxabicyclic ketone synthon (4) can be devised by a retro [4+2] electron cycloaddition reaction 
to produce a substituted furan starting material (5). 
 
Heterosubstituted furans have been found useful as reactive dienes in the preparation of 7-
oxa[2.2.1]bicycloheptane structures using Diels-Alder methodology. The compatible functional groups to 
incorporate as X in the 3-position of the furan starting material (Scheme 1.25) was narrowed to those 
labile to hydrolysis when connected to an isolated olefin. This allows for ether, ester, amide or amine 
substituents as the most accessible functionalities to include in this synthon. It was also decided at this 
point that if the C(3) substituent were to contain a chiral centre, it could act as a chiral auxiliary in the 
subsequent cycloaddition reaction to prepare a single enantiomer in excess. Amine-containing (X = N)
chiral compounds are abundant and enamines are readily cleaved under aqueous acidic conditions, hence 
an amine substituent was chosen as the C(3) heteroatom. Literature research at this time revealed that 
little was known about the preparation or chemistry of 3-amino substituted furans and we were aware 
that the design of an expedient synthesis would be desirable. 
 
Ring C was first disconnected by a retro Aldol or Reformatsky reaction to produce a substituted 
butanone attached to a vinyl acetic ester. Disconnection of the ester provides a 1,3-keto alcohol that can 
be rationalised as the retro aldol product between 3-furaldehyde and acetone (Scheme 1.26). 
Construction and connection of the vinyl acetic acid fragment will depend on the stability of the furfurol 
8. If an esterification procedure that preserves stereochemistry is required, -halovinyl esters may be 
obtained directly through a deconjugation/esterification procedure using -bromocrotonyl chloride in 
which case the activating substituent on the ester chain would be a halide. If stereochemistry at the 
alcohol is to be inverted during esterification, an activated vinyl acetic acid is then desired. 
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Scheme 1.26: Disconnection of ring C to the 3-furyl substituted butanone (7) followed by ester cleavage to the 3-
furyl alcohol (8). The 1,3-ketoalcohol can be disconnected by a retro-Aldol reaction between 3-furaldehyde and 
acetone. The ester cleaved from 7 can be prepared from variety of acid chlorides accessible from crotonic acid. 
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Furans serve as versatile building blocks in synthetic chemistry [1,2] and many biologically 
active molecules [3] and natural products [4] incorporate the furan moiety. This has resulted in the 
continued development of many routes to furan derivatives [5]. Although the chemistry of furans permits 
ready functionalisation at the C(2) and C(5) positions, similar operations at the C(3) or C(4) positions are 
difficult to achieve. The C(3) and C(4) substituted furans are typically produced by ring closing 
reactions, rather than by direct substitution of furan itself. The aromaticity and reactivity of furan will be 
discussed in the context of the preparation of nitrogen or ’aza’ substituted furans, and strategies for the 
incorporation of nitrogen substituents at the C(3) position will be outlined. 
2.1 Conjugation and Aromaticity 
 
The increased stability of conjugated compared to isolated double bonds has been demonstrated 
experimentally from the partial hydrogenation of 1,3-butadiene [6] (Scheme 2.1).  
 
Hohydrog. H
o
hydrog.
-110 kJ/mol -126 kJ/mol  
Scheme 2.1: Stepwise energies for the partial hydrogenation of 1,3-butadiene [6].  
 
In a conjugated carbon chain, the extra stability can be partially attributed to the shortened bond 
distances in  bonds formed from overlap of sp2 orbitals, compared to  bonding involving only sp3
orbitals [6] as in ethane. According to molecular orbital theory, the  bond is created by a combination of 
two p orbitals. The  orbital results from combining two 2p molecular orbitals (MOs) of separate carbon 
atoms and the in-phase combination (lower energy) accounts for the bonding orbital ( MO), whilst the 
out-of-phase combination (higher energy) accounts for the antibonding molecular orbital (* MO). This 
is shown using a simple molecular orbital diagram for the example ethylene (Figure 2.1) where electrons 
occupy the lowest energy bonding orbitals. The  orbital is the highest occupied molecular orbital 
(HOMO) and these electrons are the most available for chemical reactions. Each sp2 hybridised orbital 
forms a framework of unpolarizable  bonds, with one unhybridised -orbital perpendicular to the 
trigonal hybrid orbitals. In the conjugated 1,3-butadiene example, the interaction between  bonding 
Synthesis of 3-Furylamines 
62 
orbitals of each double bond provides additional stabilization energy due to a greater delocalisation of 
electrons.  
 
Figure 2.1: Energy level diagram demonstrating the molecular orbitals resulting from the combination of p- atomic 
orbitals in ethylene and 1,3-butadiene. 
 
The energy of the highest occupied molecular orbital (HOMO) 2 is a good approximation to the 
lowest ionization potential of the molecule and represents the least tightly held electrons. The lowest 
unoccupied molecular orbital (LUMO) 3 describes the easiest pathway for the addition of more 
electrons to the system. 
 
In cyclic unsaturated compounds, the possibility of resonance-hybrid structures can contribute an 
additional degree of stability such that  bonds do not posses the typical reactivity observed in acyclic 
conjugated olefins. This phenomenon was first observed in benzene and benzene-containing compounds 
and associated with an enhanced aroma.  Hence the term now used to describe this extra stability is 
aromaticity. The experimental heat of hydrogenation of benzene demonstrates an aromatic stability, or 
resonance energy, of 152 kJ/mol compared to the calculated value for cyclohexatriene [7]. The 
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delocalised p electrons in the lowest energy bonding orbital of benzene are best described as doughnut-
shaped clouds above and below the benzene ring (Figure 2.2). 
 
H
HH
H
H H
6e-
Figure 2.2: Canonical forms of benzene and a Chemdraw representation of the - cloud in the benzene ring. 
 
In 1931, Erich Hückel noticed that all compounds demonstrating aromaticity are conjugated, 
planar, monocyclic compounds with 6 p-orbital systems containing (4n + 2)  electrons. The Hückel rule 
can be applied to unsaturated ring systems of all sizes to predict aromaticity and is of relevance to the 
five membered furan heterocycle under investigation.  Heterocyclic compounds such as thiophene, 
pyrrole and furan, obey the Hückel aromaticity rule and contain four p-orbital electrons contributed by 
double bonds, and two p-orbital electrons from the heteroatom. Resonance energies contributed by 
aromaticity are 121, 88 and 67 kJ/mol respectively [7], and the furan ring possesses a lesser degree of 
aromaticity than the other heterocycles mentioned. Unlike benzene, these aromatic heterocycles have 
nonequivalent positions and are more reactive at the 2-position, in close proximity to the heteroatom. The 
canonical forms of furan are shown in Figure 2.3.   
 
O O O O OO
1
2
34
5
6e-
Figure 2.3: Canonical forms of furan and a Chemdraw representation of the - cloud in the furan ring. 
 
Syntheses of the furan ring commonly involve an intramolecular cyclization of a 1,4-diketone 
system. An established method for the preparation of 2,5-disubstituted furans is the Paal-Knorr 
synthesis, which can be modified to also prepare pyrrole and thiophene compounds [8]. Mild heating in 
the presence of the Lewis acid catalyst zinc chloride (ZnCl2) is sufficient to cyclize hexane-2,5-dione to 
2,5-dimethylfuran, which is reversible to the 1,4-diketone system under strongly acidic conditions 
(Scheme 2.2). The furan product acquires an additional portion of resonance energy upon formation of 
the aromatic conjugated  system. In this example, aromaticity is a crucial factor in the formation of the 
furan system and favorably moves the dehydration of the hemi-ketal intermediate towards the complete 
formation of the stabilized furan product.  
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Hexane-2,5-dione 2,5-Dimethylfuran
1
4
Scheme 2.2: Paal-Knorr synthesis; Lewis acid promoted cyclization of hexane-2,5-dione to produce 2,5-
dimethylfuran [8]. 
 
The Feist-Benaig synthesis involves a condensation between chloroacetone and ethyl 
acetoacetate using pyridine as a base to create the 1,4-diketone system (Scheme 2.3). The intermediate 
ketone undergoes dehydration to yield the 2,5-dimethyl furan with an ethyl carboxylate substituent at the 
C(3) position [9]. 
 
O
Cl
O
OO
N
O
O
O
OH
O
O
O
-H2O
O
O
O
O
1 4
3
2,5-Dimethyl-furan-3-
carboxylic acid ethyl ester
Scheme 2.3: Feist-Benaig synthesis; Base mediated condensation to produce the 1,4-diketone and subsequent 
cyclization to produce 2,5-dimethyl-furan-3-carboxylic acid ethyl ester [9].  
 
2.1.1 Stability Considerations of Heterosubstituted Furans  
 
The amine containing furan compounds are properly named as furylamines attributing 
nomenclature to the highest ranking amine group, however the name 3-aminofuran has more often 
appeared in the literature and both are used interchangeably. Although the primary furan-3-ylamine has 
not been reported in the literature, some attention has been shown towards the predicted instability 
associated with this compound. In particular, C(3)-amino and hydroxy substituted furans have been 
modeled by Bodor, Dewar and Harget [10] using semi-empirical SCF MO theory with Hückel , 
approximation in ideal, gas phase conditions. Heats of atomization (Ha) were calculated for the furan-3-
ylamine and the non-aromatic furan-3-ylidene-ammonium tautomer and the difference value used as an 
indicator of the enthalpy of tautomerisation. The aromatic form was predicted to be more stable than the 
imino compound, although its enthalpy of tautomerization is remarkably low (0.061 eV)[10]  (Scheme 
2.4) and in solution may exist in equilibrium and provide a facile pathway for unwanted side reactions. In 
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contrast, the C(3) hydroxy derivative is predicted to exist predominately as the furan-3-one ketone 
tautomer indicated by a negative enthalpy of tautomerisation (Scheme 2.4).   
 
O
NH2
O
NH2
Furan-3-ylidene-ammoniumFuran-3-ylamine
O
OH
O
O
Furan-3-ol Furan-3-one
Ha = 49.085 eV Ha = 49.024 eV

Ha = 0.061 eV
Ha = 45.725 eV Ha = 45.580 eV

Ha = -0.755 eV
 electron population
C(3) group 
O(1)
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 NH2
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 OH
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Scheme 2.4: Enthalpy of tautomerization for furan-3-ylamine and furan-3-ol [10] and a listing of -electron 
population density values for C(3) amine, hydroxy and methoxy substituted furans in comparison to the 
unsubstituted furan [11]. 
Aromatic stabilization energies for furans possessing electron withdrawing groups (EWG) and 
electron donating groups (EDG) have been approximated by John et al. [11] using standard LCAO SCF 
MO theory, and the geometry of the furan nucleus taken from the STO-3G basis set. Substituent effects 
were measured by comparison of stabilizing influence on furan compared to the benzene nucleus. Their 
findings suggest that, relative to a phenyl group, the furyl group acts as a -electron donor and -electron 
acceptor. Inductive -electron withdrawal by the ring oxygen is more pronounced at the C(2)-position 
and -electron density is enhanced from overlap with oxygen -orbitals, resulting in higher C(2) HOMO 
energy values relative to C(3).  
 
In general, a -EWG at C(2) or C(3) stabilises the aromaticity of the furan nucleus. A -EWG at 
C(2) stabilises the furan system by participating in conjugative -interaction and -EWG at C(3) enhance 
stabilisation by resonance delocalisation of charge onto the oxygen ring (Scheme 2.5). The charge 
distribution for a range of C(3) oxa and aza substituted furans indicates an increased  electron density 
on the ring oxygen and at the C(2) position relative to the unsubstituted furan (Scheme 2.4). This 
effectively suppresses electron delocalization from the oxygen. Stabilization energies for amine, hydroxy 
and methoxy substituents were calculated by John et al. [11] to be –11.6, -14.9 and –2.5 kJ/mol, 
respectively. The negative values indicate a destabilised system and this is not surprising considering the 
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-electron donor, -electron accepting nature of the heteroatom substituents is opposing the same 
electronic trend inherent in the furan moiety. 
O
X
O
XH
O OX XH O XH
X = NH2, OH
X = NH2, OH
X = N, O X = N, O
X = N, O
2
3
X =  -electron donating group (EDG)
 -electron withdrawing group
O
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O
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O OZ Z O Z
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Z = N ; R = O
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O
R
O
Z O
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Z =  -electron withdrawing group (EWG)
 -electron withdrawing group  
Scheme 2.5: Resonance stabilised structures of C(2) and C(3) substituted furans attached to -EWG (Z) and -EDG 
(X). 
 
The C(2) heterosubstituted structures are predicted to be more stable due to resonance 
considerations (Scheme 2.5) and this is in agreement with theoretical findings by both John [11] and 
Bodor [10]. Theoretical studies by Shokhen et al. [12] suggest that proton affinity for the C(3) amine is 
higher than the C(2) amine derivative, however hydrolysis of the quaternary ammonium salt is likely in 
both cases. 
 
The synthesis of aza substituted five membered heterocycles can be carried out by functional 
group interconversions on the aromatic ring or by synthesis from acyclic precursors and both approaches 
will be discussed in the following sections. Given the inherent instability of the unsubstituted 3-
aminofuran, approaches to the preparation of mono and bis N-substituted 3-aminofurans were 
investigated. 
 
2.2 Syntheses of Aza-substituted Furans by Modifications on the Furan 
Ring 
Early efforts towards introducing an aza group to the furan ring proceeded via functional group 
rearrangement of a C(3) carboxylic acid or ester substituent. Preparation of 3-furoyl azide from 
commercially available 3-furoic acid [13, 14] has allowed access to the isocyanate using a thermally 
induced Curtius rearrangement [7] (Scheme 2.6). The methodology described by Prugh et al. [15] 
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towards the 3-furylamine involved reaction of the isocyanate with methanol (MeOH) to provide methyl 
N-(3-furyl)carbamate, followed by alkylation with iodomethane (CH3I). Reduction of the carbamate with 
lithium aluminium hydride (LiAlH4) gave furan-3-yl-dimethyl amine (Scheme 2.6) and 1H NMR data for 
this compound was reported. The authors report that upon workup of the reaction, the free base amine 
was only stable under inert atmosphere at 0ºC and isolation was conducted using preparative-scale gas 
chromatography. The stable trimethylammonium salt was formed by reaction of the amine with CH3I at 
0ºC and biological studies found these materials to be toxic in cats and rodents [15]. 
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3-Furoic acid 3-Isocyanato-furan
Scheme 2.6: The nitrogen heteroatom can be introduced at the C(3) position via the Curtius Rearrangement and the 
3-isocyanato-furan product has been reacted to prepare N-furan-3-yl-benzamide [14] and furan-3-yl-dimethyl amine 
[15]. 
 
No other literature examples could be found featuring the 2,4,5-unsubstituted-3-aminofurans, 
although the 3-acetaminofuran has been studied by a number of researchers [13, 14, 16]. N-Furan-3-yl-
benzamide has been prepared by Burtner [14] from the isocyanate by reaction with phenyl magnesium 
bromide and found to be a stable white crystalline solid (Scheme 2.6). Kuhn et al. [16] prepared a range 
of C(5)-ethylene-diol substituted N-furan-3-yl-acetamines via the Curtius rearrangement protocol and 
derivatization of the amide with CH3I was reported to produce the trimethylammonium salt. Although 
this general methodology provided the aza substituent at the desired C(3) position on the furan ring, the 
rearrangement strategy appeared inflexible for the easy incorporation of a range of amine substituents.  
 
The interconversion of 2-furoic acid to the corresponding carbamate was later reported by 
Ninomiya et al. [17] using diphenylphosphoryl azide (N3PO(OPh)2) in the presence of triethylamine and 
tBuOH. Synthesis of the 3-alkoxycarbonylaminofurans was more recently improved upon by Campbell et 
al. [18] using the one step methodology to provide the 3-(tbutoxy-carbonylamino)furan in moderate 
yields (Scheme 2.7). The authors mention that repeated attempts to isolate 3-aminofuran by removal of 
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the carbamyl group under a range of conditions led to decomposition and confirmed the material to be 
unisolable. 
O
N3PO(OPh)2
TEA, t-BuOH
O
O
HNOH
O
O
Scheme 2.7: The interconversion of 3-furoic acid to 3-(tbutoxycarbonylamino)furan has been reported by Campbell 
et al. [18] using N3PO(OPh)2.
The introduction of substituents directly at C(3)/C(4) on the unsubstituted furan ring is 
complicated since the most reactive positions are those closest to the heteroatom at the C(2)/C(5) 
positions. Protons H(2)/H(5) are acidic and can be removed to form the stable organo-lithium 
nucleophile, allowing substitution by means of reaction with alkyl halides and acid anhydrides or 
chlorides. Furan is the least aromatic of the heterocycles mentioned in Section 2.1, however this is 
conducive for functional group interconversion by electrophilic aromatic substitution. Resonance 
structures for intermediates resulting from electrophilic attack at the C(2) position; exemplified by the 
nitration of furan (Scheme 2.8), indicate greater delocalisation of positive charge around the furan ring 
compared with reactions at the C(3) position [19]. This permits furan to readily undergo electrophilic 
aromatic substitution at the C(2)/C(5) positions in preference to the C(3)/C(4) positions.  
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Scheme 2.8: The nitration of furan is an example of typical electrophilic substitution at the C(2) position and is 
stabilised by enhanced delocalization of positive charge, in contrast to the unfavoured substitution at C(3) [19]. 
 
In some furan systems, the nitro group leads to the amino furan via catalytic reduction using 
palladium on calcium carbonate (CaCO3) under a hydrogen atmosphere. An appropriate example is the 
preparation of 5-amino-furan-2-carboxylic acid methyl ester by Freure et al. [20] (Scheme 2.9, top), and 
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Padwa et al. [21] have more recently found use of this furan as a diene in Diels-Alder reactions to 
preparing substituted anilines. An alternate method for introduction of the amine substituent at the C(2) 
position is the direct nucleophilic displacement on 2,5-dinitrofuran [17] to produce 1-(5-nitro-furan-2-
yl)-piperidine (Scheme 2.9, bottom), although no reports could be found involving similar methodology 
at the C(3) position. 
 
OO2N NO2 OO2N NO2
NH
OO2N N
-HNO2
NH
O CO2Me O CO2MeO2N O CO2MeH2N
HNO3 Pd/CaCO3
H2
5-Amino-furan-2-carboxylic acid
methyl ester
1-(5-Nitro-furan-2-yl)-piperidine2,5-Dinitro-furan
Scheme 2.9: Top; Introduction of the amine substituent by nitro reduction with Pd/CaCO3 /H2 [20, 21] to produce 5-
amino-furan-2-carboxylic acid methyl ester. Bottom: Nucleophilic displacement of 2,5-dinitrofuran with piperidine 
to produce 1-(5-nitro-furan-2-yl)-piperidine [17]. 
 
EWG substituents in benzene systems have a meta-directing effect on subsequent electrophilic 
substitution reactions. In five membered heterocycles, EWG at the C(3)/ C(4) positions have a strong 
meta-directing influence and the directed position is the already favoured C(2)/C(5) position. In the 
example given in Scheme 2.10, the C(3) acetyl EWG in 1-furan-3-yl-ethanone directs nitration toward 
the C(5) position. EWG in the C(2)/C(5) positions generally do not have enough influence over the 
resonance stabilised intermediates to give C(3) or C(4) electrophilic substitution products unless a Lewis 
acid is used. The acetylation of 2-nitro-1H-pyrrole in the presence of boron trifluoride etherate 
(BF3.Et2O) Lewis acid, gives the C(3) acetyl product almost exclusively (Scheme 2.10). 
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Scheme 2.10: EWG at the C(3) position of 1-furan-3-yl-ethanone directs nitration to the meta- position C(2). With 
the incorporation of BF3.Et2O, the acetylation of 2-nitro-1H-pyrrole has been reported to occur predominately at the 
meta- position C(4) [19]. 
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The electrophilic bromination of furan systems containing a carbonyl EWG in the 2- position 
produce polybrominated compounds at low temperature as the result of multiple additions of bromine. At 
–15ºC 2-furoic acid reacts with bromine to give the saturated tetrabromo-compound [22] (Scheme 2.11). 
At higher temperatures the bromofuran is formed as the HBr elimination product to give 5-bromo-furan-
2-carboxylic acid predominately [23]. In the case of 2-furaldehyde, Gol’dfarb et al. report the use the 
Lewis acid aluminium chloride (AlCl3) and two equivalents of bromine to produce the unstable 4,5-
dibromo-furan-2-carbaldehyde (7) exclusively at temperatures above 60ºC [24].  Studies by Chadwick et 
al. [25] applied this reaction protocol at 50ºC in 1,2-dichloroethane (DCE) and identified brominated 
intermediates by GLC analysis, reporting the meta-substituted product 4-bromo-furan-2-carbaldehyde (8)
in 20% yield as a mixture with 7 (40%) and the unreacted aldehyde (30%) (Scheme 2.11). Reactions 
conducted without AlCl3 have been reported to provide the 5-bromo-furan-2-carbaldehyde (9) as a single 
product [26].  Although the aldehyde EWG has an enhanced meta-directing influence in the presence of a 
Lewis acid, stabilizing effects from C(2) EWG are still not adequate to give the C(4)-substituted 8 furan 
exclusively.  
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Scheme 2.11: Bromination of 2-furoic acid produces the tetrabrominated product at low temperature and 5-bromo-
furan-2-carboxylic acid at higher temperatures. The reactivity of 2-furaldehyde is similar, although bromination in 
the presence of AlCl3 can provide the 4-bromo-furan-2-carbaldehyde 8 in low yields at 50ºC [25] or 7 as a major 
product above 50ºC [24]. 
3-Bromofuran and 3-chlorofuran have been prepared by Shepard et al. [27] and reported as 
distillable, acid sensitive liquids. These aromatic halogen substituents can be interconverted to the amine 
functionality using palladium coupling reactions. It is not the aim of this thesis to review the vast scope 
and flexibility of palladium coupling reactions in organic synthesis [28], however the research relevant to 
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3-halofuran coupling will be mentioned. Recent progress in palladium coupling of aryl halides by 
Tomori et al. [29] has involved the investigation of suitable electron rich phosphine ligands to 
sufficiently catalyse a wide range of Suzuki coupling and amination reactions. Reports by Wolfe et al. 
[30] have described the efficient coupling of diarylamines to aryl halides using the newly developed 
ligands and high yields of 3-bromofuran-coupled triarylamine products have been reported by Harris et 
al. [31] (Scheme 2.12). This prompted the investigation in this work of an expedient pathway to 4-
bromo-2-methyl-furan (10) to explore the potential of the palladium coupling system as a flexible 
methodology for the preparation 3-furylamines (Scheme 2.12).  
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Scheme 2.12: The N,N-diaryl 3-furylamine has been prepared by palladium coupling of 3-bromofuran to an 
aromatic 2° amine using an approriate phosphine ligand [31]. This methodology could be applied to the preparation 
of 5 from 10.
2.2.1  Synthesis of 3-Bromo-5-methylfuran 
 
Bromination of 2-furaldehyde was undertaken according to the procedure of Chadwick et al. [9]. 
Two and one half equivalents of AlCl3 reacted exothermically with the aldehyde in DCE to form a solid 
complex and required cooling to prevent decomposition. Two molar equivalents of Br2 were added and 
the solution heated at 50ºC for 3.5 hr to produce a mixture of brominated products, with complete 
reaction of the starting furaldehyde contrary to the reported outcome. Formation of 8 (20%) and 9 (40%) 
was confirmed by molecular ions in GC-MS analysis (Figure 2.4, top left) in a mixture of 
polyhalogenated products, all of which show a characteristic [M-1]+ peak corresponding to a -
unsaturated aldehyde. Polychlorinated tetrahydrofurans and acid chlorides were formed as a major by-
product at low temperatures and the ratio of halogens was determined by isotopic ratios (Appendix 2.1)  
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Figure 2.4: Top left; GC-MS of the reaction mixture for the bromination of 2-furaldehyde at 50°C in the presence 
of AlCl3 to form 8 in 20% yield. Bottom: GC-MS of the crude Wolff-Kishner reduction product indicating the 
successful formation of 10 in low yields. 
 
Isolation of the monobrominated furans was achieved by rapid elution of the crude material with 
diethyl ether (Et2O) on silica gel using flash column chromatography to produce the unstable products as 
an inseparable mixture indicated by GC-MS analysis. The 5-bromo-furan-2-carbaldehyde 9 was 
distinguished from the isomer 8 in GC analysis by comparison with a pure sample of 9 (tR = 5.35), 
prepared by bromination in the absence of AlCl3 [32]. The dibrominated furaldehyde 7 formed in 85% 
upon performing the bromination at 60ºC and found stable to distillation whereas the monobrominated 
species 8 and 9 were prone to decomposition. Gol’dfarb et al. [33] report good yields of the 4-bromo-2-
ethylfuran via Wolff-Kishner reduction of the corresponding 4-bromo-2-acetylfuran and this strategy was 
applied to the mixture of aldehydes 7-9. Wolff-Kishner reduction of the brominated aldehydes was 
conducted with the Huang-Minlon conditions [34], using hydrazine (NH2NH2) and potassium hydroxide 
(KOH) in diethylene glycol. Direct distillation from the reaction vessel gave small amounts of the 
C(2)/C(5) methylated products 10 (0.5%) and 11 (4%) as identified by GC-MS analysis (Figure 2.4, 
bottom) and the dibrominated furan 7 could not be reduced under the same conditions (Scheme 2.13), 
instead undergoing decomposition to a black tar. The 2-bromo compound 11 is suspected to have 
undergone displacement by hydrazine followed by hydrolysis during reaction work-up to produce a 
major impurity at tR = 3.77 min with a molecular ion at m/z 98, equal to the 2-hydroxy-5-methyl product 
(Appendix 2.2).  
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a) 2.5 Equivalents of AlCl3, 1.5 equivalents of Br2, DCE, 50ºC, 3.5 h b) Performed at 60ºC c) NH2NH2, KOH, 
diethylene glycol, 195ºC.  
 
Scheme 2.13: Formation of an AlCl3 complex with 2-furaldehyde enhances the electron withdrawing effect of the 
carbonyl substituent and provided a mixture of the dibrominated furan 7, and monobrominated compounds 8 and 9.
The latter are stable to reduction using the Wolff-Kishner reaction to provide 5-methyl products 10 and 11 in poor 
yields. 
 
The 4-bromo-2-methyl furan product 10 was more stable to the reduction conditions, however 
reaction mixtures contained many by-products of similar boiling point. Decomposition at room 
temperature, accompanied by darkening of the small amount of material obtained, prevented the products 
from being used for further reactions. Shepard and coworkers describe the halogenated furans as 
colourless oils that darken upon standing and eventually change to insoluble resins, and suggest storage 
in sealed ampules over alkaline hydroquinone [28]. Alkaline hydroquinone was effective in minimising 
decomposition at room temperature, however dicolouration was also reduced when stored in a dark 
environment, indicating that sensitivity to UV light may be a contributing factor towards decomposition. 
This observation is consistent with the reported photochemical reactivity of bromofurans [26].  
 
A more selective approach to 10 was pursued starting from methyl 2-furoate 13. Conditions 
described in the patent literature [35] were optimised to prepare 2,3-dibromofuran 16 (Scheme 2.14), 
followed by methylation and debromination using conditions based on literature by Katsumura et al. [36] 
to give 10. Although this approach appeared straightforward, reproducing the patent literature proved 
time consuming and required optimization of most procedures. The optimized experimental methods are 
described in Section 6.1. 
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Scheme 2.14: Dibromination of methyl-2-furoate 13, followed by saponification and subsequent decarboxylation 
using copper in quinoline to produce 2,3-dibromofuran 16.
Initial bromination conditions in carbon tetrachloride (CCl4) at 80ºC gave good yields of 4,5-
dibromo-furan-2-carboxylic acid methyl ester 14, although over-brominated products were identified by 
GCMS analysis, indicating a range of high molecular weight compounds containing the characteristic 
tetrabrominated isotope pattern (Figure 2.5). When performed in chloroform (CHCl3) overnight at 70ºC 
the reaction was 96% selective for 14 (Scheme 2.14) owing to the decreased efficiency of CHCl3 as a 
bromination solvent. The progress of this reaction could be monitored by the evolution of HBr gas from 
the boiling solution and 14 was stable upon storage at 0ºC in a dark environment.  
 
Figure 2.5: GC-MS analysis for the bromination of 13 in CCl4. Tetrabrominated peaks at tR = 18 min have the 
characteristic isotope pattern for four bromine atoms. 
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Saponification of the ester in 4 M sodium hydroxide (NaOH) solution provided quantitative 
conversion to 4,5-dibromo-furan-2-carboxylic acid (15) which could be purified in only moderate size 
batches by recrystallization from boiling water, since solubility was found to be ~10 g/L. 
Decarboxylation was achieved using copper bronze powder in quinoline at 180ºC to produce 2,3-
dibromofuran (16) as a distillable light blue liquid that underwent decomposition upon exposure to UV 
light. Optimization was realised when reproducible high yields of 16 were obtained upon performing the 
reaction without agitation. With magnetic stirring the yield was reduced to 30%; this can be explained by 
considering that the decarboxylation relies on the presence of the copper(I) species [37], which upon 
exposure to air oxidise to copper(II). The use of copper(I) halides directly in the reaction gave 
disappointing results as did the use of mercury salts, also known to mediate decarboxylation [38] via the 
furan mercurial.  
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Scheme 2.15: Preparation of the 5-furyl lithium intermediate from 16 and LDA, followed by methylation (CH3I) at 
the C(5) position and debromination (tBuLi) at the C(2) position to provide 10.
After removal of the C(5) proton using the hindered base lithium diisopropylamine (LDA) to 
produce the 5-lithiofuran intermediate, methylation of the furan was achieved by the addition of 
iodomethane (CH3I) to give 2,3-dibromo-5-methyl-furan (12) in quantitative yield (Scheme 2.15). Mono-
debromination could be performed in the same reaction mixture using tertiary-butyl lithium (tBuLi) in 
THF at -78ºC to give excellent yields of 10 provided temperature conditions were closely controlled. The 
identity of 10 was confirmed by a molecular ion in GC-MS and was characterised by 1H and 13C NMR 
analysis. The product was found to be a colourless, sweet smelling oil that was UV sensitive and required 
storage at –18ºC in a dark environment.  
 
2.2.2 Palladium Coupling of Secondary Amines to 3-Bromo-5-methylfuran 
 
Palladium (Pd(0)) catalysed amination of aryl bromides has become a promising synthetic 
method for halide to amine functional group interconversions (see Section 2.2) and recently applied to 
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the coupling of 3-bromofuran in a sequential one pot synthesis of triarylamines (Scheme 2.16). The 
catalytic palladium species, Pd(0) is generated in situ from a Pd(II) source as the diacetate Pd(OAc)2 or 
the dibenzylidene acetone (dba) complex Pd(dba)2 or Pd2(dba)3 are often used since the complexing 
ligands are labile. High yields of coupling products with aryl halides have been reported using both aryl 
and alkyl amines provided a phosphine ligand is incorporated into the catalytic cycle. Mechanistic 
studies on this system show that the mixture of amine and sodium tertiary-butoxide (NaOtBu) base are 
responsible for the reduction of the Pd(II) precatalyst to the Pd(0) species which is in turn stabilised by 
the phosphine ligand [39]. The success of the coupling system is not only reliant on the phosphine ligand 
for stabilization of the reactive Pd(0) species, but it has also been suggested that the phosphine acts to 
inhibit the formation of the catalytically inactive palladium bis(amine)arylhalide complex [39]. As a 
result many phosphines have been trialed in palladium coupling systems and the bidentate 2,2'-bis-
diphenylphosphanyl-[1,1']binaphthalenyl (BINAP) [39], DPPF [40] and monodentate di-t-butyl-ortho-
biphenylphosphine (P(tBu)2-o-biphenyl) [30] (Scheme 2.16) have been successfully applied.  
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Scheme 2.16: One-pot Pd(0) catalysed amination of 1-bromo-4-methylbenzene with 4-methoxyphenylamine, 
followed by 3-bromofuran to produce the triarylamine product furan-3-yl-(4-methoxyphenyl)-p-tolyl-amine. 
Ligands used in palladium coupling reactions include the electron rich phosphines BINAP and P-(tBu)2-o-biphenyl 
[32].   
 
The catalytic Pd(0) coupling cycle begins with ‘oxidative addition’ of the aryl halide to the 
palladium complex to form an intermediate which can co-ordinate with the amine (Scheme 2.17). 
Deprotonation of the amine followed by ‘reductive elimination’ produces the aryl-amine product and 
regeneration of the Pd(0) catalyst. The catalytic cycle is shown for the Pd(BINAP) catalyst system, 
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which has been thoroughly investigated [41]. The Pd(P(tBu)2-o-biphenyl)2 system proceeds by a similar 
mechanism, however the phosphine is now a mono-dentate ligand and requires at least two equivalents to 
form the active catalyst.  
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Scheme 2.17: The palladium coupling cycle involves oxidative addition across the Pd(0)(BINAP) catalyst, followed 
by complexation of the amine and reductive elimination under basic conditions to produce the arylated amine Ar-
NR1R2.
4-Bromo-2-methylfuran 10 contains two EWG’s, namely bromine and oxygen, with one EDG, 
methyl, and overall is considered as an electron poor aromatic system. Although this system is 
unfavourable for palladium coupling reactions, phosphine ligands prepared by Tomori et al. [29] have 
facilitated coupling of electron poor aryl halides and triflates with dialkyl- and diaryl- secondary amines. 
The coupling of 3-bromofuran to diarylamines has been reported by Harris et al. [31] to proceed in 
excellent yields using the Pd(P(tBu)2-o-biphenyl)2 ligand [30], however the coupling of dialkyl amines 
with the halofuran was not mentioned.  
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Scheme 2.18: Palladium coupling of 10 with morpholine under conditions described by Harris et al. [31] provided 
4-(5-methylfuran-3-yl)morpholine (5a) in 30% yield. 
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Coupling of pyrrolidine and diisopropylamine to the furylhalide 10 under conditions described 
by Harris et al. [31] gave clean mixtures of starting materials with no detectable formation of coupled 
product by GC-MS analysis. GC-MS monitoring of the reaction of 10 with morpholine (Section 6.2) 
indicated a maximum yield of 30% for the coupled product 4-(5-methylfuran-3-yl)morpholine (5a) after 
4 h at 70ºC (Scheme 2.18) and longer times gave slow decomposition of the aminofuran. Higher 
temperatures and increased quantities of palladium complex or base did not improve yields 
proportionately and made isolation of 5a increasingly difficult. The amine 5a was not stable to 
distillation from the crude mixture, which required refrigeration soon after workup to avoid 
decomposition. Purification by extraction into aqueous acid led to fast decomposition of 5a and the furan 
also proved unstable to chromatographic separation on deactivated silica.  
 
Figure 2.6: GC-MS of the Pd(0)[P(tBu)2-o-biphenyl]2 coupling of 10 to morpholine to produce 5a in 30% yield 
relative to 10.
Rapid elution with Et2O through a small fluorosil column resulted in an improvement in product 
purity but decomposition continued to accompany chromatographic separation techniques. At this point 
the coupling strategy seemed problematic. It was suspected that the coupling system was effective but the 
inherent instability of the 3-furylamine system was not conducive to preparations involving elevated 
temperatures above 70ºC. Optimization of this particular Pd(0) coupling reaction may involve the 
preparation of suitable phosphine ligands and is far beyond the scope of this work. Rather than 
reconsider the synthetic strategy for ring A the scarce mention of 3-aminofurans in the published 
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literature and the largely unexplored chemical properties of these compounds encouraged the persistence 
of research. Synthetic methodologies from acyclic precursors were investigated as an alternative 
approach and will be presented in the following section. 
 
2.3 Synthesis from Acyclic Precursors 
 
Literature searches revealed numerous syntheses towards C(3) aza substituted furans from 
acyclic precursors. However in many instances product intermediates required the incorporation of 
substituents at the C(2) and C(5) positions. Recent publications towards 3-furylamines include a 
procedure developed by Redman et al. [42] involving the condensation of ethyl glycolate with -
cyanoketones under Mitsunobu conditions (Scheme 2.19, top). Deprotonation adjacent to the ester using 
NaH in THF led to cyclization from nucleophilic attack at the nitrile and subsequent tautomerisation to 
the furan. In this instance the primary aminofuran is formed and the furan ring is stabilised by the ester 
EWG, which also contains orbitals that contribute to the conjugated aromatic system.  
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Scheme 2.19: Pathways towards carboxylate substituted 3-aminofurans. 
The multicomponent reaction described by Ma et al. [43] uses a thiazole carbene as an umpolung 
to react with benzaldehyde and dimethylacetylene dicarboxylate (DMAD) giving the tetrasubstituted 3-
aminofuran diester in moderate yields (Scheme 2.19, bottom). Both pathways necessitate the introduction 
of ester substituents in the furan product since the reaction mechanisms rely on the properties of the ester 
EWG to facilitate the formation of reaction intermediates. 
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The aryl substituted 3-aminofuran ring has been prepared by a number of methods and there are 
three syntheses in the literature for the preparation of dialkyl-(5-methyl-2,4-diphenyl-furan-3-yl)-amines. 
Mageswaran et al. [44] have reported the base catalysed [3,2]-sigmatropic rearrangement of a phenyl-
(prop-2-ynyl) ammonium ylide in protic solvent. Upon heating, cyclization via intramolecular 
nucleophilic addition of the enol oxygen to the allene intermediate gives the dimethyl-(5-methyl-2,4-
diphenyl-furan-3-yl)-amine (Scheme 2.20, top; R = Me). The authors report this compound to be rather 
unstable and prone to rapid decomposition upon exposure to light and air. This is not surprising since, in 
contrast to the stabilizing effect of the electron withdrawing ester substituent, the phenyl substituents are 
EDG and destabilise the aromatic system.  
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Scheme 2.20: Novel pathways towards the 2,4-diphenyl substituted 3-aminofurans. 
Ficini et al. have prepared dimethyl-(5-methyl-2,4-diphenyl-furan-3-yl)-amine using the Feist-
Benaig synthesis shown in Scheme 2.3, followed by interconversion of the ester substituent to the amine 
via the Curtius rearrangement as seen in Scheme 2.6 [45]. A novel methodology was also reported, 
involving the reaction of 3-diethylamino-2,4-diphenyl-cyclobut-2-enone with methyl Grignard reagent 
(Scheme 2.20, bottom). Rearrangement of the Grignard intermediate results in ring expansion to the five-
membered heterocyclic benzylic anion, stabilised by the magnesium bromide cation [45]. This reaction 
proceeds via a ring expansion/rearrangement process to provide diethyl-(5-methyl-2,4-diphenyl-furan-3-
yl)-amine in one step from the amine substituted cyclobutenone (Scheme 2.20; R1 = Et). 
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Mageswaran et al. [44] described the hydrolysis of dimethyl-(5-methyl-2,4-diphenyl-furan-3-yl)-
amine under aqueous acidic conditions to give 5-methyl-2,4-diphenyl-furan-3-one (Scheme 2.21). A 
brief investigation was conducted in this work into the preparation of the 4-methyl-3(2H)-furanone (16)
as a potential precursor via condensation of the ketone with an amine, ie: pyrrolidine, to give the furan 5a
as the imine tautomer. 
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Scheme 2.21: The hydrolysis of dimethyl-(5-methyl-2,4-diphenyl-furan-3-yl)-amine was reported under aqueous 
acidic conditions [44] to the produce corresponding 5-methyl-2,4-diphenyl-furan-3-one. Conversely, the 5-methyl-
furan-3-one 16 may provide 5a by a condensation reaction with pyrrolidine. 
 
Following a procedure reported by Cui et al. [46], the Claisen condensation between acetone and 
ethyl 2-chloroacetate was used in an attempt to prepare 1-chloropentane-2,4-dione. The lithium enolate 
of acetone was prepared by the reaction of a stoichiometric ratio of LDA and acetone at –30ºC. The 
reaction was cooled to –50ºC and the enolate reacted with one half equivalent of ethyl 2-chloroacetate to 
allow for the acidity of protons at the -position to the ester. Upon aqueous workup the 1-chloro-
pentane-2,4-dione product was not observed and GC-MS analysis revealed a molecular ion for 16 in a 
low yield as a result of base mediated cyclization to the furanone (Scheme 2.22). At room temperature, 
the cyclic product 16 has a reported half-life of 60 minutes in the presence of base [47] and polymerises 
as it forms to give a low 10% yield (Section 6.3).  
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Scheme 2.22: Preparation of 4-methyl-3(2H)-furanone 16 from the Claisen reaction between acetone and 
chloroacetic acid ethyl ester, followed by base catalysed cyclization. 
Synthesis of 3-Furylamines 
82 
The ketone 16 was easily isolated by column chromatography on silica using a hexane:EtOAc 
gradient elution to give a clear oil and 1H NMR data was in agreement with that reported by Hofmann et 
al. [48]. Although the compound was stable in solution, the neat compound required refrigeration to 
prevent polymerization. The condensation between 16 and pyrrolidine was trialed in benzene using a 
Dean-Stark trap to remove the water formed from dehydration (Scheme 2.22). The 1,4-addition product 
could be expected to form under these conditions as a possible byproduct, but this was not observed and 
instead 16 underwent slow polymerization and the amine reagent remained unchanged and was observed 
in high concentration in GC-MS analysis after the polymerization of 16 was complete. p-Toluene 
sulphonic acid (p-TsOH) was added to aid dehydration by protonation of the amine, in an attempt to 
prevent base catalysed polymerization and perhaps aid in the dehydration of cyclization intermediates. 
Unfortunately, the same results were obtained as for the neutral conditions and condensation trials with 
morpholine indicated no improvement.  
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a) Benzene, Dean-Stark trap, Pyrrolidine, 90ºC 
 
Scheme 2.23: The condensation of 16 and pyrrolidine failed to give the furan 5a or the 1,4-addition product and 
instead led to decomposition products. 
Despite failed attempts to condense 16 with secondary amines, the tendency for cyclization of 
the 1,3-diketone system containing labile or reactive substituents at the terminal -position was duly 
noted.  The possibility of incorporating the amine into the 1,3-diketone backbone as an enamine 
functionality was investigated as a consequence of these observations. Literature research into the 
preparation of -hydroxy--aminoethylenic ketones revealed two references, both of which mentioned 
the isolation of an aminofuran rather than the enamine intermediate. Gusev et al. [49] propose that the 
reaction of diacetylenic glycols with 30% diethylamine solution under aqueous conditions produces the 
-aminoethylenic ketone or ‘enaminone’ system by di-addition of the amine to the alkynes, followed by 
hydration of one enamine group. Continued heating facilitated a retro-aldol reaction of the -hydroxy 
carbonyl chain and subsequent cyclization to give diethyl-(5-methyl-2-propyl-furan-3-yl)-amine in 
moderate yields (56%) (Scheme 2.24). The product was characterised by UV, IR and 1H NMR 
spectroscopy, as well as by elemental analysis. This approach provided furans containing additional 
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substitution at C(2) and removal or modification of alkyl substituents while following the same synthetic 
methodology may be quite difficult.  
 
HO OH
OH
N
EtEt
H
O O
H
OH
N
EtEt
H
O O
O
NEt
Et
OH
N
EtEt
H
O
aq. (C2H5)2NH
100oC
+
100oC
56%
Retro-Aldol
reaction
Diethyl-(5-methyl-2-propyl-
furan-3-yl)-amine
Dodeca-5,7-diyne-4,9-diol


Scheme 2.24: Reaction of dodeca-5,7-diyne-4,9-diol with aqueous diethylamine at 100ºC provides moderate yields 
of dimethyl-(5-methyl-2-propyl-furan-3-yl)-amine via a retro-aldol pathway [49]. 
Research conducted by Bowden et al. [50] on the addition of amines to conjugated ethynyl 
ketones describes the preparation of stable enaminones using primary and secondary amines, occurring 
by 1,4-addition at the -position to the carbonyl group (Scheme 2.25, top). This reaction is commonly 
referred to as a Michael-type 1,4-conjugate addition reaction [7].  
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Scheme 2.25: Top; Addition of amines to ethynyl ketones provides stable -enaminones [50]. Upon purification by 
sublimation, the imine tautomer 4-phenylimino-butan-2-one was formed for the aniline addition product. Bottom; 
the Michael addition of piperidine to 7-hydroxy-dec-5-yn-4-one resulted in the formation of the 1-(2,5-dipropyl-
furan-3-yl)-piperidine via the enaminone intermediate [50]. 
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Both acyl and benzoyl enaminone products were found to possess strong near UV absorption 
characteristics similar to butadiene and the values for maximum wavelength of light absorption (max) are 
given in comparison to the non-aminated derivatives, demonstrating the powerful auxochromic effect of 
the amine substituent in this conjugated system. The authors report that the Michael-type addition of 
piperidine to 7-hydroxy-dec-5-yn-4-one resulted in the formation of the 1-(2,5-dipropyl-furan-3-yl)-
piperidine upon standing in Et2O for 2 days. Workup involved extraction of the aminated intermediates 
into aqueous acid, followed by basifying the solution with 2 N NaOH and extraction to yield the furan 
product. The enaminone intermediate was not isolated during this process and it is likely that the furan 
product is prepared in the workup procedure rather than upon standing in the ethereal mixture (Scheme 
2.25, bottom). 
 
Although reference to the mechanism for the 3-aminofuran formation was not found, cyclization 
of -hydroxy-,-unsaturated systems has been mentioned by the same group [51] during the hydration 
of the hex-3-en-5-yn-2-ol using mercuric sulphate (HgSO4) and sulfuric acid under steam distillation 
conditions. In this instance hydro-oxo-biaddition at the alkyne [6] following the Markovnikov rule and 
subsequent acid hydrolysis gives the ,-unsaturated ketone, which undergoes thermal cyclization and 
dehydration to yield the furan (Scheme 2.26). Intermediates in the cyclization process are unknown, 
although an anionotropic rearrangement has been reported in these systems as a possible source for the 
production of hexane-2,5-dione [51], the furan precursor in Scheme 2.2.  
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Scheme 2.26: Studies by Heilbron on the preparation of 2,5-dimethyl-furan via an anionotropic rearrangement of 5-
hydroxy-hex-3-en-2-one [52].   
 
This isomerization may occur more easily in the -aminated compounds by tautomerisation 
involving the nitrogen. The imine isomer 4-phenylimino-butan-2-one has been isolated from sublimation 
of the aniline addition product (Scheme 2.25, top) and was reported to isomerise back to the ,-
unsaturated tautomer upon standing at 25ºC [50].  
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The cited literature references containing details on the preparation of the 3-aminofurans are 
general publications addressing the reactivity of acetylinic alcohols. No studies have been conducted 
concentrating on the utility or flexibility of this approach towards 3-furylamines for use in synthetic 
chemistry. The next section will detail a study on the preparation of the 3-furylamine compounds from an 
acyclic enaminone, prepared using a Michael-type addition to the appropriate alkynone backbone. 
 
2.3.1  Preparation of Protected Ketoalkynols 
From the studies presented in Section 2.3, the substituted furylamine 5 can be retrosynthetically 
derived via the enaminone, from the ketoalkynol 18 (Scheme 2.27). The alcohol 5-hydroxy-pent-3-yn-2-
one has been reported in the literature by Duranti et al. [52] and characterised to be a reactive oil, 
sensitive to light, heat and air, and stores poorly even in a dark environment at –20ºC. It was therefore 
more desirable to use the hydroxy protected derivative 18 and literature procedures describe a short 
synthesis from prop-2-yn-1-ol, incorporating the tetrahydropyran-2-yl (THP) protecting group [52].  
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Scheme 2.27: Retrosynthesis for the preparation of 3-aminofuran heterocycles 5 from the hydroxy protected 
alkynone 18 via the enaminone. 
Prop-2-yn-1-ol was first protected as the tetrahydropyran-2-yl (THP) derivative in neat 3,4-
dihydro-2H-pyran using a catalytic amount of phosphoryl chloride (POCl3) following methodology by 
Henbest et al. [53] (Scheme 2.27). The THP protection proceeds by acid catalysis, and once derivatised 
is extremely stable under strong basic conditions even in the presence of water. Addition of a KOH pellet 
to the neat mixture was sufficient in neutralizing the catalyst and the crude material was distilled directly 
to give a 90% yield of 3-(tetrahydropyran-2-yloxy)prop-1-yne 17. The acetylinic proton was removed 
using sodamide (NaNH2) in boiling Et2O under inert conditions following methodology reported by 
Duranti et al. [52] to provide a suspension of the sodium acetylide salt. The tetramethylsilyl (TMS) and 
tetraethylsilyl (TES) protected derivatives of 17 were found to undergo silyl rearrangement to the 
terminal acetylinic position upon deprotonation using sodamide or LDA.  
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Scheme 2.28: Acid catalysed THP protection of prop-2-yn-1-ol in 3,4-dihydro-2H-pyran to produce 17. The sodium 
acetylide salt of 17 was acylated with Ac2O (R1 = Me) to provide 18a and propanoic anhydride (R1 = Et) to produce 
18b.
Reaction of the sodium acetylide suspension of 17 with acetic anhydride (Ac2O) at –10ºC 
(Scheme 2.28; R1 = Me) gave the 5-(tetrahydro-2-yloxy)pent-3-yn-2-one 18a and the structure was 
confirmed by 1H and 13C NMR and GC-MS analysis (Figure 2.7). The methyl singlet at 
 2.3 ppm in 1H
NMR and the carbonyl 13C signal at 
 184 positively confirmed the presence an acetyl group and THP 
signals at 
 4.8 and 
 1.8 - 1.5 signify that the protecting group was still attached to the molecule. H(6’A)
and H(6’B) are locked in axial and equatorial configurations on the pyran ring and appear as separate 
signals at 
 3.8 and 2.6. Weak signals are present for the quaternary C(4) and C(3) acetylinic carbons at 

88 and 85 respectively and these chemical shifts are in the agreement predicted values generated using 
Chemdraw. A small [M-1]+ ion can be seen at m/z 181 in the GC mass spectrum and this is characteristic 
of conjugated ketones [54]. The m/z 85 fragment ion is the base peak in the MS of 18a and this fragment 
is characteristic of a THP group and is generated from heterolysis at the acetal carbon. 
 
If the crude mixture of 18a was kept cool and under inert atmosphere during workup, the 
unreacted acetylene 17 was effectively removed under high vacuum and the remaining alkynone was 
often used without further purification. Otherwise, 18a was purified by vacuum distillation (93ºC/1mm 
Hg) as a clear viscous oil. The 6-(tetrahydropyran-2-yloxy)hex-4-yn-3-one 18b was prepared in good 
yields by reacting the sodium acetylide suspension with propanoic anhydride (R1 = Et) following the 
same procedure.  
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Figure 2.7: 200 MHz 1H and 50 MHz 13C NMR analysis of 18a and EIMS fragmentation.  
 
The 4-(tetrahydropyran-2-yloxy)but-2-ynal 18c (R1 = H) was prepared from 17 using conditions 
described by Journet et al. [55] (Scheme 2.29).  
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Scheme 2.29: Formylation of the terminal acetylene of 17 using DMF with acidic quenching to provide 18c.
Deprotonation of 17 with n-butyl lithium (n-BuLi) at –40ºC produced the lithium acetylide, 
which was subsequently formylated with N,N-dimethylformamide (DMF). Quenching in an aqueous 
solution of potassium dihydrogen orthophosphate (KH2PO4) as an acidic buffer (pH 4.1 – 6.7) gave the 
aldehyde by hydrolysis of the lithio intermediate. Acidic quenching conditions are necessary since 
dimethylamine is liberated during hydrolysis and must be protonated in order to prevent Michael-type 
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addition to the newly formed 4-(tetrahydro-pyran-2-yloxy)-but-2-ynal 18c. The THP protecting group 
was found to be stable in the aqueous acidic buffer and 18c was prepared in high yield (84%). The 
procedures for synthesis of 18a-c are included in Section 6.4.1 with characterization data. 
 
2.3.2  1,4-Conjugate Addition to Alkynones 
The 1,4-addition product from the reaction between 18 and a nucleophile produces a substituted 
ethylenic system that can exist in either the E- or Z- isomeric forms (Scheme 2.30). Bowden et al. [50] 
mention that the reaction of 18a produces the enaminone product as a single isomer and Michael et al. 
[56] report that the E-isomer is formed when R1 = Me and the Z-isomer predominates is cases where R1 =
H due to intra-molecular hydrogen bonding with the nitrogen.  
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Scheme 2.30: Nucleophilic addition to 18 can result in E- or Z- isomers dependant on the acyl substituent R1.
Michael-type addition reactions when R1 = Me, Et gave quantitative yields when performed 
under solventless conditions by the addition of equimolar amounts of the amine to the stirred oil 18a or
18b. Smaller alkyl amines react exothermically during the addition and decomposition was minimised by 
initial cooling in a 10ºC water bath followed by stirring at room temperature for two hours. The more 
sterically hindered amines diisopropylamine and dibenzylamine required mild heating (60ºC) and 
prolonged stirring in order to achieve optimal yields. GC and 1H NMR analysis of the crude products 
indicated complete reaction of the alkyne in clean mixtures using the primary and secondary amines 
(Table 2.1) to produce enaminones 19a-k. In the case of ethylene diamine, one half equivalent of the 
amine was used to produce a quantitative yield of di-addition product 19f. The addition of amines might 
proceed via the nucleophilic mechanism for addition to ,-unsaturated carbonyls, followed by proton 
abstraction from the enaminium ion and enolization [7] (Scheme 2.31).  
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Energy minimised (MM2) Chem 3D models of the addition product 4-morpholino-5-(tetrahydropyran-2-
yloxy)pent-3-en-2-one 19a indicate the E-isomer to be more stable than the Z-isomer (Figure 2.8). The 
carbonyl in the Z-isomer is slightly out of plane with the olefin due to steric interference with the amine 
substituent, disrupting the planar geometry favorable for resonance stabilization of -electrons [57]. The 
3D model of the E-isomer shows a planar conjugated system as the amine and carbonyl substituents are 
in a geometrically distant spatial arrangement. It should also be noted that H(2’) on the THP protecting 
group is a chiral center and has a diastereotopic relationship to H(5).  
 
Figure 2.8: Energy minimised (MM2) Chem3D models of E- and Z- geometric isomers of 19a. The proximity of 
the carbonyl in the E-isomer has an influence on the C(5) hydrogens in 1H NMR studies. 
R1 R2R3NH 
% yield 
(19)
a) Me Morpholine > 97A
b) Me Diethylamine > 97A
c) Me Diisopropylamine > 97B
d) Me Pyrrolidine > 97A
e) Me Dibenzylamine > 97B
f) Me Ethylenediamine > 97A
g) Me n-Butylamine > 97A
h) Me  Cyclohexylamine > 97A
i) Et Morpholine > 97A
j) Et Diethylamine > 97A
k) Et n-Butylamine > 97A Scheme 2.31: Possible mechanism for the Michael 
addition to the alkynone. The morpholine addition 
product of 18a (R1 = Me) provides 19a as the E-
isomer. 
Table 2.1: Yields of 19a-k. APerformed neat 
at 10ºC-25ºC. BPerformed neat at 60oC
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1H and 13C NMR characterization of 19a revealed the addition product had formed as a single 
isomer (Figure 2.9). An AB quartet 1H NMR signal for the C(5) methylene group at 
 5.29 and 4.71 (J =
11.9 Hz) indicates non-equivalent chemical environments for the attached H(5A) and H(5B) protons and 
restricted rotation of the tetrahydropyran-2-yloxy group. This is in agreement with the 3D model for the 
E-isomer, whereby the proximity of the carbonyl to the cis- oriented methylene group is not equidistant 
to both C(5) protons. A new signal at 
 5.2 with an integral area equal to one proton is in agreement with 
Chemdraw predictions for the -proton H(3) and suggests successful formation of the enaminone. 
Reaction of the triple bond is confirmed by the absence of 13C quaternary acetylinic signals at 
 88 and 
85 for C(4) and C(3) as seen in 18a, and the presence of a protonated olefinic carbon at 
 98
corresponding to C(3) and a quaternary -enamine signal for C(4) at 
 159. Mass spectrometry 
fragmentation indicates a molecular ion at m/z 269 in agreement with the molecular weight of 19a and 
fragments m/z 85 and 84 correspond to fragmentation of the THP and morpholine rings, respectively. 
General trends observed in EI fragmentation of the enaminones 19a-n include ions as a result of THP 
cleavage, observed in 19a as a major fragment m/z 185, and subsequent homolysis of the acetyl group to 
give a base peak at m/z 142 in 19a (Appendix 2.3).   
 
Figure 2.9: 200 MHz 1H and 50 MHz 13C NMR analysis of 19a and EIMS fragmentation.   
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Extended studies on the addition of nucleophiles to the alkynone 18a gave interesting results 
(Table 2.2). This study was used to gain insight into the reactivity of the alkynone and reveal limitations 
in nucleophiles that can successfully be used in addition reactions. Aniline underwent 1,4-addition in 
good yields upon heating the neat mixture at 50ºC for 24 hr, however diphenylamine did not react under 
solvent-less conditions or in THF at 60ºC and is perhaps limited by steric crowding of the nitrogen atom. 
N-methylaniline showed only 15% addition product by GC-MS using solventless conditions, however 
yields improved to 90% upon heating in THF at 60ºC for 2 days. Imidazole behaved similarly indicating 
95% yield by GC-MS after 24 hr at 60ºC. Pyrrole failed to provide any addition product, even after 
heating for prolonged periods (7 days) and this can be explained by the low nucleophilicity of the 
aromatic heterocycle. Similarly, formamide, acetamide and N-methyl formamide were inert to addition 
reaction due to the low nucleophilcity of amides. Sodium azide and the sulphur nucleophile, ethanethiol 
anion, underwent facile addition to the alkynone at room temperature and provided clean reaction 
mixtures. Sodium ethoxide failed to react as a nucleophile, resulting in an unidentified mixture of by-
products, presumably since it can act as a base due to the acidity of the -carbonyl hydrogens in 18a. The 
successful formation of the ,-unsaturated addition products was confirmed by molecular mass 
fragment ions in GC-MS studies and integrals of characteristic H(5A)/H(5B) 1H NMR signals. The 
products listed below are not fully characterised and are beyond the scope of this synthetic study. 
 
R1 Nucleophile (Nu:) 
% yield (19)
(GC-MS) 
Me Aniline 91A
Me N-Methyl aniline 90B
Me Pyrrole - 
Me Diphenylamine - 
Me Formamide - 
Me  Acetamide - 
Me  N-Methylacetamide -
Me  Imidazole 95B
Me  Indole 15B
Me  DIMCARB (CH3)2NH+CO2- > 97A
Me CH3CH2S-Na+ > 97C
Me CH3CH2O-Na+ -
Me CH3COO-Na+ -
Me Na+N3- > 97C
Table 2.2: Extended studies on the addition of nucleophiles to 18a. Yields are measured by GC-MS and products 
not fully characterised. APerformed neat. BPerformed in THF at 60ºC. CPerformed in THF at room temperature. 
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The aldehyde 18c (R1 = H) was reacted in quantitative yields by slow addition to a solution of the 
amine in dry THF at 5oC (Scheme 2.32). The morpholine, diethylamine and n-butylamine addition 
products were prepared and the reactivity of the aldehyde toward nucleophiles appeared comparable to 
the ketones 18a-b.
THPO
O
R1
18c R1 = H
R1
O
N
THPO
R3R2a)
19l-n  
1H and 13C NMR analysis of product 19l showed a second order AB quartet for the methyene 
protons H(4A) and H(4B) at 
 4.6 and the expected 8.1 Hz coupling between the aldehyde H(1) and 
olefinic -proton H(2) (Figure 2.10). The H(4) AB quartet system in 19l was closer to a second order 
signal compared with the methylene AB system for H(5) in 19a. This is concordant with the Z-isomer 
whereby the carbonyl substituent is trans- to the C(4) pyranyl ether and no longer exerts shielding effects 
to influence the chemical and magnetic environments of H(4) protons. The smaller diethylamine 
analogue 19m showed a singlet for the H(4) signal, indicating that geometrical hindrance to rotation 
about the C(3)/C(4) bond due to the amine size may also be responsible for the second order nature of the 
diastereotopic methylene signals. Product 19n gave a 2:1 mixture of E- and Z- isomers as indicated from 
the integral areas of the H(1) or H(2) protons and individual signals for each isomer were confirmed by 
1H COSY 2D NMR (Appendix 2.4). 1H Frequency differences for H(4A) and H(4B) were measured for 
the E- and Z- isomers of 19n using the formula 5.022 )4( JCAB =  [58] and found to be 108.9 and 23.8 
times the respective coupling constants. As chemical shift differences J/ approach 10, the peaks 
appear with second order splitting as shown in Figure 2.10. Upon removal of residual THF under strong 
vacuum, decomposition products began to appear in product mixtures of 19l-n suggesting that THF 
solvation was essential for stabilizing the aldehyde. The apparent quartet signals in the 1H spectrum of 
19n at 
 3.17 and 3.10 correlate to the H(1’’) protons for E- and Z- isomers and 1H COSY NMR show 
these peaks to be second order AB quartets. The H(1)/H(2) protons in the E-isomer of 19n are in a cis-
arrangement and have a smaller coupling constant of 2.6 Hz. 
 R1 R2R3NH 
% yield 
(19)
l) H Morpholine > 97 
m) H Diethylamine > 97 
n) H n-Butylamine > 97 
Table 2.3: Yields of 19l-n. a) NHR2R3, dry THF, -5°C, quantitative 
Scheme 2.32: 1,4 Addition to 18c to prepare 19l-n.
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Figure 2.10: 200 MHz 1H NMR for the Z-isomer of 19l and the mixture of E- and Z- isomers of 19n.
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2.3.3 Preparation of 3-Aminofurans from Enaminones  
In the presence of acid, deprotection of the THP protecting group (Scheme 2.33) follows the 
reverse mechanism to that shown in the protection Scheme 2.28. The enamine nitrogen is protonated 
under these conditions; however reports suggest the -acyl enaminium ion is stable to hydrolysis in 
dilute aqueous acid [50].  
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Scheme 2.33: Acid catalysed THP deprotection to form the -acyl enaminium ion. 
 
Acids trialed for the deprotection step included hydrochloric acid (HCl), sulphuric acid (H2SO4), 
nitric acid (HNO3), and p-TsOH in chlorinated aprotic solvents (CHCl3, DCM) and protic solvents 
(MeOH, EtOH, H2O) to give multicomponent mixtures containing no detectable product by GC-MS and 
1H NMR analysis. One exception is the reaction of 19a with p-TsOH in methanol at 70ºC, which 
provided clean conversion to the cyclised hydrolysis product 16 in 40 min as confirmed by 1H and 13C
NMR data of the known compound. Orthophosphoric acid (H3PO4) in DCM gave promising results and 
during reaction monitoring by GC-MS analysis the furan was observed as the major product with a 
molecular ion of m/z 167 matching the mass of the furan target 5a. The workup procedure reported by 
Bowden et al. [50] involving extraction of the hydrolysis product into aqueous acid led to 
multicomponent mixtures and without detectable formation of the furan product. Material obtained upon 
workup by neutralization with sodium bicarbonate (NaHCO3) showed no 1H NMR furan signals in the 
expected aromatic 
 6 – 7 region. Re-analysis of the isolated material by GC-MS analysis showed no 
material matching the retention time and fragmentation of the product observed in the crude reaction in 
progress. Upon extraction of the enaminium salt from the H3PO4/DCM reaction solution into distilled 
water, the protonated intermediate was stable for a short period of time (ca. 15min). After immediate 
basification (pH 14) of the aqueous extract, the freebase amines were extracted from the cloudy yellow 
mixture with Et2O. GC-MS analysis revealed a 20% yield of 5a and decomposition products were 
reduced considerably by using 1,2-dichloroethane (DCE) rather than DCM. Further improvements 
involved the use of anhydrous trifluoroacetic acid (TFA), and color changes from green-blue to red were 
often observed in association with the progress of the reaction. An optimal reaction time of 40 min was 
found experimentally for the deprotection to reach completion and longer reaction times encouraged the 
formation of by-products. When basification and extraction procedures were performed at 0ºC-5ºC, 
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excellent yields of 5a were obtained in >98% purity by GC-MS. The tertiary substituted 3-aminofurans 
were stable as the free bases and could be stored for long periods at -18oC. 
 
O R
1
N
R3
R2
THPO
R1
ON
R2 R3
HO
R1
ONH
R2 R3
CF3COO
19 5
a) b)
a) CF3COOH, DCE b) 4 M NaOH 
 
Scheme 2.34: Preparation of tertiary 3-aminofurans 5a-e, i-j, l-m 
from the corresponding enaminones in Table 2.4. 
 
Table 2.4: Yields of furans 5a-e, i-j, l-m.
The morpholine substituted furan 5a was reproducibly prepared on multigram scales in almost 
quantitative yield. 2D HETCOR analysis of 5a is shown in Figure 2.11 with DEPT 135 spectrum. Furan 
signals at 
 6.82 and 
 5.86 each integrate as one proton and are in the predicted region for aromatic 
proton signals H(2’) and H(4’) respectively. The protonated aromatic signals showed 13C NMR 
correlation to C(2’) at 
 123.9 and C(4’) at 
 100.2 and both signals were confirmed as C-H groups by 
DEPT 135 data, as deduced from the positive signal orientation. The highest frequency protonated 
signals in the HETCOR spectrum are assigned to H(2’)/C(2’) and occur at lower frequency than 
observed in the unsubstituted furan ring. The (5’)-position is closest to both -electron withdrawing 
heteroatoms and deshielded with respect to diamagnetic anisotropy resulting in typically high frequency 
shift for H(2’). High -electron density at C(2’) creates in a decrease in paramagnetic shielding due to 
repulsion of electrons away from the nucleus. This results in an ~20 ppm upfield shift for C(2’) in 13C
NMR and a small 0.5 ppm upfield shift for H(2’) in 1H NMR with respect to that observed in furan. The 
chemical shift of the H(4’) proton is in close agreement with that reported by Gusev et al. [49] for 
diethyl-(5-methyl-2-propyl-furan-3-yl)-amine (Scheme 2.24) of 
 5.72. The methyl group H(6’) at 
 2.22
is correlated to a positively oriented CH3 signal at 
 14.0 and the quaternary aromatics carbons C(3’) and 
C(5’) are absent from the DEPT spectra, but appear in the 13C NMR as weak signals at 
 152.5 and 
141.7. The higher frequency quaternary signal can be assigned as C(5’) since it is attached to the more 
electronegative ring oxygen and has electron movement from the oxygen lone pair into the -system in 
its resonance forms. The 1H NMR multiplet at 
 3.81 with an integral area of four protons is assigned to 
the H(6) and H(2) methylenes, adjacent to the ether oxygen of the morpholine ring and this signal 
correlates to a single negatively oriented CH2 peak at 
 66.6 in 13C DEPT 135 NMR analysis. Similarly, a 
1H NMR multiplet at 
 2.87 corresponding to four protons is assigned to the H(5) and H(3) methylene 
(19) R1 R2R3NH
% yield 
(5)
a) Me Morpholine 96 
b) Me Diethylamine 90 
c) Me diisopropylamine 95 
d) Me Pyrrolidine 84 
e) Me dibenzylamine 73 
i) Et Morpholine 91 
j) Et Diethylamine 88 
l) H Morpholine 67 
m) H Diethylamine 64 
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protons adjacent to the amine and correlates to a single CH2 peak at 
 50.8 in DEPT 135 data. The 
chemical formula of 5a was confirmed by electrospray ionization high-resolution mass spectrometry 
analysis (ESI-HRMS) and provided an accurate mass for the protonated amine C9H14NO2 in agreement to 
three decimal places of the theoretical value (168.1025 calc., m/z 168.1019 found). ESI-HRMS were 
obtained for all new furan compounds in Table 2.4 and are listed in Appendix 6.1. EIMS analysis of 
furans 5a-n gave a molecular ion and often an [M+1]+· from proton abstraction. Typical furan losses 
include heterolytic cleavage of the amine substituents to give the C5H5O+· ion (m/z 81), and loss of CH3·
to give the m/z 152 ion, followed by cleavage of CO to give the m/z 124 ion in a two-step reaction [15] 
(Appendix 2.5).   
 
Figure 2.11: EIMS and 200 MHz 1H/50 MHz 13C HETCOR NMR analysis of 5a. 13C DEPT 135 NMR data is on 
the right margin. CH and CH3 groups are positive, CH2 groups are negative. 
 
1H and 13C NMR chemical shifts for the aromatic furylamine ring C(2’)/C(3’)/C(4’)/C(5’) were 
very similar for all analogues of 5 where R1 = Me or Et. Aromatic furan 1H NMR signals were usually 
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broad singlets, however J3’5’ = 1.1 Hz coupling was observed for 5i. In analogues 5l-m where R1 = H, 
chemical shifts reported were close to those of the only literature example reported, furan-3-yl-
dimethylamine [15]. Coupling constants for 5l are J2’4’ = 1.1 Hz, J2’5’ = 1.6 Hz and J4’5’ = 1.8 Hz 
(Appendix 2.6) in close agreement with the dimethyl analogue quoted as J2’4’ = 1.1 Hz, J2’5’ = 1.8 Hz and 
J4’5’ = 1.8 Hz [15]. 
 
Deprotection and cyclization of secondary alkyl enaminones performed better in chloroform than DCE. 
3-N-Alkyl substituted furans 5f-h, k and n (R3=H) were stable in solution at 0oC and gave molecular ions 
in GC-MS analysis, but required conversion to the N-acetyl derivatives 21 for isolation and 
characterization (Scheme 2.35). Confirmation of the amide derivative was established using 13C NMR by 
the presence of an amide carbonyl at 
 171.0. 13C NMR signals for the furan ring suggest that the 
aromatic system is no longer -electron rich as the C(5) carbon has shifted by 
 16 toward higher 
frequency compared to the dialkylated amines in Table 2.4, due to decreases paramagnetic shielding. The 
amide group has an electron withdrawing effect on the nitrogen atom and the quaternary C(4) proton has 
shifted to a 
 10 lower frequency due to corresponding decreases in substituent electronegativity. The 
chemical formulae of 3-furylamides 21f-h, k, n were confirmed by ESI-HRMS and provided masses 
accurate to three decimal places for each compound. Spectral characterization for 21g is shown in 
Appendix 2.7. The experimental procedures for the syntheses of 5, 19 and 21 are included in Section 6.4. 
O O
R1 R1
N N
R2
H
R2
Ac
5 21
a) or b)
Et2O, Et3N
When R1 = Me or Et, higher product yields were obtained than for the unsubstituted R1 = H
compounds. The amine substituents containing more hydrophilic groups gave higher yields of cyclised 
product compared to N,N-dibenzyl-5-methylfuran-3-amine 5e, which contains bulky aromatic 
substituents and this may indicate that the aqueous workup is less efficient for more hydrophobic amines. 
(19) R1 R2R3NH 
% yield 
(21)
f) Me ethylenediamine 73A
g) Me n-butylamine 90A
h) Me cyclohexylamine 86A
k) Et n-butylamine 84A
n) H n-butylamine 65A
Table 2.5: A The secondary C(3)-amines 
were isolated as N-acetyl derivatives.  
a) Ac2O, when R2 = n-butyl, ethylene diamine 
b) AcCl, when R2 = cyclohexylamine. 
Scheme 2.35: Preparation of 3-furylamides 21.
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It is worth noting that 5e was the only furan product that was stable at room temperature and did not 
require storage at –20ºC. The aniline conjugate addition product successfully cyclised to the furan 5
however an efficient derivatization method for the N-(furan-3-yl)aniline has not yet been found and the 
free amine is only stable for 1-2 h in ethereal solution at room temperature. 
 
In the series of aminofurans discussed, aromatics unsubstituted at the 2, 4 and 5 positions were 
less stable upon storage and preliminary studies towards the preparation of the 5-arylaminofuran (R1 =
Ar) resulted in compounds that underwent decomposition within a few minutes after workup and in 
CDCl3 while trying numerous attempts to collect NMR data. 
 
Products 19a-n and 5a-n discussed in Section 2.3.2 and 2.3.3 were characterised by 1H NMR, 
13C NMR, GC-MS analysis. Products 5a-n were also characterised by FTIR and data is listed in 
Appendix 6.1. 
 
2.3.4 1H NMR Studies on Cyclization Intermediates  
The cyclization procedure described in Section 2.3.3 has been flexibly applied to the preparation 
of a range of 3-furylamines, however no cyclization intermediates could be identified in the crude furan 
mixtures. A small investigation was undertaken to examine intermediates in the cyclization scheme 
indicative of acid or base mediated cyclization, and perhaps elucidate a mechanism for the formation of 
the furan.  
 
Figure 2.12: 200 MHz 1H NMR spectrum of 19i with peak assignments.  
 
The morpholine addition product 19i (Figure 2.12) was dissolved in CDCl3 and mixed with 
100µl of TFA in an NMR tube. The protonated enaminone was analysed by 1H NMR and the successful 
THP deprotection was indicated from the collapse of the AB quartet from H(6A) and H(6B) to form a 
singlet at 
 5.50 (Figure 2.13, top) with an integral area of two protons. The olefinic C(4) proton has a 
decrease in shielding due to protonation of the conjugated nitrogen in 19i-int and can be seen as a broad 
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down-field signal at 
 6.24 in agreement with Chemdraw predictions. The CH2 groups H(3’) and H(5’) 
are closest to the morpholine nitrogen and appear as two separate downfield signals at 
 3.72 and 
 3.60
when the nitrogen group is protonated. The THP group appears to have reacted with TFA as indicated by 
a methine singlet at 
 6.04. Olefinic signals from 2,3-dihydro-2H-pyran were not observed and instead a 
sharp single proton corresponding to the predicted shift for the H(2’) signal in trifluoroacetic acid 
tetrahydropyran-2-yl ester ring was present.  
 
Figure 2.13: Top; 200 MHz 1H NMR spectrum of 19i with TFA in CDCl3 to give the proposed compound 19i-int.
Middle;  CDCl3 solution after extraction with D2O. Bottom; 1H NMR of the D2O extract and assignments for the 
proposed intermediates 19i-int2 and 19i-int3.
The amine products were removed by extraction with D2O and subsequent 1H NMR analysis of 
the remaining CDCl3 solution indicated persistence of the proposed trifluoroacetic acid tetrahydropyran-
2-yl ester H(2’) singlet at 
 6.04 and THP signals at 
 1.30-1.80 as a major component (Figure 2.13, 
middle). The D2O extract mixture required multiple attempts to obtain a clean spectrum (Figure 2.13, 
bottom). The highest frequency 1H NMR signal is a singlet at 
 5.73 with an integral area of one proton 
and can be assigned to a olefinic enamine hydrogen. Resonance due to the ethyl chain appears as a 
quartet H(6) and triplet H(7) at 
 2.15 and 
 0.68 (J6,7 = 7.5 Hz) but both signals have shifted upfield 
(lower frequency) in comparison to the previous spectrum shown (Figure 2.13; Figure 2.12, top), 
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indicating that the ethyl substituent is no longer adjacent to carbonyl or enol functionalities. This finding 
suggests that the protonated intermediate formed upon extraction into D2O is in the cyclic hemiketal 
form. If the enamine double bond was present between C(3) and C(4), a methylene CH2 signal would be 
expected at approximately 
 4.4 and this was not the case. Two new signals are observed at 
 2.7 and 
integrate as one proton, indicating that a portion of this signal may have been deuterated from the D2O
solvent whilst undergoing tautomerizarion. The chemical shift of this signal also indicates that it is not 
attached to the same carbon as a heteroatom. The larger signal at 
 2.72 appears as an AB quartet (J = 4.4
Hz) whereas the smaller one, perhaps due to the mono-deuterated compound is a singlet at 
 2.79. The 
AB quartet suggests that these protons are in a locked conformation and the chemical shift most likely 
corresponds to the H(3) protons in the structure 19i-int2 and the deuterated compound 19int-3 (Figure 
2.13). Attempts at longer 2D experiments on this intermediate failed due to changing signal shifts and 
intensities, and since assignments are only based on 1H NMR data the structural assignments proposed 
are only tentative.   
 
Figure 2.14: Top; 200 MHz 1H NMR of the C(2’)-deuterated furan D(2’)-5i in CDCl3 obtained from basification of 
the D2O extract with NaOD and extraction into CDCl3. Bottom; 200 MHz 1H NMR spectrum of the non-deuterated 
furan 5i.
The cyclization procedure gave extremely low yields when conducted in deuterated solvents and 
needed to be performed rapidly in order to obtain enough material to obtain a spectrum of the furan 
product. Basification of the aqueous D2O NMR solution with NaOD and extraction into CDCl3 gave a 
Chapter 2 
101 
clean 1H NMR spectrum of the deuterated furan structure 4-(2-deutero-5-ethyl-furan-3-yl)-morpholine 
D(2’)-5i (Figure 2.14). Preparation of the non-deuterated furan derivative 5i followed by treatment with 
D2O showed the disappearance of the aromatic H(2) signal at 
 6.83 indicating that the deuterium 
exchange did not take place as part of the mechanism and instead the C(2) proton is acidic and labile to 
2H isotope exchange. This observation is consistent with results published by Campbell et al. [18] who 
mention C(2) deuterium exchange during 1H NMR experiments of 3-(tbutoxy-carbonylamino)furan in 
D2O, indicating a degree of enamine character in the C(3) aza furan derivatives. The aromatic H(4’) in 
D(2’)-5i has an integral area of one proton and no decrease in intensity due to deuteration via the 19int-3 
intermediate. This observation suggests heavy isotope effects [7] in the cyclization as a primary reason 
for the large decrease in product yield in D2O, whereby the final aromatization under basic conditions 
proceeds much more slowly for 19int-4 or 19int-3 than 19int-2 and results in decomposition.  
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Scheme 2.36: Proposed reaction pathway for the cyclization of the enaminone 19 to the furan 5.
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Based on the above study, a proposed cyclization mechanism for the formation of 3-furylamines 
is shown in Scheme 2.36. The key steps in the proposed sequence are as follows; 
 
1. The THP deprotection proceeds in DCE and reacts with TFA to produce trifluoroacetic acid 
tetrahydropyran-2-yl ester and the deprotected enaminium ion 19i-int.
2.  Cyclization to the hemi-ketal 19int-2 occurs upon extraction into water and the enamine double 
bond is free to tautomerise via the imine to the C(5)/C(4) position. In doing this, deuteration can 
occur at the C(3) position to produce 19int-3 or 19int-4.
3. Dehydration occurs via a base mediated mechanism using aqueous NaOH to provide the furan 
product. 
 
2.4 Preparation of Chiral 3-Furylamines  
The preparation of a chiral 3-furylamine derivative has been reported by Schlessinger et al. for 
use in a Diels-Alder approach towards the construction of (+)-cyclophellitol [59, 60]. In this case, 
synthesis of the 3-furylamine involved progressively building the furan around the amine structure, 
starting with (S)-2-(1-methyl-1-methoxypropyl)-pyrrolidine (Scheme 2.37), a L-proline derived chiral 
secondary amine. Alkylation of the nitrogen atom with methyl 2-bromoacetate provided the tertiary 
amine, that was subsequently deprotonated at the -position to the ester using potassium 
hexamethyldisilazane (KHMDS) and reacted with (tert-butyl-dimethylsilanyloxy)acetaldehyde to 
produce 3-[(S)-2-(1-methyl-1-methoxypropyl)-pyrrolidin-1-yl]-5H-furan-2-one. Treatment with an 
additional portion of KHMDS gave the furan via enolization of the carbonyl under basic conditions and 
subsequent reaction with triisopropylsilylchloride (TIPSCl) produced the 2-triisopropylsiloxy ether 
substituted furan in 56% overall yield from the starting amine.  
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Scheme 2.37: Synthesis of 2-((S)-1-methyl-1-methoxypropyl)-1-(2-triisopropylsilanyloxy-furan-3-yl)pyrrolidine 
from the L-proline derivative (S)-2-(1-methyl-1-methoxypropyl)pyrrolidine. 
The authors report this furan to be highly reactive in pericyclic reactions and provide excellent 
face selectivity of <97:3 upon Diels-Alder reaction with methyl acrylate in DCM at 22ºC [59]. The 
authors also mention that the isolation of the furan product is cumbersome and reactions are carried out 
by preparation of the furan in situ from the furanone. `The reports by Schlessinger et al. motivated the 
synthesis of a proline derived auxiliary for use in the furylamine synthesis. Reduction of L-proline to (+)-
(S)-2-(hydroxymethyl)pyrrolidine with LiAlH4 following a procedure described by Enders et al. [61] 
failed to produce clean reduction mixtures and 10-15% recovery of a mixture of L-prolinol and L-proline 
was common. (Scheme 2.38) This was most likely due to the effective complexation of prolinol with the 
Al3+ reducing agent and small amounts of material could be recovered from heating the Al(OH)3 workup 
residue in 1 M/HCl.  
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a) LiAlH4, THF, 10% b) SOCl2, BnOH >97% c) 18a, neat >97% d) TFA, DCE, r.t. e) 4 M NaOH, 35% 
 
Scheme 2.38: Low yields of (+)-(S)-2-(hydroxymethyl)-pyrrolidine were obtained from the reduction of L-proline. 
Preparation of 5o was achieved in low yields using the L-proline benzyl ester 22.
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The reduction of L-proline seemed problematic and a proline ester was prepared and trialed as an 
indicator of the stability of proline derived 3-aminofurans. L-Proline benzyl ester 22 was prepared by 
reaction of L-proline with SOCl2 in benzyl alcohol (BnOH) by modified procedures to those described in 
the literature [61]. The 1,4-conjugate addition of 22 to the alkynone proceeded in quantitative yields, 
however the ester-containing substituent led to a large decrease in yield for the cyclization reaction to 
provide the furan 5o in low yields (35%) (Scheme 2.38). The product was also prone to decomposition, 
requiring protection from air and storage below –20ºC and the experimental details are included in 
Section 6.5.1.  
 
Many of the furans prepared in Section 2.3.3 had a similar tendency to decompose and required 
frequent distillation, although compounds containing larger alkyl and arylamine substituents 
demonstrated increased stability. The N,N-dibenzyl-5-methylfuran-3-amine 5e was a stable white solid at 
room temperature, indicating that chiral secondary amines containing aromatic substituents may be more 
suitable for the preparation of stable chiral 3-furylamines.  The ephedrine diastereomers (1S,2S)-(+)-
pseudoephedrine 23 and (1R,2S)-(-)-ephedrine 24 differ in stereochemistry at the C(1) hydroxy group 
and were chosen as cheap chiral pool auxiliaries to be attached to the furan ring (Figure 2.15).  
 
N
H
OH
(1S,2S)-(+)-Pseudoephedrine
23
1
2 3 N
H
OH
(1R,2S)-(-)-Ephedrine
24  
Figure 2.15: Structures of (1S,2S)-(+)-pseudoephedrine 23 and (1R,2S)-(-)-ephedrine 24 differ in stereochemistry at 
the C(1) carbon.  
 
1,4-Addition reactions of 23 and 24 with the alkynone 18a were conducted in dry THF and GC-
MS analysis indicated the complete reaction of starting materials after 4 hr to produce a mixture of 
isomers (Figure 2.16, bottom) with identical mass spectrum and no molecular mass ion. Thermal 
interconversion between isomers was noticed during chromatographic separation as indicated by tailing 
on the leading edge of the analyte peak, even at low concentrations. GC-MS traces of the addition 
product of 23 indicated the formation of 19p as two major isomers (Figure 2.16, top left), however the 
addition product of 24 produced 19q as three or more major isomers (Figure 2.16, top right) and 
complete GC resolution of intermediates 19p-q was not achieved.   
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Figure 2.16: Left; GC trace of product mixture 19p starting at 70ºC followed by 10ºC/min temperature ramp. Right; 
GC trace of product mixture 19q starting at 50ºC followed by 10ºC/min temperature ramp. Bottom; The electron 
impact mass spectrum for 19p and 19q contain the same major mass fragment ions and a spectrum of 19q is shown.  
 
13C NMR analysis of the addition product 19p (Appendix 2.8) revealed a mixture of two major 
isomers and two minor isomers. Two strong carbonyl signals are apparent at 
 207 and indicate a loss of 
the ,-unsaturated system in comparison to addition products 19a-n, exemplified by 19b (Figure 2.9), 
in which case the carbonyl can be observed upfield at 
 195.9. The absence of quaternary enamine 
signals at 
 158.8 and olefinic proton signals at ~
 5.2 in 1H NMR also support this finding. 2D HMQC 
NMR analysis (Figure 2.17) indicates 13C NMR signals at 
 95.5 – 96.9 are due to non-protonated 
carbons and the chemical shift is indicative of attachment to two heteroatoms. This observation suggests 
that the hydroxy group on the phenyl-propanol chain had reacted with the quaternary enamine carbon to 
form the five membered cyclic oxazolidine ring. Studies by Walker et al. [62] on the mass spectrum of 
ephedrine and pseudoephedrine derived oxazolidines identify characteristic fragment mass ions m/z 148, 
118 and 91. All of these fragment ions are present in the mass spectrum of 19p (Appendix 2.8) and 19q
(Figure 2.16, bottom) supporting the five-membered heterocyclic structure 1-(3’,4’-dimethyl-5’-phenyl-
2’-((tetrahydro-2H-pyran-2’’-yloxy)methyl)oxazolidin-2-yl)propan-2-one (Scheme 2.39) that can exist as 
erythro or threo isomers at the C(2’) carbon.  
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Scheme 2.39: Addition products of 23 and 24 with 18a produce the enaminone intermediate that rapidly undergo 
isomerization to the five membered oxazolidine structures 19p and 19q.
NMR assignments were made for the major isomeric structures of 19p using HMQC NMR data 
(Figure 2.17). Non-protonated 13C NMR signals at 
 96.8 and 96.2 are assigned to the C(2’) heterocyclic 
quaternary oxazolidine carbon. Two separate sets of AB quartet signals between 
 4.06 – 3.44 are 
assigned to H(7’’) and correlate to C(7’’) carbon signals at 
 70.4 and 69.8. Two 1H NMR signals at 

2.82 appear as second order peak splitting and correlate to the C(1) carbon signals at 
 49.5 and 49.6. 
Correlations between H(4’), H(5’) and H(6’) on the ephedrine chain were confirmed by COSY analysis 
(Appendix 2.9) and revealed that H(1) methylene signals are overlapped with the H(4’) methine signal. 
The ephedrine analogue 19q was characterised by 1H and 13C NMR, although the increased number of 
isomers led to broad indistinguishable 1H NMR peak shapes (Appendix 2.10) and low signal to noise for 
distinguishing quaternary carbons. Differences in 1H NMR chemical shifts for H(4’), H(5’) and H(6’) 
due to anisotropic effects of the benzene ring were consistent with that observed by Hyne [63], and 
multiple broad singlets for the N-CH3 H(7’) suggest that 19q is in equilibrium with the enaminone form 
(Scheme 2.39, bottom). A broad uncorrelated singlet at 
 5.19 in the COSY NMR analysis also supports 
this hypothesis and is most likely the -olefinic hydrogen (Appendix 2.10).  
 
The hydrolysis kinetics of ephedrine derived oxazolidines has been well studied [64] and 
complete hydrolysis has been achieved at pH 1-11 at 37ºC under aqueous conditions. It was thus 
Chapter 2 
107 
assumed that hydrolysis of the oxazolidine would be facile and occur during aqueous workup procedures. 
Cyclization of 19p-q using the workup procedure described in Section 2.3.3 resulted in a messy mixture 
of products and attempts to extract the protonated enaminone into distilled water were ineffective due to 
the bulky hydrophobic ephedrine group. 
 
Figure 2.17: 300 MHz 1H/75 MHz 13C HMQC NMR of 19p. 1H and 13C NMR correlations are shown for the major 
oxazolidine isomer. 
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A significant portion of the enaminones 19p-q underwent hydrolysis to the ketone in aqueous 
acid at 0ºC, as evidenced by the identification of 23 and 24 in product mixtures by mass spectrum library 
match (Wiley 6 library, 92%). Aromatic 1H NMR signals at 
 6.73 and 5.82 and a molecular ion m/z 245 
in GC-MS spectrum confirmed the presence of the furan structure (1R,2S)-2-(N-methyl-N-(5-
methylfuran-3-yl)amino)-1-phenylpropan-1-ol (5q) (Appendix 2.10) and separation of the ephedrine 
impurity by rapid flash column chromatography using Et2O on silica was successful, although always 
accompanied by some decomposition of the furan. Decomposition was indicated by a bright red colour 
and was noticed when the column was run too slowly, or at temperatures higher than STP. The workup 
procedure was modified by quenching the TFA/DCE deprotection mixture with ice-cold 5 M NaOH 
solution, directly in a separating funnel followed by vigorous mixing. The solution changed from a deep 
red colour when initially agitated, to a very pale yellow colour when the cyclization was complete. This 
led to quantitative recovery of cyclised product 5q, however under conditions required for cyclization, 
some THP- group migration to the benzylic oxygen occured to produce 5q-THP (Scheme 2.40) as 
indicated by the characteristic H(2’’’) methine signal at 
 4.41 and broad aliphatic signals at 
 1.66 - 1.44
in 1H NMR, and m/z 85 fragment ion in GCMS analysis (Appendix 2.10). 
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Scheme 2.40: Cyclization of the oxazolidines 19p-q using TFA, followed by THP deprotection in EtOH provided 
the ephedrine and pseudoephedrine substituted furans 5p and 5q in high yields. 
On treatment with TFA the ephedrine derived furan 19p gave complete migration of the THP 
group to form <97% 5p-THP (Scheme 2.40) according to GC-MS signal integration although molecular 
ions were absent for both 5p-THP and 5q-THP. Complete THP deprotection was achieved by heating at 
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60ºC with p-toluenesulphonic acid in ethanol. Furan products 5p-5q were stable in aqueous acid at 0ºC 
and purified by extraction into cold ice-cold 2 M HCl, washing the aqueous solution with DCM to 
remove the 2-ethoxytetrahydropyran, then basification to pH 14 with ice-cold 3 M NaOH (Scheme 2.40).  
Extraction with DCM provided 96% isolated yield of 5p and 5q in >98% purity by 1H NMR and GC-MS 
analysis and the products were stable for long periods upon storage at -18°C. 1H and 13C NMR data is 
presented in Figure 2.18 for the furan 5p along with mass fragmentation data.  
Figure 2.18: 300 MHz 1H and 75 MHz 13C NMR data for (1S,2S)-2-(N-methyl-N-(5-methylfuran-3-yl)amino)-1-
phenylpropan-1-ol 5p showing. The mass spectrum of 5p shows a molecular ion at m/z 245. 
 
In the 1H NMR of 5p (Figure 2.18) a double quartet is observed for the H(2) proton at 
 3.26 (J2,3 
= 9.6 Hz, J2,1 = 6.6 Hz) with coupling to doublets at 
 4.46 and 0.80 corresponding to the H(1) (J1,2 = 9.6 
Hz) and H(3) (J1,3 = 6.6 Hz) doublets at respectively. Aromatic 1H NMR furan signals are seen at 
 6.87
for H(2’’) and 
 5.94 for H(4’’) and are at typical chemical shifts for the 5-methyl-3-aminofuran 
substitution pattern. The low intensity C(5’’) and C(3’’) 13C NMR quaternary signal are observed at 

152.5 and 140.8 respectively and the aromatic methyl C(6’’) at 
 14.1 is accompanied by an expected 1H
NMR singlet H(6’’) at 
 2.25. The three protons from the nitrogen methyl H(4) appear as a singlet at 

2.60 and the C(4) signal can be assigned to the 13C NMR peak at at 
 33.0 in close agreement with 
Chemdraw predictions. The experimental protocol for the preparation of 5p-q is included in Section 
6.5.2 with a listing of NMR characterization data.  
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Diels-Alder Reactions of 3-Furylamines  
3.1 The Diels-Alder Reaction 
 
Otto Diels and Kurt Alder were the first two scientists to offer theoretical grounding for the [4
+2] electron cycloaddition reaction, first mentioned in synthetic literature by Zincke in 1892-1912 [1] 
and later identified by von Euler in 1923 [2], nowdays called the “diene synthesis” or the Diels-Alder (D-
A) reaction. Publication by Diels and Alder [3] on the theoretical considerations of the mechanism 
allowed the basic understanding necessary for organic chemists to apply D-A chemistry to synthesis. The 
D-A reaction has since become a versatile tool in organic chemistry for the preparation of functionalised 
six-membered rings and the principal researchers were awarded a Nobel Prize in 1950 for their 
contributions.  
 
Mechanistically, the D-A reaction is considered to be a concerted pericyclic reaction with an 
aromatic transition state and the driving force is the formation of two new -bonds. The classical D-A 
reaction involves the formation of a six-membered ring by reaction of a conjugated 4-electron system, 
called the ‘diene’ and a 2-electron system called the ‘dienophile’. No intermediate is involved in the 
bond making and breaking process, thus proceeding in a concerted fashion during which up to four 
stereogenic centres can be introduced simultaneously (Figure 3.1).  
 
m m
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Figure 3.1: Diene and dienophile undergo a [4 + 2] electron cycloaddition reaction, during which orbital 
symmetry is conserved with respect to the mirror plane m.
When either the diene or the dienophile contains sp2 heteroatoms at the reactive positions in the 
conjugated system, labeled X, Y and Z in Figure 3.1, the cycloaddition reaction can proceed to give the 
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six membered heterocycle. In this way, the D-A reaction can also be used to form carbon-heteroatom or 
heteroatom-heteroatom bonds and in either case the reaction is called a hetero Diels-Alder reaction. 
 
The understanding of pericyclic reactions was revolutionised in 1965 after Woodward and 
Hoffmann published a number of preliminary publications on the theoretical and experimental 
examination of concerted processes [4]. The authors inferred that concerted processes occur readily when 
frontier orbital symmetry of the reactants and products is conserved with respect to the mirror plane m
(Figure 3.1). A thorough explanation of the conservation of orbital symmetry using a frontier molecular 
orbital (FMO) approach to explain thermally allowed [4 + 2] concerted processes was published in 
1969 [5] and has formed the basis for organic chemists to rationalise the production of isomers from D-A 
reactions. The versatility of D-A chemistry was greatly enhanced by the predictive capability of the 
orbital symmetry approach and is now one of the most widely used synthetic methods in organic 
chemistry, providing a direct route to highly functionalised ring systems such as those found in 
carbohydrate and terpenoid structures [6]. In Section 3.1.1 a short discussion on the use of simple Hückel 
molecular orbital theory (SHMO) in the quantitative prediction of regiochemical outcomes is presented, 
highlighting the role of FMOs in determining the reactivity of dienes and dienophiles. A short review is 
also given on the popular methods for rate and regioselectivity enhancement in D-A chemistry followed 
by a description of strategies for enantioselectivity in D-A chemistry.  
 
3.1.1 Application of MO-Theory to the Prediction of Regiochemical Outcomes  
 
Simple Hückel molecular orbital theory (SHMO) is a reliable method to describe the reactivity 
between planar conjugated -systems. Reactive dienes must be able to form a cis or quasi cis 
conformation of the diene system [7] and participating MOs can be formed from the linear combination 
of atomic orbitals (LCAO) and must be symmetric or antisymmetric with respect to the mirror plane [5]. 
Basic assumptions for the use of MO theory have been outlined by Gimarc [8] and suggest that only the 
unhybridised valence electrons need to be considered in the analysis of the olefinic reagents. 
Contributions by Fukui [9] and Houk [10] have established that the FMO HOMO and LUMO determine 
the reactivity of the Diels-Alder system. The reaction between -electron systems is determined by the 
magnitude of constructive HOMO/LUMO orbital overlap and is most efficient for reagent orbitals that 
are closest in energy.  
 
Analysis of solutions to the electronic Schrödinger equation provides a description of the 
distribution of electrons and the discrete energy of electrons with that distribution. The time independent 
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Schrödinger equation for the electronic wave function using the Born Oppenheimer approximation is 
shown in Equation 3.1, 
=

EH (3.1) 
 
where ] is the Hamiltonian operator and describes the motion of N electrons,  is the electronic wave-
function and E is the electronic energy expressed as an eigenvalue. Qualitative molecular orbital theory 
can be applied using the Hückel approximations to provide -system eigenvalues and -orbital 
coefficients. The total energy of the molecule is taken as the sum of individual valence electron orbital 
energies and the Fock operator (F) is approximated to the effective Hamiltonian (heff). The Hückel 
independent electron assumption (IEA) is used to describe the unhybridised -orbitals where NN = the 
number of orbitals (Equation 3.2) and electron-electron interactions are ignored.  
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Since only the unhybridised orbitals are considered, overlap between adjacent  orbitals is 
approximated to zero. Using computational software [11] the calculated energy is expressed as an 
expectation value of the MO (Equation 3.3), the effective Hamiltonian is differentiated with respect to 
the coefficient CA to give Equation 3.4 and the matrix elements are diagonalised as shown in Equation 
3.5. Derivations of the Equations 3.2 to 3.5 are described in Rauk [7] and the number of matrix elements 
in the determinant goes up quadratically as the number of basis orbitals increases.  
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The diagonal matrix elements hAA are designated the term  and describe the energy of an 
electron in the 2p orbital of an sp2 hybridised carbon atom. The off-diagonal matrix elements hAB are 
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designated the term  and represent the energy of interaction between two 2p orbitals of sp2 carbon atoms 
which are attached by a  bond. Energy levels of bonding and antibonding orbitals are expressed relative 
to  in energy scale in units of |.|. Interaction diagrams are presented by representing  orbitals of 
SHMO theory on the same energy scale as , * and non-bonding orbitals to visually represent the 
mixing of orbitals to form the product. Although this approach is not strictly theoretically accurate, 
molecular orbital energy diagrams can be used to gain an understanding of the interacting orbitals during 
the formation of new sp3  bonds.  
 
The conservation of orbital symmetry in pericyclic reactions is best summarised by the 
paraphrase from Woodward and Hoffmann,  “The characteristic of concerted processes is that it is 
possible to transform continuously the molecular orbitals of reactants into products in such a way as to 
preserve the bonding character of all occupied orbitals at all stages of the reaction.” [10]. This is 
exemplified by the simplest reaction between 1,3-butadiene and ethylene presented in the interaction 
diagram (Figure 3.2) using SHMO energy levels. In this symmetry allowed process, no bonding energy 
level moves to a higher energy level that crosses the energy gap E0, to correlate to an antibonding level. 
The [4+2] cycloaddition reaction is under thermal control and is photochemically forbidden [5]. 
 
The D-A reaction of 1,3-butadiene and ethane is difficult, requiring high temperatures and 
pressures (185ºC, 125 bars, 36 h) [12] but has been shown experimentally to proceed in a concerted 
fashion [11].  The HOMO of butadiene and LUMO of ethylene are antisymmetric (A) and orbital overlap 
via a boat-like transition state leads to the formation of a new  bond between these orbitals. The ease of 
electron delocalisation between these orbitals determines the reactivity of the system. The HOMO of 
ethylene and LUMO of butadiene also stabilise the interactive overlap and are both symmetric (S) with 
respect to m, with symmetry being retained throughout the reaction to give constructive overlap in the 
new bond. FMO considerations for two such interacting systems have been discussed by Fukui [13] 
using second order perturbation theory and indicate that the larger the orbital overlap and smaller the 
energy level separation (EHOMO/LUMO) of the two overlapping HOMO/LUMO orbitals, the larger the 
contribution of the orbital pair to stabilization of the system. 
Chapter 3 
120 
S 1
A 2
S 3*
A 2*
LUMO
S()
A(*)
1,3-Butadiene Ethylene
A(4*)
S(3*)
A(*)
S()
A(2)
S(1)
HOMO
 + 2.00||
 + 1.00||
 - 1.00||
 - 2.00||
 or E0
Cyclohexene
EHOMO/LUMO
 
Figure 3.2: Interaction diagram of ethylene and 1,3-butadiene to form cyclohexene using SHMO energy level 
approximations. 
 
Decreases in the energy gap are hence accompanied by increases in reaction rate or changes in 
isomeric composition. The incorporation of EWG or EDG into D-A reactants causes polarization of the 
frontier orbitals and corresponding changes in energy levels and orbital coefficients at the reactive olefin 
centers. Reagents containing EDG or EWG are sometimes called ‘activated’ dienes and dienophiles. 
Theoretical studies on the polarization effect of substituents has been documented by Gleiter et al. [14] 
who emphasise that interaction between two large and two small MOs is more efficient than the 
interaction of four FMOs of the same size. 
 
When the FMO gap between reactants is large, side reactions can predominate in progressive 
attempts to force the reaction towards completion. A decrease in the energy gap can be achieved by the 
incorporation of one or more EDG in the diene, thus leading to an increase in HOMO energy levels, and 
the incorporation of one or more EWG in the dienophile to produce a corresponding decrease in LUMO 
energy. This is referred to as a normal electron demand activation. The effect of an amine as an example 
of an EDG at C(1) or C(2) of the 1,3-butadiene chain can be modeled using SHMO approximations and 
the relative coefficient magnitude and symmetry of the frontier HOMO orbitals are represented using 
shaded and un-shaded circles, generated using software written by Cannings [11]. Similarly the effect of 
a carboxyl EWG on the dienophile LUMO energy can be shown on the same scale, demonstrating the 
role of activating groups in decreasing the frontier orbital energy gap (Figure 3.3, left).   
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Figure 3.3: Differences in FMO energy levels between neutral and activated dienes and dienophiles are exemplified 
by SHMO energy diagrams of reactants incorporating an amine EDG (Rx = NH2) and carboxyl EWG (Rx = COOH). 
Magnitudes of orbital coefficients are represented by the shaded and un-shaded circles. 
 
Inverse electron demand D-A reactions involve the LUMO of the diene and the HOMO of the 
dienophile, therefore the incorporation of an EDG in the diene and EWG in the dienophile is necessary to 
provide a decreased activation energy for the concerted process. This is also illustrated in Figure 3.3, 
right, using the same activating substituents. Reactions between reactants without activating substituents, 
e.g. ethylene and butadiene, are called neutral D-A reactions.  
 
FMO magnitudes of furan and 1,3-butadiene are symmetrical with respect to m in contrast to the 
C(1) and C(2) substituted examples shown in Figure 3.3 and the 3-furylamine dienes. The incorporation 
of substituents into the D-A reagents provides two possible regioisomeric products, and approaches 
towards the prediction of regioselectivity have involved the use of FMO Hückel coefficients with some 
success [15, 16]. Analysis of constructive overlap of HOMO and LUMO lobes for symmetry allowed 
MOs indicates preferential overlap for coefficients that are closest in energy [9]. The greater the 
difference between orbital coefficients of the reactive olefin carbons, the more regio-selective the 
cycloaddition will be. Polarization of the frontier orbitals in activated dienes and dienophiles of both 
inverse and normal demand (Figure 3.4) provide ortho/para substitution in the final product for 
monosubstituted reactants.  
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Figure 3.4: Magnitudes of FMO coefficients indicate that the para product is favored in the reaction between the 
C(2) aminobuta-1,3-diene and acrylic acid. The ortho product is favored in the reaction between C(1) aminobuta-
1,3-diene and acrylic acid.  
 
In this study, appropriate reagents were chosen to model the D-A reaction between the 3-
furylamines 5 and methyl acrylate (MAC) by considering only the core skeletons of the reacting species, 
namely 3-aminofuran and acrylic acid. 3-Aminofuran is an activated furan as observed from a calculated 
increase in HOMO energy level, represented in the SHMO diagram in Figure 3.5. Additional increases in 
reactivity can be expected from the -donor effect of the amine contributing towards a decrease in 
aromatic stabilization, as discussed in Section 2.1.1 Symmetry allowed orbital diagrams were constructed 
and computationally derived Hückel energies [11] are shown in Figure 3.5 for the interacting 
HOMO/LUMO orbitals.  
 
Figure 3.5: Simple Hückel orbital diagram for furan, and model reagents 3-aminofuran and acrylic acid. The energy 
gap between FMOs involved in the concerted pericyclic D-A pathway is indicated.  
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In the [4+2] transition state involving activated reactants, overlap between lobes possessing 
the largest coefficients contribute a larger degree of  bond formation [15], demonstrating a degree of 
asynchronicity in the reaction of activated adducts. During the asynchronous process, the  bonds are 
simultaneously but dissymmetrically formed and bond formation is dependent on the ability of the 
substituents to stabilise the charge on each reactant at the transition state [17]. Although a small 
EHOMO/LUMO leads to enhanced reactivity and thermodynamically stable products, reagents and 
intermediates may be chemically amphoteric and self-reactive. Prediction of regiochemical outcome in 
the D-A product between 3-aminofuran and acrylic acid using frontier orbital coefficients indicates 
constructive overlap and closely matched coefficient values when substituents are in the para orientation 
(Figure 3.6). This provides antisymmetric overlap with respect to m, whereas the meta orientation does 
not conserve orbital symmetry in the product and has non-constructive overlap indicated by large 
differences in coefficients. 
 
Figure 3.6: Regioprediction by comparison of FMO orbital overlap using simple Hückel coefficients indicates the 
para isomer as the favored product for the reaction between 3-aminofuran and methyl acrylate. 
 
Sucessful regiochemical predictions have also been proposed based on matching electrophilicity 
of the diene and nucleophilicity of the dienophile [18]. MAC is considered a strong electrophile and has a 
larger LUMO coefficient at the -position. In general, the terminus  to an alkyl or conjugating 
substituent has a larger HOMO coefficient, in which case the reactive portion of the furan provides the 
same regiochemistry as observed in the Hückel model. A review covering qualitative and quantitative 
theories that have successfully been used to model the D-A reaction are in literature by Ess et al. [17].   
 
Bond formation in the D-A reaction is a suprafacial process that preserves the cis or trans 
conformation of the dienophile. Substituents in both diene and dienophile rotate in a disrotatory motion 
relative to each other to maintain orbital overlap symmetry and reactions can proceed via two possible 
suprafacial arrangements, named endo and exo, to provide a mixture of diastereomeric products. This 
concept is exemplified in Scheme 3.1 by the reaction between 3-aminofuran and acrylic acid. In the endo 
arrangement the bulkier sides of the reactants lie next to each other, and in the exo arrangement the 
dienophile substituents are geometrically distant from the diene system. The endo isomer is usually 
Chapter 3 
124 
formed in excess and this observation was originally justified by Alder and Stein [19] as a tendency of 
maximum accumulation of unsaturation, then later explained by Woodward and Katz [20] as the 
consequence of additional stabilization from secondary -orbital interactions between the diene and 
carbonyl orbital. The endo compound has the substituent on the inside concave face of the bicyclic ring, 
however in most cases the exo isomer is the thermodynamically favored product as the substituent is 
pointed towards the convex face which is geometrically distant to the ring and contributes less steric 
energy. Salts and solvents can heavily influence D-A reaction kinetics and is discussed in the following 
section. 
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Scheme 3.1: The [4+2] electron cycloaddition is reversible and proceeds in a disrotatory manner with respect to 
substituents on the reactive carbons. Often the kinetically favoured endo diastereomer predominates due to 
secondary -orbital interactions in which case the exo form is thermodynamically more stable due to steric 
considerations.  
 
In most instances the Diels-Alder reaction is reversible with the retro Diels-Alder process 
leading to an equilibrium involving regeneration of the original reactants. This has been demonstrated 
experimentally by the interconversion of pure D-A regioisomers upon heating [21]. Endo-exo 
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isomerization of D-A adducts has been documented by Berson et al. [21,22] and is commonly observed 
in reactions involving stabilised transition states that have only small differences in free energy (~12 
kJ/mol) [14]. Studies of the temperature dependence on diastereomeric ratios in reactions between 
cyclopentadiene and a range of acrylates [21] have been shown to closely fit the Arrhenius equation  
 
RTEEAAkk endoexoexoendoexoendo 303.2/)()/(log)/(log += (1.6) 
 
where the product ratio endo/exo is equal to the specific rate coefficients kendo/kexo, A is the frequency 
factor and E is the activation energy [21].  Although not all reactants fit the Alder rule for the preference 
of endo isomer, Berson et al. demonstrated using linear free energy relationships a strong linear 
correlation between empirical solvent polarity and log(kendo/kexo ) [22]. The non-polar D-A diene, 
cyclopentadiene showed preference towards the endo cycloadduct with increasing solvent polarity in 
reactions with MAC, methyl methacrylate, and methyl trans-crotonate. The authors attribute the changes 
in reactivity to the occurrence of a greater permanent electric dipole in the endo transition state, which is 
stabilised by polar reaction media. More recent theoretical work by Schlachter et al. [23] supports these 
experimental findings, demonstrating that in the gas phase the exo product is favored and preference for 
the endo adduct is a result of solvation at the transition state. 
 
D-A reactions with activated dienophiles containing conjugated EWG can undergo reactivity and 
regioselectivity improvement upon co-ordination of the carbonyl oxygen lone pair. Protonation or Lewis-
acid complexation at the oxygen of an ,-unsaturated carbonyl system increases the electron-
withdrawing effect of the carbonyl group on the carbon-carbon double bond, resulting in lower MO 
energies and an enlarged terminal LUMO lobe [24]. Rate and selectivity enhancement in D-A chemistry 
has been heavily researched and approaches toward improvement in reaction efficacy are described in 
Section 3.1.2 along with a discussion addressing changes in diastereoselectivity with solvent polarity and 
the use of this concept in synthesis.  
 
3.1.2   Rate and Selectivity Enhancements in Diels-Alder Reactions 
 
D-A reactions that are slow or produce a number of isomers have been enhanced by ultrasonic 
irradiation, catalysis and increased pressures. The application of these techniques in synthesis have been 
reviewed by Pindur et al. [25]. Reactions performed under increased pressure proceed due to an 
accompanying negative volume of activation, although a pressure of 1500 atm (1.5 kbar) are required to 
create rate enhancement approximately 10 times that observed at 1 atm [26]. The reaction between 2-
methylfuran and a range of ,-unsaturated ketones has been investigated by Rimmelin et al. [27] and 
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sucessfully carried out under very high pressures in DCM (13.5 kbar, 37ºC, 23-25 h). Both mono and di-
activated dieonphiles were reported to give excellent yields of cycloadduct under increased pressure, and 
mono activated dienophiles gave the ortho oriented products, exemplified by the adduct obtained from 2-
methylfuran and MAC which is reported to proceed in quantitative yield (48:52 endo:exo) [27] (Scheme 
3.2). The heteroatom in furan does not contribute towards activation of the diene since it is involved in 
stabilizing the aromatic system and the low reactivity of furan dienes towards D-A addition with 
monoactivated dienophiles at atmospheric temperature and pressure is partially due to aromaticity. 
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Scheme 3.2: 2-Methyl furan undergoes facile cycloaddition in DCM at 13.5 kbar and mono activated dienophiles 
provide ortho- orientation of substituents in the cycloadduct [27].  
 
Ultrasound irradiation has been reported to influence D-A reaction kinetics in heterogenous 
mixtures and improvements have been ascribed to more efficient mixing of reactants, although increases 
in yield and exo selectivity have also been achieved in the reaction between cyclopentadiene and methyl 
vinyl ketone upon sonication in halogenated solvents [28]. 
 
As mentioned earlier in Section 3.1.1, Lewis-acids increase the rate of D-A reactions by 
coordination of the lone pair of electrons on one of the reactants to produce a corresponding decrease in 
MO energy levels. For example, AlCl3 can coordinate to the oxygen lone pair of an ,-unsaturated 
carbonyl system with "1 -character to increase the electron-withdrawing effect of the carbonyl group, 
resulting in lower LUMO energy at the  olefinic carbon. Inuka et al. have researched the catalytic effect 
of AlCl3 on the cycloaddition reaction between butadiene and MAC, demonstrating a rate enhancement 
at 20ºC by a factor as large as 105 [29]. The authors attributed a reduction in enthalpy of activation to the 
effect of Lewis acids on the rate of D-A reactions, leaving entropy almost unaffected [29]. AlCl3 has 
been used as a D-A catalyst by Hosomi et al. [30] to accelerate the cycloaddition of the relatively 
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unactivated 2-trimethylsilylmethyl-1,3-butadiene with a range of ,-unsaturated carbonyls to provide 
excellent regioselectivity (>93%) for the para products for use in terpene syntheses. BF3.Et2O has been 
used to catalyse D-A reactions involving activated dienes under very mild conditions [31] and the 
catalysed reaction of furan with methyl vinyl ketone has been modeled using DFT calculations [32] 
demonstrating the role of BF3.Et2O to bring the reactants together for interaction. The application of 
lithium perchlorate diethyl ether clatherate Li+(OEt2)2ClO4- in D-A catalysis has been included in a 
review by Kumar [33] who suggests the action of a combination of catalytic effects attributed by the Li+
Lewis acid and polar conditions. Lewis-acid catalysis using transition metal (Fe3+, Cr3+) exchanged 
montmorillonite and bentonite clays has been reported by Adams [34] to facilitate the D-A reaction of 
furan and pyrrole with ,-unsaturated carbonyls in low yields at room temperature and under 
heterogeneous conditions, achieving an increase in rate by as much as a factor of 106 (Scheme 3.3).   
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Scheme 3.3: Cr3+ exchanged clays prepared by Adams [34] catalyse the room temperature D-A reaction of furan 
and pyrrole with MAC in low yield.   
 
Substituents can be influenced by electron donation or withdrawal by the solvent to induce 
corresponding changes in FMO coefficients. In normal electron demand reactions, the LUMO energy of 
dienophiles with -accepting groups is lowered by hydrogen bonding, similar to Lewis-acid catalysis, 
leading to enhanced mixing with the HOMO of the diene. Water has found a novel place as a D-A 
solvent due to the special effects observed from strong hydrogen bonding interactions on non-polar 
solutes and the mechanism of rate enhancement has been reviewed by a number of authors [34, 35]. The 
use of aqueous reaction media for D-A reactions was reported in 1931 by Diels and Alder [3] who 
demonstrated the reaction of furan with the doubly activated dienophile maleic acid in water at 20ºC. The 
novel applications for water as a versatile D-A reaction medium was not properly recognised until the 
1980s by Rideout et al. [36] who demonstrated that the rate of the D-A reaction between cyclopentadiene 
and methyl vinyl ketone in water was 740 times the rate observed in isooctane. Further rate enhancement 
of was reported upon reaction in an aqueous solution of 4.86 M lithium chloride (LiCl) and kinetics 
studies showed a rate 1818 times that in isooctane, in contrast to MeOH which gave only a 12 times 
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increase. The second order rate constants reported by Breslow et al. [36] are tabulated in Scheme 3.4 for 
reactions at 20°C.  
O
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Scheme 3.4: Second order rate constants reported by Breslow et al. indicates an increase in reaction kinetics in 
aqueous media and in the presence of antichaotropic salt (LiCl) [36]. Increases in selectivity for the endo product 
are reported upon increase in solvent polarity [37].  
Preference for the endo diastereoisomer upon increases in solvent polarity has also been 
measured by Breslow et al. [37] (Scheme 3.4) and improvement in rate and selectivity were attributed to 
enhanced hydrophobic interactions between non-polar reigons in aqueous solvent. Hydrophobic 
interaction is the term used to describe the tendency of non-polar molecules to aggregate in aqueous 
media and the hydrophobic effects between the non-polar reigons of organic molecules are suggested to 
be important in protein folding and molecular recognition including enzyme-substrate binding [38]. 
Neutron scattering studies by Jancsó et al. have shown the presence of short range hydration shells on 
non-polar solutes to aid the dissolution process [39] and this has been reviewed by Finney et al. [40]. The 
hydration shell is involved in micelle behavior at high dilution, which can occur before the occurrence of 
phase separation. Theoretical studies using Monte Carlo simulations by Jorgensen [41] have indicated a 
decrease in calculated transition energy barriers for endo:exo regioisomers with the inclusion of 500 
water molecules, suggesting stabilization of the transition state due to solvation. Breslow et al. support 
the role of hydrophobic interactions experimentally by the addition of LiCl as an ‘anti-chaotropic’ 
salting-out agent [42], which diminishes the hydration shells and hence solute solvation to result in an 
increase in reaction kinetics. The ‘chaotropic’ salt guanidinium chloride (GnCl, 4.86M) was later 
investigated and shown to increase solvation and decrease noticeable non-polar effects in the reaction 
between N-ethylmaleimide and anthracene compared to pure water [43]. 
 
The utility of polar effects in D-A chemistry has been implemented in the synthesis of 
quassinone natural products by Grieco et al. during the diasteroselective preparation of the fused tricyclic 
ring [44] (Scheme 3.5). Cycloadducts from the reaction between functionalised bicyclic dienophiles and 
the ester, acid and sodium salt of a diene carboxylate (Scheme 3.5, top) gave regioselective addition in 
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polar and organic solvents to provide the tricyclic quassinone skeleton. The newly fused cyclohexene 
ring has a cis- conformation with respect to the cyclohexanone ring and the tricyclic structure is produced 
as mixture of H(14)- and H(14)- diastereoisomers. Increases in rate and considerable improvements in 
yield were reported for reactions performed in water when R = Et, H demonstrating preference for the 
H(14)- isomer in polar reaction conditions and when the reaction was performed neat. Aggregation 
effects were suggested on the basis of experimental data showing further increases in rate and selectivity 
for the  product (Scheme 3.5, top; R = Na) when diene concentrations were progressively increased in a 
rapidly stirred aqueous mixture [44]. 
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Scheme 3.5: D-A methodology towards quassinoid natural products by Greco et al. [44, 45] involves the 
preparation of a functionalised tricyclic skeleton as a mixture of C(14) diastereoisomers. Changes in proportions of 
 and  isomers where observed upon changes in solvent polarity. 
 
Studies by Grieco et al. on the catalytic effects of water and 5 M LiClO4/Et2O for the reaction 
between functionalised ,-unsaturated bicyclic ketones and carboxyl diene derivatives (Scheme 3.5, 
bottom) [45] indicate similar catalytic effects for both ionic solvents, with selectivity for the  isomer. A 
small degree of selectivity for the  isomer was reported for reactions in non-polar aromatic solvents. 
The examples discussed show a reversal of selectivity from the  isomer in nonpolar solvents, to the 
isomer in ionic reaction media.  
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The methods for introducing chirality in the synthesis of simple chiral molecules has been 
described in Section 1.5 and approaches towards diastereoselectivity in D-A reactions is discussed in 
Section 3.1.3. 
 
3.1.3  Diastereoselectivity in Diels-Alder Reactions 
 
Diastereoselectivity in D-A reactions can be achived by the incorporation of chiral auxiliaries in 
either diene or dienophile reagents, although optically active dienophiles are employed more frequently 
for D-A selectivity since they are more conveniently prepared. The individual diastereomeric products, 
once separated from each other, are generally isolated in enantioenriched form (high ee). A relevant 
example of this is the chiral dienophile (-)-1-cyanovinyl camphanate prepared from the incorporation of 
the (-)-camphanoyl auxiliary by condensation of (-)-camphonyl chloride with 2-oxopropiononitrile [46]. 
Research by Vogel et al. [46] has involved the zinc iodide (ZnI2) catalysed cycloaddition of furan to (-)-
1-cyanovinyl camphanate to prepare a mixture of diastereomeric bicyclic cyanohydrins (Scheme 3.6).  
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Scheme 3.6: Vogel et al. [46] have used the (-)-camphoryl auxiliary in the optical pure dienophile (-)-1-cyanovinyl 
camphanate to provide the optically pure (1R, 4R)-7-oxabicyclo[2.2.1]hept-5-en-2-one via the separation and 
hydrolysis of the cyanohydrin intermediate. 
 
Recrystallization to >98% ee was achieved for a single isomer from hexane, before hydrolysis to 
the optically pure (+)-(1R,4R)-7-oxabicyclo[2.2.1]hept-5-en-2-one in 29% yield overall. Resolution of 
the bicyclic ketone from a racemic mixture was later reported using successive recrystallizations of the 
cyanohydrin-brucine complex from MeOH followed by hydrolysis to provide the optically pure (+)-(1R,
4R)-isomer in 20% yield [47]. The pure bicyclic enantiomer has since proven to be a flexible starting 
material for the preparation of a range of optically pure sugars [48], myo-inositol derivatives [49] and 
subunits for macrotetrolide [50] and aminoglycoside [51] antibiotics. Enzymatic resolution of the 
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cyanohydrin ester with Aspergillus lipase has been reported by Sef et al. [52] to provide the ketone in 
20% ee and stereospecific functionalization with Candida cylindracea was also mentioned to provide 
products in >97% ee and in moderate yields. 
 
High diastereoselectivities have been accomplished in the reaction between 5-benzyloxymethyl-
1,3-cyclopentadiene and the chiral dienophile (-)-(R)-menthyl acrylate by the addition of aluminium 
chloride as catalyst [53]. The aluminium complex of the (S,S)-stilbenediamine derived sulfonamide has 
been used by Corey [54] as a chiral catalyst for the D-A reaction between acrylyloxazolidinone and 5-
benzyloxymethyl-1,3-cyclopentadiene and proposed that the action of the catalyst is via coordination of 
the acrylyl carbonyl (Scheme 3.7). Chiral D-A catalysts have been heavily investigated and 
bis(oxazoline) copper complexes [55] as well as Jacobsen-type complexes formed with chromium and 
cobalt [56] are reported to successfully catalyse face selective cycloadditions.  
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Scheme 3.7: D-A reaction of the complex prepared from acrylyloxazolidinone and a chiral sulfonamide catalyst 
with 5-benzyloxymethyl-1,3-cyclopentadiene has been reported by Corey [54] to proceed in excellent yield and 
selectivity at low temperatures.  
 
Chiral dienes are typically prepared by the incorporation of a chiral auxiliary into the 
appropriately substituted diene backbone. Barluenga et al. [57] have incorporated the proline derived (+)-
(S)-2(methoxymethyl)pyrrolidine as a chiral auxiliary into 2-amino-1,3-butadienes to produce highly 
functionalised cyclohexanones using D-A chemistry (Scheme 3.8). D-A reactions of (E)-dienes with a 
range of nitroalkenes in MeOH at –80ºC were reported to produce the endo cycloadducts in moderate 
yields with exclusive para regioselectivity relative to the nitro and amine substituents. Excellent 
diastereoselectivity was reported for dienes containing the tert-butyldimethylsiloxy (R1 = TBDMS) 
group and a decrease in enantiomeric excesses for the methyl derivative (R1 = Me) was accompanied by 
an increase in yield, perhaps indicating the role of steric influence of the oxygen substituent (R1) towards 
the rate and diastereoselectivity of the cycloaddition. Hydrolysis of the chiral auxiliary at pH 4.6 using a 
CH3COOH/CH3COONa buffer in THF provides a useful methodology for the preparation of 
functionalised cyclohexanones as chiral synthetic building blocks (Scheme 3.8, top). Reaction of 1-
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nitropropene with the corresponding (Z)-dienes produced the open chain Michael addition products, 
which were reported to cyclise to the chiral 2-substituted furan upon stirring in aqueous acid (Scheme 
3.8, bottom). 
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Scheme 3.8: Top; D-A reactions with (+)-(S)-2(methoxymethyl)pyrrolidine substituted (E)-dienes have been 
reported by Barluenga et al. [57] to give endo cycloadducts in high diastereoselectivity and hydrolysis in mildly 
acidic (pH = 4.6) buffer provided the functionalised cyclohexanone. Bottom; Reaction of (Z)-dienes are reported to 
give the Michael addition product and hydrolysis in acid gave the chiral C(2) substituted furan [57]. 
 
Although chiral dienes are effective at directing the stereochemical outcome of the newly formed 
D-A adducts, appropriate methodology must firstly be available for the incorporation of auxiliaries into 
dienes containing the desired substitution. The activated diene 1-methoxy-3-(trimethylsiloxy)-butadiene, 
named Danishefsky’s diene after the principal researcher, has provided not only a reactive diene for D-A 
studies but a reliable protocol for the incorporation of heterosubstitutents on the 1,3-butadiene chain [58]. 
1-Amino-3-siloxy-1,3-butadienes have been obtained using similar methodology [59] and the C2-
symmetric (+)-trans-diphenylamine, (2R,5R)-2,5-diphenylpyrrolidine has been used by Kozmin et al. 
[60] as an effective chiral D-A auxiliary for the total synthesis of (-)--elemene (Scheme 3.9). 
Cycloaddition reaction of the chiral 1-amino-3-siloxy-1,3-butadiene with methacrolein are reported to 
give the ortho/para product with respect to the amine and siloxy substituents with exclusive selectivity 
for the endo diastereomer. Wittig methylenation followed by hydrolysis in aqueous acidic THF allowed 
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the preparation of the chiral vinyl-cyclohexenone in good enantiomeric purity (85% ee) and 
interconversion of the ,-unsaturated ketone was performed in four steps to provide (-)--elemene in 
seven steps from the chiral diene.  
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Scheme 3.9: Kozmin et al. [59] have incorporated the (2R,5R)-2,5-diphenylpyrrolidine auxiliary into 1-amino-3-
siloxy-1,3-butadiene to achieve good enantioselectivity in D-A reactions with methacrolein. This provides a direct 
pathway to the functionalised cyclohexenone in high yield which was transformed in four steps to (-)--elemene. 
 
Petrzilka et al. have comprehensively reviewed the preparation and D-A reaction of 
heterosubstituted 1,3-dienes for the chemical literature to 1981 [31], however no literature review 
specifically addressing the D-A reactions of heterosubstituted furan dienes was found. The role of furan 
in D-A chemistry will be briefly discussed and the reactivity of C(3) heterosubstituted furans reviewed 
with focus on achieving enantioselectivity in D-A reactions involving C(3) hetersubstituted furan dienes.  
 
In summary for Section 3.1, the synthetic value of the D-A cycloaddition can be attributed by the 
following features: 
 
- It can potentially set four stereocenters in one step. 
 
- If unsymmetrical dienes and dienophiles combine it is highly selective and gives ‘ortho’ and 
‘para’ products as the predominant regioisomers, and the endo cycloadduct as the predominant 
diastereomer. 
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- If a disubstituted (Z)-alkene is used, the orientation of the two substituents in the product will be 
cis, alternately an (E)-alkene will give trans geometry in the product. The (E/Z) information from 
the diene is also retained in the cycloadduct. 
 
- Stereochemical information in either diene or dienophile is also transferred to the D-A product in 
varying degrees. By using the appropriate chiral catalyst or auxiliary the cycloaddition can be 
made diastereoselective leading to enantiomerically enriched products. Multiple rings can be 
created in the same step with defined stereochemistry. 
 
3.2  The Role of Furan in Diels-Alder Chemistry 
 
The Diels-Alder reaction of furan is one of the most direct methodologies for preparing 7-
oxabicyclo[2.2.1]heptanes, also called 7-oxanorbornanes. As mentioned in Section 3.1.2, furan is 
considered to be a poor diene due to its aromaticity [61] and is often not compatible as a D-A diene at 
high temperatures due to facile reversion by retro-Diels-Alder reaction to the stable aromatic furan 
system. The heat of reaction of furan with ethylene has been reported to be 32 kJ/mol lower that the 
reaction between cyclopentadiene and ethylene due to aromaticity and differences in ring strain [62]. The 
retro D-A process is a useful synthetic strategy and has been applied to the synthesis of 3-bromofuran 
and 4-bromo-2-methylfuran (10) via the D-A reaction of furan with maleic anhydride. Bromination of 
the cycloadduct intermediate has been reported to provide the trans-dibromo product, and thermally 
mediated dehydrohalogenation and retro-D-A reaction in the presence of quinoline provides the furan 
products (Scheme 3.10) [63]. The exo face of the 7-oxanorbornane structure is less hindered and more 
reactive towards synthetic transformations. This is exemplified in the selective dehydrohalogenation of 
the exo bromine of the dibromoadduct during heating in quinoline, prior to retro D-A reaction to the 
bromofuran (Scheme 3.10) [63]. 
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Scheme 3.10: The 7-oxanorbornanes prepared via the D-A reaction of furan and 2-methyl furan with maleic 
anhydride, undergo facile bromination across the olefin and dehydrohalogenation followed by retro-D-A reaction to 
the furan has been reported upon heating in quinoline [63]. 
Access to substituted furan derivatives allows for the preparation of specifically functionalised 7-
oxanorbornanes using D-A chemistry, that may have required a more lengthy process and a greater 
number of steps to prepare by other means. Cycloadducts prepared using activated furans are most 
convenient when the activating substituent or substituents are readily interconverted to useful or relevant 
functionality for the formation of the target molecule. CBS-QB3 computational studies discussed by 
Pieniazek et al. [64] have involved the calculation of activation and reaction enthalpies for the D-A 
reactions of C(2) and C(3) methyl, methoxy and halogenated furans with ethylene. Their results indicate 
that the inverse demand reaction using EWG substituted halofurans is more facile than reactions with 
furan or EDG substituted furans. A significant increase in exothermicity was indicated for the reaction 
with 2-fluorofuran and calculations indicate that all halogen substituents at the C(3) position produced a 
similar decrease in activation enthalpy, but to a lesser extent than to the C(2) analogue. Incorporation of 
EDGs at C(3) were calculated to produce a more significant influence on enthalpy values than at C(2) 
and the methoxy substituent was shown to have a larger effect than the methyl substituent due to -donor 
effects.  
 
Although the role of C(3) heteroatom activating substituents on the furan ring is the primary 
research topic involved in the synthetic pathway under investigation, the successful D-A reactions of 
C(2) heterosubstituted furans and their practical application should briefly be mentioned. Furans 
containing C(2) oxygen heterosubstituents have been prepared by Cella [65] and used in D-A chemistry 
for the preparation of substituted aryl ethers via acid catalysed aromatization of the 7-oxanorbornane 
cycloadduct (Scheme 3.11, top). 
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Scheme 3.11: Top; Cella [65] has prepared 2-p-tolyloxy-furan for D-A reaction with maleic anhydride and reports 
hydrolysis of the ketal ether bridge and aromatization. Bottom; D-A reaction between MAC and 5-aminofuran-2-
carboxylic acid methyl ester followed by aromatization using BF3.Et2O has been reported to give the substituted 
amine and phenol products in high yields [65]. 
 
Similarly, Cochran et al. [66] and Padwa et al. [67] have carried out the D-A reaction between 
the 5-aminofuran-2-carboxylic acid methyl ester diene (Section 2.2) and MAC to give the cycloadduct in 
high yield in benzene at 80ºC (Scheme 3.11, bottom). D-A reactions of both C(2)-oxa and C(2)-aza 
substituted furans involve the formation of acetal and hemi-aminoacetal type functionality in the 
cycloadduct which undergoes acid mediated or even spontaneous cleavage of the bicyclic ether ring. 
Smooth dehydration of the alcohol intermediate was reported using BF3.OEt2 to provide the aniline 
product in high yields [67].  
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Scheme 3.12: Intramolecular D-A reaction of 2-furylamides has been reported by Padwa et al. [67] to proceed in 
good yield to produce the functionalised hexahydroindolinone skeleton for use in natural product synthesis.  
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Intramolecular D-A reactions using C(2) amide substituted furans has been conducted by Padwa 
et al. [67] and applied to the synthesis of key intermediates for the preparation of the 
hexahydroindolinone structure as precursors to the cis-3a-aryloctahydroindole skeleton, observed in the 
Sceletium alkaloids [68] (Scheme 3.12). Literature on the D-A reactions of both C(2) and C(3) 
heterosubstituted furans is relatively scarce and relevant publications involving cycloaddition of C(3) 
heterosubstituted furans is reviewed in the following section. 
 
3.2.1 Diels-Alder Reactions of C(3) Heterosubstituted Furans 
 
The incorporation of -electron donor substituents on the furan ring has a destabilizing effect on 
the aromatic system as discussed in Section 2.1, and hence decreases the tendency for retro D-A 
reactions, although the potential for Michael-type side reactions with electrophiles is increased when the 
C(2) and C(5) positions of the activated furan are unsubstituted. Comparison between the room 
temperature D-A reaction of furan and the diactivated 3,4-dimethoxyfuran with 1,4-benzoquinone under 
high pressure have been discussed by Jurczak et al. [69], who demonstrate furan to react at 22 kbar in 
Et2O, whereas 3,4-dimethoxyfuran required only 9 kbar in toluene. D-A reactions between 3,4-
dimethoxyfuran and maleic anhydride derivatives have been published by Matsumoto et al. [70] and are 
reported to proceed under high pressure (10 kbar) at room temperature in THF.  
 
Studies towards the D-A reaction of 3,4-dimethoxyfuran (Scheme 3.13; R = Me) and 3,4-bis-
benzyloxyfuran (Scheme 3.13; R = Bn) at atmospheric pressure have been conducted by Koreeda et al. 
[71], who report successful D-A reactions with acyclic ,-unsaturated ketones in benzene at 80ºC and 
upon catalysis with ZnI2 at ambient temperature. Reaction of 3,4-dimethoxyfuran with 10 equivalents of 
cyclohex-2-enone using ZnI2 catalysis in benzene was reported to occur at the C(2) and C(5) furan 
positions to give the di-1,4-addition product (Figure 3.13, top). The cycloaddition between 3,4-bis–
benzyloxyfuran with MAC was reported to proceed in excellent yields and has been utilised by Koreeda 
et al. [71] for the preparation of (+)-methyl triacetylshikimate (Scheme 3.13, bottom). Cycloadducts 
prepared in benzene at 80ºC gave 2:1 selectivity for the endo product and quantitative yields were 
reported for neat reactions carried out with ZnI2 catalyst to give an improved 15.3:1 endo:exo ratio. 
Olefin reduction with PtO2 catalyst was reported to be selective for the less hindered exo face of the 
bicyclic ring and base mediated ether cleavage with LiHMDS provided the racemic cyclic oxygenated 
core of (+)-methyl triacetylshikimate in a further two steps.  
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Scheme 3.13: Koreeda et al. have investigated the reactivity of the diactivated 3,4-dimethoxyfuran (R = Me) and 
3,4-bis-benzyloxyfuran (R = Bn) at atmospheric pressure [71]. Top; When R = Me, reaction with an excess of 
cyclohex-2-enone in benzene with ZnI2 catalysis was reported to give the di-1,4-addition product in moderate yield. 
Bottom; When R = Bn, neat reaction with ZnI2 catalysis was reported to proceed in qualitative yield in 15.3:1 
selectivity for the endo product and the product was transformed to the racemic oxygenated core of (+)-methyl 
triacetylshikimate. 
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Scheme 3.14: High selectivity has been reported by Takahashi et al. [72] in the D-A reaction between the chiral 
dienophile (S)s-3-(2-pyridylsulfinyl)acrylate and 3,4-bis-benzyloxyfuran. The optically enriched cycloadducts 
provided the key precursor for a steroselective synthesis of (-)-methyl triacetylshikimate in five steps.   
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A diastereoselective approach towards the D-A reaction of 3,4-dibenzyloxyfuran has been 
published by Takahashi et al. [72] using the sulphoxide (S)s-3-(2-pyridylsulfinyl)acrylate as a chiral 
dienophile (Scheme 3.14). Reaction of the sulphoxide in the presence of diethyl aluminium chloride at –
20ºC was reported to produce a mixture of endo and exo products in high diastereoselectivity. The chiral 
sulphoxide group was removed from the major endo product by reduction with PBr3 to give the sulfide, 
which was cleaved by further reduction with LiAlH4 with concurrent reduction of the olefin at the exo 
face. (-)-Methyl triacetylshikimate was prepared in 5 steps from the alcohol by known reactions [72]. 
 
The D-A reactivity of N-3’-furylbenzamide has been investigated by Bridson [73] and was the 
only example involving 3-furylamide cycloadducts that could be found in the literature. The reaction of 
maleic anhydride in a concentrated ethereal solution of N-3’-furylbenzamide was reported to give the exo 
cycloadduct at room temperature, which crystallised from solution after 24 h (Scheme 3.15). The author 
mentions that the enamide cycloadduct was idenitifed by 1H NMR in solution but decomposed upon 
heating during recrystallization and reverted to the furylamide upon attempted isolation. The D-A 
reaction of N-3’-furylbenzamide with dimethyl maleate at reflux in isopropanol (iPrOH) was reported to 
give clean conversion to the cycloadduct in good yield (Scheme 3.15) [73]. Clean but reversible addition 
of the alcohol to the enamide was reported to produce the alkoxamide as deduced by 1H NMR studies 
and the isopropoxyl group underwent facile hydrolysis upon contact with traces of moisture. Bridson 
reports that hydrolysis of the alkoxamide was successful in water to give the exo ketone product in 
quantitative yield. 
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Scheme 3.15: Studies by Bridson [73] on the D-A reactivity of N-3’-furylbenzamide with maleic acid in Et2O and 
dimethyl maleate in iPrOH revealed good yields of D-A cycloadduct and hydrolysis of the enamide was reported to 
be successful by stirring in water.  
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The endo product was obtained by conducting the D-A reaction in MeOH and the hydroxyamide 
intermediate was suggested as the identity of the isolated product on the basis of 1H NMR, IR and 
elemental analysis, and is stabilised by intramolecular hydrogen bonding to the carbonyl [73] (Scheme 
3.16, top). Bridson reports that the reaction of a 2:1 mixture of N-3’-furylbenzamide and MAC in a 
solution of toluene at 111ºC gave the D-A cycloadduct, followed by substitution at the C(5) olefin with a 
second equivalent of furan via the C(2’) aromatic carbon. The acrylate and amide activating substituents 
react with para regioselectivity in the D-A adduct as indicated from the relative orientation of 
substituents in the final adduct (Scheme 3.16, bottom).  
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Scheme 3.16: Top; Bridson [73] reports that D-A reaction of N-3’furylbenzamide with dimethyl maleate in MeOH 
proceeds in low yield followed by the addition of water to give the endo hydrogen bond stabilised hydroxylamine 
cycloadduct. Bottom; D-A of a 2:1 mixture of N-3’-furylbenzamide with MAC in toluene was reported to produce 
the C(5) furan adduct [73] of the D-A product in a non-reversible reaction.  
 
Campbell et al. [74] have found that 3-(tbutoxycarbonylamino)furan provides a low yield of the 
hydroxycarbamate cycloadduct via D-A reaction with dimethylacetylenedicarboxylate (DMAD) in 
toluene followed by reaction with traces of water (Scheme 3.17).  The enamine was not observed and 
subsequent hydrolysis in aqueous acid was reported to give the 7-oxanorbornane ketone in moderate 
yields. Reaction of the 3-furylcarbamate with methyl 3-nitroacrylate in Et2O for 2 days was reported to 
give a low yield of the Michael-type ,-addition product and a small amount of a stable enamine 
cycloadduct (3%) assigned as the endo configuration at the ester substituent on the basis of 1H NMR. 
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Scheme 3.17: Campbell et al. [74] have reported the D-A reaction of 3-(tbutoxycarbonylamino)furan with DMAD 
to proceed in 24% yield, however reaction with methyl 3-nitroacrylate predominately formed the Michael-type 
addition product in 9.6% yield, as well as the D-A cycloadduct in small amounts (3%). 
 
The D-A reaction of 3-methylthiofuran with a selection of mono activated dienophiles has been 
reported by Yamamoto et al. [75] and cycloadducts were obtained with exclusive regiochemistry and in 
good yields by stirring the reagents at room temperature in Et2O or neat for a number of days. D-A 
reaction with dimethyl maleate was mentioned to be successful in aqueous methanol and provided 81% 
conversion over 10 days.  
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Scheme 3.18: Yamamoto et al. [75] have reported on the D-A reactivity of 3-methylthiofuran with a range of mono 
and di-activated dienophiles and good yields of cycloadduct were prepared upon prolonged stirring at ambient 
temperature.  
 
Enantioselectivity was accomplished in the D-A reaction of 3-methylthiofuran using a chiral 
catalyst in a similar manner to Corey [54] as discussed in Section 3.1.3. 3-Acryloyl-1,3-oxazolidine-2-
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one was used as a dienophile in the presence of a catalytic portion of a chiral titanium complex prepared 
from dichlorodiisopropyl titanium (TiCl2(OiPr)2) (0.1 mol equiv.) and a tartaric acid derived 1,4-
dialcohol to give 85:15 selectivity for the endo product in 87% ee (Scheme 3.19). The authors mention 
that 3-methoxyfuran was also reacted in the presence of the titanium catalyst system to form the D-A 
cycloadduct in good yields with a small degree of chiral selectivity, although no data was included for 
these experiments [75].  
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Scheme 3.19: Yamamoto et al. [75] have reported the enantioselective D-A reaction of 3-methyl thiofuran using a 
tartaric acid derived titanium catalyst to provide the endo isomer as the major product in 87% ee.
The preparation of 2-((S)-1-ethyl-1-methoxy-propyl)-1-(2-triisopropylsilanyloxyfuran-3-yl)-
pyrrolidine by Schlessinger et al. [68] has been described in Section 2.3 and the same group has 
investigated the D-A reactivity of this chiral 3-furylamine diene. Reaction with MAC in toluene at –20ºC 
to was reported to provide the D-A adduct with exclusive ortho/para regioselectivity and the favoured 
endo diastereomer was prepared in a 19:1 endo:exo ratio with an impressive >99% ee [76] (Scheme 3.20, 
top). The D-A cycloadduct prepared by the reaction between MAC and 1-(4-bromo-2-methyl-5-
triisopropylsilanyloxy-furan-3-yl)-2-((S)-1-methyl-1-methoxy-ethyl)-pyrrolidine diene (Scheme 3.20, 
bottom) was reported to form in high yield [68] with the same para regiochemistry for amine and 
carboxyl substituents as observed for reactions involving the 2,3-diheterosubstituted furan. The authors 
report a 10:1 ratio of diastereomers with preference for the endo product in greater than 99% ee, and the 
inclusion of chlorotitanium triisopropoxide ([(CH3)2CHO]3TiCl) was observed to enhance the 
diastereomeric ratio to 15:1 [68]. 
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Scheme 3.20: Top; Schlessinger et al. have reported the D-A reaction between 2-((S)-1-ethyl-1-methoxy-propyl)-1-
(2-triisopropylsilanyloxy-furan-3-yl)-pyrrolidine and MAC to yield the endo product as the major isomer in >99% 
ee [76]. Bottom; D-A reaction of MAC with 1-(4-bromo-2-methyl-5-triisopropylsilanyloxy-furan-3-yl)-2-((S)-1-
methyl-1-methoxy-ethyl)-pyrrolidine has been reported to produce the endo cycloadduct in 99% ee in DCM at 22ºC 
[68]. 
A similar proline derived 3-furylamine has been utilised by Schlessinger et al. [77] for the 
stereoselective construction of the -glucosidase inhibitor (+)-cyclophellitol via the D-A reaction with 
dimethyl 2,3-pentadienedioate at –100ºC (Scheme 3.21). Stereoselective transformations were effectively 
performed on the bicyclic D-A adduct before cleavage of the oxygen bridge to create the same 
stereochemistry as observed in the natural product.  Hydrolysis of the enamine in aqueous acid followed 
by reduction of the ketone using sodium borohydride (NaBH4) provided reaction at the exo face to give 
the endo alcohol with respect to the bridge. Subsequent isomerization and ozonolysis produced the 
correct relative stereochemistry of substituents on the cyclohexane ring and the oxygenated core of the 
natural product was prepared by reduction in a further four steps. Epoxide ring closure was performed in 
an additional two steps to provide (+)-cyclophellitol in thirteen steps from the chiral 3-furylamine.   
 
Schlessinger et al. [78] have also reported that the aforementioned nonracemic C(3) and C(4) 
aminofurans can prepared bound to a solid polymer-substrate, facilitated by reaction of the oxygen 
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enolate with a silyl derived polymer. The polymer-bound aminofurans have been reported to provide 
cycloadducts in excellent yield and stereoselectivity (>99% ee) and the advantages of this approach have 
been mentioned to include a simplified work-up procedure and clean recovery of the chiral auxiliary.  
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Scheme 3.21: Schlessinger et al. [77] have used the D-A reaction of the proline derived 3-furylamine with dimethyl 
2,3-pentadiendioate allene to produce the endo cycloadduct in >99% ee. Hydrolysis in aqueous acidic acetonitrile 
(MeCN) gave clean hydrolysis to the ketone that was reduced using NaBH4, followed by isomerization using 
DMAP and ozolonysis. Stereoselective transformation to (+)-Cyclophellitol was achieved in a further 6 steps. 
3.3 Diels-Alder Reactions of 3-Furylamines 
 
The literature review of experimental publications and theoretical considerations presented in 
Sections 3.1 and 3.2 predict the activated 3-furylamines to be reactive dienes in D-A chemistry. Ab initio 
molecular-orbital studies suggest that the presence of an amino group on the furan ring has a 
destabilizing effect on the aromaticity of furan [79], as well as producing an increase in HOMO energy 
levels [80]. Both effects contribute to an increase in reactivity towards pericyclic reactions and promote 
exclusive selectivity in regiochemical outcomes. SHMO overlap indicates that para regiochemistry can 
be expected with respect to the orientation of activating groups in the reactants and 3-amino-5-methyl 
derivatives should prefer the ortho/para regiochemistry desired for the target natural product. The 
literature described in Section 3.1.2 indicates that to some extent, the rate and diastereoselectivity can be 
appropriately modified utilizing solvent polarity or catalysis and enantioselectivity can be controlled 
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using chiral C(3) heterosubstituents. The following section describes the D-A reactions of the appropriate 
non-chiral 3-furylamines prepared in Section 2.3, along with an investigation of face selectivity using 
optically pure 3-aza-5-methylfurans prepared in Section 2.4.  
 
3.3.1 Investigation of Diels-Alder Reaction Conditions 
 
Preparation of 3-furylamines from tetrahydropyran-2-yloxy (THP) protected alkynols has 
allowed for the incorporation of a variety of amine substituents in these Diels-Alder substrates (Chapter 
2). The mixture of products expected from the D-A reaction between the achiral 5-methyl-3-aza-furans 
and MAC consists of endo and exo diastereomers of methyl 5-(dialkylamino)-1-methyl-7-oxa-
bicyclo[2.2.1]hept-5-ene-2-carboxylate (25) as equal amounts of (1S,4S) and (1R,4R) enantiomers 
(Scheme 3.22).  
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Scheme 3.22: D-A reaction of non-chiral 3-aza-5-methylfurans with MAC should produce a racemic mixture of 
endo and exo enamines 25 which can undergo hydrolysis in aqueous acidic conditions to form endo (4a) and exo 
(4b) diastereoisomers of 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylic acid methyl ester. The 
(1S,2R,4S)-4b and (1R,2R,4R)-4a antipodes can be used in the synthesis of the natural product 1.
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The respective diastereomers of 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylic acid 
methyl ester (4a-4b) can then be obtained by hydrolysis of the enamine to provide the functionalised 7-
oxanorbornane intermediates. The exo ketone (1S,2R,4S)-4b has both methyl ester and oxygen bridge in 
the correct stereochemical orientation to that observed in the target 1, although the endo ketone 
(1R,2R,4R)-4a may also be used by means of stereochemical inversion at the C(4) position subsequent to 
transformations involving ether ring cleavage.  
 
Preliminary D-A reactions were performed by reacting 4-(5-methylfuran-3-yl)morpholine (5a)
with MAC in n-hexane (Scheme 3.23) at a range of temperatures with monitoring by GCMS analysis. 
Reaction in hexane at 40ºC was very slow, however two small peaks at tR = 12:27 and 12:33 min with 
molecular ions corresponding to the 7-oxanorbornane diastereoisomers (4) (m/z 184) appeared after 8 h, 
indicating that the hydrolysis of 25 may occur in the presence of atmospheric moisture (Figure 3.7). 
Reactions conducted at 50ºC and 70ºC had improved yields of 4, however notable decomposition 
occurred with increasing temperatures along with the accumulation of a major by-product at tR = 16:17 
min that showed no observed molecular ion in MS analysis but a characteristic high mass fragment ion at 
m/z 247. At temperatures above 50ºC, GC-MS analysis Figure 3.7 indicated the formation of a small 
amount of aminated product (m/z 173) at tR = 12:06 min featuring a morpholine fragment ion (m/z 84) 
and this molecular weight corresponds to the 1,4-addition product of the hydrolysed morpholine group to 
MAC. As such D-A reactions under conditions involving the hydrolysis of 25 required at least 2 
equivalents of dienophile to account for the reaction of the amine with MAC (Scheme 3.23). A molecular 
ion for the enamine was not observed and reactions conducted in sodium dried hexane did not improve 
yield or allow for better GC detection of either isomer of 25. Diastereoisomeric ratios and yields of 4
prepared using 5a in hexane are shown in Table 3.1. 
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Scheme 3.23: D-A reaction of 5a with MAC in n-hexane produced increasing yield of 4 at higher temperatures. The 
facile 1,4-addition reaction of morpholine to MAC occurred at 70ºC, indicated by a parent ion at m/z 173 in GC-MS 
analysis.  
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Figure 3.7: GC-MS spectrum for the reaction of 5a with MAC at 40, 50 and 70ºC show increasing yields for 4 (M+· 
m/z 184) and the hydrolysed morpholine group was observed to react with the dienophile via 1,4-addition to give 
the amine by-product (M+· m/z 173) observed as an earlier eluting component than 4 at tR = 12:06. A major by-
product is formed at high temperatures with a fragment ion of m/z 247. GC analysis conditions are listed in Section 
6.10, Instrument 1. 
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Extraction of the D-A reaction mixtures with 0.5 M HCl facilitated the removal of aminated 
biproducts and the diastereoisomers of 4 were separated by column chromatography on silica gel (10:1 
pentane:EtOAc). A pale yellow oil with TLC retention of Rf = 0.38 was isolated in >99% purity as 
confirmed by GC-MS analysis. 1H NMR analysis of the pure isomer confirmed the presence of a methyl 
substituent H(9) at 
 1.70 and a methyl ester substituent H(10) at 
 3.72 as two large singlets, each with 
an integral area equivalent to three protons (Figure 3.8). 13C NMR analysis showed the expected C(5) 
ketone and C(8) ester carbonyl peaks at 
 210.3 and 172.2 respectively (Figure 3.8). The bridgehead 
proton H(4) adjacent to the electron withdrawing ether and carbonyl functionalities can be assigned to 
the broad downfield doublet (J = 6.6 Hz) at 
 4.37 with an integral region equal to one proton. The 
COSY NMR analysis indicates that the H(4) signal is correlated with two proton signals at 
 2.33 and 

2.16, assigned as H(3A) and H(3B) resonances respectively. The H(3) peaks are confirmed by HMQC and 
DEPT 135 analysis to be attached to the C(3) methylene carbon at 
 30.9 (Figure 3.9), thus confirming 
that the cycloaddition proceeded with para selective regiochemistry with respect to the ester and amine 
substituents. The downfield negatively oriented DEPT 135 NMR signal at 
 46.0 can be assigned to the 
C(6) methylene adjacent to the carbonyl group and HMQC data shows correlation to protons H(6A) and 
H(6B) at 
 2.39 and 2.17, respectively. The H(6) protons show strong coupling to each other in COSY 
analysis and appear as second order doublets almost overlapped with the diastereotopic signals from 
H(3). Coupling constants between H(6) methylene protons J6A, 6B = 17.8 Hz, J6B, 6A = 18.4 Hz were not 
identical, indicating that H(6B) is split by an additional proton signal. The H(2) proton is assigned to the 
signal at 
 2.88 in good agreement with Chemdraw predictions and COSY analysis indicated correlations 
to H(3A) and H(3B) in agreement with the proposed structure. 1H NMR analysis conducted using 300 
MHz spectrometry did not sufficiently resolve the overlapping second order H(6) methylene signals and 
500 MHz experiments were required to provide adequate resolution to measure 1H coupling constants for 
H(3A)/H(3B). The methylene protons on C(3) exhibit first order AX splitting (J3A, 3B = 13.4 Hz) and H(3A)
was observed to be a doublet of doublet of doublets (J3A, 3B = 13.4 Hz, J3A, 4 = 6.6 Hz, J3A, 2  = 11.4 Hz) 
and the H(3B) signal appeared as a double doublet (J3B, 3A  = 13.4 Hz, J3B, 2 = 5.4 Hz). The 1H coupling 
constant between H(3B) and H(4) is ~0 Hz, and principles described by the Karplus equation suggest that 
these protons are locked in almost orthogonal positions on the 7-oxanorbornane moiety [81]. The H(2) 
signal appears as a doublet of doublet of doublets (J2, 3A = 11.4 Hz, J2, 3B = 5.4 Hz, J2, 6B = 2.1 Hz) and 
although no COSY correlation was apparent for the four-bond-w-coupling between H(2) and H(6B), 1H
homo-decoupling NMR experiments demonstrated the collapse of H(2) to form a doublet of doublets 
upon decoupling at the H(6B) frequency (Appendix 3.1). These observations indicate that the isolated 
diastereomer is 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylic acid methyl ester (4a) and is 
in the endo configuration whereby H(2) is coupled to H(6B) (J2, 6B = 2.1 Hz) and H(3A) has an equatorial 
cis relationship with H(2) and H(4), however H(3B) and H(4) are at a 90º angle as indicated by J3B, 4 = ~0 
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Hz. Confirmation of the connectivity of the bicyclic ether was established from the strong correlation 
between C(1) at 
 86.0 and C(4) at 
 81.4 in heteronuclear multiple bond correlation (HMBC) analysis 
(Appendix 3.2) and 1H homo-decoupling experiments conducted at 200 MHz are shown in Appendix 3.1 
and confirm the structure proposed for 4a.
Figure 3.8: 500 MHz 1H and COSY NMR analysis of endo 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-
carboxylic acid methyl ester (4a). The 300 MHz 1H NMR for the overlapping H(3A)/H(3B) and H(6A)/H(6B) signals 
is shown on the same scale.   
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Figure 3.9: 500 MHz HMQC spectrum of 4a, 125 MHz 13C and DEPT 135 NMR analysis is also shown with 
structural assignments. 13C NMR data for 4a is also included in Appendix 3.2.    
 
The exo diastereomer of 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylic acid methyl 
ester (4b) was produced in low concentration during the reaction of 5a in hexane and was not isolated 
from the product mixtures in suitable purity for characterization. Further D-A reactions between 5a and 
MAC were conducted in DCM to successfully yield a mixture of 4 and 25 as indicated by GC-MS 
(Figure 3.10), and no change of diastereomeric ratio was observed over time suggesting that the 
cycloaddition is under kinetic control. Reactions performed at 25ºC (Figure 3.10) and 45ºC gave identical 
product mixtures and in both cases a large GC peak with a molecular ion corresponding to the enamine 
intermediate 25 (m/z 253)  was observed at tR = 14:18 min.  
 
Diels-Alder Reactions of 3-Furylamines  
151 
Figure 3.10: GC-MS analysis of the crude D-A reaction of 5a with MAC in DCM at 25ºC indicates clean 
conversion to the cycloadduct 25 with significant in situ hydrolysis to 4 due to atmospheric moisture. Hydrolysis in 
0.5 M HCl gave 4a and 4b in a 4:1 ratio. 
 
During D-A reactions of 5a in DCM, decomposition accompanied reaction times longer than 12 
h. The enamine 25 was labile to hydrolysis from traces of moisture and crude mixtures typically 
contained both 4 and 25. Attempts to isolate 25 were unsuccessful and a retro D-A reaction to reform 5a
occurred during distillation and column chromatography on silica gel. Hydrolysis of the crude material in 
0.5 M HCl and extraction with DCM provided an isolated 93% combined yield of 4 in an endo:exo ratio 
of 4:1 as determined by GC integral regions (Figure 3.10). Cycloadditions conducted at sub-ambient 
temperatures were also successful and as expected returned a mixture of unreacted 5a and 4 due to 
decreases in reaction rates at lower temperatures (Appendix 3.3). Reactions conducted in DCM 
progressed with the formation of much less by-product than reactions in hexane and purification by 
column chromatography on silica gel (10:1 pentane:EtOAc) provided 4b in 19% yield (TLC, Rf = 0.12) 
as a pure white crystalline solid with similar GC-MS fragmentation to the endo isomer (Appendix 3.4).  
 
300 MHz 1H NMR experiments on 4b (Figure 3.11) showed a doublet for H(4) at 
 4.47 and the 
COSY spectrum indicates correlation to H(3A) (J4, 3A = 6.4 Hz) but not H(3B), suggesting a similar 90º 
dihedral angle for H(3A) and H(4) as observed in 4a. The H(2) proton at 
 2.80 appears as a double 
doublet with coupling to H(3A) and H(3B) (J2, 3A = 5.1 Hz, J2, 3B = 8.7 Hz) as corroborated by COSY data 
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and four-bond-w-coupling to the H(6) AB quartet at 
 2.25 is not observed, as expected for the exo 
configuration. The H(3) methylene signals demonstrate AX coupling (J3A, 3B = 13.4 Hz) and H(3A) (

2.52) shows COSY correlations to H(2), H(4) and H(3B), appearing in 1H NMR data as an apparent 
doublet of triplets. H(3B) (
 1.94) appears as a double doublet with the expected coupling to H(3A) (J = 
13.4 Hz) and H(2) (J = 8.7 Hz). Although 13C NMR spectrum of 4b was similar to 4a, HMQC analysis 
(Appendix 3.4) revealed that the C(2) carbon in 4b is present at 
 49.4 and appears at lower frequency 
than the C(6) methylene carbon at 
 50.5, whereas these signals are in the reverse order in 4a (C(2) 

51.1, C(6) 
 46.0, Figure 3.9). The structure of 4b was also consistent with HMBC data (Figure 3.11) and 
the ether bridge was confirmed by strong correlation of the methine bridge doublet H(4) to C(1) and 
C(2). Signals from H(3) correlate to C(2) and the C(5) carbonyl shifts and H(3A) correlates to C(4) 
whereas H(3B) correlates to C(1). The H(6) AB quartet signal correlates to the expected C(9), C(2), C(1) 
and C(5) carbon shifts.  
 
Figure 3.11: 1H 300 MHz/13C 75 MHz HMBC NMR and 300 MHz COSY NMR spectrum of 4b with correlations.  
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A simple procedure for the separation of 4b from a mixture of diastereomers of 4 was realised 
upon the addition of Et2O to D-A hydrolysis mixtures, after which the exo diastereomer 4b crystallised in 
high purity whereas the endo diastereomer 4a is completely soluble. Recrystallization of 4b in Et2O
allowed for the preparation of suitable material for X-ray crystal structure analysis and crystal data 
determined conclusively the identity of 4b as the exo product (Figure 3.12). The X-ray crystal CIF file 
and a summary of bond distances for C-C bonds is included in Appendix 3.5, and comparison with 
figures quoted by Allen et al. [82] indicate that distances are close to the expected values.  
 
Figure 3.12: ORTEP drawing of exo-methyl 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate 4b. Crystal 
Data. C9H12O4, MW = 184.19, T = 293(2) K,  = 0.71073 Å, triclinic, space group P-1, a = 7.2235(10), b =
8.1158(11), c = 8.3058(12) Å,  = 75.273(2)o,  = 74.540(3)o,  = 86.114(2)o, V = 453.89(11) Å3, Z = 2, Dc = 1.348 
Mg/m3, µ(Mo K) = 0.106 mm-1, F(000) = 196, crystal size 0.50 x 0.15 x 0.10 mm3, 2428 reflections measured, 
1583 independent reflections (Rint = 0.0587); the final wR(F2) was 0.1414 (all data) and final R was 0.0529 for 1311 
unique data [I > 2(I)]. Goodness of fit on F2 = 1.029. Crystallographic data for the structure reported has been 
deposited with the Cambridge Crystallographic Data Centre as deposition No. 288600. 
The diene 5a was not reactive with MAC in Et2O or dioxane however reactions performed with 
heating in the aromatic solvents benzene and toluene led to the exclusive formation of a by-product at tR
= 16:17 min featuring a predominant m/z 247 fragment in GC-MS analysis (Appendix 3.6). This 
compound was observed to have an identical mass spectrum to the major product formed in hexane at 
70ºC (Figure 3.7) and product mixtures obtained from toluene at 111ºC provided suitably pure material 
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for NMR analysis (Appendix 3.6). 1H and 13C NMR analysis features signals for the 7-
oxabicyclo[2.2.1]heptane moiety indicating that the D-A cycloaddition was successful. However the 
absence of a ketone or enamine signals in 13C NMR analysis suggests that the side reaction has occurred 
at the C(5) carbon. 1H NMR integral regions indicate the presence of two morpholine moieties in 
different chemical environments and 13C NMR aromatic signals characteristic of a 2,3,5-trisubstituted 
furan point toward the nucleophilic addition product involving the C(2’) position of 5a with 25 to 
provide 26 (Scheme 3.24). Similar structures have been reported by Bridson [73] during the D-A reaction 
of N-3’-furylbenzamide (Section 3.2.1) and tentative NMR assignments for 26 are included in Appendix 
3.6 based on previously assigned structures and Chemdraw predictions.   
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Scheme 3.24: Reaction of 5a with MAC in toluene at 111ºC gave 26 via formation of the D-A cycloadduct 25 
followed by addition to the C(5) enamine olefin with a second equivalent of 5a which reacts at the C(2’) furan 
carbon. 
 
The neat reaction between 5a and MAC also produced 26 in high yield and GC-MS analysis did 
not indicate the reproducible formation of cycloadducts 4 or 25 although yields >5% of 4 were 
encountered on one occasion.  
 
D-A reactions of 5a with two equivalents of MAC in aqueous media were undertaken at room 
temperature to produce excellent yields of 4 in short reaction times (Scheme 3.25). Upon rapid stirring, 
small droplets of 5a distributed throughout the aqueous heterogenous solution and after successful 
cycloaddition to form 25 the crude material slowly aggregated and formed a film on top of the water 
which partially hydrolysed to 4 with continued stirring. Attempts at progressive 1H NMR experiments in 
D2O indicated that the cycloaddition was almost spontaneous in aqueous media since the disappearance 
of furans signals was complete before the time required for 1H NMR acquisition (~1:30 min). 
Cycloadditions conducted in aqueous solution gave the cleanest product mixtures when conducted at low 
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concentrations (5.4 x 10-4 [M]) and the analysis of changes in diastereomeric ratio with temperature 
demonstrated a preference for the endo product 4a at low temperatures (Table 3.1). GC-MS analysis of 
the crude D-A extracts indicated that the intermediate 25 was present in large quantities at 2ºC and that 
the hydrolysis of 25-exo occurs rapidly whereas 25-endo is in equilibrium with 4a and is predominately 
hydrolysed in reactions conducted at 45ºC (Appendix 3.7). Complete hydrolysis of both diastereoisomers 
of 4 was achieved in aqueous acidic acid and best results were obtained by allowing 2 h reaction time for 
partial hydrolysis followed by extraction into DCM and vigorous shaking with 0.5 M HCl. In all cases 
the cycloaddition proceeds in >99% yield and the m/z 167 molecular ion for 5a was observed, even in the 
presence of 4.0 equivalents excess of MAC, and can be detected in the tailing edge of the 4b peak 
(Figure 3.13).   
O
N
O
O
N
OO
O
5a
25-exo
a) or b)
MAC
O
N
OO
O
+
25-endo
+ enantiomers
O
O
OO
O
O
OO
+
+ enantiomers
4a 4b
+ H2O
+ Morpholine
- H2O Morpholine4a + 4b
2 : 1
a)
+ H2O
Morpholine
a)
b)
4 : 1
a) H2O, 25ºC, 2 h b) H2O, 45ºC, 2 h. 
 
Scheme 3.25: D-A reaction of 5a with MAC in water (25ºC) gave rapid conversion to 25 and the hydrolysis of 25-
exo to 4b appeared to be more facile than the hydrolysis of 25-endo to 4a (Appendix 3.7). Aqueous reaction at 
45ºC gave a predominately hydrolysed 2:1 mixture of 4a and 4b whereas reaction at 25ºC gave a 4:1 mixture. 
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Figure 3.13: GC-MS analysis of the crude extract from the D-A reaction between 5a with MAC in water at 45ºC 
indicated the clean formation of cycloadducts 25 and 4 and the enamine 25 was predominately hydrolysed to 4 after 
a 2 h reaction time. The MS of the starting furan 5a could be detected in the tailing edge of 4b, suggesting the D-A 
reaction is in equilibrium with 5a with strong preference for the cycloadduct. 
These results indicate that the cycloadduct 25 is in equilibrium with 5a in aqueous reactions and 
suggest that formation of the enamine of the kinetically favoured endo product (25-endo, Figure 3.25) 
involves a lower transition state energy. A predominance of 4a may thus be obtained by conducting the 
D-A cycloaddition at low temperatures with sufficiently active dienes. Reactions at temperatures above 
45ºC encouraged the formation of by-products and this complicated repeated attempts to form a 
predominance of the exo diastereoisomer via D-A equilibration to the thermodynamic product 25-exo. It 
should also be mentioned that measurements of changing diastereoisomeric ratio over time was made 
difficult due to the facile hydrolysis to 4.
5-Methyl-3-amino furans of various amine size were trialed to study the steric effect of C(3) 
amine substituents on reactivity and changes in endo:exo selectivity. Reactions of N,N-diisopropyl-5-
methylfuran-3-amine 5c with MAC in toluene was successful at 70ºC in moderate yield (8 h, 42% yield 
4) and reactions in DCM proceeded upon prolonged stirring at room temperature (120 h, 30% yield 4). In 
both solvents a diastereomeric ratio of 1:1 was observed with significant decomposition (Table 3.1), 
leading to difficulties in purification. D-A reaction of 5c with MAC in water was observed to provide 
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excellent yields of 4 (>95%) in clean reaction mixtures with 1:2 selectivity for the exo product 4b (Table 
3.1) as indicated by GC-MS analysis (Appendix 3.8). The enamine intermediate 27 (Scheme 3.26) was 
not isolated and mostly hydrolysed after 4 h reaction times at ambient temperature, followed by complete 
hydrolysis upon aqueous acidic workup. The cycloaddition of 5c in aqueous LiCl solutions was 
conducted in order to observe the effect of increases in ionic strength and reactions in 3.0 M LiCl had no 
effect on diasteroselectivity although complete hydrolysis to 4 was achieved in high yield (91%) under 
neutral conditions in 1 h (Table 3.1). The salting-out effect of LiCl was apparent in reacting solutions and 
5c immediately formed a biphasic solution without a period of visible micellar suspension.  
 
5 MAC (eq.) Solvent Temp. (oC) Time (h) % Yield 4A d.r.C
a 3.0 Toluene 111 12    0 - 
a 3.0 Hexane 40 8    30 5:1 
a 3.0 Hexane 50 8    45 7:1 
a 3.0 Hexane 70 8    60B 9:1 
a 3.0 Benzene 80 12    0B -
a 3.0 Dioxane 100 24    0B -
a 2.0 DCM -78 to 0  8    4 2:1 
a 2.0 DCM 4 8    69 2:1 
a 2.0 DCM r.t. 8    93 4:1 
a 2.0 Water 1 2  >95 5:1 
a 2.0 Water r.t. 2  >95 4:1 
a 2.0 Water 45 2  >95 2:1 
c 2.0 Toluene 60 8    0 - 
c 2.0 Toluene 70 8    42B 1:1 
c 1.5 DCM r.t. 120 30B 1:1 
c 1.5 Water r.t. 4  >95 1:2 
c 1.5 3.0 M LiCl r.t. 1    91 1:2 
c 1.5 0.1 M CH3COOH r.t. 1    87 1:1 
c 1.0 DIMCARB r.t. 1  >95 3:7 
b 1.5 Water r.t. 2  >95 3:2 
b 1.5 3.0 M LiCl r.t. 1  >95 1:1 
e 2.5 DCM r.t. 8    0 - 
e 2.0 Water r.t. 8  >95 4:1 
Table 3.1: Diels-Alder reactions of 3-furylamines 5a, 5b, 5c and 5e. ACombined yields of 4 as determined by GC-
MS. BSignificant decomposition. CRatio of diastereoisomers 4a:4b. Reactions in organic media performed using 1.2 
mmol of 5 in 10 mL solvent. Reactions in ionic media performed using 0.6 mmol of 5 in 20 mL solvent. 
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The ionic liquid N’,N’-dimethylamino-N,N-dimethylcarbamate (dimethylamine-CO2 adduct, 
DIMCARB) [83] provided a polar reaction media with similar hydrogen bond donating and accepting 
properties to that seen in water, in which the D-A reagents are completely soluble. Reactions of 5c in 
DIMCARB were complete in 1 h using an equi-molar quantity of MAC and produced the cycloadduct 4
with 3:7 selectivity for 4b. These results strongly suggest that the hydrogen bond donor properties of the 
solvent are predominantly responsible for increases in reaction rate of the 3-furylamine dienes whereas 
hydrophobic interactions as discussed in Section 3.1.2 may contribute to a lesser extent. 
 
D-A reactions of N,N-diethyl-5-methylfuran-3-amine 5b with MAC in water and 3.0 M LiCl 
were equally successful (>95% 4, Table 3.1) and the enamine D-A product was not observed in GC 
studies indicating complete hydrolysis to the ketone 4 after 1-2 h at room temperature. N,N-Dibenzyl-5-
methylfuran-3-amine 5e did not react with MAC in DCM but was successful in water and progressed 
slowly over 8 h to provide 4 in 4:1 endo:exo ratio. The slow reaction rate was suspected to be due to a 
decrease in solubility attributed by the larger aromatic substituents on the amine, and reaction times 
could be reduced to 1 h when ultrasonic irradiation was employed as a means of dispersing the furan in 
aqueous media.  
 
The influence of the C(5) amine group on diastereoselectivity is apparent for reactions involving 
5c whereby the steric effect of the isopropyl substituents towards crowding the furan face leads to the exo 
compound predominating due to repulsion of the ester substituent  (Scheme 3.26) and the disruption of 
secondary -orbital overlap. The ethyl substituted furan 5b produces a small excess of the endo 
compound 4a in water and an equal ratio of 4a and 4b was observed in 3.0 M LiCl solution, possibly due 
increases in reaction rate corresponding with decreases in transition state energies as suggested by 
Jorgensen [41]. Although hydrophobic effects are typically observed to encourage increases in endo 
product [36], a strong trend towards endo selectivity was not observed with increases in solvent polarity 
potentially due to the polar nature of the amine substituent. At ambient temperature furan, 5e possessing 
dibenzylamine substituents provided D-A cycloadducts in the same diastereomeric ratio as reactions 
involving the morpholine substituted furan 5a, indicating that the aromatic substituents may be oriented 
too far away from the reactive carbons to influence diastereoselectivity or alternately contribute a small 
degree of -orbital overlap with the incoming dienophile.  
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Scheme 3.26: The D-A reaction of 5c with MAC in H2O or 3.0 M LiCl produced the cycloadduct 27 in quantitative 
yield followed by hydrolysis upon continued stirring to produce the ketone in a 1:2 ratio of 4a:4b.
Reaction of 5c with MAC in 0.1 M CH3COOH was observed to produce an increase in diene 
reactivity compared to neutral conditions and the enamine cycloadduct was hydrolysed in situ to produce 
a 1:1 mixture of 4a:4b accompanied by a small amount of decomposition as indicated by GC-MS 
analysis (Appendix 8). Increases in the reactivity of 3-furylamines are expected upon protonation of the 
amine, leading to an increase in HOMO energy of the furan system (Figure 3.14). Increases in reactivity 
of the protonated 5c species may account for a decrease in exo selectivity although conformational 
changes in the protonated compound may also contribute as well as hydrogen bonding of the dienophile 
to the amine hydrogen.  
 
Figure 3.14: Chem3D generated MM2 energy minimised structures of 5c and calculated HOMO energy levels are 
shown, indicating changes in conformation of the isopropyl substituent and an increase in HOMO energy levels. 
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Although more hindered amines 5c and 5e gave poor yields in DCM, all furans studied were 
successfully transformed into D-A products in water, highlighting the unique properties of polar reaction 
media towards increasing D-A reaction rate. The rate enhancement observed in aqueous reaction media 
is in agreement with the findings of Breslow et al. [36] as discussed in Section 3.1.2, and in the research 
presented the advantage of an aqueous environment extends to the hydrolysis of the enamine D-A adduct 
thereby minimizing side reactions of the enamine. The use of water as a reaction medium for organic 
synthesis is also considered an environmentally benign or “green” alternative to the use of toxic or non-
biodegradable solvents, and the ionic liquid DIMCARB proved equally useful as a benign reaction media 
for expedient cycloadditions of 5 since the solvent can be dissociated under gentle vacuum or heating 
then recondensed as the addition product for reuse [83]. D-A reactions in ionic solvents progressed 
without decomposition provided all materials were freshly distilled whereas trials performed in organic 
solvents were not significantly affected by small impurities or adventitious moisture. In aqueous media 
gram quantities of racemic products 4a and 4b were made accessible using the furylamines 5a and 5c
and the racemates were used for subsequent preliminary studies involving ether cleavage of the 7-
oxanorbornane ring. Face selective D-A studies using the chiral amines 5p and 5q were pursued with the 
aim of producing a pure enantiomer of 4 with suitable absolute stereochemistry for use in the natural 
product synthesis. The general reaction conditions for the D-A reaction of 5a-e in organic and aqueous 
reaction media are included in Sections 6.6.1-6.6.3. 
 
3.3.2 Chiral Separation of Diels-Alder Products by Gas Chromatography 
 
In order to determine the extent of chiral induction due to the influence of optically pure 
auxiliaries, a simple method was required to determine the ratio of enantiomers of 4a and 4b.
Enantiomeric purity can easily be determined by comparison with the optical rotation of the pure 
enantiomer, however at the time of this research these values had not been reported in the literature. 
Capillary GC using chiral columns was investigated as a direct method of determining enantiomeric 
ratios and has the advantage that enantiomeric excesses of both diastereomers can be measured 
simultaneously without the physical isolation of 4a from 4b.
GC columns containing a percentage of -cyclodextrin (Chapter 1, Figure 1.24) derivatives in 
the stationary phase are useful for the chiral separation of oxygenated monoterpenes [84] and have also 
been used for comprehensive two-dimensional gas chromatography (GC x GC) for the enantioselective 
analysis of essential oils [85]. The separation and elution order of enantiomers is strongly influenced by 
temperature and optimal separation is typically achieved by using low starting temperatures and a slow 
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temperature ramp. Inversion in elution order is occasionally observed at temperatures either side of the 
isoelution temperature [86].  
 
Preliminary studies were performed on the racemate of 4 using a CP-Chiralsil-dex CB GC 
column (Varian) which contains -cyclodextrin as a chiral selector bonded to dimethylpolysiloxane, to 
achieve partial resolution of 4b with total co-elution of 4a (50ºC, 3ºC/min to 200ºC). The same 
temperature program was used chiral separation studies with a J&W Cyclosil- (Agilent) column 
consisting of 30% heptakis(2,3-di-O-methyl-6-O-t-butyl dimethylsilyl)--cyclodextrin (in stationary 
phase DB-170) to provide good separation of 4b although 4a remained unresolved (Figure 3.15, left). 
The Et-TBS--CD column (MeGA, Legnano, Italy) composed of 30% diethyl-t-butylsilyl--cyclodextrin 
in the relatively non-polar polymethylsiloxane (PS086) stationary phase provided excellent chiral 
separation for enantiomers of 4a and 4b and optimal separation was achieved using temperature program 
conditions from 60ºC to 180ºC at 2ºC /min. The crystalline exo product 4b was isolated by precipitation 
from Et2O at -18ºC and GC analysis on the Et-TBS--CD stationary phase (Figure 3.15, middle) gave 
complete resolution of enantiomers. GC analysis of the crystallization mother liquor shows a 11:1 ratio 
of 4a:4b (Figure 3.5, right) clearly differentiating the retention times for enantiomers of 4.
Figure 3.15: Left; Chromatogram of a mixture of 4a and 4b on J&W Cyclosil- column showing the separation of 
(1R/1S)-4b only. Midddle; Chromatogram of 4b after crystallization from Et2O using a Et-TBS--CD stationary 
phase. Right; Chromatogram of Et2O crystallization mother liquor consisting of 4a:4b (11:1).   
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Small changes in the retention time of analytes were observed with changes in relative peak 
heights and minor differences in column head pressure. Column dimensions and GC conditions for the 
chiral separation of 4 are included in Section 6.10. 
 
3.3.3 Enantioselective Diels-Alder Reactions 
 
D-A reactions involving non-chiral 5-methyl-3-furylamines with MAC (Section 3.3.1) 
demonstrated both DCM and water to be suitable reaction media and these conditions were subsequently 
used for enantioselective D-A studies of chiral 3-furylamines. Reaction of 5p with MAC in DCM at 0ºC 
revealed that the (+)-pseudoephedrine-derived 5-methyl-3-furylamine diene was very reactive towards 
[4+2] electron cycloadditon and GC-MS monitoring indicated the formation of a major and minor 
product featuring a molecular ion at m/z 331 in agreement with the mass of the cycloadduct (Appendix 
3.9). Fragment ions characteristic of the pseudoephedrine derived oxazolidine (m/z 91, 118, 148) as 
observed for 19p (Section 2.4, Figure 2.16) suggested that the enamine 28-int preferentially exists as the 
five membered heterocycle 28-endo. Reactions conditions were optimised by reacting 5p at –50ºC with 
slow warming to ambient temperature over 8 h to achieve 28-endo (>95% yield, GC-MS) in high purity 
and the identity of the enamine diastereoisomer was confirmed by partial hydrolysis in HCl to reveal 4a
(Scheme 3.27). Distillation, column chromatography on deactivated silica and gas chromatography in the 
presence of chemically active GC injector liners or columns led to an appreciable retro-D-A reaction of 
28, indicating that the oxazolidine form of the cycloadduct may act to prevent a facile retro [4+2]
reaction from occurring.  
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Scheme 3.27: D-A reaction of 5p with MAC in cold DCM with warming to ambient temperature gave the enamine 
cycloadduct 28-int as a single isomer in >95% which spontaneously underwent intramolecular cyclization to the 
spiro oxazolidine heterocycle 28-endo. Partial hydrolysis in 0.5 M HCl gave the  endo 7-oxanorbornane 4a.
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13C NMR analysis of the crude D-A mixture indicated a highly enriched mixture of (1S,4S,5S)
and (1R,4R,5R)-methyl 3’,4,4’S-trimethyl-5’S-phenylspiro[7-oxa-bicyclo[2.2.1]heptane-2,2’-
[1,3]oxazolidine]-5-carboxylate diastereomers 28 and chemical shifts of the major isomer are assigned in 
the HMQC NMR shown in Figure 3.16. The bicyclic structure of 28-endo was confirmed by COSY 
NMR indicating correlation between the bridgehead H(1) at 
 4.60 and methylene signals from H(6B) at 

 2.04, and correlation between H(5) at 
 2.70 with H(6A) at 
 2.55 and H(6B) (Appendix 3.10). HMQC 
and DEPT 135 analysis (Figure 3.16) agree with conclusions drawn from MS fragmentation data, 
showing the product to exist as the oxazolidine as indicated from the quaternary C(2/2’) spiro signal at 

108.8 and the C(3) methylene signal at 
 41.7 correlated to H(3A) and H(3B) at 
 2.43 and 1.85, 
respectively.  
 
Figure 3.16: 300 MHz 1H/75 MHz 13C HMQC NMR of 28-endo with structure assignments is shown and the 
quaternary C(2’)/(2) carbon is confirmed by DEPT 135 NMR. 
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The disappearance of both the C(2/2’) spiro and C(3) methylene carbon signals at 
 108.8 and 
41.5 in acidic D2O suggests facile reversion to the enamine 28-int upon protonation (Appendix 3.10) 
although full characterisation on this intermediate could not be obtained. Connectivity of the ephedrine 
and bicyclic moieties was confirmed by HMBC correlations and four-bond-w-coupling was observed in 
1H NMR consistent with the endo diatereoisomer (Appendix 11). The general experimental procedure for 
the reaction of 5p-q in DCM is included in Section 6.6.4. 
 
At this stage an attempt was made to purify by crystallization the mixture of (+)-
pseudoephedrine derived 7-oxanorbornanes shown in Figure 3.16 in order to obtain a single isomer for 
the determination absolute stereochemistry. The 28-endo mixture was a low melting semi-solid and 
crystallization was unsuccessful in hexane:ether mixtures at low temperatures (–20-0ºC). As well, the 
oxazolidine salt could not be crystallised due to facile reversion to 28-int. The oxazolidine 28-endo was 
unreactive towards reduction by NaBH4 in EtOH and LiAlH4 in Et2O and required acidic reduction 
conditions to effect interconversion to the enamine 28-int allowing reduction of the olefin to produce the 
amine product 29 (Scheme 3.28).  
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Scheme 3.28: The oxazolidine 28-endo was equilibrated with the enamine 28-int in glacial acetic acid followed by 
reduction to the tertiary amine using NaBH(OAc)3 to produce a 10:1 mixture of diastereoisomers of 29.
These conditions were satisfied by performing the reduction in glacial acetic acid using sodium 
triacetoxyborohydride (NaBH(OAc)3), preformed from NaBH4 in acetic acid according to a procedure 
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described by Hutchins et al. [87]. Clean reduction of 28-endo was achieved to give a single peak in GC-
MS analysis with no molecular ion and a base peak at m/z 226 corresponding to fragmentation of the 
pseudoephedrine chain of 29 (Appendix 3.12). The amine was easily purified by bulb-to-bulb distillation 
to provide 70% yield of 29 as a colourless resin and the structure of the reduced compound was 
confirmed by COSY correlations of H(5) at 
 3.12 to H(6) at 
 1.64 and H(4) at 
 4.40 (Appendix 3.12).  
 
Figure 3.17: 300 MHz 1H/75 MHz 13C HMQC NMR spectrum of a mixture of (1S,2S,4S,5S)-29 and 
(1R,2R,4R,5R)-29 and DEPT 135 NMR data.   
 
The exo face of the 7-oxanorbornane ring is less hindered and more accessible for reduction to 
the give cis-endo product, as exemplified in work by Koreeda et al. [71] and Takahashi et al. [72] 
(Section 3.2.1), therefore 29 is assigned as the endo C(5) amine although confirmation could not be 
obtained via coupling constants to the H(5) signal which appeared as a broad multiplet. Two 
diastereoisomers were observed in 13C NMR spectrum (Appendix 3.13) and 1H NMR integral regions of 
C(3’) indicates a 10:1 a mixture of diastereoisomers (Figure 3.17). 13C and 1H NMR assignments for the 
major isomer of 29 were made based on HMQC data (Figure 3.16) and methylene carbon signals for 
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C(6) at 
 38.3 and C(3) at 
 28.0 are confirmed by DEPT 135 analysis (Figure 3.16). HMBC analysis 
also corroborated the structure of 29 and is included in Appendix 3.13. 
 
Although the amine 29 was very stable, crystallization as the protonated amine salt produced 
hydroscopic solids with many counter-ions (Cl-, picrate, AuBr4-) that were unsuitable for X-ray crystal 
analysis. Crystallization in Et2O using HCl(g) (Section 6.6.5) produced a white amorphous hydrochloride 
salt that was filtered under a dry N2 atmosphere and redissolved in MeCN followed with counter-ion 
exchange by the addition of silver perchlorate (AgClO4) to yield a solution of the perchlorate salt 
29.HClO4 (Scheme 3.29). The AgCl precipitate was filtered from the MeCN solution after cooling to 0ºC 
and 29.HClO4 was carefully crystallised in MeCN by vapour diffusion with Et2O. 1H and 13C NMR 
analysis of 29.HClO4 indicated that the recrystallised material consisted of a single isomer (Figure 3.18) 
and NMR assignments were made based on COSY and HMQC analysis (Appendix 3.14). In comparison 
to 1H NMR data of 29, the expected downfield shifts for H(5), H(2’) and H(4’) signals were observed for 
protons situated closest to the quaternary amine in 29.HClO4 and the H(3A)/(3B) methylene signals 
appear as a second order multiplet at 
 2.30. The crude material could also be recrystallised from EtOH 
to provide a pure isomer however ethanolic solutions of the perchlorate salt were observed to decompose 
upon heating above 45ºC. X-ray crystal structure data on the major isomer of 29.HClO4 (Figure 3.19) 
revealed that the (+)-pseudoephedrine auxiliary had promoted facial selectivity in the [4+2]
cycloaddition for the (1S,4S) isomer. In this methodology, the optically pure auxiliary 23 has allowed for 
diastereoselectivity in the D-A reaction and incorporation into subsequent bicyclic derivatives provides 
diasteroisomeric differentiation of the enriched mixture of bicyclic antipode moieties.  
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Scheme 3.29: Precipitation of 29 as the hydrochloride salt followed by counter-ion exchange using AgClO4 in 
MeCN allowed the purification of (1S,2S,4S,5S)-29.HClO4 by crystallization using vapour diffusion with Et2O. 
 
The X-ray crystal structure of (1S,2S,4S,5S)-29.HClO4 also provides confirmation that the 
reduction of 28-endo had selectively occurred at the less hindered exo- face. The X-ray crystal CIF file 
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and a summary of bond distances for C-C bonds are included in Appendix 3.15, along with a comparison 
of bond lengths with literature values.  
 
Figure 3.18: 300 MHz 1H NMR and 75 MHz 13C NMR spectrum of (1S,2S,4S,5S)-29.HClO4, obtained by 
crystallization from MeCN using vapour diffusion with Et2O, indicates a single diasteroisomer.  
 
The oxazolidine 28-endo was stable to hydrolysis in aqueous environments and efficient 
hydrolysis conditions were required to facilitate clean conversion to 4a for a reliable calculation of 
enantiomeric excess. Upon heating in strongly acidic solutions (pH = 1; H2O, MeCN/H2O and 
EtOH/H2O), 28-endo underwent a retro Diels-Alder reaction via 28-int rather than hydrolysis, as 
indicated from increasing concentration of 5p in GC-MS analysis, leading to a loss in enantio- and 
diastereomeric excesses along with slow decomposition as indicated by chiral GC analysis. After many 
attempts effective hydrolysis was achieved by gentle heating in a buffer solution of NaOAc/CH3COOH 
(pH = 5.5) to give the optically enriched ketone 4a in 90% isolated yield (Scheme 3.30). Enantiomeric 
excess (ee) of 4a was measured by chiral-GC on a Et-TBS--CD column (MeGA, Italy) to provide 
baseline resolution of the enantiomers and indicating 85% ee of the (1S,2S,4S)-4a product (Figure 3.20, 
top left; Table 3.2) on reactions at < 1.0 mmol scales (< 0.25g). Reactions at multigram scales performed 
comparably well to give (1S,2S,4S)-4a in 80% ee and this measurement for enantiomeric purity is 
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consistent with 1H NMR integral regions of H(3’) in the mixture of diastereomers of 29 (Figure 3.17). 
Hydrolysis in strong acidic conditions typically gave the endo product in ~65% ee with a small amount 
of exo product, demonstrating that the equilibrating D-A reaction under aqueous acidic environments has 
a detrimental effect on stereoselectivity in the ketone product. The general procedure for the hydrolysis 
of oxazolidines 28 and 30 is included in Section 6.6.6. 
 
Figure 3.19: ORTEP drawing of (1S,2S,4S,5S)-methyl 5-(N-((1S,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-
methylamino)-1-methyl-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate perchlorate salt (1S,2S,4S,5S)-29.HClO4.
Crystal Data. C19H28ClNO8, MW = 433.87, T = 293(2) K,  = 1.54180 Å, orthorhombic, space group P-212121, a =
8.511(2), b = 15.356(5), c = 15.839(3) Å,  = 90.00o,  = 90.00o,  = 90.00o, V = 2070.1(9) Å3, Z = 4, Dc = 1.392 
Mg/m3, µ(Cu K) = 2.025 mm-1, F(000) = 920, crystal size 0.20 x 0.10 x 0.02, 2462 reflections measured, 2365 
independent reflections (Rint = 0.0230); the final wR(F2) was 0.1371 (all data) and final R was 0.0496 for 2006 
unique data [I > 2(I)]. Goodness of fit on F2 = 1.071. Crystallographic data for the structure reported has been 
deposited with the Cambridge Crystallographic Data Centre as deposition No. 288601. 
Reaction of the (-)-ephedrine derived 3-aminofuran 5q with MAC in DCM at –50ºC to 25ºC over 
8 h (Scheme 3.30) gave quantitative conversion to the oxazolidine 30 as indicated by GC-MS and 
fragmentation was almost identical to that observed in 28-endo (Appendix 3.16). Hydrolysis in 
NaOAc/CH3COOH buffer provided a 3:1 ratio of 4a:4b in 56 and 47% ee respectively as determined by 
chiral GC analysis (Figure 3.20, bottom left). Comparison of chiral GC analyses of D-A adducts prepared 
from 5p and 5q revealed both ephedrine isomers to direct face selectivity in the same manner, whereas 
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the diastereomeric outcome was quite different between the auxiliaries. The ephedrine isomers 23 and 24
(Section 2.4, Figure 2.15) have a diasteromeric relationship and differ in stereochemistry at the benzylic 
C(1’) alcohol, suggesting that the preferential face for D-A cycloaddition was determined by the 
stereochemistry at the C(2’) amine group. The decrease in endo selectivity observed when using the (-)-
ephedrine derived furan 5q may indicate a closer proximity of the benzene ring to the furan face in the 
transition state, hindering the exclusive formation of the endo isomer. The exo isomer 4b can reasonably 
be expected to have formed with preference for the same face of the furan diene as observed in the endo 
compound and the major enantiomer can be assigned as (1S,2R,4S)-4b.
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Scheme 3.30: D-A reaction of 5q with MAC in cold DCM with warming to ambient temperature gave the enamine 
cycloadduct 30-int which underwent intramolecular cyclization to the spiro oxazolidine heterocycle 30. Hydrolysis 
in NaOAc/CH3COOH solution produced an optically enriched 3:1 mixture of 4a and 4b.
Heterogeneous D-A reactions of 5p and 5q with MAC in water were very slow with stirring at 
room temperature but progressed in excellent yields and in short reaction times when performed with the 
aid of ultrasonic irradiation (>80% yield, 1.5 h). 3-Furylamine 5e containing aromatic substituents has 
been shown to react to completion without sonication, suggesting that the sonication in this case is 
simply a means of suspending the furan in solution, rather than a rate enhancing phenomenon. Small 
scale reactions (< 1.0 mmol) carried out using 5p in aqueous media gave a mixture of 28 and 4 as 
identified by GC-MS (Appendix 3.17) and the extent of hydrolysis to 4 was varied depending on the 
location of the reaction vessel in the ultrasonic bath. The excess dienophile was removed under vacuum 
to prevent the D-A reaction from occurring with unreacted portions of 5p during extraction into DCM, 
and following work-up the crude cycloadduct was heated under hydrolysis conditions for 2 h. Chiral GC 
analysis indicated good enantiomer purity (75% ee, Table 3.2) for both diastereoisomers of 4 that were 
prepared in a 9:1 endo:exo ratio (Figure 3.20, top right).  
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Figure 3.20: Chiral GC analysis using Et-TBS--CD stationary phase, showing optically enriched mixtures of 4
prepared using the chiral dienes 5p and 5q by the D-A reaction with MAC. Calculated enantioselectivities for 4a 
and 4b are listed in Table 3.2 and represent the average reproducible values. Top left; The 7-oxanorbornane 4a is 
prepared in >99% diastereoselectivity using 5p in DCM, starting at –50ºC with warming to –10ºC for 2 h and 
reaching 25ºC over an 8 h period. Bottom left; Reaction of 5q in DCM under the same conditions as for 5p 
produced a 1:3 ratio of 4a:4b. Top right; Reaction of 5p in H2O produced a 9:1 ratio of 4a:4b after 1.5 h at 
temperatures between 10 to 20ºC under ultrasonic irradiation. Bottom right; Reaction of 5q in H2O produced ratio 
of 4a:4b varying between 1.3:1 to 1:1 after 1.5 h at temperatures between 10 to 20ºC under ultrasonic irradiation. 
Diels-Alder Reactions of 3-Furylamines  
171 
During ultrasonic irradiation of 5q in aqueous media, observation of the reaction in progress 
indicated that 5q was more soluble than 5p under the same conditions and reactions with MAC gave 
endo:exo ratios ranging from 1.3:1 to 1:1 depending on the efficiency of irradiation and reaction 
temperature. GC-MS analysis showed that the enamine cycloadduct 30-int predominately underwent 
hydrolysis in situ (Appendix 3.18) likely due to enhanced solubility, and the crude material was heated in 
NaOAc/CH3COOH buffer to hydrolyse the remaining oxazolidine 30. Reasonable diastereoselectivity 
was observed for (1S,2R,4S)-4b achieving 60% ee (Table 3.2) and providing a 1:1 ratio of 
diastereoisomers when bath temperature was maintained between 10 and 20oC (Figure 3.20, bottom 
right). Poor selectivity was achieved for (1S,2S,4S)-4a (18% ee) and this lack of face discrimination can 
be expected with increases in reaction rates in hydrogen bond donating solvents.  
 
The D-A reaction of 5q with MAC in 3.0 M LiCl was observed to behave as a heterogeneous 
mixture due to ‘salting-out’ effects (Section 3.1.2) and GC-MS analysis indicated that decreases in 
solubility with increasing in ionic strength prevents the facile in situ hydrolysis of 30-int (Appendix 
3.18). No change in stereoselectivity was detected between reactions in water and 3.0 M LiCl, although a 
slight increase in 4a was noticed and can be explained by hydrophobic effects. Aqueous reactions using 
5q on multigram scales required 3 equivalents of acrylate to ensure the consumption of all starting 
material, but did not perform as well and a loss of 12 to 15%  ee was typically encountered.  
 
5
MAC 
(eq.) Solvent Temp (oC) Time (h) endo:exoA %ee (4a) %ee (4b) % YieldB
p 3.0 DCM  -50 to 25 8.0 99:1 85  n.d. 90 
p 3.0 DCM 25 8.0 9:1 79 66 90 
p 1.5 Water  10 - 20 1.5 9:1 75 75 83 
p 1.5 MeOH:Water (1:10) 25 3.0 7:3 32 15 69 
p 1.5 Dioxane:Water (1:10) 25 3.0 3:1 32 15 52 
q 3.0 DCM  -50 to 25 8.0 3:1 56 46 87 
q 1.5 Water  10 - 20 1.5 1:1 18 60 81 
q 1.5 Water, 0.5 eq. TBAI  11 - 20 2.0 3:2 - 56 64 
q 1.5 3 M LiCl  10 - 20 1.5 3:2 18 60 79 
Table 3.2: Enantioselective Diels-Alder reactions using ephedrine auxiliaries. ARatio of diastereoisomers (4a:4b)
BCombined yield of endo and exo products. Results produced on < 1.0 mmol scales. Reactions in water performed 
with ultrasonic irradiation. 
 
The addition of miscible co-solvents (dioxane, MeOH) to aid in the aqueous solubility of 5p led 
to a large decrease in diastereoselectivity (Table 3.2) for both diastereomers of 4, indicating the 
importance of hydrogen bonding to the optical induction in aqueous media. The addition of one half 
molar equivalent of tetrabutyl ammonium iodide (TBAI) surfactant to 5q in MAC also produced a 
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noticeable decrease in selectivity for 4b and results for the most successful D-A trials are included in 
Table 3.2. A general procedure for the reaction of 5p-q in aqueous media is included in Section 6.6.7. 
 
Figure 3.21: Chiral GC analyses conducted using a Et-TBS--CD stationary phase. Top; An enantioenriched 
mixture of the exo isomer was prepared on a 2 g (8.2 mmol) scale from the reaction between 5q and MAC in H2O
to provide 4b in 48% ee as determined by chiral GC analysis. Middle and Bottom; Two recrystallization from Et2O
at –18ºC provided the single (1S,2R,4S)-4b enantiomer in optical purity as indicated by chiral GC analyses. 
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 Attempts to obtain an optical rotation reading for samples of 4a, prepared in 85% ee from 5p in 
DCM, did not give a reliable reading or even an indication of the sign of rotation and this observation 
suggested that the 7-oxanorbornanes 4a and 4b do not have strong optical activity as a pure enantiomer. 
Multiple recrystallizations of an enantioenriched mixture of 4b from ether at –18ºC allowed the isolation 
of the (1S,2R,4S)-4b enantiomer in optical purity after two crystallizations, as indicated by chiral GC 
analysis (Figure 3.21). (1S,2R,4S)-4b was found to be a colourless resin at room temperature and 
enriched in the supernatant as the racemic precipitate was removed. This indicates that the 4b material 
has more efficient crystal packing as the racemate and that the maximum achievable isolated yield of 
(1S,2R,4S)-4b using this purification method is equal to the enantiomeric excess in the original D-A 
mixture. Two optical rotation measurements were performed on the (1S,2R,4S)-4b enantiomer, and were 
obtained at  = 690 nm at two different concentrations (Section 6.6.8). The product was identified to be 
dextrorotatory with an absolute optical rotation of °+= 72.1][ 25Da (c = 1.45, CHCl3) and can be assigned as 
(+)-(1S,2R,4S)-4b.
The product (+)-(1S,2R,4S)-4b has the same absolute stereochemistry at the (2R) ester and (4S)
ether functionalities as featured in Ring A of the natural product 1 (Figure 3.22). Subsequent studies were 
directed towards the synthetic modification of the exo- product 4b involving ether cleavage and 
derivitization and are detailed in Chapter 4. The development of a direct methodology for the preparation 
of ring C is also discussed along with studies towards the introduction of diastereoselectivity at the C(12) 
chiral center adjacent to the 3-furyl moiety (Figure 3.22). 
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Figure 3.22: The (+)-(1S,2R,4S)-4b enantiomer has the same absolute stereochemistry as observed in ring A of the 
natural product 1.
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Studies Toward the Synthesis of Ring A  
4.1 Investigation of 7-Oxanorbornane Ether Ring Cleavage 
 
As discussed in Chapter 3, the 7-oxanorbornane skeleton can be conveniently prepared using the 
Diels-Alder reaction with furan to access the 7-oxa-bicyclo[2.2.1]hept-2-ene 7-(oxanorbornene) moiety 
as a precursor to molecules containing the saturated oxanorbornane bicyclic ether. The 7-oxanorbornane 
ring is present in carotenoids, cantharidin, cineole as well as a range of terpenoids. Synthetic strategies 
towards these naturally occurring bicyclic structures have been reviewed by Vogel et al. [1]. 7-
Oxanorbornanes have been termed molecular ‘LEGO’® due to their flexibility as a functional unit 
towards the preparation of macrocyclic molecules and polymers containing cyclic units [1]. 
Functionalised 7-oxanorbornanes and 7-oxanorbornenes are versatile synthetic intermediates for the 
preparation of sugar and carbohydrate type polyoxygenated structures and as such, many methodologies 
exist for rearrangement of the bicyclic ring and cleavage of the ether bridge. Lautens et al. [2] have 
reviewed the regio- and enantio-selective nucleophilic ring opening of 7-oxabicyclo[2.2.1]hept-2-enes 
using transition metal catalysts. The authors also report on the efficient cleavage of 5,6-
bis(methoxymethyl)-7-oxa-bicyclo[2.2.1]hept-2-ene using Ni(COD)2/(R)-BINAP with the hydride 
nucleophile DIBAL-H [2] (Scheme 4.1, top) to yield the cyclohexenol in excellent yield and 
stereoselectivity (97% yield, 92-97% ee).  
 
Raney nickel hydrogenolysis has been used by Forsey et al. [3] for the cleavage of the benzylic 
oxabicyclic ether rings, resulting in stereo- and chemo-selectivity at C(1) during the preparation of a 
range of Podophyllium lignan skeletons (Scheme 4.1, middle). 7-Oxabicyclo[2.2.1]hept-2-ene ether 
opening with alkyl nucleophiles has been reported to occur using alkyl halides and Ni(PPh3)2Cl2/Zn 
catalysis [4] and similar results have been obtained with Grignard reagents [5] and organolithium 
nucleophiles [6]. In these cases, the carbon nucleophile reacts at the C(3) olefin as demonstrated in the 
reaction of n-BuLi with 5,6-bis(trisopropylsiloxymethyl)-7-oxa-bicyclo[2.2.1]hept-2-ene (Scheme 4.1, 
bottom), to yield the cyclohexenol in high yield (96%) at ambient temperature [6, 7].  
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Scheme 4.1: Ether ring openings of 7-oxabicyclo[2.2.1]hept-2-enes. Top; Lautens et al. have reported the 
Ni(COD)2/(R)-BINAP catalysed stereoselective hydrogenation of 5,6-bis(methoxymethyl)-7-oxa-
bicyclo[2.2.1]hept-2-ene using DIBAL-H [2]. Middle; Forsey et al. [3] have used Raney nickel hydrogenolysis for 
the cleavage of aryl substituted cyclic ether rings in the preparation of Podophyllum lignans. Bottom; Ring cleavage 
with organolithium nucleophiles has also been used by Lautens et al. [6] to prepare the functionalised cyclohexenol 
in excellent yield.  
 
Ring opening reactions of the saturated the 7-oxa-bicyclo[2.2.1]heptane ring can be facilitated by 
sufficiently acidic or basic reagents and the base mediated 7-oxanorbornane ring opening using LHMDS 
has been reported by Koreeda et al. [8] as shown in Scheme 3.13 (Section 3.2.1) in the synthesis of (+)-
methyl triacetylshikimate. A general strategy for the acid mediated ring opening of cyclic ethers has been 
reported by Tanoue et al. [9], using H2SO4 /Ac2O at room temperature to give the diacetoxy hydrolysis 
products. Similar conditions have been applied to the cleavage of 7-oxanorbornane bicyclic ethers by 
Ogawa et al. [10] who report excellent yields of 1,4-diacetylated product (94%) using sealed reaction 
vessels at 80ºC (Scheme 4.2, top) and the acetolysis product was obtained as a 1:1 mixture of isomers as 
a consequence of nucleophilic attack at both C(1) and C(4).  
 
Acid mediated cleavage of 4b under conditions reported by Ogawa et al. [10] gave the 
aromatized ester methyl 4-acetoxy-2-methylbenzoate as indicated by GC-MS library matching (Section 
6.7.1), suggesting that more mild acidic conditions are essential to prevent aromatization. 
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Scheme 4.2: Top; Ogawa et al. [10] have reported the acid mediated hydrolysis of the 7-oxanorbornane ring using 
AcOH/Ac2O/H2SO4 to produce the 1,4-diacetoxy isomers in a 1:1 mixture. Bottom; Luo et al. [11] report the acid 
mediated dehydration of aryl bicyclic ethers using HCl/Ac2O to yield the aromatised product, as shown in the 
preparation of 5,12-dihydronapthacene.   
 
Luo et al. [11] report the acidic cleavage of aryl bicyclic ethers using HCl/Ac2O to also facilitate 
dehydration to the conjugated aromatic system in high yield, as shown in the preparation of 5,12-
dihydronaphthacene (Scheme 4.2, bottom). This example suggests that even weaker acidic conditions 
may be unfavourable for the preparation of dioxa- ether cleavage products of 4 and the ring opened 
alcohol, if formed, is likely to dehydrate to the stable aromatic product.  
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5
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Scheme 4.3: Ether cleavage pathways for the transformation of 4a and 4b to 2.
As mentioned in Section 3.3.1 the exo ketone (1S,2R,4S)-4b can be used directly in the 
asymmetric synthesis of the target 1 via the ether ring opening/rearrangement to 3, followed by 
acetylation to the convergent precursor 2. The endo ketone (1R,2R,4R)-4a may also be used but can be 
expected to produce the alcohol C(5)-epi-3 upon ether cleavage which would require acetoxy inversion at 
C(5) to yield 2 (Scheme 4.3). The racemic ethers (1R,2R,4R)/(1S,2S,4S)-4a and (1S,2R,4S)/(1R,2S,4R)-
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4b were used to explore ether cleavage/rearrangement reactions and the pathway presented has not yet 
been completed using the optically pure ketone (1S,2R,4S)-4b.
The ethers 4a-b are new compounds and as such, no conditions had been reported for functional 
group modification of the skeleton of 4. Studies towards ether cleavage under acidic and basic conditions 
are presented in Section 4.1.1 and the identification of cleavage products are accompanied by a number 
of proposed mechanisms. Lewis-acid mediated ether cleavage of 7-oxabicyclo[2.2.1]heptanes are 
reviewed in Section 4.1.2 and products from the reaction of 4 in the presence of Lewis-acids are 
identified.  
 
4.1.1 Acid/Base Mediated Ether Cleavage of 7-Oxanorbornanes 
Functional group transformations on the optically pure 7-oxa-bicyclo[2.2.1]heptan-2-one 
derivatives mentioned in Section 3.1.3 (Scheme 3.6) have led to the successful preparation of a range of 
optically active sugars [12] and the oxygenated cyclohex-5-ene-1,2,3,4-tetrol core of Corduritol natural 
products [13, 14]. Base mediated rearrangement of the 7-oxa-bicyclo[2.2.1]heptan-2-one ring in the 
presence of tert-butyl-dimethylsilyl triflate (TBDMSOTf) has been reported by Vogel et al. to facilitate 
C-O cleavage with retention of stereochemistry at the carbonyl -siloxy C(6) stereocentre [12, 13] 
(Scheme 4.4, top), to the give the 6-siloxy-cyclohex-2-en-1-one in high yield (89%).  
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a) TBDMSOTf, Benzene, 25ºC, 4 h; TBDMSOTf, TEA, Benzene, 25ºC, 1 h, 89% b) TBDMSOTf, -23ºC, 2 h; 
TBDMSOTf, TEA, Benzene, 25ºC, 5 h, 88%. 
 
Scheme 4.4: Top; The facile base mediated rearrangement of the 7-oxa-bicyclo[2.2.1]heptan-2-one ring using 
TBDMSOTf/TEA has been used by Vogel et al. [13] to prepare the natural product (+)-Corduritol F in moderate 
yield. Bottom; Arjorna et al. [15] have prepared the glycoside containing cyclohex-5-ene-1,2,3,4-tetrol using 
similar conditions, allowing access to the glycosyl-myo-inositol analogues in a further three steps.  
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Vogel’s conditions involve the slow addition of TBDMSOTf to a solution of the bicyclic ether 
and TEA in benzene and have been used by Arjona et al. [14, 15] for the preparation of glycoside 
containing myo-inositol derivatives via the ,-unsaturated Glycosyl-cordutitol substrate intermediate 
(Scheme 4.4, bottom). 
 
The conditions described above were applied to the ether cleavage of racemic 4a at room 
temperature using multiple additions of TEA and TBDMSOTf over a period of 6 h to ensure a high 
degree of conversion of the starting 7-oxanorbornane (Section 6.7.2). GC-MS monitoring revealed the 
formation of two major products at tR=13:46 min and tR=15:32 min (Figure 4.1) in 69% and 30% yields 
respectively, both of which contain the TBDMS group as indicated by the loss of a t-butyl group (m/z 
57). Omitting TEA in this procedure gave no reaction, returning 4a without decomposition. 
 
a) TBDMSOTf, Benzene, 25ºC, 4 h; TBDMSOTf, TEA, Benzene, 25ºC, 2 h. 
 
Figure 4.1: The crude GC-MS analysis for the reaction of 4a with TBDMSOTf/TEA is shown with EI-MS 
spectrum. Base peak ions for the 3’-siloxy-2’,5’-dimethylfuran fragment at m/z 225 indicate major product as 3-[(3-
tert-butyl-dimethyl-silanyloxy)-5-methyl-furan-2-yl]-propionic acid methyl ester 31, corroborated by a m/z 298 
molecular ion.  
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The MS fragmentation for the earlier eluting compound shows a molecular ion at m/z 298 in 
agreement with the desired C-O cleavage product and the second component has a molecular ion at m/z 
398 in agreement with a TBDMS transesterified cleavage product (Figure 4.1). Disappointingly, the 
notable absence of m/z 97 fragment ion [16] inferred that neither product contained the desired methyl 
cyclohexanone structure. The major product 31 was purified by column chromatography in SiO2 (5:1 
Hexane:EtOAc) and 13C NMR analysis (Figure 4.2) indicated four signals in the aromatic region at 

148.2, 138.4, 136.9, 103.2 suggesting the formation of a furan ring to produce 3-[(3-tert-butyl-dimethyl-
silanyloxy)-5-methyl-furan-2-yl]-propionic acid methyl ester. This conclusion was supported by a 
common base peak at m/z 225 present in MS analyses for both silylated products, corresponding to the 
3’-siloxy-2’,5’-dimethylfuran fragment ion (Figure 4.1) produced from homolytic cleavage of the ester.  
 
Figure 4.2: 300 MHz 1H COSY NMR and 13C NMR spectrum of 31.
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COSY NMR analysis (Figure 4.2) indicates correlations between H(2) and H(3) methylene 
signals at 
 2.85 and 2.60 corroborating that cleavage of the carbon-carbon bond between the ester C(2) 
and tertiary bridgehead C(1) had proceeded in preference to the opening of the bicyclic C(1)-O-C(4) 
ether bridge. Vinylic coupling of the H(6’) methyl signal at 
 5.66 to the furan proton H(4’) at 
 2.16 is 
also observed in agreement with the proposed structure of 31. 13C NMR signals were assigned using 
HMQC and DEPT 135 analysis (Appendix 4.1). The aromatic signals at 
 148.2, 138.4 and 136.9 are 
absent in DEPT 135 data in agreement with non-protonated C(2’), C(3’) and C(5’) furan carbon signals. 
Negatively oriented DEPT 135 signals are present at 
 20.7 and 32.8 and correspond to the C(2) and C(3) 
methylene carbons respectively in the propionate chain of 31.
At this point it occurred that the adverse C-C cleavage pathway might be assisted by ether 
oxygen protonation due to traces of trifluoromethanesulphonic acid (TfOH), formed from the hydrolysis 
of TBDMSOTf. The reaction of 4a with TfOH gave no reaction in benzene, MeCN and Et2O, although a 
number of literature examples were found that report sulphonic acid derivatives mediate 7-
oxanorbornane rearrangements to the C-C and C-O cleavage products. The ether ring opening of C-
glycoside containing 6-chloro-7-oxa-bicyclo[2.2.1]hept-5-ene derviatives using TfOH in anhydrous 
MeCN has been discussed by Pasquarello et al. [17], who theorise the cleavage of the ether bridge to 
proceed via a vinylic carbocation intermediate followed by Ritter reaction with MeCN (Scheme 4.5, top).  
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Scheme 4.5: Top; The TfOH catalysed C-O opening reported by Pasquarello et al. [17] who theorise the reaction to 
proceed via the vinylic carbocation intermediate followed by Ritter reaction with MeCN. Bottom; Vogel et al. [12, 
18] report the cleavage of substituted epoxy-7-oxa-norbonyl derivatives with HSO3F/ Ac2O to produce the furan 
product (41%) as a result of C(1)-C(2) cleavage, as well as the Wagner-Meerwein rearrangement product (24%). 
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Vogel et al. have discussed a number of acid catalysed Wagner-Meerwein type rearrangements 
[18] of 5-exo-6-exo-epoxy-7-oxa-2-norbonyl derivatives (Scheme 4.5, bottom). The authors mention an 
accompanying C(1)-C(2) bond cleavage pathway upon reaction of the ethylene acetal substituted epoxy-
7-oxa-norbonyl with fluorosulphonic acid (HSO3F) and Ac2O at –50ºC to provide the furan in moderate 
yield (41%) [12]. The described literature on the sulphonic acid mediated oxa-bicyclo cleavage suggest 
that an additional epoxy or olefin functionality may be required on the saturated 7-oxa-
bicyclo[2.2.1]heptane system to effect ether cleavage using TfOH. The ketone 4 does not satisfy these 
structural requirements and is inert to reaction with TfOH, and the TBDMS protected enolate is the most 
likely intermediate in the formation of the furan 31 but was not observed in GC-MS analyses.  
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Scheme 4.6: Proposed mechanisms for the reaction between 4a and TBDMSOTf in the presence of TEA to give the 
furan 31. Top; The acid catalysed pathway can proceed via silylation of the enolate followed by protonation of the 
ether oxygen. Bottom; The base catalysed pathway can proceed from the enolate ion via a retro 1,4-conjugate 
addition followed by ester enolate trapping with TBDMSOTf. 
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A proposed mechanism for the formation of 31 is shown in Scheme 4.6 (top) and can involve 
silylation of the enolate tautomer, followed by protonation of the bicyclic oxygen and C(1)-C(2) cleavage 
to the ester enolate. Silylation of the ester enolate by an additional equivalent of TBDMSOTf can occur 
at this stage to produce a mixture of 31 and the transesterified TBDMS ester (M+· m/z 398) upon workup 
with 1 M HCl, as observed in the crude product mixtures (Figure 4.1). 
 
A base catalysed mechanism (Scheme 4.6, bottom) may also occur whereby the enolate of 4a
undergoes a retro 1,4-conjugate addition, during which the cleavage at C(1)-C(2) occurs and the ester 
enolate is trapped by TBDMSOTf to form the conjugated furanone intermediate. The aromatic furan 
system is subsequently formed upon base mediated enolization and reaction with an additional equivalent 
of TBDMSOTf to give a mixture of 31 and the TBDMS ester upon workup with 1 M HCl. The ring 
cleavage of 4a did not occur in the presence of TEA without the incorporation of TBDMSOTf and the 
unexpected C-C bond cleavage prompted further investigation into base mediated ring opening reactions 
to reveal whether the C-O bond could be preferentially cleaved in the absence of the silylating agent. 
 
Experimental work published by McMorris et al. [19] describes the ether ring openings of 7-
oxanorbornanes with K2CO3 in iPrOH/H2O (Scheme 4.7, top) to give the ,-unsaturated ketone as 
desired in the cleavage of 4. Takahashi et al. [20] have achieved similar results using LHMDS in THF to 
produce ,-unsaturated carbonyl compounds in moderate yield (Scheme 4.7, bottom).  
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Scheme 4.7: Top; Base mediated bicyclic ether cleavage has been reported by Morris et al. [19] to proceed in good 
yields using K2CO3 to give the ,-unsaturated ketone. Bottom; Takahashi et al. [20] have utilised LiN(TMS)2 at 
low temperatures to facilitate the base mediated ether cleavage of the oxygenated bicyclic ether to produce the ,-
unsaturated ester.  
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Reaction of 4a with LHMDS in THF at low temperature (–78°C to –50°C, Section 6.7.2) gave a 
single product 32 at tR = 12:21 min in GC-MS analysis (Appendix 4.2), featuring a molecular ion at m/z 
184 and no noticeable m/z 97 fragment ion suggesting that the product does not contain the methyl 
cyclohexenone skeleton. Purification was achieved by FCC in SiO2 (5:3 pentane:EtOAc) and 1H NMR 
analysis revealed an olefinic singlet H(4’) at 
 5.44 ppm with an integral area of one proton, which shows 
attachment to a 13C NMR peak at 
 104.6 in HMBC NMR analysis (Figure 4.3). Strong HMBC 
correlations between H(4’) and a quaternary carbon signal at 
 190.5 (C(5’)), carbonyl signal at 
 204.3
(C(3’)) and methine signal at 
 85.0 (C(2’)) are evident, indicating that these functionalities are in close 
proximity. These 13C NMR chemical shifts observed in 32 closely match the 13C NMR spectrum of the 
,-unsaturated furanone 16 (Chapter 2, Section 2.3) and 1H COSY NMR analysis (Appendix 4.2) shows 
signals indicative of a propionic ester chain coupled to the H(2’) methine signal, to confirm 32 as methyl 
3-(2,3-dihydro-5-methyl-3-oxofuran-2-yl)propanoate (Scheme 4.8). The ketone 32 was positively 
identified in low yield by GC-MS analysis (Appendix 4.3) as a desilylation product upon treatment of 31
with tetrabutyl ammonium fluoride (TBAF) (Scheme 4.7) and verifies that 31 and 32 are structurally 
related tautomers. The expected -ketol product (1R,5R)/(1S,5S)-methyl 1-methyl-5-oxo-7-oxa-
bicyclo[2.2.1]heptane-2-carboxylate (C(5)-epi-3), shown as the (1R,2R)-enantiomer in Figure 4.8, was 
not observed and reactions involving 4b with base revealed identical reactivity to 4a. Studies addressing 
the stereochemistry at C(2’) were not undertaken and it was assumed that 32 is racemic as 
tautomerisation to the furan can occur under basic conditions.  
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Scheme 4.8: Treatment of 4a with LHMDS or K2CO3 did not give the expected -ketol product and instead 
underwent C(1)-C(2) cleavage to produce methyl 3-(2,3-dihydro-5-methyl-3-oxofuran-2-yl)propanoate 32. The 
structure of 32 was also confirmed by desilylation of 31 with TBAF. 
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Figure 4.3: 1H 300 MHz/13C 75 MHz HMBC NMR analysis of 32 with DEPT 135 NMR and heteronuclear 13C-1H
coupled NMR data also shown. 
 
DEPT 135 analysis clearly shows the negatively oriented H(3) and H(4) methylene signals which 
appear as triplets in heteronuclear 13C coupled NMR data and these observations support the proposed 
structure of 32. Reaction of 4a with K2CO3 under conditions described by McMorris et al. [19] gave 
similar results to reaction with LHMDS to produce a 12% yield of 32 after stirring at ambient 
temperature for 12 h. These observations confirm that the C(1)-C(2) cleavage between the ester and the 
tertiary bridgehead occurs as the result of a base mediated mechanism (Scheme 4.5, bottom) and is likely 
to proceed via the enol ketone tautomer of 4a followed by rearrangement of the enolate anion.  
 
No similar examples could be found in the literature that involve base mediated C-C bond cleavage 
chemistry of 7-oxa-bicyclo[2.2.1]heptan-2-one derivatives and this may be owing to the scarcity of 
available preparations for these structures. Selectivity in the formation of the five membered products 31
and 32 may be solely due to the positioning of the C(2) ester substituent, allowing the stabilization of the 
negative charge onto the carboxyl oxygen. A single publication by Rainer et al. [21] was found involving 
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C-C cleavage of the substituted 7-oxanorbornanone (Scheme 4.9, top) and norbornanone (Scheme 4.9, 
bottom) skeletons to provide the substituted five membered rings. The authors mention the scarcity of 
this type of ring cleavage and suggest a mechanism involving a four membered hemiacetal intermediate, 
formed between the ketone and alcohol functionalities [21].  
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(45%)
1:2, E:Z
(94%)
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DMF, CH3I
DMF, CH3I
1
3
Scheme 4.9: Rainer et al. [21] describe the C-C cleavage in some bicyclic structures using NaH and suggest a four-
membered hemiacetal intermediate formed from the 1,3-keto-alcohol system. The 7-oxanorbornanone (top) and 
norbornanone (bottom) skeletons behaved similarly to produce the five membered cyclic olefins.  
 
Although the same mechanism would not be possible for the formation of 31 and 32 from 4a due
to the absence of the necessary substitutents, this example highlights that the substitution on the bicyclic 
structure has an important role in the C-C bond breaking reactions discussed in Section 4.1.2. This 
consideration suggests that the reaction of 4a with Lowry-Brönsted bases leads to the five membered 
heterocyclic products, however the same conditions may not be able to be applied to even closely related 
structures without obtaining unpredictable results. This outcome initiated a re-direction in studies toward 
the 7-oxa-bicyclo[2.2.1]heptan-2-one ether cleavage to focus on Lewis-acids in an attempts to effect C-O 
cleavage via an alternate mechanism. 
 
4.1.2    Lewis-Acid Facilitated Ring Cleavage of 7-Oxanorbornanes 
Due to the unforseen side reaction of 4a under basic conditions to give the five membered 
heterocycle, Lewis-acid catalysed ether cleavage was investigated and was expected to proceed by co-
ordination of the lone pair electrons on the bicyclic ether oxygen bridge. A review of Lewis-acid 
mediated 7-oxanorbornanone ether cleavages was undertaken to find suitable conditions for the reaction 
of 4.
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Vidari et al. [22] have reported on the stereoselective rearrangement reactions of geraniol 
epoxide using Fe(III) and Zr(IV) Lewis-acids to yield the substituted cyclohexenol structures as chiral 
intermediates in terpene synthesis. The action of ferric(III) chloride hexahydrate (FeCl3.6H2O) on 
geraniol epoxide was reported to form a 1:1 mixture of (1S,5R)-5-(hydroxymethyl)-4,6,6-
trimethylcyclohex-3-enol and the 7-oxanorbornane in modest yield (40%) (Scheme 4.10, top). The 
authors suspected that the bicyclic product was an intermediate in the formation of the dialcohol, and this 
conclusion was supported by the reaction of the isolated bicyclic product with an additional portion of 
FeCl3.6H2O to give a small yield of the dialcohol (37%). Vidari et al. [22] also report on an improved 
ether cleavage reaction using ZrCl4 under anhydrous conditions to produce (1S,5R)-5-(hydroxymethyl)-
4,6,6-trimethylcyclohex-3-enol in quantitative yield from the 7-oxanorbornane intermediate, and in 
moderate yield (52%) from geraniol epoxide (Scheme 4.10, bottom). 
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(>99%)
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(1S,5R)-5-(Hydroxymethyl)-
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Scheme 4.10: Research conducted by Vidari et al. [17] involves the Lewis-acid mediated rearrangement of geraniol 
epoxide. Top; FeCl3.6H2O was reported to produce the cyclohexenol via the 7-oxanorbornane intermediate. 
Bottom; ZrCl4 was reported to give improved results for both the 7-oxanorbornane and geraniol epoxide 
rearrangements.  
 
No reaction was observed upon treatment of 4a with FeCl3.6H2O or ZrCl4 under conditions 
described by Vidari et al. [22] and reactions at higher temperature also returned only starting material.  
Reaction of 4a with TiCl4 under anhydrous conditions as described by Arjona et al. [23] was also 
unsuccessful and returned 4a without decomposition.  
 
Boron trifluoride etherate (BF3.(Et2O)) Lewis-acid in the presence of the iodide ion has been 
discussed by Mandal et al. [24] as a mild and selective reagent for the cleavage of alkyl and aryl ethers. 
The BF3.(Et2O)/iodide system has also been used for 7-oxanorbornane ether cleavage by Mehta et al. 
[25] in the synthesis of novel inositols. Tetrabutylammonium iodide (TBAI) was used as the iodide 
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source and results in nucleophilic attack by the iodide ion with inversion of stereochemistry to provide 
the ring opened tertiary alcohol. The iodinated compound was modified in two steps to produce the novel 
neo-inositol derivative containing the octahydroxydecalin core [25] (Scheme 4.11, top).  
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Scheme 4.11: Top; Research conducted by Mehta et al. [25] involves 7-oxanorbornane cleavage using 
BF3.(Et2O)/TBAI to produce the iodinated product with inversion of stereochemistry, followed by conversion to the 
neo-inositol derivative in two steps. Bottom; Research conducted by Gschwend et al. [26] involved 7-
oxanorbornane ether cleavage using BF3.(Et2O)/Ac2O to produce the acetoxy substituted product as a 1:1 mixture 
of olefin isomers. 
 
Gschwend et al. [26] have reported the successful 7-oxanorbornane ether cleavage using 
BF3.(Et2O) in the presence of Ac2O during the preparation of 3a-phenylisoindolines, to produce the 
acetoxy derived product with retention of stereochemistry as a 1:1 mixture of olefin isomers (Scheme 
4.11, bottom).  
 
No reaction occurred between 4b and BF3.(Et2O) in DCM at a range of temperatures (-78-25ºC). 
Reaction of 4b with BF3.(Et2O) in the presence of TBAI performed according to procedures described by 
Mehta et al. [25] and Mandal et al. [24] was also unsuccessful, returning only the starting ether as 
indicated by GC-MS monitoring. Reaction of 4b with BF3.(Et2O)/Ac2O (Section 6.7.3) under conditions 
described by Gschwend et al. [26] gave one major product 33 (Scheme 4.12) at tR = 13:49 min in 68% 
according to GC-MS analysis (Figure 4.4), showing a large m/z 43 base peak indicative of an acylated 
product [16] and a m/z 243 fragment ion, although no molecular ion was observed.  
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Figure 4.4: GC-MS of the crude ether cleavage reaction of 4b with BF3.(Et2O) in the presence of Ac2O to give 68% 
conversion to the acylal derivative 33. The molecular ion M+·m/z 286 is not seen and the largest fragment ion m/z 
243 and corresponds to the loss of an acetyl group (m/z 43). 
 
Separation of 33 from the unreacted 4b using column chromatography (pentane:EtOAc 4:1) 
provided suitable material for 1H/13C HMQC NMR and DEPT 135 NMR analysis (Appendix 4.4). NMR 
data shows signals characteristic for a substituted 7-oxa-bicyclo[2.2.1]heptane of similar structure to 4b
including a methine bridgehead doublet at 
 5.10 corresponding to H(4). A notable absence of the 
carbonyl signal at 
 211.0 inferred that derivatization of the ketone of 4b had occurred upon reaction 
with BF3.(Et2O)/Ac2O. Two 1H NMR signals at 
 2.05 with an integral area equivalent to 6 protons, and 
13C NMR ester carbonyl signals 
 169.0 and 168.7 (Appendix 4.4) indicate two acetoxy substituents to 
identify 33 as the 5,5-diacetate derivative methyl 5,5-diacetoxy-1-methyl-7-oxa-bicyclo[2.2.1]heptane-2-
carboxylate (Scheme 4.12). This conclusion is supported by the appearance of a quaternary aliphatic 
signal at 
 107.9 in close agreement with Chemdraw predictions for the C(5) resonance. The largest 
fragment ion (m/z 243) observed in EIMS analysis (Figure 4.4) can be rationalised by the facile cleavage 
of an acetyl substituent (m/z 43) from the acylal 33 (MW 286).  
 
Studies Towards the Synthesis of Ring A 
196 
O
O
OMeO
a)
4b
O
OMeO
33
O O
O O
(MW 286)
243 m/z
5
O
OMeO
O a) or b)
(MW 226)
O
2
Methyl 5,5-diacetoxy-1-methyl-7-oxa-
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Scheme 4.12: Reaction of 4b with BF3.(Et2O) produced the C(5) acylal derivative methyl 5,5-diacetoxy-1-methyl-7-
oxa-bicyclo[2.2.1]heptane-2-carboxylate 33 in moderate yield (68%). The desired methyl 5-acetoxy-2-methyl-4-
oxocyclohex-2-enecarboxylate 2 was not seen. 
 
BF3.(Et2O) [27] and other Lewis-acids [28] in the presence of acid anhydrides have been 
reported to convert a range of aldehydes to the 1,1-diacetate or ‘acylal’ derivatives. Although this 
transformation is typically poor when applied to ketones, Curini et al. [28] report the formation of the 
acylal of cyclohexanone in low yields using the heterogenous catalyst zirconium sulfophenyl 
phosphonate [27]. Unfortunately, the ketone 4b showed a strong preference for acylal formation rather 
than undergoing ring cleavage to (1R,5S)/(1S,5R)-methyl 5-acetoxy-2-methyl-4-oxocyclohex-2-
enecarboxylate 2, shown as the (1R,5S) isomer in (Scheme 4.12). This result suggests that BF3 has a 
more predominant Lewis-acid interaction with the lone pair electrons on the carbonyl oxygen, rather than 
the bicyclic ether oxygen. A likely reason for this is that BF3 was used as the commercially available 
Et2O complex (Sigma-Alrich) and it occurred that a boron reagent in non-ethereal solvent could be more 
appropriate for the ether cleavage of 4. Boron tribromide (BBr3) obtained as a 1M solution in DCM 
(Sigma-Alrich) was used in subsequent studies and the larger size of the bromine halogen substitutents 
was thought more likely to stabilise tertiary carbocation formation upon C-O cleavage at C(1). 
 
Literature relevant to the BBr3-mediated ether cleavage of 7-oxa-bicyclo[2.2.1]heptanes was 
reviewed, paying particular attention to suggested mechanistic pathways.  The stereo- and regio-selective 
ether bridge cleavage of 1,2,3,4-tetrahydro-1,4-epoxy-2,3-carbonyldioxyl arenes using BBr3 has 
been studied by Koreeda et al. [29, 30] who used AM1 calculations to correlate the observed 
regioselectivity to the stabilization of the benzylic carbocation in the bay region of the arene system. The 
authors later rationalised that the BBr3 Lewis-acid forms a complex with the ether oxygen lone pair, 
resulting in polarization of the C-O bond followed by cleavage to a benzylic carbocation that reacts in a 
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face-selective manner with the bromine ion from the bromoborane ether intermediate [31] (Scheme 
4.13).    
O
O
O
O
O
O
O
OBBr2
H
BBr3

+

+

-
Br
O
O
O
OBBr2
HH
Br
O
O
O
OH
H
BrO
O
O
Br
H
OH
+
Observed Ratio 1 : 30
Bay reigon
H2O
Hf = 89.31 Kcal/mol : 96.40 Kcal/mol
O
O
O
OH
O
O
O
HO
3 equiv. BBr3
-40oC, DCM
(83%)
 
Scheme 4.13: Koreeda et al. [29] have conducted studies on the stereo- and regioselective ether opening of 1,2,3,4-
tetrahydro-1,4-epoxy-2,3-carbonyldioxyl arenes using BBr3. The authors have rationalised the reaction to 
proceed via a stabilised carbocation intermediate based on AM1 calculations in support of experimental findings 
[31]. 
 
Mosimann et al. [32] have described a number of BBr3-mediated ring openings of 7-
oxabicyclo[2.2.1]heptanes during the stereoselective preparation of tetradecahydrophenanthrene type 
diterpenes. Reaction of acetoxy substituted 7-oxanorbornanes with HBr in AcOH was reported to give 
the brominated product in good yield (80%) as the result of SN2 type acid mediated hydrolysis (Scheme 
4.14, top), with stereochemical inversion at C(4) but retention of stereochemistry at the C(1) acetoxy 
position. Reaction of the same compound with BBr3 was reported to provide the ether cleavage product 
in 69% yield without the incorporation of bromine. The authors propose an intermediate incorporating 
the adjacent endo acetoxy moiety based on migration of the C(2) acetoxy group to the C(1) position with 
inversion of stereochemistry upon quenching in aqueous NaHCO3, whereas stereochemistry of the C(4) 
hydroxyl group is preserved with respect to the ether bridge [32]. Mosimann et al. also report 
chemoselectivity in the BBr3 facilitated cleavage of C(1)/C(12) and C(4)/C(7) bicyclic ether moieties 
(Scheme 4.14, bottom) contained on an anisoate (An) substituted tetra-decahydrophenanthrene backbone 
[32]. Carefully controlled reaction temperatures gave selective cleavage of the C(1)/C(12) ether in 84% 
yield at –50°C and both ethers in 50% yield upon reaction at –18°C. The authors report stereochemical 
inversion at both C(7) and C(12) in the ether cleavage products and suggest similar involvement from the 
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anisoate group in the ring opening mechanism to that shown for the acetoxy products but without acyl 
migration. In all examples shown in Figure 4.14 the crude reaction was quenched in NaHCO3 and in the 
bottom scheme the alcohol products were subsequently acetylated with Ac2O and DMAP in pyridine. 
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a) HBr/AcOH, 55ºC, 18 h b) BBr3, DCM, -18ºC, 45 min c) Aq. NaHCO3, 0ºC, 5 min d) BBr3, DCM,  -50ºC, 15 min 
e) Ac2O, Pyridine DMAP  
 
Scheme 4.14: Mosimann et al. [32] have described the stereo- and chemo-selective cleavage of the 7-oxanorbornane 
ether ring. Top; Reaction with HBr was reported to undergo an SN-2 type inversion with the bromide ion. Cleavage 
with BBr3 provided retention of stereochemistry at C(4) but inversion at C(1) via an intermediate involving the 
adjacent C(2) acetoxy group. Bottom; The chemoselective BBr3 cleavage of carbocycles containing two 7-
oxanorbornane functionalities using controlled temperatures to produce the anisoate (An) substituted 
tetradecahydrophenanthrene structures.  
 
Further studies towards the BBr3 ether cleavage of 7-oxabicyclo[2.2.1]heptanes have been 
presented in research by Jotterand et al. [33] during the total asymmetric synthesis of carba-
hexopyranoses. Short reaction times (10 min) were used to cleave the ether bridge of the pentapivaloate 
substituted 7-oxanorbornanes (Scheme 4.15) and the authors mention that both alcohol groups which are 
formed as a result of ether cleavage are oriented on the same face of the cyclohexane skeleton. An 
intermolecular SN-2 type inversion with H2O at the quaternary C(1) position is suggested to be unlikely 
due to steric constraints. A plausible mechanism offered by Jotterand and co-workers [33] involves the 
formation of a cationic intermediate with the adjacent pivaloate (Piv) substituents, followed by 
intramolecular equilibration and subsequent hydrolysis upon workup in aqueous NaHCO3 solution to 
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provide the 1,4-diol in high yield (88%). Both hydroxyl groups are situated on the same face with 
retention of stereochemistry with respect to the bicyclic ether bridge in the reactant. 
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Scheme 4.15: Jotterand et al. [33] report the BBr3-mediated cleavage of the pentapivaloate derived 7-
oxanorbornanes to yield the 1,4-dihydroxy hydrolysis products with retention of stereochemistry. The authors 
propose that the reaction intermediates the pivaloate group and equilibration followed by quenching in NaHCO3
leads to cis-oriented hydroxyl groups in the cleavage product. 
 
Pasquarello et al. [17] have reported the BBr3-mediated ether cleavage of glycoside substituted 
7-oxanorbornenes (Scheme 4.16) and suggest a vinylic carbocation intermediate, similar to that observed 
for the acid mediated ring opening with TfOH (Section 4.1.1, Scheme 4.5). Quenching in aqueous 
NaHCO3 was reported to form the C(2) hydroxy product in good yield (72%) with the incorporation of 
bromine at C(5) on the same face as the hydroxyl group. The authors suggest that the brominated product 
results from the reaction of a bromide ion from the bromo-borane with a cationic reaction intermediate 
onto the least sterically hindered face [13]. The relationship between the equatorial C(5) bromine and 
axial C(2) hydroxy was deduced from NMR studies and a half-chair confirmation suggested for the 
cyclohexene ring based on coupling constants.   
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Scheme 4.16: Research presented by Pasquarello et al. [17] involves BBr3-mediated ether cleavage of the 7-
oxanorbornenes and the authors suggest a vinylic carbocation intermediate followed by reaction with the bromide 
ion at C(5) on the same face as the bromoborane ether, followed by quenching in saturated NaHCO3 to give the 
C(2) alcohol in good yield (72%) with retention of stereochemistry. 
 
Studies by Barrero et al. [34] have focused on the synthesis of oxygenated monocarbocyclic 
sesquiterpenoids and incorporate the BBr3-mediated 7-oxanorbornane cleavage of (2’,5’-epoxy-2’,6’,6’-
trimethyl)cyclohexyl-methyl acetate (Scheme 4.17; Top). Quenching in a solution of 1M collidine/DCM 
was reported to give the rearranged cleavage product with retention of stereochemistry at the C(1) 
hydroxyl group in a mixture of exocyclic and endocyclic olefin regioisomers (72%). Later studies by 
Barrero et al. [35] involve similar conditions with 4-(2',5'-epoxy-2',6',6'-trimethyl)cyclohexyl-2-
butylacetate to produce the rearranged C(1) hydroxyl derivative 3-(3'-acetoxybutyl)-2,2,4-
trimethylcyclohex-3-enol in high yield (89%) with retention of stereochemistry (Scheme 4.17; Bottom). 
Chemoselectivity was reported for the ring opened endocyclic C(3)/C(4) olefin and the less substituted 
olefin isomers were not mentioned as isolable side-products [35]. 
 
The reaction of 4b with BBr3 in dry DCM was performed at 0ºC followed by quenching in 
NaHCO3 solution according to methodology described by Jotterand et al. [34] and GC-MS analysis of 
the product mixtures revealed that no reaction had occurred (Scheme 4.18). Similar results were obtained 
upon quenching in H2O using methodology described by Koreeda et al. [29] and procedures that avoid 
aqueous quenching mixtures were subsequently investigated. 
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Scheme 4.17: Research presented by Barrero et al. [34, 35] describes the ether cleavage of 7-oxanorbornanes using 
BBr3 followed by quenching in 1 M collidine. Top; 4-(2',5'-Epoxy-2',6',6'-trimethyl)cyclohexyl-2-butylacetate 
undergoes rearrangement to give a mixture of olefin isomers with retention of stereochemistry at the C(1) hydroxyl 
group [34]. Bottom; Treatment of 4-(2',5'-Epoxy-2',6',6'-trimethyl)cyclohexyl-2-butylacetate with BBr3/collidine 
was reported to give chemoselective cleavage to 3-(3'-Acetoxybutyl)-2,2,4-trimethylcyclohex-3-enol in 89% yield 
[35]. 
 
Conditions described by Barrero et al. [34, 35] appeared to be suitable for the transformation of 
4b directly to 3 as formation of the olefin accompanies ether cleavage and is likely to form in 
conjugation with the ketone. Procedures reported by Barrero et al. [35] were trialed and the reaction of 
4b in dry DCM with BBr3 at ambient temperature followed by quenching in 1 M collidine/DCM solution 
gave a complex mixture of by-products. Optimization procedures revealed the reaction of BBr3 with 4b
to be very temperature sensitive and upon decreasing reaction temperatures to 5ºC a small number of 
major products were formed selectively as indicated GC-MS analysis (Figure 4.5, top). EI-MS for peaks 
at tR = 13:06 and tR = 13:08 min feature molecular ions m/z 264, 266 in agreement with the molecular 
weight for the C(2) brominated isomers (1S,2RS,5S)/(1R,2RS,5R)-methyl 2-bromo-5-hydroxy-2-methyl-
4-oxocyclohexanecarboxylate 34 (15%) (Scheme 4.18) and a [M - Br]+· ion at m/z 185 and m/z 97 ion 
characteristic of the methyl cyclohexanone fragment [16] support the ring opened structure. 
 
Studies Towards the Synthesis of Ring A 
202 
 
O
OMeO
Br2BO
O
O
OMeO
a), b)
c)
+ Collidine hydrobromide
O
HO
OMeO
Br
O
OMeO
HO
3
+
34
Temp of a)
5oC
0oC
-1oC
3 (%)
6
35
61
34 (%)
15
5
0
1
4b
2
(1S,2RS,5S)/(1R,2RS/5R)-
Methyl 2-bromo-5-hydroxy-2-
methyl-4-oxocyclohexanecarboxylate
a), d)
4b
0oC
(1S,5R)/(1R,5S)-
Methyl 5-hydroxy-2-methyl-4-
oxocyclohex-2-enecarboxylate
Table 4.1: Yields of 3 and 34 by 
GC-MS at a range of temperatures
a) BBr3 in DCM, 10 min b) 1 M Collidine in DCM, 25-30ºC to r.t., 35 min c) 1 M HCl, d) Aq. NaHCO3, r.t. 
 
Scheme 4.18: Reaction of 4b with BBr3 followed by quenching in aqueous NaHCO3 returned the starting ether with 
no detectable formation of 3. Reactions involving quenching in 1M collidine/DCM gave the desired ,-
unsaturated ketone (1S,5R)/(1R,5S)-methyl 5-hydroxy-2-methyl-4-oxocyclohex-2-enecarboxylate 3 and small 
quantities of the C(2) bromo isomers (1S,2RS,5S)/(1R,2RS,5R)-methyl 2-bromo-5-hydroxy-2-methyl-4-
oxocyclohexanecarboxylate 34.
In the same mixture, an ether cleavage product at tR = 12:15 min featuring a m/z 184 molecular 
ion in agreement with the structure of (1S,5R)/(1R,5S)-methyl 5-hydroxy-2-methyl-4-oxocyclohex-2-
enecarboxylate 3 was observed as a minor component (6%). Reactions conducted at –1ºC (Figure 4.5) 
gave significantly improved selectivity to return 3 as the major ether cleavage product (61%) and EI-MS 
fragmentation features a large m/z 97 ion and m/z 41, 55 fragments as expected for the cyclic ketone 3
[16]. Reactions with BBr3 conducted below –5ºC demonstrated extremely low reactivity and returned 
only the starting compound. GC-MS analysis of either the crude reaction in progress or the DCM 
quenching mixture gave poor and irreproducible data. Distinguishable and reproducible GC signals were 
only observed after conducting the workup procedure, involving multiple extractions with 1 M HCl and 
this observation strongly suggests the formation of a bromoborane ether intermediate (Scheme 4.18).  
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Figure 4.5: Top; GC-MS analysis of the BBr3 ether cleavage of 4b conducted at 5ºC, followed by quenching and 
workup using the described procedures gave a mixture of products amongst which the peaks at tR = 13:06 min and 
tR = 13:08 min show a molecular ion corresponding to the ring opened brominated product 34. Bottom; GC-MS of 
the ether cleavage of 4b conducted at –1ºC shows a single major product at tR = 12:15 min in 61% with fragments 
m/z 97, 55, 41 characteristic of a cyclic ketone [16] and a molecular ion at m/z 184 in agreement with the structure 
of 3.
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The fortuitous occurrence of quenching at 30ºC in a 1 M collidine solution prepared using LR 
grade DCM revealed optimal conditions to provide 3 in 61% yield with respect to 4b, without side-
reactions or decomposition as indicated by GC-MS analysis (Figure 4.5, bottom). Further studies using 
dry DCM as the quenching diluent returned more complex reaction mixtures than experienced with LR 
grade reagents and repeated trials suggested that a small amount of moisture in the quenching solution 
may be advantageous for the clean formation of 3. Studies involving the addition of stoichiometric 
equivalents of water to the quenching solution were not undertaken but may have indicated more clearly 
the role of water in this reaction process. The broad differences in reactivity observed between reactions 
quenched in aqueous NaHCO3 and 1M collidine in DCM suggests that the BBr3 complexation may occur 
with selectivity at low temperatures and the ether cleavage proceeds upon mixing with the appropriate 
base during quenching. Trials were conducted using TEA, N,N-diisopropylethylamine (Hünigs base), 
2,6-lutadine and pyridine in DCM quenching mixtures with poor results and no further improvements 
could be found for this process. Typical ether cleavage reactions were performed using 75 mg (0.41 
mmol) of 4b in 100 ml of dry DCM and limitations to the BBr3-mediated process were experienced upon 
a two-fold increase the concentration of 4b, resulting in decomposed reaction mixtures. The ether 
cleavage performed more satisfactorily when BBr3 was used as the limiting reagent (0.30 mmol, 0.73 
mol equivalents) and the yield of conversion to 3 based on BBr3 was calculated at a desirable 84%, 
assuming the reaction with 4b proceeds in a stoichiometric fashion. Larger scales (300 mg 4b/400 ml 
DCM) did not perform as well and a 20 to 25% decrease in yield was observed but without 
decomposition. Disappointingly, reactions involving quantities of 4 larger than 500 mg were ineffective 
and trials using increased temperature or BBr3 could not be optimised to provide 3 in >5% yield.   
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Scheme 4.19: The purification of 3 by FCC methods led to C(5) racemization likely via the conjugated enol tautmer 
to provide a mixture of 3 and C(5)-epi-3.
Attempts to purify the ring opened product 3 by FCC on SiO2, alumina (neutral) and fluorocil 
using pentane:EtOAc in various ratios (1:1-8:1) all led to the isolation of a mixture of 3 and the -ketol 
epimer C(5)-epi-3 (Figure 4.6, left) presumably due to keto-enol tautomerisation during retention on the 
stationary phase (Scheme 4.19). The ,-unsaturated ester containing the 1,2-olefin was not observed in 
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GC-MS or NMR analyses of the crude ring cleavage mixtures or FCC purified products establishing that 
the 2,3-olefin is stable in conjugation with the ketone. GC-MS analysis of column fractions obtained 
from FCC purification on SiO2 indicated mixtures of 3 and C(5)-epi-3 ranging from 9:1 to 1:2 with later 
eluting fractions containing higher amounts of C(5)-epi-3 which displays slightly greater retention on the 
stationary phase. Attempts to prevent tautomerization involved deactivation of the SiO2 by stirring with 
TEA/pentane, but gave little improvement in TLC and FCC separation. Disappointingly, column 
chromatography on cellulose acetate using EtOH/water mixtures [36] also resulted in slow C(5) 
epimerization but to a lesser extent than the previously mentioned stationary phases.  
 
Figure 4.6: GC traces for the purification of crude BBr3/collidine ether cleavage mixtures. Left; Isolation by FCC 
on silica gel shows a mixture of the ether cleavage product 3 and the C(5) diastereoisomer C(5)-epi-3 as a result of 
on-column keto-enol tautomerisation of the carbonyl. Right; Purification of 3 by semi-preparative HPLC separation 
shows the isolated product in >99% purity without epimerization.  
 
The successful isolation of 3 was eventually achieved by semi-preparative HPLC on a 
Phenomenex C-18 stationary phase. On the C-18 column, retention times for 3 exceeding 12 minutes led 
to gradual epimerisation at the C(5) hydroxyl stereocenter as indicated by GC-MS analysis of the 
purified fractions. Optimal resolution was achieved using 55:45 MeCN:H2O ratio as the mobile phase to 
provide separation of 3 in 5:04 min using a maximum loading of 33 mg of crude material per injection. 
HPLC results for optimised separation conditions are presented in Section 4.4. Extraction from the LC 
solvent revealed 3 as a colourless oil and analysis by GC-MS (Figure 4.6, right) indicated a single 
compound with no detectable epimerisation at C(5). The structures of both epimers of 3 were 
characterised by 13C and 1H NMR and the relative stereochemistry of substituents were verified by 
COSY and NOESY 2D analysis as presented in Section 4.2. 
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The chemo- and stereo-selective preparation of the C(5) hydroxy substituted cyclohex-2-enone 3
is not reported in the literature and few synthetic methodologies towards this type of functionalised 
skeleton exist. The lack of known syntheses of enantiomerically enriched ’-acetoxy- and ’-hydroxy-
,-unsaturated cyclic ketones has been addressed in studies by Tanyeli et al. [37] (Scheme 4.20) who 
accessed the racemic (R/S)-2-oxocyclohex-3-enyl acetate (72%) by means of the manganese(III) acetate 
(Mn(OAc)3) oxidation of cyclohex-2-enone in benzene using a Dean–Stark trap. Chiral resolution of the 
racemic ’-acetoxylated product was reported by the same group [38] utilizing chemo-enzymatic 
hydrolysis with Pig Liver Esterase in a pH = 7.00 phosphate buffer to selectively hydrolyse the (R)-
isoform to the alcohol (R)-6-hydroxycyclohex-2-enone.  
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Scheme 4.20: Tanyeli et al. have reported the preparation of racemic (R,S)-2-oxocyclohex-3-enyl acetate via the 
Mn(OAc)3 oxidation of cyclohex-2-enone [37]. Chemo-enzymatic resolution of (S)-2-oxocyclohex-3-enyl acetate 
was achieved using Pig Liver Esterase [38] and the ’-acetoxylated compound was purified by FCC, also providing 
the racemic alcohol (R,S)-6-hydroxycyclohex-2-enone.  
 
The authors report successful purification by FCC on SiO2 (Hexane:EtOAc, 3:1) to isolate the 
(S)-2-oxocyclohex-3-enyl acetate enantiomer in 46% and 97% ee (Scheme 4.20), but also mention that 6-
hydroxycyclohex-2-enone was not isolated in an enantiomerically enriched form and attribute this to the 
fast racemization and/or rearrangement of ’-hydroxylated cyclic enones [38]. This is a similar finding to 
the results presented in Section 4.1.2 and suggests that FCC is inappropriate for the separation of ’-
hydroxylated cyclic enones, but might be effective for the purification of the '-acetoxy derivatives. 
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4.2  NMR Characterisation of Methyl-5-hydroxy-2-methyl-4-
oxocyclohex-2-enecarboxylate (3 and C(5)-epi-3)
The ,-unsaturated ketol 3 is a new compound and an important intermediate in the natural 
product synthesis of 1, so NMR characterization data was carefully examined to confirm the structure 
and relative stereochemistry in both C(5) isomers of 3. 1H COSY NMR (Figure 4.7) of the HPLC 
purified alcohol 3 indicated a single compound confirming that no detectable epimerisation at C(5) had 
occurred in agreement with GC-MS data.  
 
Figure 4.7: 300 MHz 1H COSY NMR of 3 with structural correlations and coupling constants shown.  
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The structure of 3 was confirmed by 1H COSY NMR cross-peaks (Figure 4.7) which show 
correlation between the H(6) methylene protons and the H(1) -ester proton at 
 3.55, corroborating with 
the C-O cleavage of the ether bridge, rather than C-C bond breakage as observed in basic reaction media. 
The downfield '-carbonyl proton H(5) appears as a double doublet at 
 4.15 and shows 1H COSY NMR 
correlations to the diastereotopic methylene protons H(6A) (J5,6A = 5.6 Hz) at 
 2.59 and H(6B) (J5,6B = 
13.6 Hz) at 
 2.14, confirming that the six-membered ring is intact in agreement with the structure of 3.
The H(6A) proton shows geminal coupling (J6A,6B = 12.4 Hz) and appears as a doublet of triplets at higher 
frequency than H(6B), suggesting an equatorial position for H(6A) on the carbocyclic ring. The H(6B)
signal shows COSY cross-peaks with the geminal proton (J6A,6B = 12.4 Hz), H(1) (J1,6B = 12.4 Hz) at 

3.55 and H(5) (J5,6B = 13.6 Hz) appearing as a broad apparent quartet (J = 12.4 Hz) in 1H NMR data. The 
olefinic H(3) signal at 
 6.05 integrates as one proton and confirms that the position of the endocyclic 
,-unsaturated bond is in conjugation with the ketone. Weak 1H COSY NMR correlations are observed 
between H(3) and the vinylic protons of the methyl group H(8) at 
 1.98 and also H(1) at 
 3.55.
Although vinylic coupling between H(3) and the methyl signals H(8) is not resolved in the 300 MHz 1H
NMR spectrum, vinylic coupling between H(3) and H(1) is apparent and results in a poorly resolved 
signal for the expected H(1) doublet of double doublets, also split by H(6A) and H(6B). 
 
13C NMR signals were assigned using HMQC data (Figure 4.8) and support the structure 3. The 
diastereotopic H(6A) and H(6B) methylene signals show correlation to the same carbon signal C(6) at 

34.2, and the olefinic signal H(3) correlates to a positively oriented DEPT 135 signal at 
 127.7 (C(3)) in 
the 13C NMR olefinic region. The ketone C(4) and ester C(7) carbonyl signals are observed at 
 199.1
and 171.4 respectively, also the C(2) quaternary olefin signal is assigned to the weak 13C NMR resonance 
at 
 158.7 in close agreement with Chemdraw predictions. The connectivity of 3 was verified by HMBC 
analysis (Appendix 4.5) and the chemical formula of 3 was confirmed by ESI-HRMS to provide an 
accurate mass for the [M +  Na]+· ion C9H12O4Na  in agreement to three decimal places of the theoretical 
value (207.0633 calc., m/z 207.0627 found). 
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Figure 4.8: 300 MHz 1H/ 75 MHz 13C HMQC NMR of 3 with structural assignments and DEPT 135 NMR data. 
 
Although the ,-unsaturated backbone of 3 is a rigid system of sp2 hybridised orbitals, the 
saturated portion of the ring incorporating C(6), C(5) and C(1) can adopt pseudo-boat and pseudo-chair 
conformations. Semi-empirical MO calculations with Chem3D using an MM2 Hamiltonian were carried 
out for the pseudo-chair and pseudo-boat conformers of 3 and the estimated heats of formations reveal 
only a small difference in H values (Figure 4.9, left) suggesting that facile inversion between the two 
conformers might be possible, however NMR data shows signals for only one conformer at 20ºC. The 
large coupling constants (~12 - 13 Hz) observed between H(5)/H(6B) and H(1)/H(6B) indicate that these 
vicinal protons have a trans diaxial relationship (180° dihedral angle) to H(6A), in agreement with the 
pseudo-chair conformation for the cyclohexenone ring of 3. The energy minimised model for the pseudo-
boat conformer of 3 (Figure 4.9, left) shows a gauche geometry between H(1), H(6) and H(5) protons on 
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the saturated section of the ring, with characteristically smaller dihedral angles by comparison with the 
pseudo-chair conformer.  
 
Figure 4.9: Left; Energy minimised models of the pseudo-chair and pseudo-boat conformers for 3 calculated using 
Chem3D (MM2). Right; 500 MHz 1H-1H NOESY NMR analysis of 3 with cross-peaks shown. 
 
500 MHz 1H-1H NOESY NMR analysis of 3 shows NOE correlation between H(1)/H(5) (Figure 
4.9, Right) indicating that both protons are most likely positioned on the same face of the cyclohexenone 
ring. Strong NOE correlations are also observed between H(5)/H(6A) and H(1)/H(6A), but NOE 
correlations between H(6B) with both H(1) and H(5) are very weak. This observation supports 1H-1H
coupling data and conclusively establishes the pseudo-chair conformation for 3 whereby H(6B) has a 
trans diaxial relationship with the adjacent methine protons.  
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The pseudo-boat conformation is calculated to be slightly more sterically favoured and this is 
contrary to the structure deduced from NMR data. Discrepancy in the calculated model are overcome 
upon considering that in the pseudo-chair conformation, the periplanar relationship between the carbonyl 
oxygen and hydroxy substituent may allow for additional energies of stabilization such as weak hydrogen 
bonding interaction and -orbital overlap. A more advanced modelling approach is required to refine the 
structural parameters responsible for the observed conformer and was left as a topic for future studies. 
 
The C(5) hydroxyl epimer (C(5)-epi-3) also required characterization before the structure of 3
could be assigned unambiguously. A number of samples containing mixtures of both 3 and C(5)-epi-3
were isolated during attempts at purification by FCC on SiO2 and GC-MS data for a typical FCC purified 
mixture is shown in Figure 4.6, although epimeric ratio was varied depending on the time spent on the 
stationary phase. 1H NMR signals due to C(5)-epi-3 were identified using COSY NMR analysis, 
conducted on a 2:1 mixture with the epimer 3 and is included in Appendix 4.6 along with 13C NMR data. 
500 MHz NOESY analysis was performed on a 1:1 mixture of 3 and C(5)-epi-3 (Figure 4.10) to enable a 
direct comparison in NOE strength for each epimer and 1H NMR structure assignments for C(5)-epi-3 are 
indicated by numbering with the epi- prefix. The notable absence of NOE between epi-H(1)/epi-H(5) 
conclusively verifies the cis relative stereochemistry between H(1)/H(5) in 3 and confirms that the BBr3-
mediated ether cleavage proceeds with retention of stereochemistry at the C(5) hydroxyl group.  
 
Assignments for epi-H(6A)/epi-H(6B) methylene signals were established using NOESY data and 
1H NMR coupling constants. 1H NMR data shows the epi-H(5) signal as a doublet of doublets at 
 4.39
(dd, Jepi-5,epi-6A = 13.3 Hz, Jepi-5,epi-6B  = 5.5 Hz) with almost identical coupling constants to the downfield 
H(5) signal for 3 at 
 4.15, suggesting coupling to a trans diaxial oriented vicinal proton assigned as epi-
H(6A). In corroboration with 1H NMR coupling data, the epi-H(5) signal shows no NOE correlation with 
the vicinal axial proton epi-H(6A) which appears as a doublet of triplets (dt, Jepi-5,epi-6A = 13.3 Hz, Jepi-6B,epi-
6A = 13.3 Hz, Jepi-1,epi-6A  = 6.0 Hz) at 
 2.12 overlapped with signals from H(6A). NOE is observed 
between epi-H(5) and the adjacent equatorial proton epi-H(6B) at 
 2.69, which appears as a doublet of 
doublet of doublets (Jepi-6A,epi-6B = 13.3 Hz, Jepi-5,epi-6B = 5.5 Hz, Jepi-1,epi-6B = 1.8 Hz). The epi-H(1) signal 
appears as a broad doublet (J = ~6.0 Hz) at 
 3.41 and is upfield from the equivalent H(1) signal due to 3,
but in both cases this signal is poorly resolved due to additional vinylic coupling. Both epi-H(6A) and epi-
H(6B) show NOE with epi-H(1), indicating a gauche relationship between H(1) and H(6) methylene 
protons. 
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Figure 4.10: 500 MHz 1H-1H NOESY NMR analysis of a 1:1 mixture of 3 and C(5)-epi-3 with 1H NMR 
assignments for the C(5)-epi-3. The absence of NOE between epi-H(5)/epi-H(1) in C(5)-epi-3 unambiguously 
confirms the relative stereochemistry of H(1)/H(5) for 3.
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The observed 1H-1H NMR coupling constants and NOE correlations suggest that C(5)-epi-3
exists in the pseudo-boat conformation. Comparison of the heats of formation estimated from the MM2 
energy minimised Chem3D models for the pseudo-chair and pseudo-boat conformers are shown in 
Figure 4.11 and indicate the latter conformer to be favoured, in agreement with the structure deduced by 
NMR observations.  
 
Figure 4.11: Energy minimised models of the pseudo-chair and pseudo-boat conformers for C(5)-epi-3 calculated 
using Chem3D (MM2) are shown and comparison of estimated heat of formation suggests C(5)-epi-3 to exist as the 
pseudo-boat conformer in support of NOESY NMR data. 
 
The geometry of protons in the pseudo-chair conformer (Figure 4.11) would be expected to show 
similar coupling values to those observed in 3. This considered, NMR characterization clearly identifies 
C(5)-epi-3 to exist as the pseudo-boat conformer and is easily identified in a mixture with 3. The 
confirmation of relative stereochemistry in the C(5)-epimer conclusively proves that the stereochemistry 
of 3 is retained throughout the oxabicyclo[2.2.1]heptane cleavage of 4b to provide the H(1)/H(5) cis 
relative stereochemistry as desired in the natural product 1.
4.2.1 BBr3 Cleavage of 4a and Mechanistic Considerations 
 
The optimised conditions for the BBr3/collidine ether cleavage were applied to the ether cleavage 
of the endo isomer 4a (Scheme 4.21) in order to gain insight into the utility of this system as a general 
protocol for the ether cleavage of 4. Reaction of 4a with BBr3 in DCM at –1ºC for 10 min followed by 
quenching in 1 M collidine at 30ºC provided ether cleavage without decomposition as indicated by GC-
MS analysis (Figure 4.12), to yield the desired ’-hydroxy enone as a mixture of C(5) epimers.  
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Scheme 4.21: The ether cleavage of 4a using BBr3 formed a mixture of 3 and C(5)-epi-3 in 55:45 ratio, indicating 
racemization during the ring opening process to yield a small excess of 3 as the C(5) stereochemically inverted 
product. 
 
Figure 4.12: GC-MS analysis of the BBr3 cleavage of 4a conducted under optimised conditions shows a 55:45 
mixture of 3:C(5)-epi-3 and the products were verified by comparison of GC retention times and MS fragmentation. 
 
This observation reveals that the BBr3/collidine ether cleavage system can be applied to the ring 
opening of 4a, although stereochemistry at C(5) is not retained and the epimer 3 predominates, 
presumably as the result of a stabilised intermediate in the ring opening mechanism. The ,-unsaturated 
cyclic enone is able to tautomerise to the conjugated diene and the resulting 1,2-dioxy system might be 
encouraged by Lewis-acid attraction of the C(5) boron enolate to the lone pair electrons of the C(4) enol 
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oxygen (Scheme 4.22). Equilibration to the C(4) boron enolate is also possible although more detailed 
characterization of these intermediates was not feasible. The tendency of 4b towards yielding 3 as a 
single ether cleavage product, as compared to 4a which unavoidably forms a mixture of C(5) isomers but 
enriched in the inverted epimer 3, is strong evidence for anchimeric influence from the carboxylic ester. 
The Lewis-acid properties of the borane ether intermediate may allow for interaction with the ester 
carbonyl via a seven-membered dioxy type complex as shown in Scheme 4.22, leading to an excess of 3
upon workup with aqueous acid.  
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Scheme 4.22: The proposed mechanism for the BBr3/collidine ether cleavage of 4a and 4b is based on ratios of 
3:C(5)-epi-3 obtained from reaction at –1ºC, and involves co-ordination of BBr3 with the ether oxygen as described 
by Gopalaswamy et al. [31] followed by abstraction of H(6) during quenching in collidine. The observed C(5) 
epimerization during the cleavage of 4a can be rationalised as the result of enolization and intramolecular 
interaction with the ester carbonyl leading to equilibration to give 3 in a small excess upon work-up. The 2,5-diol 
was not formed upon quenching in aqueous media, indicating that a carbocation intermediate is unlikely. 
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 During reaction of 4a or 4b at –1ºC, co-ordination of BBr3 with the oxygen bridge might be 
primarily responsible for facilitating the ether cleavage due to weakening of the C(1)-O bond as 
suggested by Gopalaswamy et al. [31], allowing deconjugation by abstraction of an -carbonyl proton 
followed by rearrangement. As such, the mechanism proposed in Scheme 4.20 for the formation of 3
proceeds via complexation of the ether oxygen without tertiary carbocation formation. This conclusion 
was supported by experiments involving quenching of the BBr3 coordination complex of 4a and 4b in 
saturated NaHCO3 solution, that were shown by GC-MS to return the starting ethers 4, rather than the 
C(2)-hydroxy compound as reported in research by Mosimann et al. [32] (Scheme 4.12) and Jotterand et 
al. [33] (Scheme 4.14). Treatment of the co-ordinated intermediate prepared at –1ºC with the hindered 
base collidine facilitates removal of the -keto proton to produce the ,-unsaturated borane ether which 
is hydrolysed in 1M HCl (Scheme 4.22). Chirality at the C(5) hydroxy stereocenter is removed upon 
tautomerisation of the carbonyl to the diene sp2 system, which is encouraged by boron complexation of 
the enolate oxygen. The cis H(1)/H(5) relative stereochemistry may equilibrate as the stabilised keto- 
form the due to intramolecular Lewis-acid attraction between the '-bromoborane ether intermediate and 
the ester carbonyl oxygen. This proposed pathway is supported by the experimental outcomes described 
in Section 4.1.4 and provides a plausible explanation for the observed predominance of 3 in the BBr3
ether cleavage reaction of 4a and 4b.
4.3  Preparation and Characterisation of (1R,5S)/(1S,5R)-Methyl 5-acetoxy-2-
methyl-4-oxocyclohex-2-enecarboxylate (2)
Acetylation of the alcohol 3 was achieved using a large excess of acetyl chloride (AcCl) in the 
presence of a tertiary amine base to produce 2 (tR = 13:39 min) as confirmed by a m/z 226 molecular ion 
in GC-MS analysis (Figure 4.13) and a m/z 97 fragment consistent with the methyl cyclohexanone 
backbone. Acetylation of a purified sample of 3 was successful in the presence of TEA and pyridine 
bases to give excellent conversion to 2 (ca. 95%) with a small amount of decomposition but 
unfortunately these mixtures also demanded the HPLC purification of 2. An optimised one-pot 
methodology was realised upon carrying out the acetylation of 3 with a large excess of AcCl, added 
directly to the 1 M collidine/DCM quenching solution (Scheme 4.23) at 22ºC. This approach was 
convenient from a preparative perspective and complete consumption of 3 was achieved in 35 min to 
give a two component mixture of 4b and 2 with minimal decomposition and no epimerization at C(5) as 
indicated by GC-MS analysis (Figure 4.13).  
Chapter 4 
217 
O
OMeO
O
O
c), d)
2
100% conversion from 3
(40% isolated yield)
O
OO
HO
3
(60%)
O
O
OMeO
4b
a), b)
5
5
(racemic)
(racemic)
(racemic)  
a) BBr3, DCM, -1ºC, 10 min b) 1 M Collidine in DCM 25-30ºC, 35 min c) 2  ml AcCl, 22ºC, 35 min d) 1 M HCl. 
 
Scheme 4.23: Acetoxylation of the C(5) hydroxyl group was most conveniently achieved by the addition of AcCl to 
3 in the 1 M collidine/DCM quenching mixture and led to the complete consumption of 3 in 35 min as indicated by 
GC-MS monitoring. The separation of 2 was achieved by semi-preparative HPLC to give 2 in 40% isolated yield.  
 
Figure 4.13: Top; Middle; GC-MS analysis of the crude acetylation mixture indicating the complete acetylation of 
the alcohol 3 in 35 min to produce a high yield of 2 with a small amount of by-product. Bottom; EI-MS of the 
acetylated product shows an M+· ion at m/z 226 in agreement with 2.
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In a similar manner to the alcohol 3, the C(5) acetoxy epimer of 2 was formed during FCC 
purification attempts, as indicated in the GC-MS analysis of chromatography fractions (Appendix 4.7). 
The isolation of 2 was achieved by semi-preparative HPLC separation using an MeCN:H2O (55:45) 
mobile phase to provide baseline LC separation of 2 in a short retention time (tR = 7.24) min (Section 
4.4) and under favourable conditions to prevent epimerisation at the C(5) chiral center. HPLC separation 
of the crude acetylation mixture shown in Figure 4.13 (Middle) provided the acetoxy product 2 in 40% 
isolated yield. 
 
Figure 4.14: 300 MHz 1H/75 MHz 13C HMQC NMR and DEPT 135 NMR of 2 with structural assignments.  
 
1H COSY NMR analysis (Appendix 4.8) confirmed the isolated product to be a single compound 
and showed the expected correlations between the downfield H(5) doublet of doublets (J5, 6A = 11.9 Hz, 
J5, 6B = 6.4 Hz) at 
 5.32 and H(6) methylene protons at 
 2.44 which appear as an overlapped multiplet 
with an integral area of two protons as shown in Figure 4.14. Strong correlation exists between H(6) and 
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the broad, highly split H(1) signal at 
 3.58 and weak correlation between H(3) and the vinylic H(1) and 
H(10) methyl singlet at 
 1.98 is also observed and correlations are indicated in Appendix 4.8. The 
acetoxy H(9) methyl singlet is apparent at 
 2.17 with an integral area equal to three protons as 
anticipated in the acylated product 2.
Structural assignments for 13C NMR signals were confirmed by HMQC correlations (Figure 
4.14) and are in close agreement with the predicted Chemdraw values. The presence of an acetoxy 
carbonyl signal C(8) at 
 170.3 and methyl signal C(9) at 
 21.0 are in agreement with the structure of 2,
and olefinic signals at 
 157.1 and 127.7 are assigned as C(2) and C(3) respectively in agreement with 
the ,-unsaturated ketone. DEPT 135 NMR data (Figure 4.14) shows a negatively oriented C(6) 
methylene signal at 
 31.7 correlated to the H(6) multiplet at 
 2.44 consistent with the structure of 2.
Connectivity of the cyclohexenone ring was verified by HMBC data and is included in Appendix 4.9.  
 
4.4  HPLC Separation Studies and Characterisation of Significant By-
products  
 
HPLC separation studies were conducted using a Phenomenex C-18 (250 mm × 10 mm) 
stationary phase with a maximum loading of 33 mg of crude product mixture per injection, followed by 
detection using UV-Vis spectroscopy, monitored at 254 nm (Section 6.10.3). HPLC studies on a range of 
different reaction mixtures indicated the possible interference from the brominated by-products 34, that 
were found to increase in concentration upon prolonged stirring (>50 min) of 3 in the quenching mixture. 
This result strongly suggests that the C(2)-bromo products are produced due to the olefin addition 
reaction between 3 and HBr as discussed in Section 4.1.2, which is gradually released by BBr3 upon 
contact with atmospheric moisture during the experimental protocol. The clean and expedient acetylation 
of 3 required a large excess of AcCl (>120 mol equiv.) and preliminary studies using lesser quantities of 
AcCl showed only partial conversion to 2 as indicated by GC-MS analysis (Figure 4.15), along with the 
formation 34 showing a minor and major brominated isomer at tR = 13:06 min and tR = 13:08 min with 
characteristic m/z 264, 266 molecular ions. The mixture shown was used to optimise the mobile phase for 
HPLC separation to avoid the co-elution of 34 with 3 or 2. The EI-MS fragmentation of the later eluting 
C(2)-isomer of 34 (tR = 13:08 min) is shown in Figure 4.15 and as expected is very similar to the earlier 
eluting C(2)-isomer at tR = 13:06 min shown in Figure 4.5 (Section 4.1.2) which was prepared as the 
major isomer from the reaction of 4b with BBr3 at 5ºC.  
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Figure 4.15: GC-MS spectrum for the partial acetylation of 3 prepared using 40 equivalents of AcCl to produce a 
mixture of 4b, 3, 2 and 34. The mixture shown was used to optimise the mobile phase for HPLC separation to avoid 
the co-elution of 34 with 2 or 3.
Optimization of the mobile phase for HPLC separation of the ring cleavage products revealed 
55:45 MeCN:H2O to provide baseline separation of 3 at tR = 5:04 min and 2 at tR = 7.24 min from 34
which appears at tR = 6.24 min between the two ,-unsaturated compounds (Figure 4.16, Left). The UV 
spectrum of 2 and 3 (Figure 4.16, Right) show a similar shape and identical UV absorbance maxima at 
max = 235 nm due to the strong absorbance of the ,-unsaturated carbonyl chromaphore [39]. The 7-
oxanorbornane 4b does not have a strongly absorbing UV-Vis chromaphore and was not observed during 
monitoring at 254 nm, although NMR analysis of the HPLC fractions revealed that the components were 
isolated without interference from the co-elution of 4b.
The UV spectrum of the brominated compound 34 shows a broadened range of absorption and a 
shifted absorption maximum at max = 225 nm towards a shorter wavelength compared to 2/3 (235 nm) 
and the observed hypsochromic shift is due to the removal of the conjugated system. The HPLC purified 
fraction collected at tR = 6.24 min gave 34 as a yellow resin in >3% yield and 1H NMR characterization 
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revealed that the single LC peak labelled 34 in Figure 4.16 (Left) contained a mixture of co-eluting 
isomers in 1.0:0.3 ratio, consistent with GC-MS data (Figure 4.15). 
 
Figure 4.16: Left; The HPLC UV-Vis trace (254 nm) for the separation of the ether cleavage mixture shown in 
Figure 4.15, using the optimised mobile phase 55:45 MeCN:H2O. Baseline separation of 3 at tR = 5:04 and 2 at tR =
7.24 min from 34 at tR 6.24 min was achieved as shown. Right; UV-Vis spectrum (200 to 325 nm) for 3 and 2 are 
similar since both contain the ,-unsaturated enone chromaphore and a common max = 235 nm. The C(2)-bromo 
compound 34 shows a broad absorbance with max = 225 nm.  
 
1H NMR signals for the major isomer of 34 were assigned using COSY correlations and 1H-1H
NMR coupling constants (Figure 4.17). The H(3) methylene signal appears as an AB quartet (J3A,3B = 
17.3 Hz) at 
 2.26 with an integral area equivalent to two protons, confirming the absence of the olefin. 
The equatorial H(6A) signal at 
 2.52 appears as an overlapping doublet of doublet of doublets (J6A,6B = 
13.4 Hz, J6A,5 = 6.2 Hz, J6A,1 = 5.3 Hz) and shows COSY correlation to the H(6B) doublet of doublets 
(J6B,6A = 13.4 Hz, J6A,1 = 8.7 Hz) at 
 1.95. Both H(6A) and H(6B) show correlation to the H(1) doublet of 
doublets (J1,6B = 6.2 Hz, J1,6A = 5.3 Hz) at 
 2.80, however the H(5) doublet (J5,6A = 6.2 Hz) at 
 4.47 only 
shows coupling to the H(6A) signal indicating an approximate 90° dihedral angle between H(5) and the 
axial H(6B) signal. 1H COSY NMR correlations for the major isomer are consistent with the 
cyclohexanone ring present in 34 and vicinal coupling constants between 5 - 9 Hz observed for 
H(5)/H(6) and H(6)/H(1) suggests a gauche relationship for the ring protons. 
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Figure 4.17: 300 MHz COSY analysis of the isolated HPLC peak at 6:24 min (Figure 4.16) shows a 1.0:0.3 mixture 
of cis-34 and trans-34 isomers and the structure of cis-34 was confirmed using 1H-1H NMR coupling constants. 
 
The Markovnikov addition of HBr to the olefin of 3 is expected to proceed more readily at the 
least sterically hindered face to produce 34 with C(1) methyl ester and C(2) methyl substituents in the 
cis- relative stereochemistry (cis-34). An MM2 energy minimised model of cis-34 was constructed using 
Chem3D and the chair conformer shown in Figure 4.18 was calculated as the sterically favoured product, 
featuring H(1) and H(5) protons in the equatorial configuration with dihedral angles >90° with respect to 
the H(6) protons. This model is consistent with the observed vicinal coupling constants in the major 
isomer, confirming that signals assigned in Figure 4.17 are due to the cis-34 C(2)-epimer which appears 
at tR = 13:08 min in GC-MS analyses. The H(6A)/H(6B) protons of cis-34 are partially overlapping with 
H(6) signals due to the minor component trans-34, as indicated by the respective integral areas. Resolved 
1H NMR signals due to trans-34 shown in Figure 4.17 include the H(5) double-doublet (J5, 6B = 11.9 Hz, 
J5, 6A = 7.7 Hz) at 
 4.23 and H(1) double-doublet  (J1,6B = 13.2 Hz, J1,6A = 3.4 Hz) at 
 3.52, both of 
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which feature large coupling constants indicative of an anti relationship with the vicinal axial H(6B)
proton. Ring cleavage procedures conducted at 1ºC gave a 1.0:0.7 ratio of cis:trans 34 and the structure 
of the trans-34 C(2)-epimer was confirmed using 1H COSY NMR correlations (Appendix 4.10). MM2 
energy minimised models constructed using Chem3D show a low steric energy conformer for the 
H(1)/H(5) axial configuration (Figure 4.18), consistent with the observed NMR coupling data. 13C NMR 
characterization for cis-34 was achieved with the aid of DEPT 135 data (Appendix 4.11) and negative 
oriented signals for C(3) at 
 49.5 and C(6) at 
 29.5 were observed in agreement with the cis-34
structure.  
 
Figure 4.18: The addition of HBr to 3 forms a mixture of cis- and tras-34. Energy minimised models of the chair 
conformations for both isomers calculated using Chem3D (MM2) are shown with estimated heats of formation.  
 
The cis-34 isomer was not separated from the trans-34 isomer using LC separation techniques 
and conditions conducive to the preparation of either C(2) brominated isomer exclusively would provide 
access highly functionalised molecules that might also be used as intermediates in the synthesis of 1 or
related structures. Changes in the epimeric ratio of cis- and trans-34 in BBr3/collidine cleavage mixtures 
was found to be heavily depending on reaction temperature. The implication of reaction temperature on 
the ether cleavage mechanism was considered and is outlined in Section 4.4.1 along with possible 
directions for further study. The NMR characterisation of cis/trans-34 are included in Section 6.8. 
 
4.4.1 Mechanistic Rationale for the Formation of Brominated Isomers 34 
When the BBr3/collidine cleavage reactions were conducted at 0 to 1ºC, or allowed to stand for 
prolonged periods at ambient temperature after quenching, small amounts of the brominated isomers 34
were observed in GC-MS analyses (Figure 4.19; top right) and indicated the predominance of the cis-34
product in these cases. The formation of 34 as a product of in situ HBr olefin addition was verified by the 
addition of 48% HBr to a solution of the isolated alcohol 3 in 1M DCM/collidine to give cis-34 as the 
major isomer (Figure 4.19, top left) as a result of HBr addition across the less hindered olefin face in a 
Markovnikov fashion. GC-MS analysis of reaction mixtures after treatment with 48% HBr also shows a 
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by-product in 16% at tR = 12.49 min, featuring a m/z 166 molecular ion and m/z 77 fragment ion (Figure 
4.19, bottom right) in agreement with the aromatised product, formed due to dehydration of the ’-
hydroxy enone 3.
Figure 4.19: Top left; The addition of 48% HBr (10 equiv.) to 3 followed by stirring at 22ºC for 10 min led to the 
formation of 34 in 51% yield in a 14:37 cis:trans ratio. Bottom left; An aromatised product was identified at tR =
12:44, showing a molecular ion M+· m/z 166 corresponding to the substituted phenol and a m/z 77 fragment ion 
characteristic of a benzene ring. Top right; Isomers of 34 formed during the reaction of 4b with BBr3/collidine at 
0ºC shows a 77:23 cis:trans ratio with a predominance of cis-34 (tR = 13:08 min). Bottom right; Isomers of 34 
formed upon reaction of 4b with BBr3/collidine at 5ºC shows a 35:65 cis:trans ratio with a predominance of the 
trans-34 isomer (tR = 13:06 min). 
 
The action of BBr3 on 4b at 5ºC gave more complex reaction mixtures, also shown in Figure 4.5 
(Section 4.1.2), featuring 34 in 15% yield with a predominance of trans-34 as the major isomer (tR =
13:06 min) in a 35:65 cis:trans ratio (Figure 4.19, bottom right). The aromatised product at tR = 12:44 
min was also seen to increase at higher temperatures than 0ºC. A significant finding in this study is that 
the ring cleavage and bromination to form trans-34 at temperatures < 5ºC proceed with retention of 
stereochemistry with respect to the ether ring of 4b. A proposed mechanism for the observed face 
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selectivity in the cleavage of 4b at 5ºC is rationalised as due to an intramolecular SN1 reaction between 
the boron ether intermediate and the tertiary carbocation formed as the result of C-O cleavage at C(1) in 
4b, during which the bromide ion reacts at the same face as the borate group (Scheme 4.24). The face 
selective BBr3 cleavage of 4b is consistent with studies by Koreeda et al. [29, 30] and Gopalaswamy et 
al. [31] in support of a ring opening mechanism involving the stable tertiary carbocation intermediate.   
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Scheme 4.24: The BBr3 ether cleavage of 4b at 5ºC was found to give a 15% yield of the brominated isomers 34 in 
a 35:65 cis:trans ratio. A proposed mechanism to account for the predominace of trans-34 involves the formation of 
a carbocation intermediate at C(1) followed by reaction of the bromide ion at the same face as the boron ether 
intermediate. At the same time a mixture of cis- and trans-34 can form due to the in situ reaction of 3 with HBr. 
 
The cis-34 product may arise in the same product mixture via deconjugation to the ,-
unsaturated borane ether upon treatment with collidine followed by HBr olefin addition, or alternately by 
the intermolecular reaction of the carbocation with a bromide anion contributed by a second borane 
intermediate to result in stereochemical inversion at C(2). Attempts to form trans-34 as the exclusive 
C(2)-bromo isomer at temperatures as high as 25ºC led to extensive decomposition and the trans-34
isomer was unable to be isolated in sufficient purity by FCC to achieve characterisation by 13C NMR 
analysis without slow epimerization at C(5).  
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During the synthesis of 2 and 3, the brominated by-products 34 are avoidable by closely 
controlled reaction conditions. In this study, the ratio of cis:trans isomers of 34 prepared under a range of 
conditions has proven to give valuable information about the reaction mechanism. Factors preventing this 
methodology from being applied at reaction scales larger than 100 mg remain unknown and a better 
understanding of reactive intermediates is essential for further optimisation of this synthetic methodology 
toward ring A. Future studies may include BCl3 mediated ether cleavage of 4 (Scheme 4.25), which has 
been reported by Koreeda et al. [30] to produce the cis- chlorinated alcohol in high yield and following 
the same mechanism as suggested for BBr3.
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Scheme 4.25: Top; Koreeda et al. [30] have discussed the BCl3 mediated cleavage of the 7-oxanorbornante moiety 
in high yield and mild under conditions (-20ºC) to produce the cis-chloro alcohol in a 3.5:1 ratio with the 1-
epimer. Bottom; Further work towards the ether cleavage of 4 may involve reaction with BCl3 to produce either the 
chloro-alcohol or ,-unsaturated alcohol 3.
The authors report the chlorinated products to be more stable to isomerization than the 
brominated equivalents, suggesting that BCl3 cleavage of 4b may be a viable pathway to 3 but requiring 
dehydrohalogenation of the chloro-intermediate.  
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4.5  Preliminary Studies Towards 1,4-Gilman Reactions with (1R, 
5S)/(1S,5R)-Methyl 5-acetoxy-2-methyl-4-oxocyclohex-2-enecarboxylate 
(2) and Further Work 
The final step in the synthesis of ring A involves the 1,4-conjugate addition to 2 as a means of 
introducing the vinyl group at C(2) to be used as a functionalised substituent for the attachment of ring 
C. The steric influence of the C(1) ester and C(5) acetoxy substituents, which occupy the same face of 
the cyclic enone 2, are likely to provide stereochemical control in the 1,4-conjugate addition with 
preference for the Si face (Scheme 4.26). This would result in the trans- oriented C(2) vinyl group with 
respect to C(1) and C(5) substituents, yielding C(2) in the S- configuration in agreement with the natural 
product 1. Transformation of 2 by reaction at the -olefinic carbon requires a reactant that can act as 
suitable Michael donor to achieve selectivity for -attack at the enone, without reacting at the 
electrophilic C(4) carbonyl. The proposed pathway uses organocopper reagents to achieve this process. 
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Scheme 4.26: The final transformation in the synthesis of Ring A involves the Michael-type addition reaction of a 
vinyl copper reagent to the -olefinic carbon of (1R,5S)-2. The S- configuration can be expected at C(2) as a result 
of 1,4-addition to the least Si hindered face. 
 
Organocopper reagents have found a central role in natural product synthesis and are utilised in 
the examples of clerodane syntheses shown in Section 1.6.2. They are highly chemo-, regio- and stereo-
selective, reacting as a soft nucleophile with a range of Michael acceptors as well as aldehydes and alkyl 
halides under very mild conditions [40]. Organo-copper nucleophiles show selectivity for the soft 
electrophilic -carbon of ,-unsaturated Michael acceptors, in contrast to hard organometallic 
nucleophiles such as Grignard and organolithium reagents that preferentially react at the hard carbonyl 
centre. 
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Early research on the preparation and chemistry of mono- and di-alkylcopper (homocuprate) 
compounds was published by Gilman and co-workers between 1936-1952, who successfully 
differentiated the ether insoluble mono-alkyl derivative from the soluble di-alkylcopper species during 
reactions between methyllithium and copper (I) salts [41] Scheme 4.27, left). These organocuprate 
compounds are nowdays called ‘Gilman’ reagents. The synthetic utility of Gilman reagents was later 
recognised by House et al. [42] in 1966 who discuss changes in the 1,2-regioselective reaction of 
MeMgBr with trans-3-penten-2-one upon catalysis by copper (I) iodide (1.2 mol %), to form the 1,4-
conjugate addition product exclusively. This observation was rationalised to proceed by transmetalation 
to the mono-organocopper intermediate prior to conjugate addition [42]. Modern techniques more 
commonly involve homocuprate reagents (R2CuLi or R2CuMgX) due to the enhanced nucleophilicity, 
stability and homogeneity compared to their mono-organocopper counterparts, and a good description of 
the reported organocopper reagent types can be found in literature by Taylor [40].  
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Scheme 4.27: Left; The reaction of one equivalent of MeLi or MeMgCl with cuprous iodide (CuI) in Et2O was 
reported by Gilman et al. [41] to give the mono-organocopper compound as a yellow precipitate. Reaction with a 
second equivalent of MeLi gives the homocuprate, which is soluble in Et2O and gives a clear solution. Right; The 
mechanism for the 1,4-cuprate addition to enones has been reviewed by Woodward [43] and is shown using 
acrolein as an example. Complexation of the -system followed by alkylation to produce the enolate, and can be 
‘trapped’ at this stage by reaction with TMSCl, accompanied by enhanced reaction rate and yields.  
 
The mechanism by which the organocuprate reacts with the enone system has attracted some 
interest from the scientific community owing to the synthetic usefulness of this transformation. A 
comprehensive review was not undertaken as part of this work and the literature addressing theoretical 
and experimental data on reaction intermediates is best summarised in a review by Woodward [43] and 
includes material published up to the year 2000. The currently accepted mechanism, shown using the 
example acrolein (Scheme 4.27, right), involves an intermediate complex featuring co-ordination 
between the soft homocuprate anion with the -cloud of the olefin. The Gilman counter-ion M+ is usually 
a charged Lewis-acid (eg. Li+, MgX+) and is able to co-ordinate with the lone pair electrons of the 
carbonyl oxygen in a hard-hard interaction which is essential for the 1,4-addition to occur [43]. 
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Transformation of the complex to the enolate occurs by reaction of only one of the two carbocuprate 
groups at the C(4) olefin. Although the transition states for this process are still uncertain, Corey et al. 
[44] have suggested a copper (III) -adduct involving reversible -complexation and more recent studies 
by Woodward [43] support this hypothesis.  
 
The vinyl Gilman reagent was prepared in THF at -30ºC (Scheme 4.28, top) following a 
modification of the procedure described by Kato et al. [44] using copper(I) iodide (0.5 equiv.) and the 
commercially available Grignard reagent vinyl magnesium bromide (2.5 equiv.). The formation of the 
intermediate mono-vinyl cuprate was apparent during the addition of Grignard reagent by the initial 
formation of a precipitate, which gradually disappeared to leave an opaque yellow solution of the 
homocuprate following the completion of Grignard addition. The homocuprate divinyl Gilman reagent 
was cooled to -50ºC after which the enone 2, shown as the (1R,5S)-enantiomer (Scheme 4.28, bottom) 
was slowly added over 2 h followed by quenching with aqueous NH4Cl at -50ºC.  
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Scheme 4.28: Top; Formation of the divinyl homocuprate was achieved by the reaction of vinyl magnesium 
bromide with Cu(I)I in THF at –30ºC. Bottom; Reaction of 2 with the divinyl homocuprate was conducted at –50ºC 
but alkylation at C(2) did not occur. The product mixture returned a mixture of 2 and C(5)-epi-2 due resulting from 
C(5) racemization.  
 
Analysis of the product mixture revealed that the enone 2 was stable to the Gilman reaction 
conditions but did not form the desired 1,4-addition product as shown by GC-MS analysis (Figure 4.20). 
Instead, epimerization at C(5) occurred to give a mixture of 2 and C(5)-epi-2 and this observation 
suggests that the Mg2+ ion shows strong Lewis-acid affinity for the -acetoxy carbonyl functionality.  
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Figure 4.20: GC trace of the product mixture obtained from the reaction of 2 with the divinyl homocuprate in THF 
at –50ºC showing a mixture of 2 and C(5)-epi-2.
Attempts at increased temperatures (-78 to 25ºC) according to methodology described by 
Trauner et al. [45] also failed to form the desired structure Ring A. Disappointingly, trials involving the 
divinyllithium homocuprate, prepared from vinyl lithium in place of the vinyl Grignard, were not 
attempted due to time and financial constraints. Reaction of 2 with the mono-vinylcopper intermediate 
was also attempted without success. Limited scale quantity and purification capacity leading to time 
consuming isolation of only small quantities of 2 and 3 (>50 mg) were major hindrances in a speedy 
conclusion to this final step. Ideas and comments on further work are included in the following section 
along with general conclusions for Chapter 4. 
 
4.6   Conclusion and Further Work 
Although improvements in the 1,4-conjugate addition to the enone of 2 might be found upon 
utilizing the divinyllithium organocuprate, vast improvement is more likely to be realised by using rate 
enhancing additives. A large number of techniques are available to alter the reactivity of organocuprates 
and relevant examples will be briefly outlined. Improvements in the reaction of mono-organocopper 
Gilman reagents in the presence of Lewis-acids has been reviewed by Yamamoto [46], who highlights 
catalysis of a range of organocuprates with BF3.Et2O as a means of improving the 1,4-addition to ,-
disubstituted acrylates. Lipshutz et al. [47] have described significant rate enhancement for the addition 
of divinyl Gilman to the trimethylated cyclohex-2-enone structure using BF3.Et2O catalysis (Scheme 
4.29).  The effects of BF3.Et2O on Gilman organocuprates has also attracted some research and Lipshutz 
et al. [47] have identified modified cuprates in NMR experiments upon reaction in THF. The authors 
suggest that both the formation of reactive cuprate intermediates and co-ordiation of the carbonyl lone 
pair electrons can contribute to changes in reactivity. 
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Scheme 4.29: Improvements in the 1,4-addition of vinyl Gilman organocuprates to 3,5,5-trimethylcyclohex-2-enone 
have been reported by Lipshutz et al. [47] using BF3.Et2O catalysis. 
 
Corey et al. [44] have discussed the compatibility of TMSCl with Gilman reagents at –78ºC and 
report enhancement in reaction rate to yield the ‘trapped’ TMS-enolate (Scheme 4.30, top). Gilman 
reaction involving the -ether substituted cyclohexenone and lithium divinylcuprate was reported to show 
excellent trans- selectivity in the presence of TMSCl. The authors propose that silylation occurs during 
the reversible -conjugate addition transition state [44] and describe reaction times of less than two 
minutes in the presence of five equivalents of TMSCl.  
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Scheme  4.30: Top; Corey et al. [44] have published the 1,4-addition of lithium divinylcuprate to a -ether 
substituted cyclohexenone and report enhanced rate and selectivity in the presence of TMSCl. The authors propose 
silylation to occur in the transition state. Bottom; Smith et al. [48] describe yield and selectivity improvements in 
the conjugate addition of Gilman reagents to ’-acetoxy substituted cyclopentenones upon the addition of TMSCl. 
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Smith et al. [48] have studied the effect of TMSCl on Gilman reactions involving the 1,4-
congugate addition to -oxa substituted cyclopentenones. The ’-acetoxy substituted cyclopentenone 
was reported to show diastereofacial selectivity for the trans- product and improved in yield in the 
presence of TMSCl, whereas in the absence of silylating agent the cis- isomer predominately forms 
(Scheme 4.30, bottom). Reactions in the presence of TMSCl were reported to give the TMS enol-ethers 
as Gilman products that were subsequently deprotected using TBAF. The authors attribute selectivity in 
this reaction to electronic effects involving polarization of the enone -system rather than steric effects 
and support this hypothesis with computational studies [49].  
 
Further work towards the divinylcuprate conjugate addition to 2 could possibly utilise rate 
enhancement using BF3.Et2O Lewis-acid catalysis or reaction in the presence of TMSCl. Selectivity for 
the trans- conjugate addition product, as expected in the latter methodology, is in favour of the desired 
stereochemistry for the natural product 1. Examples involving the conjugate addition of Gilman reagents 
to structures containing similar functionality to 2 are shown in Scheme 4.26 and Scheme 4.27 and 
strongly encourage that the desired transformation of 2 can be achieved and without racemization at 
C(5). 
 
In conclusion, ether cleavage of the Diels-Alder adduct 4 was much more complicated than 
expected. As shown throughout Chapter 4, ether cleavage of the 7-oxabicyclo[2.2.1]heptane moiety can 
follow a number of hydrolysis and rearrangement pathways, and the necessary methodology for ether 
modification is predominately dependent on the position and functionality of substituents on the bicyclic 
core. In this chapter, both the Lewis-acid and base mediated ether cleavage pathways have been 
investigated for the new compounds 4a and 4b. An unreported base mediated C-C cleavage of 4 has been 
identified and presents itself as a unique pathway to specifically substituted furans and furanones 31 and 
32. The successful BBr3 mediated ether cleavage of 4 to yield the desired cyclohexenone 3 also revealed 
that the Lewis-acid facilitated ether cleavage of 4b proceeds with retention of stereochemistry at C(5) 
whereas the cleavage of 4a does not. A mechanism for the BBr3 ether cleavage has been proposed based 
on the ratio of brominated epimers 34 and is consistent with the existing literature. D-A face-selectivity 
in the preparation of the (1S,2R,4S)-enantiomer of 4b using 5q has been achieved as described in Chapter 
3, and the optimised BBr3 ether cleavage as reported establishes a stereoselective pathway from 24 to 
(1R,2S)-2 in 60% ee as a chiral precursor to the natural product 1 (Scheme 4.31). The syntheses 
presented in this chapter were conducted using the racemic 7-oxanorbornanes (1S,2R,4S)/(1R,2S,4R)-4b
and  (1R,2R,4R)/(1S,2S,4S)-4a, and optical rotation data for the non-racemic ether cleavage products 
(1R,2S)-3 and (1R,2S)-2 are yet to be recorded. 
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Scheme 4.31: The chiral furylamine 5q prepared from the commercially available 24 has been shown to undergo D-
A reaction with MAC in H2O to give the exo-cycloadduct (1S,2R,4S)-4b in 60% ee as a 1:1 mixture with the endo 
isomer. Ether cleavage using BBr3 at -1ºC followed by quenching in collidine provides (1R,2S)-3 with retention of 
stereochemistry and in situ acetyl with AcCl provides (1R,2S)-2 in 40% overall from (1S,2R,4S)-4b. Ring A can be 
accessed in a stereoselective manner by reaction of (1R,2S)-2 with vinyl Gilman reagent. 
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Studies Towards the 
-Lactone Ring C of Salvinorin A  
Ring C of salvinorin A (1) contains the 6-(furan-3-yl)-tetrahydropyran-2-one 
-lactone skeleton 
and retrosynthetic analysis of 1 involving disconnection at ring B [(Scheme 5.1, top), shown in detail; 
Scheme 1.21 (Section 1.7)], gave the ,-unsaturated lactone 6-(furan-3-yl)-5,6-dihydro-4-methyl-3-
vinylpyran-2-one (S)-6. This convergent precursor contains the C(8) stereocenter of the target product 
and has same functionality as ring C without specific stereochemistry at the C(3)/C(4) olefin. The chiral 
center in 6 at C(6) is attached to both the 3’-furyl substituent and carboxylic functionality of the 
-
lactone ring, and the (S)-configuration is required for the asymmetric synthesis of the natural product 1.
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Scheme 5.1: Top; Disconnection of ring B gave the ,-unsaturated lactone (S)-6 as a convergent precursor for the 
synthesis of 1. Bottom; Cleavage of the C(3)/C(4) olefin shows (S)-35 (X = H) or (S)-7 (X = Br) as a possible 
synthons for a retro-aldol type condensation; cleavage of the ester indicates the furyl alcohol (S)-8 and a vinylacetic 
acid derivative as potential starting materials for the preparation of 7.
The synthesis of 6 was not found in the literature and no direct methodology could be found for 
the incorporation of the 3-furyl moiety at C(6) and vinyl substituent at C(3) during the formation of the 
unsaturated 
-lactone ring. Disconnection of 6 to accessible starting materials involved cleavage at the 
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olefin and ester functionalities (Scheme 5.1, bottom). Intramolecular cyclization of an ester sidechain 
with a nearby carbonyl has been facilitated by an aldol or Reformatski reaction in a number of reported 
syntheses [1, 2] resulting in 
-lactone fragments. Likewise, the preparation of lactone 6 was thought 
possible by ring closure of a vinylacetic ester indicating that (S)-1-(furan-3-yl)-3-oxobutyl but-3-enoate 
(S)-35 or (S)-1-(furan-3-yl)-3-oxobutyl 2-bromobut-3-enoate (S)-7 are possible as retro-aldol type 
synthons. Disconnection of the ester shows the furyl alcohol (S)-4-(furan-3-yl)-4-hydroxybutan-2-one 
(S)-8 as an accessible starting material for the synthesis of (S)-6.
The 
-lactone 6-(furan-3-yl)-tetrahydropyran-2-one unit (Ring C) of 1 is common to a range of 
tricyclic Labdane natural products (Section 1.4.4, Figures 1.21 to 1.24) and this moiety has been found to 
significantly contribute to the bioactivity of trans-neo-clerodanes 1 (Section 1.3.2, Figure 1.15) and 
bacchotricuneatin A (Section 1.4.4, Figure 1.24). 
 
The following section briefly discusses the role of the 3-furyl group as a precursor for highly 
oxygenated furanones in natural product syntheses and mentions the significance of the pyranofuran-type 
structures as pharmacophores in some bioactive products. This is followed by a short literature review of 
the synthetic methods towards the racemic and non-racemic 6-(furan-3-yl)-5,6-dihydro-pyran-2-ones 
unit. The last section describes the synthesis of racemic 6 (R,S)-6-(furan-3-yl)-5,6-dihydro-4-methyl-3-
vinylpyran-2-one and details an investigation of appropriate vinylacetic acid derivatives to achieve 
acylation and ring closure of 8, with preliminary studies and strategies towards the introduction of 
chirality in 6. Conclusions and further work completes the research presented in this thesis. Experimental 
and instrumentation details are found in Chapter 6. 
 
5.1  Synthetic Strategies Towards 6-(Furan-3-yl)-5,6-dihydro-pyran-2-
ones 
 
The 3-furyl group is present at C(12) on the clerodane backbone of a large number of 
components isolated from Salvia divinorum so far (Section 1.1, Figure 1.2) and furyl or furanone type 
C(12) substituents are a common feature of clerodane natural products [3]. Synthetic strategies that 
introduce the 3-furyl substituent at C(12) on the clerodane core have been reported by a number of 
groups [4, 5, 6] who use the furan as a precursor to access the C(12) -substituted -hydroxyfuran-2(5H)-
one moiety, present in pyranofuranone containing clerodane compounds. This transformation is achieved 
by oxidation of the furan using photochemical methods, as illustrated in the final transformation for the 
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preparation of the gram-positive antibacterial 16-hydroxycleroda-3,13(14)Z-dien-15,16-olide (Scheme 
5.2, top) reported by Hagiwara et al. [4], also mentioned in (Section 1.6.1). 
 
H
O
H
O
OH
O
O2, Tungsten lamp
Rose Bengal
Hunigs Base
DCM,  -70ºC to -55ºC
(63%)
16-Hydroxycleroda-3,13(14)Z-
dien-15,16-olide


16
OHO
O
O
HO
Manoalide
O
O
O
6-(Furan-3-yl)-5,6-dihydro-pyran-2-one Pyranofuranone
O
Li
H
O
H
3-Furyllithium
THF, -78ºC
2 steps
12
 
Scheme 5.2: Top; Hagiwara et al. [4] incorporate the 3-furyl group on the bicyclic aldehyde at C(12) using 3-furyl 
lithium followed by deoxygenation in two steps. Oxidation of furan to the -hydroxyfuran-2(5H)-one was achieved 
using photochemical methods to give the clerodane 16-hydroxycleroda-3,13(14)Z-dien-15,16-olide. Bottom; de 
Rosa et al. [7] have prepared 6-(furan-3-yl)-5,6-dihydro-pyran-2-ones as a means of accessing the bioactive 
pyranofuranone unit of manoalide. 
 
Non-racemic 6-(furan-3-yl)-5,6-dihydro-pyran-2-ones have been prepared by de Rosa et al. [7] 
as intermediates to access the pharmacophoric pyranofuranone groups of some powerful anti-
inflammatory marine compounds such as manoalide (Scheme 5.2, bottom). A brief literature review was 
undertaken on synthetic strategies toward the 6-(furan-3-yl)-5,6-dihydro-pyran-2-ones core, with focus 
on the incorporation of the furan group and methods for asymmetric synthesis.  
 
The 3-furyl substituted 
-lactone has been prepared by Hagiwara et al. [8] in their synthesis of (-
)-methyl barbascoate and the simple but costly 3-furyllithium nucleophile was used to incorporate this 
heterocycle as also shown in Scheme 1.15. This methodology has been adopted by a number of 
researchers [4, 5, 8, 9] for the introduction of the furyl substituent during the total synthesis of Labdane 
diterpenoids. An effective protocol has been used by Liu et al. [10] to construct of the CD ring system of 
the limonoid mexicanolide. Oxidative cleavage of a chiral hexahydro-1H-indene-1,2-diol derivative 
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using periodic acid (HIO4) produced the 
-hydroxy lactone and subsequent reaction with 3-furyl lithium 
at -78ºC was reported to produce the furyl lactone as a single diastereoisomer in 43% with syn-oriented 
C(8a) and C(1) substituents (Scheme 5.3). Transformation to the convergent 1-(furan-3-yl)-6,7,8,8a-
tetrahydro-6,8a-dimethyl-5-methylene-1H-isochromen-3(5H)-one precursor was achieved in low yield in 
four steps. The reported selectivity in the organolithium addition is likely due to the orientation of the 
C(8a) methyl group and products reported by Liu et al. [10] were prepared as a racemic  
(1R,6R,8aR/1S,6S,8aS)-mixture with the (R,R,R)-enantiomer shown in Scheme 5.3 as found in 
mexicanolide.  
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C D
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2
1-(Furan-3-yl)-6,7,8,8a-tetrahydro-6,8a-
dimethyl-5-methylene-1H-isochromen-3(5H)-one
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R R
R
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1
Hexahydro-1H-indene-1,2-diol 
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Scheme 5.3: Preparation of the CD ring system of mexicanolide was achieved by Liu et al. [10] using HIO4 diol 
cleavage, followed by reaction with 3-furyllithium. The racemic precursor was prepared in a further four steps and 
the synthetic sequence is shown for the (R,R,R)-enantiomer as observed in mexicanolide.  
 
Fernándes-Mateos et al. [11] have reported a simple preparation of the limanoid DL-
pyroangolensolide by reaction of the lithium enolate of 2,6-dimethylcyclohenenone with 3-furaldehyde 
to give the syn-addition product exclusively (Scheme 5.4), and the authors suggest complexation with the 
lithium ion to aid this process. Acetylation followed by intramolecular aldol-type cyclization of the 1,3-
acetoxyketone with LDA followed by dehydration with SOCl2 was reported to produce the racemic ,-
unsaturated 
-lactone unit of the natural product [11] in excellent yields. A similar process has been 
reported by Shing et al. [6] for the preparation of quassinoid ,-unsaturated lactone units.   
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Scheme 5.4: Fernándes-Mateos et al. [11] constructed DL-pyroangolenolide, shown as the (R)-enantiomer, using 
the aldol addition with furaldehyde followed by a base-mediated intramolecular aldol-type cyclization of the 1,3-
acetoxyketone followed by dehydration.  
 
Syntheses reported by Liu et al. [10] and Fernándes-Mateos et al. [11] describe strategies toward 
the racemic 6-(furan-3-yl)-5,6-dihydro-pyran-2-ones and with syn-diastereoselectivity in the fused 
bicyclic products. De Rosa et al. [7] have reported a high yielding and stereoselective approach to a 
range of monocyclic 6-(furan-3-yl)-5,6-dihydro-pyran-2-ones using a Ti(IV)/(R)-BINOL catalyzed 
enantioselective aldol condensation of O-silyl dienolates to 3-furaldehyde, producing the (R)-furfurol 
products. Quantitative cyclization to the -ketolactone was reported using K2CO3/MeOH and efficient 
interconversion to the ,-unsaturated 
-lactone was achieved in a further two steps (Scheme 5.5).  
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O
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O
R1
Ti(OiPr)4
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2 stepsK2CO3/MeOH
r.t.
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H
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CH2Ph
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25
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R
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3
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3-Furaldehyde
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Scheme 5.5: De Rosa et al. [7] describe the stereoselective aldol reaction between 3-furaldehyde and O-silyl 
dienolates using Ti(IV)/(R)-BINAP catalysis to produce the (R)-furfurol in good yield, and subsequent cyclization 
with K2CO3/MeOH followed by functional group modification gave (R)-6-(furan-3-yl)-5,6-dihydro-pyran-2-ones as 
the optically enriched products. 
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De Rosa et al. [7] report highest yields and stereoselectivity using the C(5) unsubstituted 
dienolate (R1 = H), and reduced yield and selectivity were noted with increasing substituent size (R1 =
Me, CH2Ph). The same group later published chiral aldol studies involving a range of aryl aldehydes 
[12], offering a suitable approach for the preparation of a range of 6-aryl-5,6-dihydro-pyran-2-ones. A 
similar synthetic sequence to prepare 6-(furan-2-yl)-5,6-dihydro-pyran-2-ones has been described by 
Cahard et al. [13] as intermediates for the synthesis of (2Z)-terpenoic acids.  
 
The syntheses reported by de Rosa et al. [7, 12] use the (R)-BINOL titanium complex, and the 
(S)-aldol product is accessible using the (S)-BINOL ligand via the same methodology. This approach 
represents a direct stereoselective pathway to the 6-(furan-3-yl)-5,6-dihydro-pyran-2-one system, but was 
not used for the synthesis of 6. The O-silyl dienolate starting material required to introduce C(3) vinyl 
and C(4) methyl substituents is not readily accessible from commercial sources, indicating a custom 
dienolate synthesis or further transformation on the cyclized 
-lactone product would be necessary. For 
this reason, an intramolecular aldol-type ester ring closure was investigated as proposed in Scheme 5.1, 
involving the reaction of readily available vinyl acetic and crotonic carboxylates with the furfurol 8.
Preliminary synthetic studies using the inexpensive 2-furaldehyde were conducted and are presented in 
the following section, followed by the presentation of the final pathway towards the racemic 6 from 8.
5.2 Synthesis of (R,S)-6-(Furan-3-yl)-5,6-dihydro-4-methyl-3-vinylpyran-2-
one (6)
5.2.1 Preliminary 
-Lactone Research Using a 2-Furaldehyde Model  
 
The -keto-alcohol system in 8 can be generated by the aldol reaction between acetone and the 
furyl aldehyde, and reaction proceeds by the removal of a -carbonyl proton followed by nucleophilic 
reaction of the anion with the aldehyde carbonyl (Scheme 5.6). A mild procedure for the aldol addition of 
aromatic aldehydes to acetone has been reported in studies by Shokat et al. [14] at 0ºC and is performed 
neat with a catalytic portion of NaOH. These conditions were applied to the reaction of acetone with the 
inexpensive model compound 2-furaldehyde. Optimization of reaction conditions using GC-MS 
monitoring allowed the preparation of 4-(furan-2-yl)-4-hydroxybutan-2-one 36 (M+· m/z 154, tR = 16:61 
min) in >92% yield by warming from -10 to -5ºC over 30 min, followed by neutralization with 0.5 M 
HCl. At reaction temperatures above -5ºC, the formation of a major by-product showing a molecular ion 
for the ,-unsaturated furyl ketone (E)-4-(furan-2-yl)but-3-en-2-one (M+· m/z 136, tR = 16:75 min) was 
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more predominant in GC-MS analysis and is the result of base catalyzed dehydration as typically occurs 
in the aldol condensation [15]. Dehydration of 36 was facile in the presence of acidic and basic reagents 
at ambient temperature and occurred to a small extent during storage at -18ºC.  
 
O OH
O
O
O
(E)-4-(Furan-2-yl)but-3-en-2-one 4-(Furan-2-yl)-4-hydroxybutan-2-one
O
O
H
O
OH
H
H
H
O
Acetone
2-Furaldehyde
O O
O
36
H or HO
H+
0.045 mol% NaOH
42

Aldol Reaction
-10 to -5ºC
over 30 min
136 MW
-H2O
Scheme 5.6: The aldol reaction proceeds by first removal of the -carbonyl proton with a hydroxide anion, shown 
above using the example acetone, followed by reaction at the carbonyl of 2-furaldehyde to give the -hydroxy 
ketone 36. Condensation involving the loss of water across C(4)/C(3) can occur under acidic or basic conditions to 
give the ,-unsaturated ketone (E)-4-(furan-2-yl)but-3-en-2-one.  
 
Due to the facile tendency of 36 towards dehydration, a very mild or neutral procedure was 
required for the esterification of the C(4) alcohol to the vinyl acetate ester to form 35. Esterification using 
the Mitsunobu protocol was attempted between 36 and vinyl acetic acid under conditions described 
Couladouros et al. [16] (DEAD, Ph3P, toluene, 45ºC) resulting in a number of failures and further 
literature searches revealed a mild preparation of vinyl acetic esters from crotonyl chlorides [17, 18]. 
Ozeki et al. [17] have reported a double bond shift from the ,- to the ,- position in the reaction of 
crotonyl chloride in presence of TEA with an alcohol, as a related process to the Einhorn reaction. A later 
publication by Iwakura et al. [14] describe improvements in this process by performing the reaction in 
THF at 20ºC and report the deconjugated i-BuOH ester to form in >98% as shown in Scheme 5.6 (top). 
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Figure 5.1: Top; The aldol condensation product at (M+· m/z 136, tR = 16:61 min) formed predominately upon the 
reaction of acetone with 2-furalehyde at 5 to 10ºC over 30 min, in the presence of a catalytic amount of NaOH. 
Bottom; Reaction from -10 to -5ºC over 30 min gave the desired alcohol 36 in 92% yield and the identity was 
confirmed by a m/z 154 molecular ion at tR = 16:75 min. 
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The authors suggest this reaction to proceed by hydrogen abstraction of the -methyl group 
resulting in dehydrochlorination and rearrangement to a ketene intermediate, as supported by 
experimental results revealing the slow addition of acid chloride to a mixture of amine and alcohol to 
give highest conversion to the ,- conjugated ester. To date this methodology appears not to have been 
used in the preparation of larger organic molecules.  
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O
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HO
O
O O
O
O
O O
O
O
Cl
O
OH
sec-butanol
H
C O
-HCl
O
O
35
Crotonyl Chloride
Buta-1,3-dien-1-one sec-Butyl but-3-enoate


H
H
H
N(Et)3
Mitsunobu
conditions
(TEA)
Crotonyl Chloride
TEA, 20ºC
20ºC
Scheme 5.7: Top; The esterification of crotonyl chloride and sec-butanol in the presence of TEA has been reported 
by Iwakura et al. [18] to proceed with double bond migration to the ,-position via the buta-1,3-dien-1-one ketene 
intermediate. Bottom; The furfurol 36 underwent decomposition during esterification with vinyl acetic acid using 
Mitsunobu conditions. Methodology described by Iwakura et al. [18] was subsequently employed to give 35 in 
>94% under mild conditions. 
 
Crotonyl chloride was prepared according to procedures by Jeffery and Vogel [19] and reacted 
with the furfurol 36 under conditions described by Iwakura et al. [18] provided clean conversion to the 
,-unsaturated ester 35 in nearly quantitative yield (Scheme 5.7, bottom) as indicated by a single peak at 
tR = 18.93 min in GC-MS analysis (Appendix 5.1) containing a molecular ion at m/z 222 in agreement 
with 35. A small amount of the ,-unsaturated furyl ketone was also observed in the crude GC trace at 
tR = 16.52 min and was removed upon washings with NH4Cl. The structure of 35 was positively 
confirmed by 1H NMR analysis which shows terminal vinylic protons H(4A) and H(4B) at 
 5.15 and 5.09 
respectively and the H(3) proton as a complex multiplet at 
 5.85 in close agreement with Chemdraw 
predictions. A listing of 1H NMR chemical shifts for this model intermediate is shown in Appendix 5.1. 
13C NMR analysis shows signals in the alkane region for C(1’) and C(2’) at 
 64.6 and 45.8 respectively 
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in support of the structure 35 and carbonyl, ester and aromatic signals are present and are assigned in 
Figure 5.2. Experimental procedures for the preparation of the model compound are included in Section 
6.9.2. 
 
Figure 5.2: 200 MHz 1H NMR analysis is shown for 36 with structural assignments and integral regions. The 50 
MHz 13C NMR spectrum is also shown indicating the expected resonances for 36 in agreement with Chemdraw 
predictions. The assigned structure is also shown.  
 
Intramolecular ring closure of the vinyl ester was attempted on 35 (Scheme 5.8) using LDA at -
78ºC following procedures described by Fernándes-Mateos et al. [11]. This method failed to produce the 
lactone even at higher temperatures (-25ºC) (Appendix 5.1), with dehydration to the familiar ,-
unsaturated ketone at tR = 16.52 min predominating upon exposure of 35 to basic conditions. This result 
indicated that the deconjugation protocol could be a very facile pathway to 6 although the incorporation 
of an activating or reactive substituent at the -position to the ester is required to more effectively 
complete the 
-lactone ring closure. The following section gives a few relevant literature examples of 
intramolecular lactone formation using -activated esters and also details the final successful approach to 
the racemic 6 using readily available precursors.  
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O O
O
O
35
O
O
O
O
O
tR = 16.52 min
LDA, THF
-78ºC to -50ºC
LDA, THF
-78ºC to -50ºC

6136 MW  
Scheme 5.8: Attempted lactone ring closure with LDA did not give the desired cyclic product 6 and instead the ,-
unsaturated dehydration product was formed as indicated by GC-MS monitoring (Appendix 5.1).  
 
5.2.2 Preparation of 1-(Furan-3-yl)-3-oxobutyl 2-bromobut-3-enoate (7) 
After the failed lactone formation of 35 using LDA, other methodologies for this transformation 
involving -ester activating substituents were researched and will be discussed. Lactone formation using 
an -bromo ester has been described by Iwadate et al. [20] in the stereoselective synthesis of steroids 
from the withanolide family. The bromoacetate was treated with triethylphosphite (PO(OEt)3) (Arbusov 
reaction) to form the diethylphosphonate intermediate followed by Wittig-Horner ring closure using NaH 
in THF to give the 5,6-dihydro-pyran-2-one system (Scheme 5.9, top).  
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Scheme 5.9: Top; Iwadate et al. [20] have reported an intramolecular cyclization by reaction of the -bromoester 
with PO(OEt)3 followed by Wittig-Horner ring closure using NaH. Bottom; Zhu et al. [1] discuss failed attempts at 
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lactone ring closure using Reformatsky-type conditions and have achieved lactone formation by reaction with SmI2
followed by dehydration with POCl3.
A similar intramolecular -bromoester cyclization has been used by Zhu et al. [1] for the 
preparation of bicyclic lactone systems during their studies towards a total synthesis of clavulactone and 
reports the -acetoxy ketone to be labile to -elimination in acidic and basic environments. 
Disappointing results were reported under Reformatsky-type conditions using Zn/ZnI2 (Scheme 5.9, 
bottom) which resulted in the ,-unsaturated product [1] and the authors achieved facile ring closure to 
the lactone using SmI2 followed by dehydration using POCl3 in pyridine.  
 
Fortunately, relevant literature for the preparation of -bromo-,-unsaturated esters was 
described by Cardillo et al. [21] using a similar deconjugation pathway as shown in Scheme 5.7. The 
reaction of (Z)-2-bromobut-2-enoyl chloride with a mixture of TEA and benzyl alcohol (BnOH) in Et2O
at -78ºC was reported to give quantitative conversion to the ester in a 30:70 mixture of ,-:,- products 
[21].  
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Br
a) b) c)
(Z)-2-Bromobut-2-enoyl chlorideCrotonic acid -Bromo-crotonic acid  
a) DCM, 1.1 equiv. Br2, 24 h, 96% b) Pyridine, 100ºC, 4 h, 72% c) SOCl2, reflux, 2 h, 67%. 
 
Scheme 5.10: Top; Cardillo et al. [21] report double bond migration of (Z)-2-bromobut-2-enoyl chloride during 
esterification with BnOH in the presence of TEA to give 70% of the ,-unsaturated -bromo ester. Bottom; 
Brominaton and dehydrohalogenation of crotonic acid was achieved in 96% and 72% yield respectively under 
conditions described by Pfeiffer [22] to give -bromo-crotonic acid. Conversion to the acid chloride was achieved 
by heating with SOCl2 using procedures by Zitrin et al. [23], and the pure product was distilled in 67% yield 
(Section 6.9.1). 
 
-Bromocrotonic acid was prepared in two steps from crotonic acid following literature by 
Pfeiffer [22]. The bromination of crotonic acid was achieved using Br2 in DCM (96%) and 
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dehydrohalogenation upon heating with pyridine regenerated the ,-unsaturated product to produce -
bromocrotonic acid in 72% yield as a light brown powder with m.p. 104-105ºC in agreement with the 
literature value (m.p. 105ºC, [22]). Heating of -bromocrotonic acid with thionyl chloride (SOCl2) gave 
the acid chloride (Z)-2-bromobut-2-enoyl chloride (67% yield) that distilled at 164-170ºC in agreement 
with the literature preparation described by Zitrin et al. [23] (Section 6.9.1). 4-(Furan-3-yl)-4-
hydroxybutan-2-one 8 was prepared by the aldol reaction between acetone and 3-furaldehyde using 
optimised conditions from those shown for the model compound 36 (Scheme 5.6), involving warming 
from –9 to –6ºC over 40 min. The aldol addition product 8 was prepared in >98% yield as confirmed by a 
molecular (M+· m/z 154) at tR = 10:63 min in GC-MS analysis of the crude reaction extract (Appendix 
5.3).  
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O
8

42
3'
 
a) 1% NaOH solution dropwise at -9ºC, 0.06 mol% NaOH with respect to 3-furaldehyde b) -9 to -6ºC over 40 min 
c) 0.5 M HCl to pH 7, 98% yield 8.
Scheme 5.11: Optimal conditions for the aldol reaction between 3-furaldehyde and acetone was conducted from –9 
to –6ºC with a catalytic amount of NaOH to produce the furfurol 8 in >98% yield.  
 
1H NMR analysis (Figure 5.3) of 8 shows H(2’) and H(5’) protons at 
 7.33 and 7.22 
respectively with an integral region equal to two protons, and the H(4’) signal appears upfield at 
 6.34
with an integral region of one proton, in agreement with the C(3’) substituted furan in 8. The H(4) proton 
on the butanone chain appears as a double-doublet at 
 5.07 (J4,3A = 8.7 Hz, J4,3B = 3.9 Hz) with coupling 
constants equal to those observed in double-doublets for H(3A) (J3A,4 = 8.7 Hz, J3A,3B = 17.3 Hz) and 
H(3B) (J3B,4 = 3.9 Hz, J3A,3B = 17.3 Hz) at 
 2.75 and 2.85. The structure of 8 was confirmed by COSY 
correlations (Figure 5.3) between the H(5’)/H(4’) and H(2’)/H(4’) furan signals as well as cross-peaks 
between H(4)/H(3) in agreement with the observed 1H NMR coupling constants. 13C NMR data is shown 
in Appendix 5.4 and shows a C(2) carbonyl signal at 
 209 as well as the expected furan signals in the 
aromatic region (
 140 to 100) in agreement with 8. DEPT 135 NMR is also shown in Appendix 5.4 and 
features a negatively oriented C(3) peak at 
 50.5 in support of the 3-furfurol structure 8.
Chapter 5 
252 
 
Figure 5.3: 300 MHz 1H COSY NMR analysis of 8 with structural assignments. 
 
Under conditions described by Cardillo et al. [21], the drop-wise addition of (Z)-2-bromobut-2-
enoyl chloride to a mixture of 8 and TEA was carried out in Et2O at -78ºC (Scheme 5.12). The formation 
of the ketene was accompanied by the appearance of a deep blue colour, which gradually progressed to 
dark red as esterification took place and the product 7 was isolated as a red coloured resin in 92% 
isolated yield. GC-MS analysis of the product mixture (Figure 5.4) indicated a major product at 13:95 
min with M+· m/z 300, 302 in agreement with the brominated product 1-(furan-3-yl)-3-oxobutyl 2-
bromobut-3-enoate (7) and other small peaks at tR = 14:41 and 15:01 min showed the same molecular ion 
indicative of syn and anti C(1’)/C(2) structural isomers. Results for this reaction were surprisingly 
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reproducible given that the reaction mixture had a tendency to cake and required mechanical stirring to 
ensure proper mixing. 
+
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a) b)
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(Z)-2-Bromo
but-2-enoyl chloride
 
a) TEA, -78ºC, Et2O b) -78ºC, 45 min, 92% yield  
 
Scheme 5.12: Preparation of 7 was achieved in 92% yield from the reaction of (Z)-2-bromobut-2-enoyl chloride 
with 8 in the presence of TEA at -78ºC.  
 
Figure 5.4: GC-MS analysis of the crude esterification of 8 using (Z)-2-bromobut-2-enoyl chloride and TEA in 
Et2O at -78ºC showing the formation of 7 as the major product at tR = 13:95 min. 
 
1H NMR analysis of the crude material (Figure 5.5) showed only characteristic signals for the 
,-unsubstituted ester product, featuring terminal olefinic signals H(4A) (J4A,3 = 10.2 Hz, J4A,4B = 3.4 Hz) 
at 
 5.27 and H(4B) (J4B,3 = 17.0 Hz, J4B,4A = ~4.5 Hz) at 
 5.37 which may also be coupled with the 
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vinylic H(2) proton as inferred from the larger geminal coupling for H(4B). 1H NMR integral regions 
were found to be in agreement with the expected number of protons for 7 and 13C NMR analysis features 
C(3’) ketone and C(1) ester signals at 
 204.0 and 167.0 in support of the desired product. The expected 
double-doublet for the furfurol proton H(1’) is apparent at 
 6.26 (J1’,2A’ = 8.1 Hz, J1’,2B’ = 5.2 Hz) and the 
notable absence of signals due to structurally related impurities indicates that thermal double-bond 
isomerization is facile during GC separation and the ester product was in fact obtained as a single olefin 
isomer.  
 
Figure 5.5: 300 MHz 1H/75 MHz 13C HMQC NMR analysis of 7 with structural assignments. The DEPT 135 NMR 
spectrum of 7 is also shown. 
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Two sets of clearly resolved but overlapping double-double-doublets are seen for the H(3) olefin 
signal at 
 6.11 (J3,4B = 17.0 Hz, J3,4A = 10.2 Hz, J3,2 = 9.4 Hz, 1H, H-3, isomer 1) and 
 6.09 (J3,4B = 17.0 
Hz, J3,4A = 10.0 Hz, J3,2 = 9.4 Hz, 1H, H-3, isomer 2) in closer proximity to the (2) chiral center, 
suggesting that 7 exists as C(1’)/C(2) syn/anti-diastereomers in nearly equal ratio (Scheme 5.12). 
Overlapping double-doublets are also observed for the H(2B’) proton signals of each isomer at 
 2.89
(J2B’,2A’ = 16.9 Hz, J2B’,1’ = 5.2 Hz, 1H, isomer 1) and 
 2.88 (J2B’,2A’ = 16.9 Hz, J2B’,1’ = 5.5 Hz, isomer 2)
in support of this conclusion, and all other 1H NMR signals are completely overlapped including the 
H(2A’) double-doublet (J2A’,2B’ = 16.9 Hz, J2A’,1’ = 8.1 Hz) at 
 3.16.  
 
Structural NMR assignments for 7 were made using HMQC NMR data (Figure 5.5) which 
features cross peaks for C(2’) at 
 48.0 correlating to the H(2’) methylene protons, as well as C(4) at 

120.6 correlating to the H(4) olefin protons and both 13C NMR signals appear negatively oriented in 
DEPT 135 data in agreement with the structure of 7. A closer look at the 13C NMR spectrum showed 
two sets of signals of almost equal intensity for each diastereomer and these chemical shifts are labeled 
on the HMBC spectrum shown in Appendix 5.5 although each isomer was not individually assigned. 
COSY NMR of 7 (Appendix 5.6) was found to contain the expected correlations between H(1’) with 
H(2A’)/H(2B’), as well as H(3) with H(4A)/H(4B)/H(2). 
 
Formation of the ,-unsaturated ester (Z)-1-(furan-3-yl)-3-oxobutyl 2-bromobut-2-enoate (37)
was encouraged during the esterification of 8 at temperatures above -78ºC, or upon the exclusion of TEA 
from the reaction mixture. Isomerization from the ,-unsaturated compound 7 to the conjugated ester 37
was facile during purification attempts by vacuum distillation and FCC on SiO2 (pentane:EtOAc, 4:1) 
(Scheme 5.13) as shown by the appearance of a peak in GC-MS analysis (tR = 14:24 min) with molecular 
ions m/z 300, 302 corresponding to an isomer of 8 (Appendix 5.7). The conjugated ester 37 was isolated 
in high purity after multiple FCC elutions and the identity of the product was confirmed by COSY NMR 
analysis (Figure 5.6) to be a single compound. Cross-peaks are observed between the H(3) olefinic 
quartet at 
 7.34 (J3,4 = 6.8 Hz) and the H(4) methyl group which appears as a large doublet at 
 1.93 (J4,3 
= 6.8 Hz) and integrates as three protons. The expected correlations are also observed for the H(1’) signal 
at 6.28 and H(2A’)/H(2B’) at 
 3.20 and 2.91. NMR assignments for 37 were confirmed by HMQC and 
DEPT 135 analyses as shown in Appendix 5.8. 
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Figure 5.6: 300 MHz 1H COSY NMR of the conjugated ester 37.
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O O
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4 : 1, pentane : EtOAc
or 
Scheme 5.13: Isomerization of 7 to the ,-unsaturated ester 37 occurred during column chromatography or heating 
of 7.
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Following the development of a simple approach to the -bromo-,-ester 7, studies towards the 

-lactone ring closure were pursued using the halogen as a point for metal insertion so it may act as a 
nucleophile for intramolecular reaction with the ketone carbonyl. The next section describes the 
formation of the cyclic ester 6 by mean of intramolecular ring closure using the zinc mediated 
Reformatsky reaction and outlines the relevant literature.   
 
5.2.3 Preparation of 6-(Furan-3-yl)-5,6-dihydro-4-methyl-3-vinylpyran-2-
one (6)
Although studies by Zhu et al. [1] (Scheme 5.9, bottom) report the organozinc approach to be 
unsuccessful for the bromoacetyl lactone closure, the allylic organozinc system present in 7 offers a 
higher degree of stabilization for the organometallic product due to electron delocalization involving the 
olefin. For this reason, functionalized allylic zinc reagents have been exploited in synthesis and literature 
by Knochel et al. [24] gives a discussion of the history and scope of organozinc chemistry, highlighting 
the selective nucleophilicity of RZnX type organozinc towards aldehyde, ketone and acid chloride 
carbonyl electrophiles, but relative inertness to ester groups. As such, the reactivity of organozinc 
compounds can allow compatibility for the presence of both ester and organozinc functionalities in the 
same system. In many ways the organozinc nucleophile behaves like a Grignard reagent and studies by 
Vaughan et al. [25] on the Reformatsky reaction of ethyl 2-bromo-2-methylpropanoate suggest that the 
bromozinc enolate of the ester to be the reactive intermediate involved in this system (Scheme 5.14, top). 
This conclusion was based on their IR studies showing the disappearance of the ester absorbance at 1730 
cm-1 and appearance of zinc-oxygen absorption band at 1525cm-1.
Dreiding et al. [26] have prepared the Reformatsky reagent from methyl 4-bromocrotonate in a 
number of solvents and report solvent effects to influence - or -addition of the allyl organozinc to the 
carbonyl during the reaction with a range of cyclohexanones. Reactions conducted in 1,2-
dimethoxyethane (1,2-DME) were reported to occur at the -position to give the cyclohexanol product in 
39% yield. Saponification followed by dehydration with Ac2O/HCOOH was reported to yield the 
endocyclic cyclohexenone in 57% with a small amount of the exocyclic conjugated carboxylic acid 
(15%) (Scheme 5.14, middle). 
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Scheme 5.14: Top; Vaughan et al. [25] report the preparation of the ethyl 2-bromo-2-methylpropanoate 
Reformatsky reagent and suggest the organozinc compound to exist as the bromozinc enolate based on IR 
experiments. Middle and bottom; Dreiding et al. [26] report the reaction between the methyl 4-bromoacetate 
Reformatsky reagent and cyclohexanone to yield the -addition product when conducted in 1,2-DME. The -
addition product predominated upon reaction in Et2O and the alcohol was successfully dehydrated to the endocyclic 
product.  
 
The authors report reactions conducted in Et2O to behave differently, producing the -addition 
product with cyclohexanone in 60% yield (Scheme 5.14, bottom) which was dehydrated using 
ZnCl2/AcOH to form the endocyclic cyclohexenone product exclusively in 50% yield. More hindered 
substituted cyclohexanones were reported to yield the -product preferentially and the authors suggest 
steric hinderence and solvent effects to be determining factors in this type of Reformatsky reaction, but 
do not comment on whether a metalide shift or stabilized allyl complex are involved as intermediates. 
 
It was hoped that the Reformatsky reagent prepared from the vinyl ester 7 (Scheme 5.15) would 
intramolecularly react with the C(3’) carbonyl to form the energetically favoured six-membered ring. The 
C(4) alcohol intermediate can be dehydrated under acidic conditions or using methodology described by 
Dreiding et al. [26] to give the convergent target 6. A proposed mechanism is shown in Scheme 5.15 and 
involves the bromozinc enolate as described in studies by Vaughan et al. [25]. 
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Scheme 5.15: Lactone closure of 7 was achieved by formation of the Reformatsky reagent using Rieke Zinc to 
affect intramolecular ring closure with the C(3) ketone and a proposed mechanism is shown based in research by 
Vaughan et al. [25]. The alcohol C(4) 38 was not observed and the conjugated dihydro-pyranone 6 was isolated in 
92% after stirring with 2 M HCl at ambient temperature.  
 
An experimental procedure for the Reformatsky mediated ring closure of 7 was adapted from the 
literature by Knochel et al. [24]. Commercially available Rieke Zinc (5%w/v suspension in THF, 
Aldrich) was used as a highly reactive form of zinc metal to improve the yield of organozinc formation 
and the reaction was conducted in THF rather than Et2O to give a larger solvent boiling range. Reaction 
of the ester 7 with three equivalents of Rieke Zinc in dry THF at 0ºC and no detectible lactone formation 
was observed by GC-MS monitoring during warming to 40ºC. The reaction was heated at reflux, which 
was required for five hours for complete consumption of the halide, then the mixture was quenched in 2 
M HCl and allowed to stir for 1 h. GC-MS analysis of the Et2O extract showed a single major product at 
tR = 14:17 min with a molecular ion at m/z 204 in agreement with the dehydrated product 6. The 
intermediate alcohol 38 was not observed in the GC trace indicating that prolonged stirring in the acidic 
quenching mixture was sufficient to achieve selective dehydration for a single diene product. The major 
product was purified by FCC on SiO2 using gradient elution with pentane:EtOAc (20:1 to 8:1) to yield a 
deep yellow resin in high recovery. 
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Figure 5.7: GC-MS analysis of the crude Reformatsky product mixture shows the formation of the target dihydro-
pyranone 6 as the major product at tR = 14:17 min in 92% yield, as identified by a M+· ion at m/z 204.  
 
1H NMR characterization (Figure 5.8) indicated a single compound with the expected number of 
signals at frequencies in close agreement with predicted Chemdraw values for 6. Broad peaks for the 
protonated furan signals at 
 7.49 (H-5’), 7.42 (H-2’) and 6.45 (H-4’) are present in the same regions as 
seen in 7 and 8, and the H(9) methyl signal is present as a 3H singlet at 
 2.11 with an integral area of 
three protons. This suggests that the endocyclic dehydration of 38 had occurred and the presence of 
double-doublets at 
 2.78 (J5A,5B = 18.1 Hz, J5A,6 = 11.5 Hz) and 2.54 (J5B,5A = 18.1 Hz, J5B,6 = 3.8 Hz) for 
H(5A) and H(5B) respectively confirmed that the olefin is in conjugation with the ester carbonyl, 
consistent with the 6-(furan-3-yl)-5,6-dihydro-4-methyl-3-vinylpyran-2-one product 6. The H(6) methine 
signal appears as a double-doublet at 
 5.35 (J6,5A = 11.5 Hz, J6,5B = 3.8 Hz) and coupling constants are 
consistent with those observed for the H(5) protons. The terminal olefinic protons H(8A) and H(8B) are 
present as broad double-doublets at 
 5.72 (J8B,7 = 17.7 Hz) and 
 5.47 (J8A,7 = 11.5 Hz) and the H(7) 
olefin appears as a double-doublet at 
 6.55 (J7,8B = 17.7 Hz, J7,8A = 11.5 Hz), consistent with C(3) vinyl 
substituent on the dihydro-pyranone 6.
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Figure 5.8: 300MHz 1H/75 MHz 13C HMQC NMR analysis of 6 with structural assignments shown. DEPT 135 
NMR data is also included. 
 
13C and DEPT 135 NMR analyses (Figure 5.8) were used to confirm signals due to non-
protonated carbons C(2), C(4), C(3) and C(3’), as well as the methylene carbons C(8) and C(5). The 
connectivity of 6 was verified and NMR structural assignment made using HMBC analysis (Figure 5.8). 
The H(9) methyl shows strong long range correlations to C(5), C(8) and C(4) at 
 37.7, 121.0 and 150.3 
respectively and H(5A)/H(5B) methylene signals show cross-peaks with C(6) at 
 70.8, C(8) and C(4). 
Attachment of the vinyl group was confirmed by correlation of the H(8A)/H(8B) methylene signals with 
C(3) (
 125.4) and C(7) (
 128.9), and COSY correlations (Appendix 5.9) as well HMQC NMR data 
(Appendix 5.10) support the assigned structure of 6. The chemical formula of 6 was confirmed by ESI-
HRMS to provide an accurate mass for the [M + Na]+· ion C12H12O3Na in agreement to three decimal 
places of the theoretical value (227.0684 calc., m/z 227.0677 found). 
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 The surprising absence of the alcohol 38 in the crude product mixture of 6 prompted a brief 
study involving quenching of the Reformatsky reaction with alternate media to address whether 
dehydration to the C(3)/C(4) olefin occurs spontaneously or is mediated by the acidic conditions. 
Conditions for the reaction between Rieke zinc and 7 were followed as described in Scheme 5.15 and the 
reaction was quenched in a biphasic solution of 1 M HCl/Et2O and allowed to stir for only 15 min before 
workup and purification by FCC on SiO2 as described for 6. GC-MS analysis indicated one major 
product at tR = 14:49 min that featured a molecular ion at m/z 222 in agreement with the molecular 
weight of the alcohol 38. A smaller peak at tR = 14:37 min was found to have an almost identical EI-MS 
fragmentation to the major product and can be identified as one of a number of possible C(3)/C(4)/C(6) 
diastereoisomers (Scheme 5.16).  
 
Figure 5.9: GC-MS analysis for the Reformatsky reaction of 7 shows two diastereoisomers of the alcohol 38.
The major product was characterized using HMQC and DEPT 135 NMR data (Appendix 5.11) 
and confirmed as the C(4) substituted 
-lactone by the appearance of a doublet at 
 3.00 (J4,3 = 9.1 Hz) 
corresponding to the H(3) proton at the -carbonyl position. The presence of a C(4) quaternary signal in 
the aliphatic region at 
 71.1, as well as a broad hydroxy resonance at 
 2.50 are in agreement with the 
assigned structure of 38. The minor isomer could not be fully characterized by NMR analysis and energy 
minimized models were calculated using Chem3D (MM2) to provide a comparison of the steric energy 
of various conformations of 38 (Scheme 5.16). The (6S)-38 diasteromer of the 
-lactone is present in 1
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and was modeled for each C(3)/(C4) distomer to indicate the trans-C(3)/C(4) geometry as sterically 
favoured compared to the cis- oriented methyl and vinyl groups. 1H NMR signals for the major isomer of 
38 include a double-doublet for H(6) at 
 5.73 (J6,5B = 11.9 Hz, J6,5A = 3.4 Hz) indicative of a trans-
diaxial relationship between H(6)/(5B) as observed in 3 (Section 4.2, Figure 4.7). Energy minimized 
structures for the chair conformer of (3R,4R,6S)-38 and (3S,4S,6S)-38 were calculated to have similar 
values (Scheme 5.16) and in the case of (3S,4S,6S)-38 an alternate pseudo-chair conformation was found 
as a theoretically favored geometry showing a gauche H(6)/H(5) arrangement.  
 
a) THF, 3 equiv. Rieke Zinc in THF at 0ºC, 70ºC for 5 h b) 1 M HCl/Et2O, 15 min c) 2 M HCl, r.t., 1 h, 92%.  
 
Scheme 5.16: Lactone closure of 7 was achieved under Reformatsky conditions and the alcohol 38 was isolated 
upon quenching in 1 M HCl/Et2O. Energy minimized models of the chair conformations for diastereoisomers of 38 
were calculated using Chem3D (MM2) and are shown with values for steric energy. The trans-C(3)/C(4) products 
(3R,4R,6S)-38 and (3S,4S,6S)-38 were calculated as the favoured isomer. 
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Contrary to this result, coupling constants characteristic of the gauche conformation between 
H(6)/H(5), as seen in C(5)-epi-3 (Section 4.2, Figure 4.10), were not observed. Both the major and minor 
isomers were found to have similar coupling constants (Appendix 5.11) in agreement with the calculated 
chair geometry for the anti-C(3)/C(4) products of 38. Experiments to differentiate (3R,4R,6S)-38 from 
(3S,4S,6S)-38 isomers were not pursued due to time constraints. 
 
Positive identification of the alcohol 38 indicates that the 2 M HCl quenching solution, described 
the procedure shown in Scheme 5.16, provides a sufficiently acidic environment for dehydration of 38 to 
yield the ,-unsaturated product 6 exclusively. Since 38 formed as a single isomer in high yield (92%) 
and purity, this pathway appears advantageous as a direct preparation of 
-lactones with analogous 
functionality.  
 
In conclusion an efficient and high yielding synthesis for the racemic precursor 6-(furan-3-yl)-
5,6-dihydro-4-methyl-3-vinylpyran-2-one (6) has been developed using cheap and readily available 
precursors. Relevant intermediates and products have been fully characterized by NMR and MS analysis 
and analytical data is listed in Section 6.9.3. The work presented in Chapter 4 and Chapter 5 has been 
published as a journal manuscript [27] and this section in the current work concludes the synthetic 
studies completed in this project. Preliminary studies towards the (6S)-6 chiral precursor are outlined in 
the following section with a discussion of future work and concluding remarks. 
 
5.3 Preliminary Studies Towards the Synthesis of (S)-6-(Furan-3-yl)-5,6-
dihydro-4-methyl-3-vinylpyran-2-one ((S)-6) and Future Work  
Preliminary efforts towards the stereoselective synthesis of 6 have involved the investigation of a 
chiral aldol reaction between acetone and 3-furaldehyde. The catalytic asymmetric aldol reaction has 
been reviewed by Machajewski et al. [28] and is a very valuable tool in organic synthesis. The C(4) 
alcohol is a newly created stereocenter of the aldol product 8 and correlates to the C(6) chiral center of 6
and the C(8) stereocenter of 1. The (S)-4 configuration is desired for the asymmetric natural product 
synthesis and asymmetric catalysis using the amino acid proline was researched in hope that the 
commercially available catalyst could be conveniently recycled.  
 
Asymmetric synthesis using L-proline has been described in Chapter 1 (Scheme 1.3) and 
recently List et al. [29] have shown that L-proline can often be used alone for enantioselective reactions 
since the molecule is bifunctional, containing both the acidic carboxylic acid and basic amine functional 
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groups. The scope of proline catalyzed organic reactions is reviewed in literature by List [30] along with 
a proposed mechanism addressing the bi-functional role of proline in the aldol reaction of acetone, as 
shown in Scheme 5.17. Crossed-aldol proline catalysis has since been used by Pihko et al. [31] for the 
preparation of chiral lactones in excellent enantioselectivity (>99% ee) and further studies have been 
discussed by Peng et al. [32] who conduct their experiments in aqueous micelles.  
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Scheme 5.17: Top; A proposed mechanism by List et al. [29] for the L-proline catalyzed aldol addition, shown 
using the reactants acetone and isobutyraldehyde which have been reported to produce the (R)-4-hydroxy-5-
methylhexan-2-one in high optical and yield. Bottom; The reaction of 3-furaldehyde did not produce the optically 
enriched alcohol and only the dehydration product was observed.  
 
The reaction 3-furaldehyde with acetone was carried out in the presence of L-proline following 
methodology by List et al. [29] and GC-MS monitoring revealed that the aldol alcohol was not formed 
and only a small amount (<5%) of the dehydrated ,-unsaturated product was detected. Other methods 
to introduce chirality into the 1,3-ketoalcohol system were sought including resolution of the racemic 
mixture. Kinetic resolution of racemic furfuryl alcohols using the Sharpless reagent (Ti(OiPr)4/t-
BuO2H/L-(+)-DIPT) has been discussed by Kobayashi et al. [33] to access enantiomerically pure 
(1R,3R)-1-(furan-2-yl)-3-(tetrahydro-2H-pyran-2-yloxy)butan-1-ol in excellent yield. Reaction of 2-
furyllithium with the optically pure aldehyde (R)-3-(tetrahydro-2H-pyran-2-yloxy)butanal was reported 
to produce the racemic C(1) alcohol and diastereoselective oxidation of the (1S)-enantiomer allowed the 
isolation of the optically enriched (1R,3R)-enantiomer in high yield (Scheme 5.18).  
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Scheme 5.18: Kobayashi et al. [33] have prepared (1R,3R)-1-(furan-2-yl)-3-(tetrahydro-2H-pyran-2-yloxy)butan-1-
ol in high optical purity by kinetic resolution of the racemic C(1) alcohol in excellent yield. 
 
It occurred that the single enantiomer (S)-6 can be obtained by either a chiral aldol reaction with 
selectivity for the (S)-8 enantiomer, kinetic resolution as described above, or by chemoenzymatic 
hydrolysis of the ester 7 or pyranone 6 as has been briefly mentioned at the end of Section 4.1.2. These 
directions are a focus for future studies to complete an asymmetric synthesis of the convergent precursor 
(S)-6.
The final goal in this synthesis is the joining of ring A and C and current ideas for this last 
transformation are proposed. The Gilman addition to 2 is described in Section 4.5 and this step allows for 
trapping of the TMS-enolate as an intermediate reactant for the subsequent reaction (Scheme 5.19). 
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Scheme 5.19: Proposed synthetic methodology for the joining of rings A and C to prepare the target 1.
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1,4-Addition of the enolate to (S)-6 provides the terminal dienes from both convergent molecules 
for ring closure metathesis (RCM) using Grubbs ruthenium based catalysts [34]. Hydrogenation of the 
metathesised product is proposed to yield the natural product 1 leaving an ambiguous stereochemical 
outcome at chiral centers adjacent to the C(8) ester and C(10) ketone carbonyls, which can be 
equilibrated to their most stable configuration 1 under basic conditions if necessary.  
 
5.4 Thesis Conclusions 
In the current work, a novel synthetic pathway towards the trans-neoclerodane natural product 
salvinorin A (1) has been investigated using primarily newly synthesized molecules. Products and 
intermediates were characterized using NMR and MS analyses and the final products confirmed by 
HRMS. An asymmetric synthesis has been completed for the ketone ring A of the diterpene 1 and a 
successful pathway to the lactone ring C has been devised using racemic precursors. These new 
compounds have been synthesised as convergent precursors to be used in a totally non-linear synthesis of 
the neoclerodane backbone of 1.
In Chapter 2 a simple sequence for the preparation of 3-furylamines (5) has been devised and 
provided access to a large number 3-furylamine containing structures that were previously scarce in the 
literature due to their complicated preparation and low stability. The chemical stability of secondary 
substituted 3-furylamines has been shown to be low, although the tertiary substituted compounds were 
revealed to be synthetically useful as they can be stored and distilled. A trend towards greater stability 
was encountered upon increasing the size of the amine group and this result was considered during the 
selection of an appropriate chiral auxiliary for the commencement of an asymmetric synthesis. 3-
Furylamine moieties were incorporated into optically pure amine auxiliaries to be used as chiral dienes 
for a D-A approach toward ring A, as suggested from the retrosynthetic analysis of 1.
In Chapter 3 the Diels-Alder reaction between selected non-chiral 3-furylamines and methyl 
acrylate were thoroughly investigated. The reactivity of 3-furylamines towards Diels-Alder cycloaddition 
in organic reaction media was generally low when conducted in hydrocarbon solvents (hexane, benzene, 
toluene) but excellent results were achieved in the chlorinated solvent DCM. Diels-Alder reactions when 
conducted in water were found to give the best results and an increase in solvent polarity was 
accompanied by enhancement of the reaction rate to give a high yield of cycloadducts in short reaction 
times. Hydrolysis of the enamine cycloadducts occurred in situ allowing alkyl substituted 3-furylamines 
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to be reacted quantitatively and without polymerization of reactive intermediates. The preparation of 
useful quantities of the 7-oxanorbornanone intermediate 4 was achieved using this aqueous methodology, 
which also proved general for the reaction of larger aralkyl substituted 3-furylamines. Ephedrine derived 
3-furylamines were found be reactive Diels-Alder dienes in DCM or water and the optically enriched 
ketones 4a-b were quantitated using chiral gas chromatographic analysis. The absolute stereochemistry 
of the major enantiomer was determined by derivatization of 28 followed by identification of the single 
recrystallized diastereoisomer (1S,2S,4S,5S)-29.HClO4 using x-ray crystallography. Comparison with 
chiral gas chromatography results demonstrated that both ephedrine isomers direct facial Diels-Alder 
selectivity towards the (1S,4S)-4 products. This indicates that the optically enriched exo-bicyclic ketone 
4b has the correct stereochemistry to be used in an asymmetric synthesis of 1. The preparation of non-
racemic 3-furylamines and application as Diels-Alder dienes represents a previously unreported strategy 
towards chiral 7-oxanorbornanes as useful chiral intermediates for organic synthesis.  
 
Chapter 4 focuses on synthetic transformations of the 7-oxanorbornane structure 4. The 
reactivity of the new compounds 4a-b towards ether bridge cleavage required an in depth study 
addressing mechanistic reasoning for the occurrence of a number of unwanted rearrangement by-
products. Under basic conditions the ketone 4 underwent C-C cleavage to produce the five-membered 
heterocycle and C-O cleavage was accomplished using BBr3 followed by quenching in collidine to yield 
the cyclohexenone 3. Stereochemistry at the C(5) -carbonyl position was retained in the ether cleavage 
product of 4b but not in the endo-isomer 4a and this could be due to intramolecular Lewis-acid attraction 
in the intermediate boron complex. The acetylation of 3 was accomplished as a one-pot procedure by the 
addition of AcCl to the 1 M collidine/DCM quenching mixture to yield 2 in moderate yield. The isolation 
of 2 and 3 demanded HPLC separation and further investigation is necessary to develop a mild and high 
yielding ether cleavage procedure to allow simple access to 2 in larger reaction scales.  
 
Chapter 5 begins the synthesis of a convergent precursor for lactone ring C of 1. A simple 
process for the preparation of ,-unsaturated esters was used in the synthesis of the lactone ring and 
esterification of the furfurol 8 with -bromocrotonyl chloride in the presence of TEA gave the 
deconjugated -bromoester exclusively. Preparation of the Reformatsky reagent using Rieke Zinc 
facilitated intramolecular ring closure, followed by stirring in 2 M HCl to produce the ,-unsaturated 
dihydropyranone 6. Since the racemic alcohol 8 was employed in this synthesis, the racemic product was 
obtained and is labeled as (R,S)-6 in Scheme 5.20. Further asymmetric strategies are required to prepare 
the non-racemic precursor (S)-6. The synthetic protocol used for the preparation of the lactone skeleton is 
a direct and high yielding synthesis for a functional unit that is commonly incorporated in range of 
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reported natural products and could be a useful synthetic intermediate in a number syntheses involving 
this moiety. 
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Scheme 5.20: A summary of the synthesis presented in Chapters 2-5.  
 
In conclusion, significant progress has been made towards a novel asymmetric synthesis of 
natural product salvinorin A (1). Recent research by Scheerer et al. [35] describes the completion of an 
asymmetric synthesis for 1 by a more linear methodology involving the construction of a chiral 
macrocycle followed by a transannular cyclization to the fused tricyclic ring system. The current work 
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pursues a completely convergent synthetic route to the trans-neoclerodane skeleton, a challenge that 
most synthetic chemists avoid due to the potential for dead-ends due to the unexpected reactivity, 
inertness or rearrangements of intermediates. Nevertheless, the synthetic work discussed has not 
presented any challenges that cannot overcome by persistence and a basic understanding of the reaction 
mechanism. An entirely convergent synthesis for clerodane diterpenes is highly desirable to access the 
bioactive natural products of this family in the laboratory. It is hoped that the current work provides a 
significant contribution towards this accomplishment. 
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Chapter 6 
Experimental Procedures and Methodology 
Chemical structures and 3D molecular models included in this thesis were constructed using 
ChemOffice 8.0 (Cambridgesoft). Gas-chromatographic-mass-spectrometry data shown was analysed 
using W-search (Frank Antolasic, www.w-search.com) and processing of NMR spectra was performed 
using X-Win NMR (Bruker) and the scanned images are included. 
 
Unless noted, materials were obtained from Aldrich Chemical Co. and used without further 
purification. Diethyl ether and THF were dried first with CaH2, then distilled from sodium/benzophenone 
before use. Dry acetone (BDH) was obtained by refluxing over KMnO4 followed by distillation and 
storage over molecular sieves (4Å). Triethylamine was dried over KOH pellets before use. 1H and 13C
NMR spectra were recorded on a Varian Gemini 2000 (200 MHz) and a Bruker Avance 300 (300 MHz) 
NMR spectrometer and are indirectly referenced to TMS via CHCl3. FT-IR spectra were recorded on a 
Perkin-Elmer Spectrum 2000 Fourier transform IR spectrometer. GC-MS data was recorded using a 
Hewlett Packard 6890 GC with BPX-5 column, and Hewlett Packard 5973 Mass Selective Detector. 
Chiral GC separation was achieved using a diEt-TBS--CD column (MeGA, Italy), 20 m, 0.25 mm x 
0.25 µm (film thickness). Semipreparative HPLC was performed using a Varian Prostar (Model 210), 
with Phenomenex C18 column (250 x 10 mm, 5µ ODS (3), 50 x 10 mm, 5u ODS (3) guard column). 
Separation was achieved using MeCN:H2O (55:45) at 3.5 mL/min flow rate, with UV-Vis detection. 
Reactions performed under ultrasonic irradiation were performed using a Elma Transsonic Digital S, 
40kHz variable power ultrasonic bath. Optical rotations were determined on a Perkin-Elmer 241 MC 
Polarimeter at 690nm wavelength using a medium pressure mercury lamp at 20°C and at the 
concentration c (g/100 mL).  
 
Single crystal X-ray crystal structures of 4b and (1S,2S,4S,5S)-29 were obtained by Associate 
Professor Jonathan White, Bio21 Institute, University of Melbourne, Melbourne, Australia. Data was 
collected on a Bruker Smart Apex diffractometer, with CCD area detection and a Enraf Nonius FR590. 
The structures were solved by the direct method: SHELXTL (Bruker AXS Incorporated, v6, 12, 2001) 
and refined by full matrix least squares method: SHELXL97 (Scheldrick, University of Gottingen, 
Germany, 1997).  
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NOE correlated NMR spectrometry of 3 and C(5)-epi-3 was performed by Dr. Jo Cosgriff and 
Dr. Rodger Mulder at CSIRO, Molecular Science, Clayton, Australia using a Bruker Avance 500 (500 
MHz) NMR spectrometer. 
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6.1 Preparation of 5-methyl-3-bromofuran (10) from 2-furoic acid methyl 
ester by optimized literature methodology. 
 
The preparation of 2,3-dibromofuran was performed via an optimized procedure from patent 
US3714197 [1]. The final transformation to 10 was achieved following methodology reported by 
Katsumura et al. [2]. Product were separated and identified by GC-MS using Method 1 (Section 6.10). 
 
6.1.1   Preparation of 2,3-dibromofuran (16) [1]. 
Preparation of 2,3-dibromofuroic acid methyl ester (14). 
 
To methyl-2-furoate (50.0 g, 0.38 mol) in boiling chloroform (100 mL) was added elemental 
bromine (177 g, 2.8 equiv.) drop-wise over 20 min. The solution was heated to reflux for 16 h then 
nitrogen was bubbled through the hot solution for approx. 2 h to remove dissolved HBr and excess 
bromine. The solvent and excess bromine was removed to leave 2,3-dibromofuroic acid methyl ester (14)
as a viscous light orange oil in nearly quantitative yield (113.4 g, <97% yield) by GC-MS and 1H NMR. 
1H NMR (200 MHz, CDCl3): 
 7.17 (arom. s, 1H), 3.89 (s, 3H). 13C NMR (50 MHz, CDCl3): 
 181.7, 
157.5, 146.0, 128.5, 103.9, 52.6. MS m/z (relative intensity) 287 (2.4), 286 (32.0), 285 (5.0), 284 (M+,
65.6), 282 (34.1), 256 (5.2), 255 (49.8), 254 (11.0), 253 (100), 252 (5.8), 251 (52.9), 241 (1.7), 228 (6.4), 
227 (2.6), 226 (13.2), 225 (4.3), 224 (6.9), 223 (2.1), 215 (2.0), 213 (4.4), 211 (2.3), 199 (11.9), 197 
(24.4), 195 (12.8), 175 (8.4), 173 (7.5), 149 (4.3), 147 (5.9), 146 (5.8), 145 (1.8), 144 (6.0), 119 (2.8), 
118 (26.0), 117 (5.4), 116 (26.2), 115 (2.7), 106 (1.9), 104 (2.0), 93 (3.2), 81 (2.2), 79 (2.2), 65 (2.1), 59 
(8.3), 53 (7.6), 52 (1.8), 51 (3.6), 38 (1.6), 37 (18.6), 36 (3.1). (tR = 21.59 min) 
 
Preparation of 2,3-dibromofuroic acid (15). 
 
To a vigorously stirred solution of NaOH (195 mL, 4M aq. solution) warmed to 50°C was added 
14 (45.0 g, 160 mmol) portion wise. The solution was warmed to 70°C, allowed to stir for 2.5 h then 
cooled in a salt/ice bath. Et2O (300 mL) was added to the stirred solution followed by the slow addition 
of HCl (73 g, conc.) in ice (110 g), keeping the mixture below 5°C. The ethereal layer was separated and 
the aqueous layer extracted with Et2O (4 x 75 mL). The combined organic layers were washed with 
Na2S2O4 (2 x 75 mL, 5% aq. solution) then dried with MgSO4 and evaporated to leave 2,3-dibromofuroic 
acid (15, 35.2 g, Yield 82%). The saponified material was recrystallized from water (10 g / 800 mL).
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(m.p. 168-169°C, lit. 167-168°C, [3]). 1H NMR (200 MHz, CDCl3): 
 7.31 (arom. s, 1H). 13C NMR (50 
MHz, CDCl3): 
 carbonyl abs., 159.6, 127.2, 120.0, 114.0. MS m/z (relative intensity) 273 (3.1), 272 
(50.0), 271 (5.7), 270 (M+, 100), 268 (49.9), 255 (5.3), 253 (11.1), 251 (5.7), 244 (1.7), 242 (1.6), 240 
(1.8), 227 (1.5), 226 (3.2), 225 (2.8), 224 (1.7), 200 (2.1), 199 (10.1), 198 (1.9), 197 (18.1), 195 (8.8), 
192 (2.0), 191 (2.7), 190 (2.4), 189 (2.3), 163 (5.2), 161 (5.4), 146 (2.3), 144 (2.6), 135 (11.8), 134 (2.1), 
133 (12.7), 132 (2.1), 119 (14.8), 117 (16.3), 116 (21.8), 115 (2.4), 107 (2.5), 106 (1.6), 105 (2.7), 104 
(1.7), 93 (2.8), 91 (2.2), 82 (1.8), 81 (3.2), 79 (3.5), 66 (1.9), 65 (1.5), 53 (8.0), 45 (11.3), 44 (2.2), 39 
(1.5), 38 (9.8), 37 (23.0), 36 (4.6), 32 (1.7). (tR = 23.28 min) 
 
Preparation of 2,3-dibromofuran (16). 
 
Purified 15 (10 g, 37.2 mmol) was added to quinoline (40 mL) and copper powder (4 g). The 
solution was stirred briefly, then submersed in a preheated oil bath (180°C) without stirring for 10 min, 
or until CO2 evolution slowed. The solution was immediately cooled in an ice bath and quenched by the 
addition of ice cold HCl (70 mL, 5 M aq.) with stirring followed by Et2O (70 mL). The biphasic mixture 
was then filtered with suction and the filtrate washed thoroughly with Et2O. The organic layer was 
separated and the aqueous layer extracted with Et2O (2 x 75 mL). The combined organic layers were 
extracted with HCl (2 x 50 mL, 0.5 M aq.), dried with MgSO4 and evaporated to leave a dark oil (7.2 g). 
Analysis by NMR showed the oil to be 2,3-dibromofuran (16) along with small amounts of polymeric 
material present in the baseline. The product was kept at -25°C, protected from UV exposure, and 
carefully bulb distilled before use. (Yield 86%, b.p. 58°C @ 15 mmHg, lit. 58°C @ 12 mmHg [4]). 1H
NMR (200 MHz, CDCl3) : 
 7.37 (d, J = 2.2 Hz, 1H), 6.42 (d, J = 2.2 Hz, 1H). 13C NMR (50 MHz, 
CDCl3): 
 144.8, 123.3, 115.7, 101.8. MS m/z (relative intensity) 229 (2.4), 228 (49.7), 227 (5.0), 226 
(M+, 100), 224 (52.4), 200 (3.6), 199 (5.1), 198 (6.6), 197 (10.1), 196 (3.3), 195 (5.4), 120 (1.9), 119 
(53.8), 118 (17.5), 117 (55.3), 116 (16.0), 113 (2.6), 93 (4.0), 91 (3.9), 81 (7.5), 79 (7.4), 38 (22.9), 37 
(22.4), 36 (4.3). (tR = 13.95 min) 
 
6.1.2 Preparation of 4-bromo-2-methyl furan (10) [2]. 
Preparation of 2,3-bromo-5-methyl furan (12). 
 
Under an inert atmosphere (N2), n-BuLi (4.5 mmol, 2.75 mL, 1.6 M in hexanes) was added drop-
wise to a solution of diisopropylamine (4.5 mmol, 0.45 g) in THF (25 mL) at 0°C. The solution was 
stirred at 0°C for 10 min then cooled to -15°C followed by the slow addition of freshly distilled 2,3-
dibromofuran (1.0g, 4.5 mmol). After stirring for 12 min, iodomethane (4.5 mmol, 0.635 g) was added 
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dropwise and the solution allowed to reach room temperature. A potion of 2,3-bromo-5-methyl furan 
(12) was characterized by spectroscopic analysis and the remaining material was reacted further from the 
same mixture. 1H NMR (200 MHz, CDCl3): 
 6.27 (arom. s, 1H), 2.28 (s, 3H). 13C NMR (50 MHz, 
CDCl3): 
 151.9, 120.0, 114.7, 97.8, 12.2. MS m/z (relative intensity) 243 (2.7), 242 (50.0), 241 (8.4), 
240 (M+, 100), 239 (8.6), 238 (52.2), 237 (2.8), 213 (4.7), 213 (4.7), 212 (1.6), 211 (9.5), 209 (4.9), 199 
(2.3), 197 (4.1), 195 (2.1), 162 (3.6), 161 (59.7), 160 (4.2), 159 (63.2), 157 (2.3), 134 (3.7), 132 (6.4), 
131 (86.0), 130 (3.2), 120 (2.2), 119 (3.1), 118 (8.0), 117 (4.2), 116 (7.5), 115 (2.0), 109 (3.1), 107 (4.9), 
106 (2.1), 105 (2.3), 104 (2.1), 81 (4.8), 80 (4.9), 79 (8.2), 66 (2.2), 65 (2.2), 53 (3.4), 52 (34.0), 51 
(80.3), 50 (36.7), 49 (9.1), 43 (15.3), 42 (2.1), 39 (1.8), 38 (3.3), 37 (10.4), 36 (2.4). (tR = 16.13 min) 
 
Preparation of 4-bromo-2-methyl furan (10).  
 
The solution of 12 from the previous step was cooled to -78°C whilst maintaining an inert 
atmosphere. tBuLi (4.5 mmol, 2.75 mL, 1.6 M in hexanes) was added dropwise and the solution allowed 
to stir for 8 min, followed by quenching with wet THF,  followed by the addition of H2O (20 mL). The 
solution was extracted with DCM (3 x 50 mL), dried with MgSO4 then evaporated under vacuum to 
leave a dark oil (0.64 g). 4-Bromo-2-methyl furan (10) was distilled as a clear oil (0.54 g, 76%) which 
which was stable for months when stored in a freezer and protected from UV light. (b.p. 120-124°C). 1H
NMR (200 MHz, CDCl3): 
 7.17 (arom. m, 1H), 6.26 (arom. m, 1H), 2.20 (s, 3H). 13C NMR (50 MHz, 
CDCl3): 
 149.1, 140.6, 113.3, 95.8, 11.4. MS m/z (relative intensity) 163 (6.0), 162 (97.4), 161 (50.1), 
160 (M+, 100), 159 (46.4), 133 (14.3), 131 (15.0), 119 (4.2), 117 (4.4), 107 (2.3), 105 (2.6), 82 (4.7), 81 
(66.4), 80 (5.5), 79 (5.3), 61 (1.6), 54 (4.7), 53 (96.3), 52 (37.2), 51 (59.9), 50 (35.6), 49 (8.9), 43 (13.3), 
42 (2.4), 39 (4.2), 38 (10.2), 37 (8.6). (tR = 6.55 min) 
6.2    Preparation of 3-furylamines by coupling of amines to aryl halide. 
 
6.2.1 Preparation of 4-(5-Methylfuran-3-yl)morpholine (5a) by Pd(dba)3/Di-t-butyl-
orthodiphenylphosphine using optimized methodology based on Wolfe et al. [5].
A flame dried flask was charged with Pd(dba)3 (15 µm, 13.8 mg), P(t-Bu)2-o-biphenyl (60 µm, 
17.9 mg) and tBuONa (230 mg, 2.4 mmol) under a nitrogen atmosphere. Morpholine (110 mg, 1.2 
mmol), 10 (190 mg, 1.2 mmol) and dry toluene (4 mL) were added sequentially and the solution heated 
to 70°C. Reaction monitoring by GC-MS showed maximum to conversion 5a (30%), identified by a 
molecular m/z 167 ion, achieved after 4 h with large amounts of decomposition. After cooling to ambient 
temperature, Et2O (20 mL) was added and the solution was washed with brine (2 x 10 mL). Attempts to 
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isolate the aminofuran by column chromatography led to decomposition, even after deactivation of the 
silica with triethylamine in ethyl acetate. The GC-MS spectrum of 5a is listed in 6.4.3.  
 
6.3    Attempted preparation of 3-furylamines from 5-methyl-furan-3-one. 
 
6.3.1    Preparation of 5-Methylfuran-3-one (16) following methodology by Cui et al. [6].
n-BuLi (120 mmol, 1.6 M in hexanes) was added drop-wise to a solution of diisopropylamine 
(12.12 g, 120 mmol) in dry THF at –30°C under a nitrogen atmosphere. The stirred solution was allowed 
to warm to 0°C and stirred for 15 min after which time it was cooled to –30°C and dry acetone (6.96 g, 
120 mmol) was added drop-wise. After stirring for a further 25 min, the solution was cooled to –50°C 
and ethylchloro acetate (7.44 g, 60 mmol) was added slowly. The solution was allowed to warm to room 
temperature, quenched with saturated ammonium chloride solution and extracted with diethyl ether (3 x 
75 mL). The combined extracts were concentrated with gentle vacuum to leave a red sweet smelling oil 
(7.6 g). The oil was transferred to a silica column (4 cm diam., 40 cm length) and 20 x 20 mL fractions 
eluted with 5:1 hexane:EtOAc. The eluent was changed to 1:1 hexane:EtOAc and the next 10 fractions 
combined and evaporated to give 5-methyl-furan-3-one (16, 1.21 g, 10.3%) as a distinct smelling pale 
yellow oil. The identity of the compound was confirmed by 1H NMR analysis which was consistent with 
that reported in the literature [7]. 1H NMR (200 MHz, CDCl3): 
 5.43 (1H, br. s), 4.45 (2H, br. s), 2.19 
(3H, br. s). 13C NMR (50 MHz, CDCl3): 
 203.2, 191.9, 105.1, 75.6, 16.9.
6.3.2    Attempted preparation of 1-(5-Methylfuran-3-yl)pyrrolidine (5d). 
 
To a solution of 5-methyl-furan-3-one (0.5 g, 5.0 mmol) in benzene (40 mL) was added freshly 
distilled pyrrolidine (0.36 g, 5.0 mmol) and molecular sieves (4Å). After stirring overnight at room 
temperature, analysis by GC-MS showed some decomposition but mainly starting materials. Heating to 
reflux for 5 h using a Dean-Stark apparatus led to complete decomposition of the starting materials as 
indicated by GC-MS monitoring. 
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6.4 Preparation of non-chiral 3-furylamines by tandem Michael 
addition/enaminone cyclization. 
 
Product and intermediates were separated and identified by GC-MS using Method 1.
6.4.1 Preparation of THP protected ketoalkynols (18a-c) as Michael acceptors. 
 
Preparation of 3-(tetrahydropyran-2-yloxyprop)-1-yne (17) following methodology by Henbest et al. [8]. 
 
POCl3 (100 mg, 1.21 mmol) was added to a neat mixture of propargyl alcohol (8.4 g, 150 mmol) 
and 3,4-dihydro-2H-pyran (12.6 g, 150 mmol) and stirred whilst cooling in an ice bath until no more heat 
evolved. The ice bath was removed and the mixture stirred at room temperature for a further 2 h. Several 
NaOH pellets were added and the 3-(tetrahydropyran-2-yloxy)prop-1-yne (17) was distilled directly from 
the reaction vessel under vacuum (19 g, 90% yield, b.p. 28°C @ 25 mmHg). 1H NMR (200 MHz, 
CDCl3): 
 4.82 (m, 1H), 4.27 (d, J = 2.4 Hz, 1H), 4.25 (d, J = 2.4 Hz, 1H), 3.84 (m, 1H), 3.56 (m, 1H), 
2.41 (t, J = 2.4 Hz, 1H), 1.85-1.45 (br. m., 6H). 13C NMR (50 MHz, CDCl3): 
 97.0, 79.9, 74.2, 62.2, 
54.2, 30.4, 25.5, 19.2. MS m/z (relative intensity) 140 (M+,1.1), 139 (10.9), 111 (1.0), 101 (5.0), 97 (1.9), 
95 (1.7), 86 (6.4), 85 (100), 84 (3.9), 83 (9.6), 82 (12.9), 81 (9.0), 79 (5.8), 77 (1.2), 71 (1.6), 70 (2.1), 69 
(7.7), 68 (3.6), 67 (10.3), 66 (2.8), 65 (2.1), 58 (1.4), 57 (25.9), 56 (44.1), 55 (29.4), 54 (7.6), 53 (11.9), 
44 (1.7), 43 (10.6), 41 (36.0), 40 (4.3), 39 (39.6), 38 (4.0), 37 (1.5), 31 (4.1). (tR = 15:56 min). 
 
Preparation of 5-(tetrahydropyran-2-yloxy)pent-3-yn-2-one (18a) and 6-(tetrahydropyran-2-yloxy)hex-4-
yn-3-one (18b) under conditions reported by Duranti et al. [9]. 
 
3-(Tetrahydropyran-2-yloxy)prop-1-yne 17 (28 g, 200 mmol) was added drop-wise under inert 
atmosphere to a stirred mixture of sodamide (7.8 g, 200 mmol) in anhydrous ether (150 mL). The 
mixture was refluxed for 5 h. The suspension was diluted with 200 mL anhydrous ether and poured into a 
vigorously stirred solution of acetic anhydride (20.4 g, 200 mmol) in anhydrous ether (300 mL), the 
temperature being kept between –5 and –10°C. The mixture was allowed to reach room temperature and 
the white solid was separated by filtration. The solvent was evaporated under reduced pressure and any 
unreacted materials were removed using a high vacuum oil pump and gentle heating on a water bath 
(60°C). The product 5-(tetrahydropyran-2-yloxy)pent-3-yn-2-one (18a) was obtained as a red oil (25 g, 
Yield 70%). 1H NMR (200 MHz, CDCl3): 
 4.78 (m, 1H), 4.40 (s, 2H), 3.81 (m, 1H), 3.56 (m, 1H), 2.34 
(s, 3H), 1.85-1.45 (br. m., 6H). 13C NMR (50 MHz, CDCl3): 
 184.2, 97.3, 87.9, 85.3, 62.1, 53.9, 32.7, 
30.2, 25.4, 19.0. MS m/z (relative intensity) 182 (M+, 0.6), 181 (4.9), 139 (1.8), 128 (1.8), 127 (24.3), 126 
Chapter 6 
280 
(1.5), 125 (3.6), 124 (5.7), 121 (2.0), 112 (2.2), 109 (6.7), 108 (1.7), 107 (2.0), 102 (2.5), 101 (36.8), 100 
(2.6), 99 (4.2), 98 (3.8), 97 (3.5), 96 (1.3), 95 (8.6), 93 (2.3), 91 (1.2), 86 (6.4), 85 (100), 84 (6.2), 83 
(27.9), 82 (89.6), 81 (23.7), 79 (3.2), 77 (1.8), 71 (4.8), 70 (1.8), 69 (6.1), 68 (3.4), 67 (20.5), 66 (21.1), 
65 (2.3), 63 (1.3), 59 (1.0), 58 (1.2), 57 (20.8), 56 (40.5), 55 (49.2), 54 (6.4), 53 (67.6), 52 (4.4), 51 (6.7), 
50 (3.6), 45 (1.6), 44 (4.9), 43 (85.4), 42 (10.5), 41 (51.3), 40 (3.8), 39 (23.1), 38 (7.9), 37 (1.8), 31 (7.5). 
(tR = 21:91 min). 
 
The same method as outlined above was used to produce 6-(tetrahydropyran-2-yloxy)hex-4-yn-
3-one (18b) using propanoic anhydride. 1H NMR (200 MHz, CDCl3): 
 4.78 (m, 1H), 4.40 (s, 2H), 3.81 
(m, 1H), 3.56 (m, 1H), 2.58 (q, J = 7.4 Hz, 2H), 1.85-1.45 (br. m., 6H), 1.12 (t, J = 7.4 Hz, 3H). 13C
NMR (50 MHz, CDCl3): 
 188.1, 97.3, 88.1, 84.8, 62.2, 54.0, 38.8, 30.2, 25.4, 19.0, 8.0. 
 
Preparation of 4-(tetrahydropyran-2-yloxy)but-2-ynal (18c) using methodology described by Journet et 
al. [10]. 
 
A solution of 17 (7 g, 50 mmol) in dry THF (100 mL) was cooled to –40°C under a dry nitrogen 
atmosphere. n-BuLi (32 mL, 50 mmol, 1.6 M in hexane) was then added dropwise and the solution 
stirred at between  –30°C and –40°C for 30 min. Anhydrous DMF (7.8 mL, 100 mmol) was added at 
once and the solution allowed to warm to room temperature. Stirring was continued at room temperature 
for an additional 30 min, and the solution was then poured into a vigorously stirred biphasic solution of 
KH2PO4 (250 mL, 10% aq.) and Et2O (200 mL) at 5°C. The organic layer was separated and the aqueous 
layer extracted with Et2O (2 x 75 mL). The combined organic phases were dried, filtered and 
concentrated to leave a viscous oil which was warmed on a water bath (60°C) under high vacuum to 
remove starting materials. 4-(Tetrahydropyran-2-yloxy)but-2-ynal (18c) was obtained as a yellow oil (7.1 
g, Yield 84%) and used without further purification. 
 
6.4.2   Preparation of the 4-amino-5-(tetrahydropyran-2-yloxy)alkenones (19a-n) by 1,4-
Michael-type addition of amines to the alkynones 18a-c.
Example 1: Preparation of 4-morpholino-5-(tetrahydropyran-2-yloxy)pent-3-en-2-one (19a)
Morpholine (0.24 g, 2.8 mmol), was added dropwise with stirring to neat 5-(tetrahydropyran-2-
yloxy)pent-3-yn-2-one (0.50 g, 2.8 mmol) 18a while cooling in a cold water bath (10°C). The viscous oil 
was then allowed to stir at room temperature for 2 h. Yield of 19a via GCMS was >98%. 1H NMR (200 
MHz, CDCl3): 
 5.29 (d, 1H, J = 11.9 Hz, H-5A), 5.20 (s, 1H, H-3), 4.71 (d, 1H, J = 11.9 Hz, H-5B), 4.68 
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(m, 1H, H-2’), 3.85 (m, 1H, H-6A), 3.73 (t, 4H, J = 5.0 Hz, H-1’’), 3.55 (m, 1H, H-6B), 3.35 (m, 4H, H-
2’’), 2.1 (s, 3H, H-1), 1.9 – 1.4, (m, 6H, H-3’, H-4’, H-5’). 13C NMR (50 MHz, CDCl3): 
 195.9 (C-2), 
158.8 (C-4), 100.0 (C-2’), 98.2 (C-3), 66.6 (C-2’’), 63.5 (C-5), 60.8 (C-6’), 47.0 (C-1’’), 32.3 (C-1), 31.0 
(C-3’), 25.5 (C-5’), 20.2 (C-4’). MS m/z (relative intensity) 269 (M+ 3.1), 210 (3.8), 186 (10.8), 185 
(100), 184 (38.5), 170 (15.4), 169 (16.2), 168 (27.7), 167 (12.3), 166 (3.8), 157 (4.6), 156 (51.5), 154 
(7.7), 152 (15.4), 150 (6.2), 143 (7.7), 142 (89.2), 140 (3.8), 138 (6.9), 137 (4.6), 136 (3.1), 127 (11.5), 
126 (60.0), 124 (9.2), 114 (9.2), 112 (9.2), 110 (9.2), 109 (11.5), 108 (3.8), 98 (4.6), 97 (7.7), 96 (6.9), 92 
(4.6), 86 (16.2), 85 (37.7), 84 (13.1), 83 (8.5), 82 (6.2), 81 (3.8), 80 (3.8), 70 (4.6), 69 (4.6), 68 (6.2), 67 
(14.6), 57 (11.5), 56 (7.7), 55 (14.6), 54 (5.4), 43 (25.4), 42 (5.4), 41 (15.4). (tR = 29:56 min). 
 
Compounds 19a,b,d,f-k were also prepared using the procedure described above and NMR data 
is included in Appendix 6.1. 
 
Example 2: 4-Dibenzylamino-5-(tetrahydropyran-2-yloxy)pent-3-en-2-one (19e). 
 
Dibenzylamine (0.54 g, 2.7 mmol), was added to 18a (0.50 g, 2.8 mmol) 3, and stirred for 45 
min in a warm water bath (70°C). The oil was allowed to stir for an additional 8 h at room temperature 
and yield of 19e via GC-MS and 1H NMR was 97%. The material produced was a dark viscous resin and 
was used directly for further reactions. 1H NMR (200 MHz, CDCl3): 
 7.40 - 7.07 (m, 10H, H-3’’, H-4’’, 
H-5’’), 5.28 (d, 1H, J = 11.5 Hz, H-5A), 5.20 (s, 1H, H-3), 4.87 (d, 1H, J = 11.5 Hz, H-5B), 4.74 (m, 1H, 
H-2’), 4.49 (AB quartet, 4H, J = 5.7 Hz, H-1’’), 3.78 (m, 1H, H-6A), 3.44 (m, 1H, H-6B), 1.95 (s, 3H, H-
1), 1.76 -1.30 (m, 6H, H-3’, H-4’, H-5’). 13C NMR (50 MHz, CDCl3): 
 195.6 (C-2), 158.8 (C-4), 136.7 
(C-2’’), 128.9 (C-4’’), 127.6 (C-3’’), 127.0 (C-5’’), 99.9 (C-2’), 97.8 (C-3), 63.1 (C-5), 61.1 (C-6), 52.8 
(C-1’’), 32.4 (C-1), 30.8 (C-3’), 25.5 (C-5’), 19.9 (C-4’). MS m/z (relative intensity) 379 (M+ 0.5), 336 
(0.5), 296 (2.3), 295 (13.1), 294 (6.2), 288 (4.6), 280 (1.5), 279 (2.3), 278 (5.4), 277 (4.6), 276 (1.5), 262 
(1.5), 252 (3.1), 236 (3.8), 234 (3.1), 232 (1.5), 205 (10.8), 204 (78.5), 189 (1.5), 188 (16.2), 186 (7.7), 
162 (10.8), 160 (1.5), 158 (1.5), 146 (4.6), 144 (5.4), 143 (1.5), 132 (1.5), 117 (2.3), 115 (1.5), 106 (1.5), 
105 (1.5), 104 (2.3), 92 (16.2), 91 (100), 85 (26.2), 67 (3.8), 65 (6.2), 57 (3.8), 55 (2.3), 43 (5.4), 41 
(3.8). 
 
Compound 19c was also prepared using the procedure described above and NMR data is 
included in Appendix 6.1. 
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Example 3: 3-Diethylamino-4-(tetrahydropyran-2-yloxy)but-2-enal (19m). 
 
4-(Tetrahydropyran-2-yloxy) but-2-ynal 18c (0.50 g, 3.0 mmol) was added dropwise over 15 min 
to a solution of diethylamine (0.22 g, 3.0 mmol) in dry THF (40 mL) at 5°C. The solution was allowed to 
reach room temperature and was stirred for an additional 4 h. The solvent was removed under vacuum to 
leave a light yellow oil. Yield of 19m via GC-MS and 1H NMR was 94% and the crude material was 
used in further reactions without purification. 1H NMR (200 MHz, CDCl3): 
 9.62 (d, 1H, J = 8.3 Hz, C-
1), 5.24 (d, 1H, J = 8.3 Hz, H-2), 4.66 (m, 1H, H-2’), 4.58 (s, 2H, H-4), 3.80 (m, 1H, H-6A), 3.53 (m, 1H, 
H-6B), 3.32 (quartet, 4H, J = 7.0 Hz, H-1’’), 1.90 – 1.40 (m, 8H, H-3’, H-4’, H-5’), 1.18 (t, 6H, J = 7.1
Hz, H-2’’). 13C NMR (200 MHz, CDCl3): 
 187.5 (C-1), 159.7 (C-3), 102.8 (C-2’), 98.1 (C-2), 62.7 (C-
4), 59.8 (C-6’), 44.4 (C-1’’), 30.5 (C-3’), 25.4 (C-5’), 19.5 (C-4’), 12.8 (C-2’’). MS m/z (relative 
intensity) 241 (M+ 1.0), 212 (1.0), 208 (1.5), 207 (5.4), 182 (1.5), 158 (3.1), 157 (8.5), 156 (27.7), 147 
(1.5), 142 (4.6), 141 (17.7), 140 (30.0), 139 (3.1), 138 (3.1), 129 (6.2), 128 (75.4), 126 (10.0), 125 (2.3), 
124 (23.1), 122 (7.7), 114 (3.1), 113 (13.1), 112 (52.3), 110 (13.8), 108 (2.3), 105 (1.5), 100 (6.2), 99 
(3.8), 98 (17.7), 97 (6.2), 96 (13.8), 95 (2.3), 94 (3.8), 86 (8.5), 85 (87.7), 84 (33.1), 83 (19.2), 82 (17.7), 
81 (3.8), 80 (3.1), 74 (3.8), 73 (10.0), 72 (19.2), 71 (19.2), 70 (55.4), 69 (23.8), 68 (19.2), 67 (27.7), 58 
(20.8), 57 (56.9), 56 (41.5), 55 (43.8), 54 (21.5), 53 (7.7), 45 (3.8), 44 (27.7), 43 (53.8), 42 (64.6), 41 
(100). 
 
Compounds 19l-n were also prepared using the procedure described above and NMR data is included in 
Appendix 6.1. 
 
6.4.3 Cyclisation of 4-amino-5-(tetrahydropyran-2-yloxy)pent-3-en-2-one (19a-n) to 3- 
furylamines. 
 
Example 1: Preparation of 4-(5-methylfuran-3-yl)morpholine (5a). 
 
Anhydrous trifluoroacetic acid (2 mL) was added to 19a (0.50 g, 2.8 mmol) in DCE (20 mL). 
The solution was then stirred for 40 min at room temperature and gradually became deep red. The 
organic layer was extracted with H2O (4 x 50 mL) and the combined aqueous extracts were extracted 
once with chloroform. Crushed ice (100 g) was added to the aqueous layer followed by the rapid addition 
of NaOH (NaOH, 4 M aq.) to pH 14. The chilled aqueous solution was immediately extracted with Et2O
(3 x 75 mL), the combined organic layers were then dried with Na2SO4 and evaporated to leave 5a in 
high purity and yield (0.44 g, Yield 96%). The yellow oil was bulb distilled directly before use in further 
reactions (b.p. 125°C @ 4mmHg) and was a white solid when stored at -10°C. IR (neat) 3140(w), 2960 
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(s), 2918 (s), 2855(s), 2820 (s), 2760 (m), 1755 (m), 1681 (s), 1621 (s), 1555 (m), 1451 (s), 1397 (s), 
1379 (s), 1359 (m), 1332 (m), 1302 (m), 1258 (s), 1228 (m), 1178 (m), 1161 (m) and 1116 cm-1 (s).  1H
NMR (200 MHz, CDCl3): 
 6.82 (s, 1H, H-2’), 5.86 (s, 1H, H-4’), 3.81 (m, 4H, H-2, H-6), 2.87 (m, 4H, 
H-3, H-5), 2.22 (s, 3H, H-6’). 13C NMR (50 MHz, CDCl3): 
 152.5 (C-5’), 141.7 (C-3’), 123.9 (C-2’), 
100.2 (C-4’), 66.6 (C-2, C-6), 50.8 (C-3, C-5), 14.0 (C-6’). MS m/z (relative intensity) 169 (18.5), 168 
(56.2), 167 (M+ 77.9), 166 (5.6), 154 (3.2), 153 (7.6), 152 (12.0), 139 (4.4), 138 (10.4), 137 (6.4), 136 
(8.4), 125 (3.2), 124 (8.4), 122 (8.0), 112 (7.2), 111 (33.7), 110 (83.1), 109 (100), 108 (12.0), 97 (2.4), 96 
(4.0), 95 (4.0), 94 (6.4), 84 (4.0), 83 (4.0), 82 (10.8), 81 (15.3), 80 (16.1), 79 (4.0), 73 (2.8), 72 (2.4), 70 
(4.4), 69 (4.4), 68 (4.0), 67 (6.0), 66 (4.8), 65 (3.2), 59 (2.4), 58 (2.4), 57 (5.2), 56 (4.4), 55 (8.8), 54 
(8.4), 53 (8.4), 52 (3.2), 51 (3.6), 45 (9.2), 44 (49.0), 43 (14.5), 42 (9.6), 41 (17.7).; HRMS calc. for 
C9H14O2N 168.1025, found 168.1019. (tR = 21:00 min) 
 
Cyclisations to give tertiary amine products (5a-e,i,j,l,m) were performed using the above 
procedure. Modifications to this procedure for the cyclisations of secondary amine products (5f,g,h,k,n)
involved using CHCl3 in place of DCE to provide superior yields. Spectroscopic data of 5a-n is included 
in Appendix 6.1 with NMR, GC-MS, HR-ESIMS and IR characterization listed. The secondary 3-
furylamines were only stable for short periods in Et2O and required derivatization by acetylation to the 
amides 21.
6.4.4 Derivatisation of Secondary 3-furylamines (5f,g,h,k,n). 
 
Example: Preparation of N-(n-Butyl)-N-(5-methylfuran-3-yl)acetamide (21g)
Crude N-(n-butyl)-5-methylfuran-3-amine (5g) cyclised material was immediately dissolved in 
dry Et2O (50 mL per 0.5 g furan) and one equivalent of triethylamine was added. Acetyl chloride (1.1 
eq.) was added and the solution stirred for 1.5 h. The solution was then filtered and evaporated under 
reduced pressure followed by bulb distillation (105°C @ 0.01 mmHg) to give 21g (Yield 84%). N.N’-
ethylenebis[N-(5-methylfuran-3-yl)acetamide] (5f) and N-butyl substituted furylamines 5k,n were 
produced using the same method, however acetyl chloride was substituted for acetic anhydride in the 
production of  N-cyclohexyl-N-(5-methylfuran-2-yl)acetamide (21h) from 5h.
Characterization of the 3-furylamide products (21f,g,h,k,n) are included in Appendix 6.1. 
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6.5    Preparation of chiral 3-furylamines.  
 
Product were separated and identified by GC-MS using Method 2.
6.5.1    Preparation of (S)-benzyl 1-(5-methylfuran-3-yl)pyrrolidine-2-carboxylate (5o). 
 
The proline derived (S)-benzyl pyrrolidine-2-carboxylate 22 [11] was used in the general 
furylamine synthesis as described for 5a in Section 6.4 to yield 5o in 30% isolated yield. This product 
was only characterized by GC-MS analysis. Mass spectrum m/z 286 (3.0), 285 (M+, 14.2), 151 (13.4), 
150 (100), 148 (2.7), 120 (1.0), 108 (5.6), 107 (1.3), 106 (1.5), 93 (1.3), 92 (1.7), 91 (12.4), 90 (0.5), 89 
(0.6), 81 (1.3), 80 (1.9), 79 (1.3), 78 (0.9), 77 (1.8), 68 (1.1), 67 (1.5), 66 (1.3), 65 (3.7), 55 (1.5), 54 
(1.3), 53 (3.3), 52 (1.0), 51 (1.3), 43 (2.6), 41 (1.9), 39 (1.9). (tR = 18:87 min) 
 
6.5.2    Preparation of (1S,2S)-2-(N-methyl-N-(5-methylfuran-3-yl)amino)-1-phenylpropan-1-
ol (5p).
Preparation of 1-((2R/S,4S,5S)-3’,4’-dimethyl-5’-phenyl-2’-((tetrahydro-2H-pyran-2’’-
yloxy)methyl)oxazolidin-2-yl)propan-2-one (19p). 
 
Free base (1S,2S)-pseudoephedrine (1.62 g, 9.8 mmol) in warm (40-55°C) dry THF (15 mL) was 
added quickly with stirring to neat 18a (1.95 g, 10.7 mmol) and allowed to stir at room temperature for 4 
h or until the Michael addition was complete as monitored by GC-MS. The THF was removed under 
vacuum to leave 19p as a viscous yellow resin. Yield via GC-MS was 99%. The crude reaction material 
was used without further purification. 1H NMR (300 MHz, CDCl3): 
 7.50-7.25 (m, 5H), 7.50-7.25 (m, 
5H), 4.67 (s, 1H), 4.67 (s, 1H), 4.44 (d, 1H, J = 8.7 Hz), 4.44 (d, 1H, J = 8.7 Hz), 4.02 (d, 1H, J = 10.6
Hz), 3.97 (d, 1H, J = 10.6 Hz), 3.87 (m, 1H), 3.87 (m, 1H), 3.56 (m, 1H), 3.56 (m, 1H), 3.57 (d, 1H, J1 =
10.6 Hz), 3.49 (d, 1H, J = 10.6 Hz), 2.95-2.75 (m, 2H), 2.95-2.75 (m, 2H), 2.46 (s, 3H), 2.44 (s, 3H), 
2.29 (s, 3H), 2.27 (s, 3H), 1.90-1.47 (m, 6H), 1.90-1.47 (m, 6H), 1.06 (d, 3H, J = 6.0 Hz), 1.06 (d, 3H, J
= 6.0 Hz). 13C NMR (75 MHz, CDCl3): 
 207.4, 207.3, 139.6, 139.6, 128.4, 128.4, 128.2, 128.2, 127.0, 
127.0, 99.5, 99.5, 96.4, 96.4, 85.9, 85.8, 72.6, 72.1, 70.4, 69.9, 65.2, 65.2, 62.3, 62.1, 46.5, 46.0, 49.8, 
49.7, 32.3, 32.3, 32.2, 32.1, 30.7, 30.7, 25.6, 25.6, 19.4, 19.3, 15.1, 14.9. Mass spectrum m/z 347 (M+,
0.1), 346 (0.1), 290 (3.0), 246 (2.3), 234 (1.6), 233 (16.7), 232 (100.0), 207 (1.0), 205 (13.5), 190 (1.0), 
188 (1.5), 174 (5.6), 160 (0.4), 149 (9.3), 148 (93.0), 147 (4.8), 146 (3.2), 144 (1.6), 133 (6.3), 132 (3.2), 
131 (4.0), 119 (1.2), 118 (26.9), 117 (19.0), 116 (1.2), 115  (5.1), 114 (2.4), 105 (4.0), 91 (11.9), 85 
(19.8), 76 (2.4), 67 (3.2), 58 (5.6), 57 (7.9), 56 (17.5), 55 (6.3), 43 (27.8). (tR = 23:63 min) 
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Signals for the enamine form of 19p, methyl 5-(N-((1S,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-
methylamino)-1-methyl-7-oxa-bicyclo[2.2.1]hept-5-ene-2-carboxylate, were not observed. 
 
The (1R,2S)-ephedrine isomer was used to prepare 1-((2R/S,4S,5R)-3’,4’-dimethyl-5’-phenyl-2’-
((tetrahydro-2H-pyran-2’’-yloxy)methyl)oxazolidin-2-yl)propan-2-one 19q following the same 
procedure. Major ions in GC-MS fragmentation were identical to 19p and 1H NMR spectra showed 
broadened indistinguishable signals due to a mixture of diastereoisomers (Appendix 2.10) and 
equilibration to the enamine form methyl 5-(N-((1R,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-
methylamino)-1-methyl-7-oxa-bicyclo[2.2.1]hept-5-ene-2-carboxylate. The GC-MS trace of 19q is 
shown in Chapter 2, Figure 2.16. Mass spectrum m/z 347 (M+, 0.1), 290 (1.0), 246 (1.0), 234 (1.6), 233 
(16.7), 232 (93.7), 207 (1.0), 206 (2.4), 205 (13.5), 204 (1.6), 190 (1.0), 189 (2.4), 188 (1.5), 176 (1.0), 
174 (5.6), 160 (1.0), 149 (10.3), 148 (100), 147 (4.8), 146 (3.2), 144 (1.6), 133 (6.3), 132 (3.2), 131 (4.0), 
130 (1.6), 119 (3.2), 118 (34.9), 117 (19.0), 116 (3.2), 115  (7.1), 114 (2.4), 105 (4.0), 103 (2.4), 91 
(11.9), 85 (19.8), 81 (1.6), 79 (1.6), 78 (2.4). (tR = 23:56 min). 
 
Preparation of (1S,2S)-2-(N-methyl-N-(5-methylfuran-3-yl)amino)-1-phenylpropan-1-ol (5p). 
 
Freshly prepared 19p was dissolved in DCE (135 mL). Anhydrous trifluoroacetic acid (5 mL) 
was added in one portion and the solution stirred at ambient temperature for 40 min upon which time the 
solution had become dark red in color. The solution was then poured into a mixture of NaOH (100 mL, 5 
M aq.) and ice (300 g) and immediately shaken vigorously in a separating funnel. The organic layer was 
separated and the aqueous layer extracted with DCM (3 x 100 mL). The combined organic layers contain 
N,5-dimethyl-N-((1S,2S)-1-phenyl-1-(tetrahydro-2H-pyran-2-yloxy)propan-2-yl)furan-3-amine (5p-
THP) and require deprotection. Removal of the THP- group: The combined organic layers containing 
5p-THP were evaporated and the residue was re-dissolved in ethanol (200 mL). p-Toluene sulphonic 
acid (4.0 g, 23.3 mmol) was added in one portion and the solution stirred for 4 h at 60°C. The ethanol 
was then evaporated under vacuum and the residue dissolved in HCl (250mL, 1 M aq.). The aqueous 
solution was extracted with DCM (3 x 150 mL), and the organic layers re-extracted with HCl (3 x 100 
mL, 1M aq.). The combined aqueous phases were extracted once more with DCM (50 mL) and ice 
(200g) was added to chill the solution to 5°C. The solution was then basified with ice cold NaOH (3 M 
aq.) to pH 14, followed by a final extraction with DCM (4 x 100 mL). The organic phases were 
combined and upon evaporation 5p was obtained as a viscous, dark-yellow oil (2.26g, 94% overall yield 
calculated from pseudoephedrine, >97% pure GCMS). Discolouration and impurities of (1S,2S)-
pseudoephedrine were removed by dissolving the material in Et2O and rapidly eluting the solution 
through short silica column deactivated with triethylamine. 1H NMR (300 MHz; CDCl3) 
 7.45-7.25 (5H, 
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m, H-2’, H-3’, H-4’, H-5’, H-6’), 6.87 (1H, s, H-2’’), 5.94 (1H, s, H-4’’), 4.46 (1H, d, J = 9.6 Hz, H-1), 
3.48 (1H, s, OH), 3.26 (1H, dq, J1 = 6.6 Hz, J2 = 9.6 Hz, H-2), 2.60 (3H, s, NCH3), 2.24 (3H, s, H-6’’), 
0.81 (3H, d, J = 6.6 Hz, H-3). 13C NMR (75 MHz; CDCl3) 
 152.5 (C-5’’), 141.5 (C-1’), 140.9 (C-3’’), 
128.6 (C-3’, C-5’), 128.2 (C-4’), 127.5 (C-2’, C-6’), 125.5 (C-2’’), 101.3 (C-4’’), 75.1 (C-1), 64.8 (C-2), 
33.0 (NCH3), 14.1 (C-6’’), 10.0 (C-3). Mass spectrum m/z 245 (M+ 1.0), 184 (1.0), 139 (11.1), 138 (100), 
124 (1.6), 123 (2.4), 122 (1.6), 120 (1.6), 108 (4.0), 105 (1.6), 97 (3.2), 96 (8.7), 95 (3.2), 94 (6.3), 91 
(2.4), 82 (1.6), 81 (4.0), 80 (3.2), 77 (8.7), 68 (2.4), 67 (1.6), 66 (1.6), 57 (1.6), 56 (2.4), 55 (1.6), 53 
(3.2), 51 (4.0), 43 (7.9), 42 (11.9). (tR = 21:14 min). 
 
The ephedrine stereoisomer (1R,2S)-2-(N-methyl-N-(5-methylfuran-3-yl) 5q was prepared in 
>98% yield following an identical procedure from 19q. 1H NMR (300 MHz; CDCl3) 
 7.45-7.25 (5H, m, 
H-2’, H-3’, H-4’, H-5’, H-6’), 6.86 (1H, s, H-2’’), 5.93 (1H, s, H-4’’), 4.45 (1H, d, J = 9.7 Hz, H-1), 4.04 
(1H, s, OH), 3.26 (1H, dq, J1 = 6.5 Hz, J2 = 9.7 Hz, H-2), 2.60 (3H, s, NCH3), 2.24 (3H, s, H-6’’), 0.81 
(3H, d, J = 6.5 Hz, H-3). 13C NMR (75 MHz; CDCl3) 
 152.4 (C-5’’), 141.5 (C-1’), 140.7 (C-3’’), 128.5 
(C-3’, C-5’), 128.1 (C-4’), 127.5 (C-2’, C-6’), 125.5 (C-2’’), 101.2 (C-4’’), 75.1 (C-1), 64.7 (C-2), 32.9 
(NCH3), 14.0 (C-6’’), 9.9 (C-3). (tR = 21:31 min). 
 
6.6    Diels-Alder reactions of 3-furylamines 
Product were separated and identified by GC-MS using Method 2 unless otherwise specified. 
6.6.1   Diels-Alder reactions in organic solvents; Preparation of (1R,2R,4R)/(1S,2S,4S)-methyl 
1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate (4a). 
 
Procedure 1: To 5a (200 mg, 1.2 mmol) in toluene (10 mL) was added MAC (310 mg, 36 mmol) 
and the solution heated to 110°C for 8 h. The solution was then evaporated under vacuum and re-
dissolved in DCM (20 mL) followed washing with brine and the combined aqueous phases were re-
extracted with DCM (2 x 10 mL). All organic phases were recombined and dried over Na2SO4, then 
evaporated to leave a dark resin (65 mg) consisting of 85% 1-methyl-5-(5-methyl-3-morpholin-4-yl-
furan-2-yl)-5-morpholin-4-yl-7-oxa-bicyclo[2.2.1]heptane-2-carboxylic acid methyl ester 26 by GC-MS 
analysis. 1H NMR (300 MHz; CDCl3) 
 6.06 (1H, s, H-4’), 5.28 (1H, d, J = 5.9 Hz, H-4), 3.74 (3H, s, H-
10), 3.71 (4H, m, H-2’’, 6’’), 3.64 (4H, m, H-2’’’, H-6’’’), 3.21 (1H, d, J = 12.5 Hz, H-2), 2.76 (4H, m, 
H-5’’, H-3’’), 2.64 (1H, d, J = 13.2 Hz, H-6A), 2.38 (2H, m, 5A’’’, 3A’’’), 2.23 (2H, m, 5B’’’, 3B’’’), 2.22 
(1H, m, H-3A), 2.20 (3H, s, H6’), 1.76 (1H, d, J = 13.2 Hz, H-6B), 1.56 (1H, dd, J1 = 12.5 Hz, J2 = 5.9
Hz, H-3B), 1.43 (3H, s, H-9). 13C NMR (75 MHz; CDCl3) 
 175.5 (C-7), 149.7 (C-2’), 144.2 (C-5’), 
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137.1 (C-3’), 102.2 (C-4’), 86.9 (C-1), 79.8 (C-4), 71.3 (C-5), 67.5 (C-5’’, C-3’’), 67.3 (C-5’’’, C-3’’’), 
54.4 (C-2’’, C-6’’), 51.7 (C-10), 49.9 (C-2’’’, C-6’’’), 43.6 (C-2), 36.3 (C-6), 24.5 (C-3), 17.9 (C- 6’), 
14.1 (C-9). Mass spectrum m/z M+ not observed, 252 (1.0), 249 (1.5), 248 (13.5), 247 (82.1), 233 (1.0), 
232 (6.4), 230 (1.0), 218 (2.5), 216 (5.7), 204 (16.8), 202 (9.5),190 (12.5), 189 (42.2), 188 (12.0), 187 
(2.1), 180 (3.5), 176 (6.8), 175 (24.7), 174 (100), 171 (4.5), 167 (2.1), 162 (8.0), 160 (12.8), 148 (11.6), 
147 (42.4), 146 (33.9), 132 (7.5), 119(10.7), 109 (14.0), 91 (11.5), 79 (11.1), 77 (14.5), 65 (14.7), 53 
(27.5), 52 (10.1), 51 (13.4), 43 (80.0), 41 (11.9), 39 (19.2).  
 
Procedure 2: Freshly distilled 4-(5-methylfuran-3-yl)morpholine 5a (200 mg, 1.2 mmol) was 
added to DCM (10mL) at ambient temperature, followed by MAC (210 mg, 2.4 mmol). The solution was 
allowed to stir at room temperature for 8hr then DCM (30 mL) was added and the reaction mixture 
vigorously shaken with HCl (0.5M, 3 x 20 mL). The aqueous acidic layers were re-extracted with DCM 
(2 x 20 mL) and the combined organic phases dried with Na2SO4 and evaporated to leave methyl 1-
methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate 4a:4b as a 4:1 mixture of diastereomers (205 
mg, combined yield 93%). The 4a diastereoisomer was purifed by column chromatography using 10:1 
pentane:ethylacetate. (4a, endo Rf = 0.38; 4b, exo Rf = 0.12). Endo-(1R,2R,4R)/(1S,2S,4S)-methyl 1-
methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate (4a). Pale yellow oil. IR (neat)/cm-1 2956w, 
1767s, 1733s, 1438w, 1388w, 1353w, 1320w, 1252w, 1203m, 1178m, 1149w, 1052w. 1H NMR (300 
MHz, CDCl3): 
 4.37 (d, 1H, J = 6.6 Hz, broad, H-4), 3.72 (s, 1H, H-10), 2.88 (ddd, 1H, J1 = 11.4 Hz, J2
= 5.4 Hz, J3 = 2.1 Hz, H-2), 2.39 (d, 1H, J = 17.8 Hz, H-6A), 2.33 (ddd, 1H, J1 = 13.4 Hz, J2 = 6.6 Hz, 
J3 = 5.4 Hz H-3A), 2.17 (apparent d, 1H, J = 18.4 Hz, H-6B), 2.16 (dd, 1H, J1 = 13.4 Hz, J2 = 5.4 Hz, H-
3B), 1.7 (s, 3H, H-9). 13C NMR (75 MHz, CDCl3): 
 210.3 (C-5), 172.2 (C-8), 86.0 (C-1), 81.4 (C-4), 
52.5 (C-10), 51.0 (C-2), 46.0 (C-6), 30.9 (C-3), 21.5 (C-9). Mass Spectrum m/z 184 (M+ 6.3), 156 (7.9), 
153 (14.3), 152 (12.7), 141 (1.6), 140 (7.1), 138 (11.1), 128 (13.5), 127 (4.0), 125 (3.2), 124 (12.7), 115 
(1.6), 114 (11.7), 113 (42.1), 112 (6.3), 111 (41.3), 110 (7.9), 109 (4.0), 100 (2.4), 99 (15.9), 98 (100), 97 
(24.6), 96 (27.0), 95 (18.3), 87 (9.5), 86 (2.4), 85 (9.5), 84 (4.0), 83 (46.0), 82 (17.5), 81 (14.3), 80 (4.8), 
79 (7.9), 73 (7.9), 72 (1.6), 71 (9.5), 70 (6.3), 69 (50.8), 68 (37.3), 67 (30.2), 65 (1.6), 59 (23.8), 58 (5.6), 
57 (3.2), 56 (3.2), 55 (51.6), 54 (6.3), 53 (22.2), 52 (3.2), 51 (5.6), 50 (2.4), 45 (4.8), 44 (3.2), 43 (84.1). 
(tR = 11:19 min) 
 
Chapter 6 
288 
6.6.2    Diels-Alder reactions in aqueous media; Preparation of (1R,2S,4R)/(1S,2R,4S)-methyl 
1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate (4b). 
 
General procedure for the Diels-Alder reaction of 3-furylamines in aqueous media 
 
Method 1: Freshly distilled 5a (100 mg, 0.60 mmol) was added to distilled water (20 mL) at 
ambient temperature, followed by MAC (78 mg, 0.91 mmol). The solution was allowed to stir at room 
temperature for 2 h and was then extracted with DCM (3 x 100 mL). The organic extracts were washed 
with HCl (0.5M, 3 x 20 mL) and the aqueous phases were re-extracted with DCM (2 x 10 mL). The 
combined organic layers were dried with MgSO4 and evaporated to leave a 2.5:1 mixture of 4a:4b 
diastereomers (127 mg, yield 84%). 
 
Method 2: Freshly distilled N,N-diisopropyl-5-methylfuran-3-amine 5c (100 mg, 0.55 mmol) was 
added to a 3 M solution of LiCl (20 mL) at ambient temperature, followed by MAC (71 mg, 0.83 mmol). 
The solution was allowed to stir at room temperature for 2 h then extracted with DCM (3 x 40 mL). The 
combined organic extracts were washed with HCl (0.5 M, 2 x 20 mL), dried with MgSO4 and evaporated 
to leave exo-(1R,2S,4R)/(1S,2R,4S)-methyl 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate 
(4b) as the major product in a 2:1 mixture with 4a (93 mg, combined yield 91%, d.r. 1:2). The ketone 4b
was separated by column chromatography using 10:1 pentane:ethylacetate, (4a, endo Rf = 0.38; 4b, exo 
Rf = 0.12) and formed white needle like crystals upon crystallization in Et2O, whereas the 4a compound 
was a pale yellow oil at room temperature. Exo-(1R,2S,4R)/(1S,2R,4S)-methyl 1-methyl-5-oxo-7-oxa-
bicyclo[2.2.1]heptane-2-carboxylate (4b). White crystalline solid, m.p. 104 – 105°C. IR (KBr disk)/cm-1 
3033m, 2961w, 1762s, 1731s, 1441m, 1431m, 1392s, 1362s, 1253m, 1222m, 1199s, 1171s, 1148m, 
1077w, 1038m, 1006s. 1H NMR (300 MHz; CDCl3) 
 4.47 (1H, d, J = 6.4 Hz, H-4), 3.73 (3H, s, H-10), 
2.80 (1H, dd, J1 = 8.7 Hz, J2 = 5.1 Hz, H-2), 2.52 (1H, apparent dt, J1 = 13.4 Hz, J2 = 5.9 Hz, H-3A), 
2.25 (2H, m, AB quartet, H-6), 1.94 (1H, dd, J1 = 13.4 Hz, J2 = 8.7 Hz, H-3B), 1.55 (3H, s, H-9). 13C
NMR (75 MHz; CDCl3) 
 211.0 (C-5), 173.0 (C-8), 86.3 (C-1), 80.7 (C-4), 52.3 (C-10), 50.5 (C-6), 49.4 
(C-2), 30.7 (C-3), 19.3 (C-9). Mass Spectrum m/z 185 (1.6), 184 (M+ 9.5), 157 (3.2), 156 (17.5), 154 
(2.4), 153 (27.8), 152 (15.9), 141 (7.1), 140 (14.3), 139 (1.6), 138 (22.2), 129 (1.6), 128 (27.0), 127 (7.9), 
125 (3.2), 124 (27.0), 123 (3.2), 115 (1.6), 114 (18.3), 113 (65.1), 111 (59.5), 110 (6.3), 109 (4.8), 100 
(1.6), 99 (15.9), 98 (98.4), 97 (39.7), 96 (41.3), 95 (17.5), 87 (10.3), 86 (3.2), 85 (11.1), 84 (5.6), 83 
(66.7), 82 (23.0), 81 (21.4), 80 (9.5), 79 (11.9), 78 (3.2), 77 (2.4), 73 (11.1), 72 (3.2), 71 (7.9), 70 (4.8), 
69 (68.3), 68 (44.4), 67 (51.6), 66 (2.4), 65 (5.6), 59 (30.2), 58 (5.6), 57 (4.0), 56 (6.3), 55 (63.5), 54 
(8.7), 53 (18.3), 52 (3.2), 51 (6.3), 50 (3.2), 45 (6.3), 44 (11.1), 43 (100), 42 (19.0), 41 (85.7). HRMS 
calc. for C9H12O4Na[M]+· 207.0633. Found 207.0631. (tR = 11:35 min) 
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Crystal Data for 4b.
Empirical Formula   C9H12O4
Formula Weight (g/mol)  184.19 
Melting Point (oC)   104-105 
Crystal Colour    Colourless 
Crystal Description   Block 
Crystal Class    Triclinic 
Space Group    P-1 
a(Å)     7.2235(10) 
b(Å)     8.1158(11) 
c(Å)     8.3058(12) 
(o) 75.273(2) 
(o) 74.540(3) 
(o) 86.114(2) 
Density (g/m3) 1.348
Crystal Size (mm)   0.50, 0.15, 0.10 
Volume (Å3) 453.89
Z 2
µ(mm-1) 0.106
F(000), e    196 
t range, o 2.59-25.0 
Index ranges    -8 < h < 8, -9 < k < 9, -6 < l < 9
Reflections collected/unique  2428/1583 [R(int)=0.0587] 
Data/restraints/parameters  1583/0/121 
Goodness of fit on F2 1.029 
Final R indices [I>2(I)]  R1 = 0.0529, wR2 = 0.1351
R indices (all data)   R1 = 0.0605, wR2 = 0.1414
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6.6.3 General procedure for the Diels-Alder reaction of 3-furylamines in ionic liquid 
DIMCARB. 
 
Freshly distilled N,N-diisopropyl-5-methylfuran-3-amine 5c (100 mg, 0.55 mmol) was dissolved 
in DIMCARB (10 mL) then MAC (78 mg, 0.91 mmol) was added in one portion. The solution was 
allowed to stir at room temperature for 1 h, evaporated and then re-dissolved in DCM (30 mL). The 
organic solution was washed with HCl (0.5M, 3 x 20 mL) and the aqueous phases were re-extracted with 
DCM (2 x 10 mL). The combined organic layers were dried with MgSO4 and evaporated to leave a 3:7 
ratio of 4a:4b (135 mg, yield 95%).  
 
6.6.4 General procedure for the Diels-Alder reaction ephedrine derived furans (5p and 5q)
in DCM.  
 
Example: Diels-Alder reaction of (1S,2S)-2-(N-methyl-N-(5-methylfuran-3-yl)amino)-1-phenylpropan-1-
ol (5p) with MAC in DCM. 
 
The furan 5p (150 mg, 0.61 mmol) was dissolved in DCM (20 mL) and cooled to –78°C. MAC 
(210 mg, 2.45 mmol) was then added and the solution was allowed to warm to –50°C where it was kept 
for 2 h, then gradually warmed to room temperature and stirred overnight. Evaporation of the solvent and 
excess MAC under vacuum gave diastereomers of optically enriched endo-(1S,4S,5S)/(1R,4R,5R)-methyl 
3’,4,4’S-trimethyl-5’S-phenylspiro[7-oxa-bicyclo[2.2.1]heptane-2,2’-[1,3]oxazolidine]-5-carboxylate 
(28-endo) as a viscous red semisolid (196 mg, Yield >97%, endo:exo d.r. >99:1). 1H NMR (300 MHz, 
CDCl3): 
 7.40-7.22 (5H, m, arom., H-2’’, H-3’’, H-4’’, H-5’’, H-6’’), 
4.60 (1H, d, J = 9.1 Hz, H-5’), 
4.54 (1H, d, J = 6.2 Hz, H-1), 3.73 (3H, s, H-10), 3.05 (1H, dq, J1 = 6.7 Hz, J2 = 9.1 Hz, H-4’), 2.70 
(1H, ddd, J = 11.4 Hz, J = 5.7 Hz, J = 1.9 Hz, H-5), 2.55 (1H, m, H-6A), 2.46 (3H, s, NCH3), 2.43 (1H, 
m, H-3A), 2.04 (1H, ddd, J = 11.4 Hz, J = 6.2 Hz, J = 5.7 Hz, H-6B), 1.85 (1H, d, broad, J = 14.4 Hz, H-
3B), 1.64 (3H, s, H-9), 1.26 (3H, d, J = 6.7 Hz, H-6’). 13C NMR (300 MHz, CDCl3): 
 173.2 (C-8), 140.9 
(C-1’’), 128.6 (C-5’’, C-3’’), 127.5 (C-6’’, C-2’’), 126.0 (C-4’’), 108.8 (C-2/2’), 85.3 (C-4), 83.1 (C-1), 
81.8 (C-5’), 67.1 (C-4’), 52.1 (C-10), 51.8 (C-5), 41.7 (C-3), 33.9 (NCH3), 29.8 (C-6), 21.0 (C-9), 13.9 
(C-6’). EI-MS (relative intensity) 331 (M+ 3.5), 301 (2.0), 300 (9.2), 290 (2.4), 289 (20.8), 288 (100), 
273 (2.1), 272 (12.3), 261 (1.3), 260 (2.7), 257 (1.1), 256 (4.7), 246 (1.0), 245 (4.3), 244 (1.3), 228 (1.8), 
217 (1.6), 216 (5.5), 205 (1.3), 204 (7.8), 203 (1.1), 202 (5.8), 197 (2.0), 189 (5.5), 174 (2.4), 154 (1.0), 
149 (7.4), 148 (68.7), 147 (3.3), 146 (3.9), 145 (1.1), 144 (1.2), 141 (11.8), 138 (2.6), 133 (4.7), 132 
(2.7), 131 (4.9), 130 (2.2), 129 (1.1), 127 (1.0), 124 (1.0), 123 (1.2), 119 (3.2), 118 (34.0), 117 (27.2), 
116 (3.7), 115 (8.9), 113 (4.6), 111 (1.2), 110 (2.6), 109 (10.7), 108 (1.4), 107 (1.0), 105 (4.5), 104 (1.3), 
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103 (3.6), 98 (1.4), 97 (2.4), 96 (1.7), 95 (4.7), 94 (1.1), 92 (1.7), 91 (14.3), 90 (1.3), 89 (2.3), 85 (2.3), 
83 (2.3), 82 (3.2), 80 (1.0), 79 (4.0), 78 (2.5), 77 (6.8), 73 (1.0), 71 (1.4), 70 (1.5), 69 (7.4), 68 (3.1), 67 
(5.2), 65 (4.1), 63 (1.3), 59 (4.4), 58 (4.6), 57 (1.9), 56 (14.7), 55 (10.3), 54 (1.5), 53 (4.4), 51 (2.2), 45 
(1.0), 44 (1.8), 43 (11.4), 42 (11.0), 41 (13.3), 40 (1.6), 39 (5.5), 32 (1.5), 30 (1.2). HRESI calc. for 
C19H26NO4 332.1862, found 332.1855. (tR = 16:27 min). (28-exo, tR = 16:59 min). 
 
Signals for the enamine methyl 5-(N-((1S,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-methylamino)-
1-methyl-7-oxa-bicyclo[2.2.1]hept-5-ene-2-carboxylate (28-int) were not observed. 
 
An identical procedure was used for the reaction of 5q in DCM to prepare a mixture of 
diastereoisomers of (1S,4S,5S)/(1R,4R,5R)-methyl 3’,4,4’S-trimethyl-5’R-phenylspiro[7-oxa-
bicyclo[2.2.1]heptane-2,2’-[1,3]oxazolidine]-5-carboxylate (30-endo, tR = 20:69 min, Method 1; tR =
16:25 min, Method 2) and (1S,4S,5R)/(1R,4R,5S)- methyl 3’,4,4’S-trimethyl-5’R-phenylspiro[7-oxa-
bicyclo[2.2.1]heptane-2,2’-[1,3]oxazolidine]-5-carboxylate (30-exo, tR = 21:75 min; Method 1; tR =
16:57 min, Method 2) (95% combined yield) in a diastereomeric ratio of 4:1 according to GC-MS 
analysis. EI-MS (relative intensity) 331 (M+ 0.6), 301 (0.7), 300 (3.7), 290 (1.3), 289 (8.4), 288 (44.3), 
273 (0.9), 272 (5.9), 261 (0.5), 260 (1.6), 257 (0.6), 256 (3.7), 246 (0.6), 245 (3.1), 244 (0.9), 228 (1.0), 
217 (1.0), 216 (6.8), 205 (1.3), 204 (7.0), 202 (4.8), 200 (0.6), 197 (2.5), 190 (1.2), 189 (4.9), 176 (1.3), 
174 (3.5), 159 (1.4), 158 (0.9), 149 (12.1), 148 (100), 146 (5.4), 145 (2.2), 144 (1.7), 143 (1.0), 142 (2.9), 
141 (23.5), 139 (0.6), 138 (3.1), 133 (6.4), 132 (4.7), 131 (4.9), 130 (2.2), 129 (1.1), 127 (1.0), 124 (1.0), 
123 (1.2), 119 (3.2), 118 (36.7), 117 (32.2), 116 (6.2), 115 (12.6), 113 (8.2), 111 (2.0), 110 (4.1), 109 
(22.2), 108 (3.7), 107 (2.3), 105 (7.9), 104 (2.0), 103 (5.8), 98 (2.6), 97 (3.8), 96 (3.0), 95 (6.3), 94 (1.9), 
92 (2.1), 91 (20.9), 90 (2.7), 89 (3.5), 85 (2.3), 83 (2.3), 82 (6.2), 80 (1.0), 79 (8.0), 78 (4.5), 77 (10.9), 
73 (1.0), 71 (1.4), 70 (3.5), 69 (12.7), 68 (7.5), 67 (9.2), 65 (6.6), 63 (1.3), 59 (12.6), 58 (10.4), 57 (4.0), 
56 (33.9), 55 (20.8), 54 (3.8), 53 (9.2), 51 (4.2), 45 (2.0), 44 (1.8), 43 (25.4), 42 (23.9), 41 (24.4), 40 
(3.2), 39 (12.8), 32 (1.5), 30 (1.2). HRESI calc. for C19H26NO4 332.1862, found 332.1855.  
 
6.6.5  Confirmation of Absolute Stereochemistry in Diels-Alder Reaction of 5p and 5q.
Preparation of methyl 5-(N-((1S,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-methylamino)-1-methyl-7-oxa-
bicyclo[2.2.1]heptane-2-carboxylate (29) using conditions described by Hutchins et al. [12] 
To glacial acetic acid (35 mL), NaBH4 (0.87 g, 23.0 mmol, crushed pellets) was added portion 
wise with cooling in an ice bath and stirred until the evolution of hydrogen ceased. A solution of 28-endo 
(2.55 g, 77 mmol), (prepared from 5p, Section 6.6.4), in glacial acetic acid (17 mL) was added drop-
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wise, followed by the portion-wise addition of NaBH4 (0.50 g,  13.2 mmol, crushed pellets). After 
stirring for a further 4 h at ambient temperature, the mixture was poured into H2O (200 mL) and carefully 
neutralized with NaHCO3 (saturated aqueous solution). The neutralized solution was extracted with 
DCM (3 x 75 mL) and the combined extracts dried over Na2SO4. Evaporation of under vacuum gave a 
red resin which after bulb distillation (150°C @ 0.1mmHg) yielded (1S,2S,4S,5S)-methyl 5-(N-((1S,2S)-
1-hydroxy-1-phenylpropan-2-yl)-N-methylamino)-1-methyl-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate, 
(1S,2S,4S,5S)-29-endo, as a viscous yellow resin (1.8 g, Yield 70%) in a 10:1 ratio with the 
(1R,2R,4R,5R)-29-endo diastereoisomer. 1H NMR (300 MHz; CDCl3) 
 7.35-7.22 (5H, arom. m, H-2’’, 
H-3’’, H-4’’, H-5’’, H-6’’), 4.40 (1H, dd, , J1 = 5.6 Hz,  J2 = 4.7 Hz, H-4), 4.27 (1H, d, J = 9.6 Hz, H-
1’), 3.78 (3H, s, H-10), 3.12 (1H, m, H-5), 2.78 (1H, m, H-2), 2.76 (1H, m, H-3A), 2.64 (1H, dq, J1 = 9.6
Hz,  J2 = 6.7 Hz , H-2’), 2.10 (3H, s, H-4’), 2.03 (1H, m, H-3B), 1.64 (2H, m, H-6), 1.57 (3H, s, H-9), 
0.66 (3H, d, J = 6.7 Hz, H-3’). 13C NMR (75 MHz; CDCl3) 
 172.7 (C-8), 142.3 (C-1’’), 128.4 (C-5’’, C-
3’’), 127.8 (C-6’’, C-2’’), 127.5 (C-4’’), 87.0 (C-1), 79.4 (C-4), 74.5 (C-1’), 64.9 (C-5), 63.2 (C-2’), 53.3 
(C-2), 52.5 (C-10), 38.3 (C-6), 33.2 (NCH3), 28.0 (C-3), 21.6 (C-9), 7.5 (C-3’). EI-MS (relative intensity) 
333 (M+ not observed), 302 (3.4), 228 (2.5), 227 (21.0), 226 (100), 182 (1.9), 168 (2.0), 166 (1.1), 151 
(2.3), 148 (3.5), 142 (1.0), 141 (1.6), 140 (10.0), 138 (2.0), 137 (5.9), 125 (1.1), 124 (4.1), 123 (2.0), 117 
(1.5), 110 (2.7), 109 (4.0), 108 (1.4), 107 (2.0), 105 (1.8), 98 (1.1), 96 (2.2), 95 (2.0), 94 (1.2), 93 (1.5), 
91 (3.1), 84 (3.9), 83 (1.3), 82 (2.4), 81 (6.1), 79 (4.7), 77 (3.6), 67 (1.2), 59 (1.7), 58 (11.6), 57 (2.0), 56 
(2.0), 55 (2.0), 43 (3.7), 42 (3.3). HRESI calc. for C19H28NO4 334.2018 found 334.2013. 
 
Full 1H NMR characterization of (1R,2R,4R,5R)-29-endo was not obtained and 13C NMR signals 
for this minor diastereoisomer are included here. 13C (75 MHz; CDCl3) 
172.7, 142.3, 128.4, 127.9, 
127.5, 87.1, 78.6, 75.1, 65.1, 63.2, 53.1, 52.2, 38.9, 33.2, 28.7, 21.7, 6.7. 
 
Preparation of (1S,2S,4S,5S)-methyl 5-(N-((1S,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-methylamino)-1-
methyl-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate perchlorate salt (1S,2S,4S,5S)-29.HClO4 [13]. 
 
To the above 10:1 mixture of (1S,2S,4S,5S)-29-endo and (1R,2R,4R,5R)-29-endo (1.0 g, 30.0 
mmol) in dry Et2O was bubbled HCl gas by means of the Kipps generator. A white hygroscopic salt 
precipitated which was quickly filtered and dried in a vacuum dessicator over drying silica. The 
hydrochloride salt was dissolved in acetonitrile (20 mL) and silver perchlorate (620 mg, 30.0 mmol) was 
added as the solution was gently warmed (50°C). After 10 min, the solution was filtered and the salt 
crystallized by slow evaporation of solvent. Recrystallization from hot EtOH gave colourless needles that 
showed only a single diastereoisomer by 13C NMR analysis. One final crystallization was performed 
from MECN by the slow diffusion of Et2O to give pure (1S,2S,4S,5S)-29.HClO4 as colourless plates 
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which were showed only a single diastereomer by 13C NMR analysis. (m.p. 227°C). 1H NMR (300 MHz; 
CD3CN) 
 7.27 (5H, arom. br. s., H-2’’, H-3’’, H-4’’, H-5’’, H-6’’), 4.76 (1H, s, OH), 4.75 (1H, m, H-4), 
4.74 (1H, d, J = 10.1 Hz, H-1’), 3.91 (1H, m, J = 5.3 Hz, H-5), 3.78 (3H, s, H-10), 3.47 (1H, m, H-2’), 
2.95 (1H, apparent t., H-2), 2.87 (3H, s, NCH3), 2.30 (2H, m, H-3), 1.95 (2H, m, H-6), 1.54 (3H, s, H-9), 
1.02 (3H, d, J = 6.8 Hz, H-3’). 13C NMR (75 MHz; CD3CN) 
 174.8 (C-8), 140.1 (C-1’’), 130.0 (C-4’’), 
129.7 (C-3’’, C-5’’), 128.3 (C-2’’, C-6’’), 88.4 (C-1), 77.0 (C-4), 72.5 (C-1’), 67.8 (C-2’), 65.3 (C-5), 
53.5 (C-10), 52.5 (C-2), 35.6 (C-6), 35.1 (NCH3), 30.7 (C-3), 20.8 (C-9), 8.7 (C-3’). 
 
Crystal structure data for 29.HClO4.
Empirical Formula   C19H28ClNO8
Formula Weight (g/mol)  433.87 
Melting Point (oC)   300 (dec.) 
Crystal Colour    Colourless 
Crystal Description   Plates  
Crystal Class    orthorhombic 
Space Group    P212121 
a(Å)     8.511(2) 
b(Å)     15.356(5) 
c(Å)     15.839(3) 
(o) 90.00
(o) 90.00
(o) 90.00
Density (g/m3) 1.392
Crystal Size (mm)   0.20 x 0.10 x 0.02 
Volume (Å3) 2070.1(9) 
Z 4
µ(mm-1) 2.043
F(000), e    920 
t range, o 4.01-64.92 
Index ranges    -1 < h < 9, -18 < k < 0, -1 < l < 18 
Reflections collected/unique  2462/2365 [R(int) = 0.0230] 
Data/restraints/parameters  2365/0/275 
Goodness of fit on F2 1.071 
Final R indices [I>2(I)]  R1 = 0.0496, wR2 = 0.1271
R indices (all data)   R1 = 0.0608, wR2 = 0.1371
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6.6.6 General procedure for the hydrolysis of ephedrine derived oxazolidines (28 and 30). 
 
Example: Preparation of (1S,2S,4S)-methyl 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate 
(1S,2S,4S)-4a.
To a solution of acetic acid (0.5 mL), sodium acetate (3 g), H2O (15 mL) was added 28-endo 
(196 mg, 0.61 mmol), as a mixture of diastereoisomers obtained from 5p (Section 6.6.4), and the solution 
heated with stirring in an oil bath at 70°C. After 2 h the solution was cooled and extracted with DCM (3 
x 75 mL). The ketone endo-(1S,2S,4S) methyl 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-
carboxylate (1S,2S,4S)-4a was purified as a pale yellow oil by flash column chromatography using 
pentane:EtOAc (5:1) (101 mg, Yield 90%, 85% ee, >98% pure GC-MS). 
 
6.6.7 General procedure for the Diels-Alder reaction ephedrine derived furans (5p and 5q)
in H2O. 
 
Example: Diels-Alder reaction of (1S,2R)-2-(N-methyl-N-(5-methylfuran-3-yl)amino)-1-phenylpropan-1-
ol (5q) with MAC in H2O
The furan 5q (100 mg, 0.41 mmol) was added to H2O (10 mL) and irradiated in an ultrasonic 
bath (80% power) maintained between 15-25°C. MAC (157 mg, 1.80 mmol) was added drop-wise over 5 
min and the solution irradiated for a further 95 min. The excess methyl acrylate was removed under high 
vacuum at room temperature and the solution extracted with DCM (3 x 35 mL). The product mixture was 
shown by GC-MS to contain both the ketones 4a-b and diastereomers of optically enriched 30-endo and 
30-exo in a 1:1 ratio and formed as a viscous red semisolid upon evaporation (110 mg, 86%, d.r. 1:1). 
 
An identical procedure was used for the reaction of 5p to prepare 28-endo and 28-exo as a 9:1 
mixture of diastereoisomers (106 mg, 84%, d.r. 9:1).  
 
6.6.8 Preparation of (1S,2R,4S)-methyl 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-
carboxylate (+)-(1S,2S,4S)-4b.
Following the general methodology outlined in Section 6.6.6, a 1:1 mixture of 30-endo:30-exo 
(110 mg) was added to a solution of acetic acid (0.5 mL) and sodium acetate (3.0 g) in H2O (15 mL) with 
heating at 70°C for 2 h. Extraction with DCM (3 x 75 mL) followed by evaporation gave a brown resin 
that was purified by flash column chromatography on SiO2 (pentane:EtOAc, 10:1) to provide (1S,2S,4S)-
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4a (30 mg, 40% yield, 18% ee) and (1S,2R,4S)-4b (31 mg, 41% yield, 60% ee). The optically enhanced 
(1S,2R,4S)-4b was crystallized from Et2O at -18oC until the supernatant solution was enriched to 
enantiomeric purity as indicated by chiral GC-MS. The Et2O was evaporated to dryness to leave optically 
pure (1S,2R,4S)-methyl 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate (1S,2R,4S)-4b (14.5 
mg, >99% ee) []D = + 1.72° (c = 1.45, chloroform) in 19% yield from 5q.
Calculation for the specific optical rotation of (1S,2R,4S)-4b is as follows;  
 
14.5 mg of (1S,2R,4S)-4b was dissolved in 1.0 mL of CHCl3 to provide a solution of c = 1.45 g/100 mL. 
The equation for specific optical rotation according to Hallas [14] is 
cl
T
D ×
=
 100][
and the measured optical rotation at c = 1.45 g/100 mL was stable at +0.025 after 24 measurements at 5 
min intervals. The specific optical rotation is thus calculated as follows, 
 
( ) ,72.1
45.11
025.0100][ 25 +=
×
+×
=D
A sample at half the concentation (14.5 mg in 2.0 mL CHCl3) c = 0.725 g/100 mL was prepared from the 
previous sample and a stable rotation value of + 0.011 was recorded after 23 measurements at 5 min 
intervals. The specific optical rotation is this calculated as follows,  
 
( ) ,52.1
725.01
011.0100][ 25 +=
×
+×
=D
The specific optical rotation was taken as the first measurement conducted at the higher concentration 
due the accumulation of error upon serial dilution to the second concentration and sample transfer 
procedure. The second measurement is simply to confirm the sign of the rotation value, determined to be 
dextrorotatory or (+). 
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6.7 Ether opening reactions of methyl 1-methyl-5-oxo-7-oxa-
bicyclo[2.2.1]heptane-2-carboxylates 4a and 4b.
Product were separated and identified by GC-MS using Method 2 unless otherwise specified.
6.7.1    Acid induced ring opening reactions.  
 
Preparation of methyl 4-acetoxy-2-methylbenzoate from 4b using conditions reported by Ogawa et al. 
[15]. 
 
The ketone 4b (56 mg, 0.30 mmol) was added to a solution of glacial acetic acid (0.52 mL), 
acetic anhydride (0.32 mL) and H2SO4 (conc., 0.034 g). The solution was stirred overnight then poured 
into dH2O (20 mL) and extracted with ethyl acetate (3 x 25 mL). The organic extracts were dried with 
Na2SO4 and evaporated to leave methyl 4-acetoxy-2-methylbenzoate in high purity. (57 mg, Yield 90%, 
91% Match NIST98 library). 1H NMR (300 MHz, CDCl3): 
 7.95 (arom. m, 1H, H-6), 6.99 (m, 2H, H-3, 
H-5), 3.88 (s, 3H, H-10), 2.61 (s, 3H, H-10), 2.30 (s, 3H, H-9). 13C NMR (75 MHz, CDCl3): 
 169.1 (C-
8), 167.4 (C-7), 153.4 (C-4), 142.8 (C-2), 132.5 (C-6), 127.2 (C-1), 124.7 (C-3), 119.1 (C-5), 52.0 (C-
11), 22.1 (C-10), 21.3 (C-9). Mass Spectrum m/z 209 (1.9), 208 (M+, 15.6), 177 (6.8), 167 (8.2), 166 
(74.9), 165 (6.9), 151 (2.1), 149 (1.1), 137 (2.5), 136 (11.1), 135 (100), 134 (33.0), 121 (1.4), 109 (1.2), 
108 (1.7), 107 (12.0), 106 (5.3), 105 (6.3), 89 (1.3), 79 (3.0), 78 (5.9), 77 (14.7), 66 (1.4), 65 (1.3), 63 
(2.6), 53 (1.9), 52 (3.1), 51 (4.5), 50 (1.7), 43 (12.0), 39 (1.8).  
 
6.7.2 Base induced ring opening reactions 
 
Preparation of 3-[(3-t-butyl-dimethyl-silanyloxy)-5-methyl-furan-2-yl]-propionic acid methyl ester (31)
from 4a using condition reported by Le Drain et al. [16]. 
 
To 4a (100 mg, 0.54 mmol) in dry benzene (1.0 mL) under an inert (N2) atmosphere was added 
1.0 mL of a solution of CF3SO3Si(t-Bu)Me2 (0.43 g, 1.63 mmol) and triethylamine (0.21 g, 2.12 mmol, 
NaOH dry) in benzene (1.5 mL) and the solution stirred at ambient temperature for 4 hours. The 
remaining regent in benzene was added and the solution stirred for an additional 2 h before pouring into 
Et2O (15 mL) and washing with HCl (10 mL, 1 M) followed by NaHCO3 (5% aq. solution). The organic 
phase was evaporated under reduced pressure and the resin subject to column chromatography on silica 
gel (5:1 hexane:EtOAc) to afford 31 as a yellow oil (111 mg, 69% yield). 1H NMR (300 MHz, CDCl3): 
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5 .66 (s, 1H, H-4’), 3.70 (s, 3H, H-4), 2.85 (apparent t., J = 8.5 Hz, 2H, H-2), 2.60 (apparent t, J = 8.5
Hz, 2H, H-3), 2.16 (s, 3H, H-6’), 0.96 (s, 9H, H-4’’, H-5’’, H-6’’), 0.14 (s, 6H, H-1’’, H-2’’). 13C NMR 
(75 MHz, CDCl3) : 
173.6 (C-1), 148.2 (C-2’), 138.4 (C-3’), 136.9 (H-5’), 103.2 (H-4’), 51.8 (C-4), 32.8 
(C-2), 25.8 (C-4’’, C-5’’, C-6’’), 20.7 (C-3), 18.2 (C-3’’), 14.2 (C-6’), -4.5 (C-1’’, C-2’’). Mass 
Spectrum m/z 299 (4.0), 298 (M+ 18.3), 283 (1.6), 267 (1.6), 243 (3.2), 242 (10.3), 241 (60.3), 227 (4.8), 
226 (15.1), 225 (81.0), 209 (4.8), 200 (4.8), 199 (19.0), 183 (4.0), 181 (4.8), 169 (9.5), 168 (3.2), 167 
(25.4), 153 (4.8), 151 (3.2), 136 (3.2), 135 (31.7), 132 (3.2), 131 (37.3), 125 (3.2), 123 (3.2), 112 (1.6), 
111 (27.0), 109 (3.2), 107 (4.8), 99 (4.8), 97 (3.2), 95 (1.6), 91 (5.6), 90 (7.9), 89 (98.4), 85 (4.8), 84 
(5.6), 83 (4.8), 77 (4.8), 76 (2.4), 75 (23.8), 74 (9.5), 73 (100), 69 (2.4), 67 (1.6), 61 (3.2), 60 (2.4), 59 
(34.9), 58 (4.8), 57 (6.3), 55 (7.1), 45 (10.3), 43 (18.3). (tR = 13:46 min) 
 
Preparation of methyl 3-(2,3-dihydro-5-methyl-3-oxofuran-2-yl)propanoate (32) from 4a using 
conditions reported by Takahashi et al. [17]. 
 
A solution of 4a (100 mg, 0.54 mmol) in dry THF (2.5 mL) under an inert (N2) atmosphere was 
cooled to -78°C in a dry ice/acetone bath. LHMDS (1.35 mmol, 1.35 mL, 1 M in THF) was then added 
dropwise and the solution stirred at -50°C for 1.5 hours. An additional volume of LHMDS (0.95 mmol, 
0.95 mL, 1 M in THF) was added and the solution stirred at -45°C for 30 min. The mixture was then 
quenched with ammonium chloride (saturated solution), and extracted with DCM (3 x 20 mL). The 
combined organic layers were evaporated and the product was subject to column chromatography on 
silica gel column (2cm diam., 20 mL length) using 5:3 pentane:EtOAc. 20 mL fractions were collected 
and fractions 14 to 17 contained pure 32. (63 mg, Yield 63%). 1H NMR (300 MHz, CDCl3): 
 5.44 (s, 
1H, H-4’), 4.49 (dd, J1 = 4.9 Hz, J2 = 7.7 Hz, 1H, H-2’), 3.67 (s, 3H, H-4), 2.46 (m, 2H, H-2), 2.27 (m, 
1H, H-3A), 2.23 (s, 3H, H-6’), 2.02 (apparent sextet, J = 7.7 Hz, 1H, H-3B). 13C NMR (75 MHz, CDCl3): 

 204.3 (s, C-3’), 190.5 (s, C-5’), 173.1 (s, C-1), 104.6 (d, C-4’), 85.0 (d, C-2’), 52.0 (q, C-4), 29.2 (t, C-
2), 26.4 (t, C-3), 17.0 (q, C-6’). Mass Spectrum m/z 185 (3.2), 184 (M+ 26.2), 154 (2.4), 153 (33.3), 152 
(34.9), 125 (14.3), 124 (19.0), 123 (2.4), 112 (7.1), 111 (100), 110 (15.9), 99 (4.0), 98 (42.9), 97 (4.0), 95 
(1.6), 88 (2.4), 87 (3.2), 85 (20.6), 83 (2.4), 82 (1.6), 81 (2.4), 71 (11.9), 69 (14.3), 68 (58.7), 67 (6.3), 59 
(13.5), 57 (11.9), 56 (5.6), 55 (81.0), 53 (4.8), 45 (2.4), 43 (42.9), 42 (11.1). (tR = 12:21 min) 
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6.7.3    Lewis-Acid catalysed ring opening reactions. 
 
Preparation of methyl 5,5-diacetoxy-1-methyl-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate (33) from 4b
using conditions reported by Gschwend et al. [18]. 
 
Under dry atmosphere (N2), 4b (50 mg, 0.27 mmol) was dissolved in DCM (10 mL) and Ac2O
(0.5 mL) was added in one portion. The solution was cooled to -78°C and BF3.Et2O (0.1 mL) was added 
dropwise. The solution was allowed to reach room temperature and stirred overnight. The solution was 
then washed with Na2CO3 (2 x10 mL, 10% aq. solution) and dried with Na2SO4. Evaporation under high 
vacuum gave a dark oil (77 mg) which was subjected to chromatography on silica gel using 
pentane:EtOAc (4:1) to give 33 (35 mg, Yield 45%). 1H NMR (300 MHz, CDCl3): 
 5.10 (d, J = 5.6 Hz, 
1H, H-4), 3.69 (s, 3H, H-12), 2.67 (dd, J1 = 5.6 Hz, J2 = 8.6 Hz, 1H, H-2), 2.27 (m, 1H, H-3A), 2.25 (m, 
2H, H-6), 2.05 (s, 3H, H-2’), 2.05 (s, 3H, H-2’’), 1.95 (m, 1H, H-3B), 1.41 (s, 3H, H-11). 13C NMR (75 
MHz, CDCl3): 
173.4 (C-8), 169.0 (C-1’), 168.7 (C-1’’), 107.9 (C-5), 86.0 (C-1), 81.3 (C-4), 52.7 (C-6), 
52.1 (C-10), 49.3 (C-2), 29.9 (C-3), 21.7 (C-2’), 21.3 (C-2’’), 18.6 (C-9). Mass Spectrum m/z 286 (M+,
not observed), 243 (5.5), 227 (1.1), 213 (4.1), 203 (1.5), 202 (9.7), 201 (87.7), 196 (1.5), 195 (12.8), 185 
(6.6), 184 (21.0), 183 (24.1), 170 (2.7), 169 (17.4), 168 (1.7), 167 (16.0), 166 (1.4), 159 (2.5), 158 (2.7), 
157 (2.9), 156 (12.1), 155 (7.6), 154 (2.6), 153 (25.9), 152 (18.7), 151 (50.5), 143 (2.1), 142 (10.6), 141 
(37.8), 140 (25.7), 139 (4.3), 138 (11.3), 137 (3.3), 136 (1.2), 135 (1.2), 135 (12.1), 129 (3.8), 128 (13.0), 
127 (8.8), 126 (2.3), 125 (18.8), 124 (14.2), 123 (13.8), 117 (2.8), 116 (12.3), 115 (1.5), 114 (8.7), 113 
(26.0), 112 (4.1), 111 (19.1), 110 (9.4), 109 (4.5), 108 (2.0), 107 (6.4), 100 (1.1), 99 (7.2), 98 (55.3), 97 
(17.1), 96 (15.7), 95 (12.1), 93 (1.3), 87 (3.9), 86 (1.4), 85 (5.2), 84 (1.8), 83 (15.8), 82 (7.6), 81 (5.3), 80 
(3.0), 79 (5.0), 77 (1.1), 73 (3.0), 71 (3.2), 70 (1.6), 69 (11.6), 68 (9.8), 67 (7.6), 65 (1.5), 59 (5.9), 58 
(1.0), 55 (11.9), 54 (1.1), 53 (4.0), 45 (1.3), 44 (2.6), 43 (100), 42 (3.6), 41 (8.8), 40 (1.3), 39 (4.7). (tR =
13:49 min) 
 
6.8 Synthesis of the Ring A precursor (1R,5S)/(1S,5R)-methyl 5-acetoxy-2-
methyl-4-oxocyclohex-2-enecarboxylate (2).  
 
Preparation of methyl (1R,5S)/(1S,5R)-5-hydroxy-2-methyl-4-oxo-2-cyclohexane-1-carboxylate (3) from 
4b using optimized conditions from those described by Barrero et al. [19]. 
 
To solution of 4b (75 mg, 0.41 mmol) in dry DCM (100 mL) at -1°C was added BBr3 (0.3 mL, 
0.30 mmol, 1 M solution in DCM) at once under dry N2. The solution was stirred at -1°C for 10 min then 
poured quickly into a well stirred quenching solution of collidine (3 g) in DCM (25 mL, LR) at 25 to 
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30°C. The solution was stirred at ambient temperature for 35 min, then extracted with HCl (3 x 75 mL, 1 
M aq.) to give a mixture of compounds as a yellow/brown resin. The sample was purified by semi 
preparative HPLC (tR = 5.1 min, max = 235 nm) to give 3 as a colourless oil (46 mg, 61% yield). IR 
(neat)/cm-1 3452m, 2956w, 2922w, 2856w, 1735s, 1683s, 1438m, 1379w, 1261m, 1197m, 1164m, 
1106s. 1H NMR (300 MHz, CDCl3): 
 6.05 (s, 1H, H-3), 4.15 (dd, J1 = 13.6 Hz, J2 = 5.6 Hz, 1H, H-5), 
3.78 (s, 3H, H-9), 3.55 (m, 1H, H-1), 2.59 (dt, J1 = 12.4 Hz, J2 = 5.6 Hz, 1H, H-6A), 2.14 (apparent 
quartet, J = ~12.4 Hz, 1H, H-6B), 1.98 (s, 3H, H-8). 13C NMR (75 MHz, CDCl3): 
 198.4 (C-4), 172.0 
(C-7), 158.9 (C-2), 125.9 (C-3), 71.2 (C-5), 52.7 (C-9), 47.4 (C-1), 34.4 (C-6), 22.2 (C-8). Mass 
Spectrum m/z 184 (M+ 1.4), 153 (2.2), 141 (7.2), 140 (72.5), 125 (2.2), 124 (2.9), 113 (7.2), 112 (100), 
109 (7.2), 108 (2.2), 98 (3.6), 97 (66.7), 96 (2.9), 95 (9.4), 82 (2.2), 81 (2.9), 80 (1.4), 79 (4.3), 78 (1.4), 
77 (5.1), 69 (5.8), 68 (1.4), 67 (8.7), 66 (1.4), 65 (2.9), 59 (2.9), 55 (5.8), 54 (1.4), 53 (11.6), 52 (2.9), 51 
(3.6), 43 (3.6), 41 (13.0), 40 (1.4), 39 (10.1). HRESI calc. for C9H12O4Na 207.0633, found 207.0627. (tR
= 12:15 min) 
 
Preparation of (1R,5S)/(1S,5R)-methyl 5-acetoxy-2-methyl-4-oxocyclohex-2-enecarboxylate (2). 
 
From the above procedure, acetyl chloride (2 mL) was added to 3 in the collidine/DCM quench mixture 
and the solution was stirred for an additional 35 min. The solution was then extracted with HCl (3 x 75 
mL, 1 M) and the organic layer evaporated to leave a brown viscous resin. The sample was purified by 
semi preparative HPLC (tR = 7.2 min, max = 235 nm) to afford 2 as a pale yellow oil (37 mg, 40% yield). 
IR (neat)/cm-1 2925m, 2857w, 1742s, 1692s, 1634m, 1442m, 1379m, 1222s, 1169s, 1078s. 1H NMR 
(300 MHz, CDCl3): 
 6.02 (s, 1H, H-3), 5.32 (dd, J1 = 11.9 Hz, J2 = 6.4 Hz, 1H, H-5), 3.77 (s, 3H, H-
11), 3.58 (m, 1H, H-1), 2.44 (m, 2H, H-6), 2.17 (s, 3H, H-9), 1.98 (s, 3H, H-10). 13C NMR (75 MHz, 
CDCl3): 
 192.2 (C-4), 171.8 (C-7), 170.3 (C-8), 157.1 (C-2), 127.7 (C-3), 71.8 (C-5), 52.8 (C-11), 47.1 
(C-1), 31.7 (C-6), 22.2 (C-10), 21.0 (C-9). Mass Spectrum m/z 226 (0.1), 184 (2.2), 166 (2.2), 153 (10.1), 
151 (5.8), 141 (8.0), 140 (89.9), 135 (4.3), 125 (1.4), 124 (1.4), 123 (13.0), 113 (4.3), 112 (100), 109 
(8.7), 108 (1.4), 107 (4.3), 97 (20.3), 96 (2.9), 95 (16.7), 85 (1.4), 81 (1.4), 80 (1.4), 79 (7.2), 78 (1.4), 77 
(5.1), 69 (2.2), 68 (1.4), 67 (13.0), 66 (1.4), 65 (2.9), 59 (4.3), 55 (2.9), 53 (1.4), 52 (1.4), 43 (35.5), 41 
(7.2), 39 (1.4). HRESI calc. for C11H14O5Na 249.0739, found 249.0734. (tR = 13:39 min) 
 
Epimerization of 3 to (1R,5R)/(1S,5S)-methyl-5-hydroxy-2-methyl-4-oxocyclohex-2-enecarboxylate 
(C(5)-epi-3). 
 
The -ketol 3 (20 mg) was subject to column chromatography on silica gel using pentane:EtOAc 
(1:1). Upon elution, the material in the middle fractions contained an equal mixture of 3:C(5)-epi-3. (3 Rf
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= 0.61, C(5)-epi-3 Rf = 0.60). C(5)-epi-3: 1H NMR (300 MHz, CDCl3): 
 6.04 (s, 1H, H-3), 4.39 (dd, J1
= 13.3 Hz, J2 = 5.5 Hz, 1H, H-5), 3.79 (s, 3H, H-9), 3.41 (apparent d., J = 6.0 Hz, 1H, H-1), 2.69 (ddd, 
J1 = 13.3 Hz, J2 = 5.5 Hz, J3 = 1.8 Hz, 1H, H-6B), 2.12 (dt, J1 = 13.3 Hz, J2 = 6.0 Hz, 1H, H-6A), 2.16, 
(s, 3H, H-8). 13C NMR (75 MHz, CDCl3): 
 199.1 (C-4), 171.4 (C-7), 158.7 (C-2), 126.0 (C-3), 69.1 (C-
5), 52.9 (C-9), 46.7 (C-1), 34.2 (C-6), 24.2 (C-8). (tR = 12:16 min) 
 
Characterization of (1S,2R,5S)/(1R,2S,5R)-methyl 2-bromo-5-hydroxy-2-methyl-4-
oxocyclohexanecarboxylate (cis-34), (1S,2S,5S)/(1R,2R,5R)-methyl 2-bromo-5-hydroxy-2-methyl-4-
oxocyclohexanecarboxylate (trans-34). 
 
Purification of ring cleavage mixtures by semi-preparative HPLC led to the isolation of mixtures 
containing cis-34 and trans-34 as a pale yellow oil (tR = 6.2 min, max = 225 nm). cis-34: 1H NMR (300 
MHz, CDCl3): 
 4.47 (d, J1 = 6.2 Hz, 1H, H-5), 3.75 (s, 3H, H-9), 2.80 (dd, J1 = 8.7 Hz, J2 = 5.3 Hz, 
1H, H-1), 2.52 (ddd, J1 = 13.4 Hz, J2 = 6.2 Hz, J3 = 5.3 Hz, 1H, H-6A), 2.26 (AB quartet, J = 17. Hz, 
2H, H-3), 1.95 (dd, J1 = 13.4 Hz, J2 = 8.7 Hz, 1H, H-6B), 1.55 (s, 3H, H-8). 13C NMR (75 MHz, CDCl3): 

 209.8 (C-4), 171.8 (C-7), 79.5 (C-5), 51.1 (C-9), 49.3 (C-3), 48.2 (C-1), 42.9 (C-2), 29.5 (C-6), 18.1 
(C-8). (tR = 13:06 min). trans-34: 1H NMR (300 MHz, CDCl3): 
 4.23 (dd, J1 = 11.9 Hz, J2 = 7.7 Hz, 
1H, H-5), 3.79 (s, 3H, H-9), 3.52 (dd, J1 = 13.2 Hz, J2 = 3.4 Hz, 1H, H-1), 3.16 (AB quartet, 2H, H-3), 
2.54 (m, 1H, H-6A), 1.93 (m, 1H, H-6B), 1.84 (s, 3H, H-8). (tR = 13:08 min). 
 
6.9 Preparation of 6-(furan-3-yl)-tetrahydro-4-hydroxy-4-methyl-3-
vinylpyran-2-one (6) as a convergent precursor to ring C 
 
Intermediates in the preparation 6 were identified by GC-MS analysis using Method 2 unless otherwise 
mentioned. 
 
6.9.1 Preparation of but-2-enoic acid derivatives. 
 
Preparation of (E)-but-2-enoyl chloride (crotonyl chloride) following methodology by Jeffery et al. [28]. 
 
To neat SOCl2 (150 g, 1.26 mol), (E)-but-2-enoic acid (95g, 1.10 mol) was added portionwise 
over 1h. During the addition, large amounts of HCl were evolved and the reaction was endothermic. The 
solution was heated to reflux for an additional 30 min then fractionally distilled, collecting crotonyl 
chloride between 110-120°C in agreement with the literature.  
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Preparation of (E)-2-bromobut-2-enoyl chloride by method of Pfeiffer et al. [20] and Klein et al. [21] in 
a three-step procedure. 
 
2,3-Dibromobutanoic acid [20]. 
 
To a solution of crotonic acid (20.0 g, 0.23 mol) in DCM (500 mL) was added elemental 
bromine (41.0 g, 0.26 mol) portion-wise over a period of 20 min. The solution was allowed to stir 
overnight then evaporated to dryness. The residual solvent and bromine were removed under high 
vacuum to give 2,3-dibromobutanoic acid (56.1 g) as a pale orange solid. 1H NMR analysis showed the 
material to be 96% pure, m.p.83-85°C (lit.87°C). 1H NMR (200 MHz, CDCl3): 
 10.89 (b, OH), 4.42 (m, 
1H), 4.41 (s, 1H), 1.94 (m, 3H).  
 
(E)-2-Bromobutenoic acid [20].   
 
2,3-Dibromobutanoic acid (56 g, 0.23 mol) was dissolved in pyridine (120 mL) and heated to 
reflux on a steam cone for 4 h with occasional agitation. Additional pyridine (70 mL) was added at this 
point to prevent the solution from caking, and the mixture heated for an additional 2 h. The reflux 
apparatus was then arranged as a distillation and 80% of the pyridine was distilled. The remaining 
solvent was removed under high vacuum and the residue triturated with Et2O (3 x 150 mL). The residual 
material was acidified with HCl (30 mL, 1 M) and extracted once with ether. Combined organic extracts 
were then thoroughly shaken with HCl (3 x 150 mL, 2 M), dried over Na2SO4 and evaporated to dryness 
to leave (E)-2-bromobutanoic acid as a pale brown powder (27.6 g) in 72% overall yield from crotonic 
acid. m.p. 104-105°C after recrystallization from water (lit. 105°C). 1H NMR (300 MHz, CDCl3): 
 7.57 
(q, J = 6.9 Hz, 1H), 1.99 (d, J = 6.9 Hz, 3H). 13C NMR (75 MHz, CDCl3): 
 167.0, 144.7, 116.9, 18.4. 
 
(E)-2-Bromo-but-2-enoyl chloride [21].  
 
To (E)-2-bromobutanoic acid (20 g, 0.12 mol) was added SOCl2 (36 mL) and the solution heated 
at reflux for 2 h. The solution was then distilled under dry nitrogen to yield (E)-2-bromobut-2-enoyl 
chloride (b.p. 164-170°C, lit. 168°C, 14.8 g, 67%), which was pure by 1H and 13C NMR analysis. 1H
NMR (300 MHz, CDCl3): 
 7.87 (q, J = 6.8 Hz, 1H), 2.11 (d, J = 6.8 Hz, 3H). 13C NMR (50 MHz, 
CDCl3): 
 161.9, 151.6, 120.6, 19.3.
Chapter 6 
302 
6.9.2 Model studies toward Ring C using 2-furaldehyde.      
 
Preparation of 4-(furan-2-yl)-4-hydroxybutan-2-one (35) under conditions described by Shokat et al. 
[22]. 
 
To a solution of 2-furaldehyde (6.4 g, 66.2 mmol) in acetone (120 mL) was added a NaOH (12 
mL, 1% solution) dropwise between –5 to -10°C. Stirring was continued for 30min, before neutralization 
with 0.5M HCl. The solution was concentrated in vacuo and the residue dissolved in water (100 mL) 
then extracted with ether (3 x 100 mL). The combined organic extracts were dried with Na2SO4 and 
concentrated to 35 in 93% purity by GC-MS analysis. Mass Spectrum m/z 155 (1.0), 154 (M+, 11.0), 139 
(4.1), 137 (1.2), 136 (8.8), 120 (5.8), 112 (2.4), 111 (8.5), 110 (1.9), 108 (1.8), 107 (2.0), 98 (4.9), 97 
(80.7), 95, (14.8), 94 (14.7), 93 (7.2), 85 (1.1), 84 (1.1), 83 (4.3), 82 (1.1), 81 (2.1), 80 (1.0), 79 (1.9), 77 
(0.8), 71 (1.3), 70 (1.2), 69 (17.7), 68 (7.2), 67 (2.9), 66 (8.1), 65 (10.0), 64 (1.5), 63 (3.0), 58 (7.2), 57 
(1.5), 55 (8.6), 53 (5.6), 52 (1.7), 51 (5.1), 50 (3.2), 44 (3.1), 43 (100), 41 (40.7), 40 (8.2), 39 (46.6), 38 
(12.6). (tR = 16:75, Method 1)
Preparation of 1-(furan-2-yl)-3-oxobutyl but-3-enoate (36) under conditions described by Iwakura et al. 
[23]. 
 
To the aldol product 35 (3.0 g, 19.5 mmol) and TEA (2.2 g, 21.4 mmol) in dry THF (20 mL), 
crotonyl chloride (2.0 g, 19.5 mmol) was added drop-wise with occasional cooling to keep the solution at 
20°C. After a further 30 min stirring, the amine hydrochloride was filtered and the filter cake washed 
with Et2O (3 x 25 mL). The ethereal washes were extracted with HCl (3 x 75 mL, 1M), washed with 
NH4Cl then dried over Na2SO4. Evaporation gave 36 (3.9 g) in 90% yield. NMR and GCMS data showed 
no detectable conjugated ester product. 1H NMR (200 MHz, CDCl3): 
 7.33 (arom. m, 1H), 6.33 (arom. 
m, 1H), 6.30 (arom. m, 1H), 6.27 (m, 1H), 5.85 (m, H), 5.13 (m, 1H), 5.05 (dq, J1 = 6.9 Hz, J2 = 1.4 Hz, 
1H), 3.08 (m, 1H), 3.02 (m, 1H), 3.02 (m, 2H), 2.14 (s, 3H). 13C NMR (50 MHz, CDCl3): 
 204.2, 170.4,
151.4, 142.7, 130.0, 118.8, 110.6, 109.2, 64.6, 45.7, 38.9, 30.4. Mass Spectrum m/z 222 (M+, 0.3), 154 
(2.4), 153 (17.0), 137 (1.8), 136 (1.1), 120 (1.8), 111 (3.7), 97 (4.5), 96 (1.1), 95 (9.9), 94 (7.8), 93 (4.7), 
85 (9.7), 69 (5.5), 68 (1.6), 67 (1.1), 66 (4.2), 65 (5.7), 63 (1.1), 53 (1.1), 51 (1.3), 44 (2.7), 43 (100), 41 
(28.8), 40 (5.1), 39 (21.4), 38 (3.6).  
 
Experimental Procedures and Methodology 
303 
6.9.3 Preparation of the Ring C precursor 6-(furan-3-yl)-5,6-dihydro-4-methyl-3-
vinylpyran-2-one (6) from 3-furaldehyde.      
 
Preparation of 4-(furan-3-yl)-4-hydroxybutan-2-one (8). 
 
To a solution of 3-furaldehyde (1.0g, 10.4 mol) in acetone (18  ) was added a 1% NaOH solution 
(2.5 mL) dropwise at -9°C to. Stirring was continued for 40min as the solution temperature was slightly 
increased to –6°C, before neutralization with 0.5M HCl. The solution was concentrated in vacuo and the 
residue dissolved in water (100 mL) then extracted with ether (3 x 100 mL). The combined organic 
extracts were dried with Na2SO4 and concentrated to leave 8 (1.60 g, >98% yield) as a yellow resin. 1H
NMR (300 MHz, CDCl3): 
 7.33 (arom. br. s, 1H, H-5’’), 7.32 (arom. br. s, 1H, H-2’’), 6.34 (arom. m, 
1H, H-4’), 5.07 (dd, 1H, J1 = 8.7 Hz , J2 = 4.0 Hz, H-4), 3.32 (m, br. s, 1H, OH), 2.85 (double AB 
quartet,  2H, J1 = 17.3 Hz , J2 = 8.7 Hz, H-3A), 2.75 (double AB quartet,  2H, J1 = 17.3 Hz , J2 = 4.0 Hz, 
H-3B), 2.14 (s, 3H, H-1). 13C NMR (75 MHz, CDCl3): 
 208.7 (C-2), 143.2 (C-2’), 138.8 (C-5’), 127.5 
(C-3’), 108.3 (C-4’), 62.7 (C-4), 50.5 (C-3), 30.5 (C-1). Mass Spectrum m/z 155 (2.3), 154 (M+ 16.9), 
139 (2.3), 136 (2.3), 126 (2.3), 121 (4.6), 113 (2.3), 111 (16.2), 107 (2.3), 98 (3.1), 97 (53.1), 96 (56.9), 
95 (28.5), 94 (15.4), 93 (10.8), 83 (6.1), 81 (2.3), 79 (2.3), 71 (3.1), 70 (3.1), 69 (64.6), 68 (12.3), 67 
(4.6), 66 (6.9), 65 (10.0), 63 (4.6), 58 (15.4), 55 (9.2), 53 (6.1), 51 (7.7), 50 (4.6), 44 (3.1), 43 (100), 42 
(18.5), 41 (51.5), 40 (9.2), 39 (52.3), 38 (13.8), 37 (4.6). (tR = 10:63 min). 
 
Preparation of 1-(furan-3-yl)-3-oxobutyl 2-bromobut-3-enoate (7) under conditions described by 
Cardillo et al. [24]. 
 
The alcohol 8 (1.0 g, 6.5 mmol) was added to dry Et2O (6 mL) then cooled to -78°C in a dry 
ice/acetone bath under inert atmosphere (N2). TEA (2.1 g, 21 mmol) was then added, followed by (E)-2-
bromo-but-2-enoyl chloride (1.9 g, 10 mmol) in Et2O (3 mL) in one portion. An additional volume of 
Et2O (3 mL) was added then the mixture was allowed to stir at –78ºC for 45 min followed by vacuum 
filtration. The filter cake was washed with Et2O (2 x 25 mL, LR), cooled to at -78ºC and allowed to stand 
at -50ºC until all precipitate had formed, then filtered under suction once more. The ethereal solution was 
washed with HCl (3 x 20 mL, 1 M), dried with Na2SO4 and evaporated to leave the ,- unsaturated ester 
7 (1.8 g, Yield 92%) as a 1:1 mixture of syn and anti diastereoisomers. IR (neat)/cm-1 3136w, 2985w, 
2917w, 1741s, 1724s, 1624m, 1504m, 1419m, 1369m, 1315m, 1289m, 1252s, 1201s, 1148s, 1092m, 
1037s. 1H NMR (300 MHz, CDCl3): 
 7.48 (arom. m, 2H, H-5’’), 7.38 (arom. m, 2H, H-2’’), 6.40 (arom. 
m, 2H, H-4’’), 6.26 (dd, 2H, J1 = 8.1 Hz, J2 = 5.2 Hz, H-1’), 6.11 (ddd, J1 = 17.0 Hz, J2 = 10.2 Hz, J2 =
9.4 Hz, 1H, H-3, isomer 1), 6.09 (ddd, J1 = 17.0 Hz, J2 = 10.0 Hz, J2 = 9.4 Hz, 1H, H-3, isomer 2), 5.37 
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(dd, 2H, J1 = 17.0 Hz , J2 = 4.5 Hz, H-4A), 5.27 (dd, 2H, J1 = 10.2 Hz, J2 = 3.4 Hz, H-4B), 4.73 (d, 2H, J
= 9.4 Hz, H-2), 3.16 (dd, 2H, J1 = 16.9 Hz, J2 = 8.1 Hz, H-2A’), 2.89 (dd, J1 = 16.9 Hz, J2 = 5.2 Hz, 1H, 
H-2B’, isomer 1), 2.88 (dd, 1H, J1 = 16.9 Hz, J2 = 5.5 Hz-H-2B’, isomer 2), 2.18 (s, 6H-H-4’). 13C NMR 
(75 MHz, CDCl3): 
 204.0 (C-3’), 204.0 (C-3’), 167.0 (C-1), 166.9 (C-1), 143.0 (C-2’’), 143.0 (C-2’’), 
140.7 (C-5’’), 140.6 (C-5’’), 132.5 (C-3), 132.5 (C-3), 123.2 (C-3’’), 123.2 (C-3’’), 120.6 (C-4), 120.6 
(C-4), 108.6 (C-4’’), 108.6 (C-4’’), 66.3 (C-1’), 66.2 (C-1’), 48.0 (C-2’), 47.9 (C-2’), 45.4 (C-2), 45.3 
(C-2), 30.5 (C-4’), 30.5 (C-4’). Mass Spectrum m/z 302 (1.0), 300 (M+ 1.0), 260 (1.0), 259 (1.0), 258 
(1.0), 257 (1.0), 221 (4.6), 161 (6.1), 155 (3.8), 154 (50.0), 153 (30.0), 149 (4.6), 147 (4.6), 137 (9.2), 
136 (9.2), 135 (2.3), 121 (22.3), 119 (15.4), 112 (7.7), 111 (7.7), 97 (3.8), 96 (6.9), 95 (46.2), 94 (72.3), 
93 (12.3), 85 (2.3), 69 (3.8), 68 (21.5), 67 (2.3), 66 (4.6), 65 (9.2), 62 (1.5), 43 (100), 40 (6.2), 39 (1.5), 
38 (20.8). (tR = 13:95 min). 
 
Preparation of (Z)-1-(furan-3-yl)-3-oxobutyl 2-bromobut-2-enoate (37) (,-unsaturated by-product). 
 
The above procedure was performed using pyridine at 0°C to give 37 in quantitative yield. 1H
NMR (300 MHz, CDCl3): 
 7.50 (arom. m, 1H, H-5’’), 7.38 (arom. m, 1H, H-2’’), 7.34 (quartet, 1H, J =
6.8 Hz, H-3), 6.42 (arom. m, 1H, H-4’’), 6.28 (dd, 1H, J1 = 8.1 Hz, J2 = 5.5 Hz, H-1’), 3.20 (dd, 1H, J1
= 16.6 Hz, J2 = 8.1 Hz, H-2A’), 2.91 (dd, 1H, J1 = 16.6 Hz, J2 = 5.5 Hz, H-2B’), 2.20 (s, 3H, H-4’), 1.93 
(d, 3H, J = 6.8 Hz, H-4). 13C NMR (75 MHz, CDCl3) : 
 204.3 (C-3’), 161.4 (C-1), 143 .5 (C-2’’), 142.0 
(C-3), 140.8 (C-5’’), 123.6 (C-3’’), 117.2 (C-2), 108.7 (C-4’’), 66.5 (C-1’), 48.2 (C-2’), 30.5 (C-4’), 17.9 
(C-4). Mass Spectrum m/z 303 (1.6), 302 (M+ 11.3), 301 (1.6), 300 (11.8), 260 (4.1), 259 (2.0), 258 (4.4), 
257 (1.6), 161 (1.4), 155 (1.3), 154 (12.6), 153 (71.2), 150 (3.9), 149 (83.5), 148 (5.0), 147 (85.4), 137 
(6.6), 136 (30.0), 135 (4.6), 122 (2.0), 121 (32.6), 120 (1.5), 119 (16.6), 112 (2.4), 111 (3.7), 110 (1.7), 
108 (3.9), 107 (1.8), 97 (1.6), 96 (11.6), 95 (88.2), 94 (90.3), 93 (26.2), 92 (1.3), 85 (4.3), 81 (1.3), 79 
(2.0), 77 (2.0), 69 (2.6), 68 (7.0), 67 (4.9), 66 (8.1), 65 (15.2), 64 (1.2), 63 (3.1), 55 (1.1), 53 (4.4), 51 
(2.3), 50 (1.2), 44 (2.4), 43 (100), 41 (2.8), 40 (7.2), 39 (35.8), 38 (4.5), 37 (1.3). (tR = 14:42 min). 
 
Preparation of 6-(furan-3-yl)-5,6-dihydro-4-methyl-3-vinylpyran-2-one (6) from 7.
A solution of 7 (1.0 g, 6.0 mmol) in dry THF (40 mL) was cooled to 0°C and a Rieke zinc 
(120mg, 18.0 mmol) suspension in THF (2.5 mL) was added in one portion. The solution was heated to 
reflux for 5 h then cooled before quenching in HCl (30 mL, 2 M). After stirring in acid for 1 h, H2O (50 
mL) was added and the solution extracted with Et2O (3 x 50 mL). The combined organic extracts were 
dried over Na2SO4 then concentrated to leave 6 (1.4 g, Yield 92%) as a deep yellow resin. IR (neat)/cm-1 
3147w, 2972w, 2933w, 1713s, 1629s, 1505m, 1430m, 1376m, 1260s, 1162s, 1122m, 1098m, 1061m, 
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1034s. 1H NMR (300 MHz, CDCl3): 
 7.49 (arom. m, 1H, H-5’), 7.42 (arom. m, 1H, H-2’), 6.55 (dd, 1H, 
J1 = 17.7 Hz, J2 = 11.5 Hz, H-7), 6.45 (arom. m, 1H, H-4’), 5.72 (d, 1H, J = 17.7 Hz, H-8A), 5.47 (d, 1H, 
J = 11.5 Hz, H-8B), 5.35 (dd, 1H, J1 = 11.5 Hz, J2 = 3.8 Hz, H-6), 2.78 (dd, 1H, J1 = 18.1 Hz, J2 = 11.5
Hz, H-5A), 2.54 (dd, 1H, J1 = 18.1 Hz, J2 = 3.8 Hz, H-5B), 2.11 (s, 3H, H-9). 13C NMR (75 MHz, 
CDCl3): 
 164.2 (C-2), 150.3 (C-4), 143.9 (C-2’), 140.2 (C-5’), 128.9 (C-7), 125.4 (C-3), 124.1 (C-3’), 
121.0 (C-8), 108.8 (C-4’), 70.8 (C-6), 37.7 (C-5), 21.1 (C-9). Mass Spectrum m/z 205 (6.1), 204 (M+
41.5), 203 (2.3), 190 (4.6), 189 (46.2), 186 (2.3), 185 (1.0), 176 (3.1), 175 (4.6), 171 (3.8), 161 (4.6), 160 
(9.2), 159 (33.1), 158 (13.8), 157 (6.1), 147 (2.3), 146 (1.5), 145 (13.8), 144 (5.4), 143 (2.3), 141 (6.1), 
136 (4.6), 133 (3.8), 132 (3.8), 131 (25.4), 130 (5.4), 129 (20.0), 128 (8.5), 127 (10.0), 119 (4.6), 118 
(4.6), 117 (18.5), 116 (13.1), 115 (29.2), 108 (6.1), 107 (2.3), 105 (2.3), 105 (6.1), 103 (4.6), 95 (20.8), 
94 (22.3), 93 (7.7), 92 (2.3), 91 (30.0), 89 (3.1), 82 (13.1), 81 (88.5), 80 (42.3), 79 (100), 78 (6.1), 77 
(27.7), 75 (7.7), 69 (1.5), 68 (3.1), 67 (7.7), 66 (17.7), 65 (27.7), 64 (3.1), 63 (11.5), 55 (4.6), 54 (2.3), 53 
(13.8), 52 (8.5), 51 (13.1), 49 (5.4), 44 (5.4), 41 (8.5), 40 (10.8), 39 (36.2). HRESI calc. for C12H12O3Na 
227.0684, found 227.0677. (tR = 14:17 min). 
 
Preparation of 6-(furan-3-yl)-tetrahydro-4-hydroxy-4-methyl-3-vinylpyran-2-one (38). 
 
Reformatski intermediates 38 were obtained by quenching the Rieke Zinc solution in a biphasic 
mixture of Et2O (30 mL) and HCl (30 mL, 1 M), followed by stirring for 15 min. Separation of the 
ethereal layer and drying over Na2SO4 gave a mixture of intermediates that were separated by flash 
column chromatography on silica gel using gradient elution with pentane:EtOAc (20:1 to 8:1). 38 was 
isolated as a 1:1 mixture of diastereomers. 1H NMR (300 MHz, CDCl3): 
 7.45 (arom. m, 1H, H-2’), 7.42 
(arom. m, 1H, H-5’), 6.44 (arom. m, 1H, H-4’), 5.94 (dt, 1H, J1 = 17.2 Hz, J2 = 9.6 Hz, H-7), 5.73 (dd, 
1H, J1 = 11.9 Hz, J2 = 3.4 Hz, H-6), 5.52 (d, 1H, J = 9.6 Hz, H-8A), 5.29 (d, 1H, J = 17.2 Hz, H-8B), 
2.95 (d, 1H, J = 9.1 Hz, H-3), 2.50 (OH), 2.24 (dd, 1H, J1 = 14.2 Hz, J2 = 3.4 Hz, H-5A), 2.05 (dd, 1H, 
J1 = 14.2 Hz, J2 = 11.9 Hz, H-5B), 1.37 (s, 3H, H-9). 13C NMR (75 MHz, CDCl3): 
 171.4 (C-2), 143.7 
(C-2’), 139.7 (C-5’), 130.1 (C-7), 124.6 (C-3’), 122.8 (C-8), 108.5 (C-4’), 71.1 (C-6), 70.4 (C-4), 56.6 
(C-3), 42.6 (C-5), 28.3 (C-9). Mass Spectrum m/z 222 (M+ 1.5), 204 (2.3), 189 (1.5), 176 (7.7), 160 (1.5), 
153 (1.5), 152 (2.3), 138 (3.8), 137 (12.3), 136 (3.1), 135 (2.3), 134 (3.8), 121 (1.5), 120 (2.3), 111 (2.3), 
110 (1.5), 97 (6.2), 96 (6.9), 95 (49.2), 94 (17.7), 93 (3.8), 92 (3.1), 91 (4.6), 85 (9.2), 84 (55.4), 82 (3.1), 
81 (7.7), 80 (3.1), 79 (3.8), 77 (3.8), 70 (4.6), 69 (93.1), 68 (59.2), 66 (6.9), 65 (12.3), 63 (3.1), 58 (3.8), 
57 (2.3), 55 (8.5), 54 (15.4), 53 (6.9), 52 (1.5), 51 (5.4), 50 (1.5), 44 (3.1), 43 (100), 41 (24.6), 40 (18.5), 
39 (46.2). (tR = 14:49 min). 
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6.10 Experimental Methods Used for Chromatographic Separation. 
6.10.1  Gas Chromatorgraphy Mass Spectroscopy. (GC-MS) 
 
Instrument 1 
GC:   Hewlett Packard 5890 GC  
MS:  Hewlett Packard 5970 Mass Selective Detector 
Voltage: 70eV 
Flow (He) 0.5 mL/min  
Split ratio:  50:1 
Column: Type: BPX-5  
Length: 30m 
Internal Diameter: 0.25mm 
Film Thickness: 0.25um. 
 
Instrument 2 
GC:   Hewlett Packard 6890 GC  
MS:  Hewlett Packard 5973 Mass Selective Detector 
Voltage: 70eV 
Flow (He)  0.5 mL/min  
Split ratio:  50:1 
Column: Type: BPX-5  
Length: 25m 
Internal Diameter:  0.25mm 
Film Thickness:  0.25um 
 
Method 1: Starting temperature:  50°C 
 Ramp Rate:  10°C/min 
 Final temperature: 280°C 
 Hold time:  20 min. 
 
Method 2: Starting temperature:  70°C 
 Ramp Rate:  10°C/min 
 Final temperature: 280°C 
 Hold time:  20 min. 
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6.10.2  Chiral Gas Chromatography 
 
Instrument 1 
GC:    Hewlett Packard 5890 GC  
Carrier gas:  H2
Make up gas:  N2
Injector:  220°C 
Detector (FID): 230°C 
Column pressure: 5.9 psi 
Column flow:  1.33 mL/min. 
Linear Velocity: 40.07 cm/sec. 
Total flow:  69 mL/min. 
Split ratio:   50:1 
 
Column:  Type: Et-TBS--CD column (MeGA, Italy). 
Length:   20m 
Internal Diameter: 0.25mm  
Film Thickness:  0.25um 
 
Method: Starting temperature:  60°C 
 Ramp Rate:  2°C/min. 
 Final temperature: 180°C
Hold time:  30 min. 
 
6.10.3  Semi Preparative High Performance Liquid Chromatography 
 
HPLC:   Varian Prostar (Model 210). 
Guard column:  50 x 10 mm, 5 micron filter. 
Analytical column: Phenomenex C-18, 250 x 10 mm, prodigy 5 micron ODS (3), 100A. 
Solvent A:  Acetonitrile. 
Solvent B:  Water. 
Solvent ratio (A:B): 55:45 
Flow rate:  3.5 mL/min. 
Pressure:  2900 psi. 
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Chapter 1 
Introduction: Appendices 
Appendix 1.1: 
 
Chemical Transmission: The structure and function of neurons and neurotransmitters. 
 
Signal processes of the central nervous system rely on cells called neurons. The cell body of the 
neuron, called the soma contains the nucleus and organelles similar to that of a normal cell, however the 
morphological features consist of a long branching pathway called an axon connecting to a bulb like 
terminal. Multiple shorter branches called dendrites are responsible for the reception of nerve impulses 
from other neurons and respond to an action potential. The axon terminal is closely situated to a 
neighboring neuron, providing a junction for chemical communication between cells called a synapse. 
Upon the reception of sufficient potential through the dendrites, the axon hillock initiates a second 
potential, which travels down the axon to the terminal. Neurotransmitters contained in vesicles at the 
terminal are then released and travel from the pre-synaptic membrane into a narrow gap between cells 
called the synaptic cleft. Proteins act as selective receptors within the post-synaptic membrane of the 
neighboring cell (including neuron, muscle cell or gland cell) and bind to neurotransmitters in a structure 
specific manner. The entire process takes approximately 1 millisecond. If binding results in excitation 
(activation, agonism) of the receptor site, depolarization of the membrane occurs and a new potential is 
created through the movement of ions through channels. Binding can also result in inhibition 
(deactivation, antagonism) of the receptor protein, leading to hyperpolarization and signal blockage. 
Modulatory action at a receptor site leads to a change the postsynaptic cells response to other connected 
synapses.  
 
Synaptic transmission is quite complex, since each axon terminal can contain many 
neurotransmitters, thousands of synapses can converge on a single neuron, or a single axon terminal can 
affect many neurons. Reception of the released neurotransmitters is also complex and for each receptor 
family there are usually many receptor subtypes. Different neurotransmitters have different synaptic 
action in that some can bind at a broad range of receptors with varying degrees of agonist or antagonistic 
action. Endogenous neurotransmitters are synthesized within the body and can be separated into four 
categories: 
 
- The amino acid neurotransmitters are the most common in the body. Excitatory amino acids 
include glutamate and aspartate, and inhibitory amino acids include glycine and -amino-butyric acid 
(GABA). GABA is the major inhibitory neurotransmitter in the CNS and plays an important role in 
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regulatory functions, anxiety/mood, analgesia (pain), sleep and cognition.  Binding of GABA to its 
receptors increases membrane potential by either opening up ligand-gated Cl- channels (GABAA-
receptor), or by activating an internal G-protein and second messenger that leads to the removal of K+ by 
active transport (GABAB-receptor). Both modes of ion diffusion counteract excitation.  
 
HH2N
COOH
H
Glycine
H2N
COOH
COOH
Aspartate
H2N
COOH
COOH
Glutamate
H2N COOH
-Aminobutyrate (GABA)  
-The monoamine neurotransmitters are produced from amino acids at the terminal via a short 
series of enzymatic steps. Dopamine is produced from tyrosine via L-DOPA and is involved in mood, 
motor activity and cognitive functions (learning and memory). It also plays a crucial role in reward-
reinforcement, and reward-related incentive learning. Dopamine receptors modulate hippocampal ACh 
release [1] and receptor signaling pathways in the nucleus accumbens caused by repeated use of drugs, 
are hypothesized to produce tolerance to the rewarding effects of receptor stimulation, leading to 
increased drug intake to satisfy reward-reinforcement pathway [1]. 
 
Serotonin (5-hydroxytryptophan or 5-HT) is produced from tryptophan and governs body 
temperature, sleep and feeding. Serotonin acts at an array of receptors that are found in both the central 
and peripheral nervous systems. 5-HT has been implicated in depression, anxiety, social phobia and 
obsessive-compulsive disorders. The effects of 5-HT are felt most predominately in the cardiovascular 
system, with additional effects in the respiratory system and the intestines. There are several types of 5-
HT receptors, most of which are coupled to G-proteins that effect the activities of either adenylate 
cyclase or phospholipase C. The catecholamine receptors are termed the - and -adronergic receptors 
and couple to intracellular G-proteins. 
 
Norepinephrine is produced from dopamine and is primarily active in the locus coeruleus, which 
monitors external stimuli and responses. Regulates mood, blood pressure, state of alertness and feelings 
of pleasure. Difficulty concentrating and feelings of apathy and depression results from problems 
associated with the norepinephrine transmitter. Epinephrine is produced from norepinephrine and is 
involved in the physiological response to threatening or exciting conditions (short-term stress reactions). 
It increases heart rate, dilates pupils and is also involved in the regulation of blood sugar levels. 
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Most amine neurotransmitters are removed from the synaptic cleft by transport mechanisms and 
catabolized for re-uptake into the pre-synaptic terminal by catechol-O-methyltransferase and monoamine 
oxidase.  
 
NH2
HO
OH
Dopamine
O
HO NH2
Serotonin (5-HT)
NH2
HO
OH
OH
Norepinephrine
H
N
HO
OH
OH
Epinephrine  
-Acetylcholine (ACh) is synthesized from choline and acetyl-CoA through the action of choline 
acetyltransferase. It is the major neurotransmitter in the peripheral nervous system and is usually 
excitatory, however the release of Ach in hippocampus plays also part in the generation of mood and the 
acquisition of short-term memory.  
 
Binding of acetylcholine to its receptors opens up ligand-gated sodium channels. The resulting 
influx of Na+ ions reduces membrane potential which if sufficient will cause an action potential to be 
generated in the postsynaptic cell. Acetylcholine however is removed rapidly from the synapse by 
enzymatic metabolism by acetylcholinesterase and not reused. Acetylcholine controls the release of the 
pituitary hormone vasopressin and is involved in protective and regulatory functions. Two main classes 
of ACh receptors are the muscarinic and nicotinic receptors. 
O
O
N
CH3
CH3
CH3
Acetylcholine  
-Peptides neurotransmitters (neuropeptides) are far more potent than others and are responsible 
for mediating sensory and emotional responses including hunger, thirst, sex drive, pleasure and pain. 
Neuropeptides can be predominately found in the brain and gut and differ from those previously 
discussed in that they are synthesized from huge precursors (about 300 amino acids) in the nucleus of the 
cell. Translation by ribosomes in cell bodies or dendrites produces the prepropeptide, which is cleaved 
into smaller fragments by peptidases during axonal transportation in vesicles to the terminal.  The 
lengthy biosynthesis and transportation processes determine that the release at the terminal is not quick. 
There is no evidence to suggest that transport mechanisms exist for the reuptake of peptide transmitters 
and once released the peptide is catabolised by membrane peptidases [2]. The earliest neuropeptide to be 
studied was substance P, which is a sensory neurotransmitter in the spinal chord involved in the 
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perception of pain. Opioid neuropeptides include endorphins, enkephalins and dynorphins and are so 
called since they bind to the same to the same postsynaptic receptors as opium derivatives. The release of 
substance P is inhibited by opioid peptides, which hyperpolarize the postsynaptic membrane and prevent 
transmission of pain signals back to the brain. Almost all of the neuropeptide receptors belong to the 
rhodopsin or glucagons-vasoactive intestinal peptide/calcitonin G-protein-coupled receptor family. 
 
HO
H2N
O
N
H
O
H
N
O
N
H
O
H
N
O
OH
S
Met-Enkephalin
NH2-Tyr Gly Gly Phe Met
Leu-Enkephalin
-Endorphin
Dynorphin
Substance P
NH2-Tyr-Gly-Gly-Phe-Leu
NH2-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-
Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu
NH2-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln
NH2-Met-Leu-Gly-Phe-Phe-Gln-Gln-Pro-Lys-Pro-Arg  
[1]  A. Sidhu, M. Laruelle, P. Vernier. “Dopamine Receptors and Transporters”, Marcel Dekker, 
ISBN: 0824708547. 
[2]  R. A. Webster (Ed.). “Neurotransmitters, Drugs and Brain Function”, John Wiley and Sons 
Ltd., 2001, 251-264. ISBN:0471978191.  
 
314 
Chapter 2 
Synthesis of 3-Furylamines: Appendices  
Appendix 2.1: EIMS of the polyhalogenated products identified by the isotope pattern in the largest 
fragment. The predicted isotope pattern was calculated using ‘Isotope 1.0’ (F. Antolasic, RMIT). 
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Appendix 2.2: Mass spectra of the 5-bromofuran-2-carbaldehyde 8 and the hydrolysis product upon 
Wolf-Kishner reduction of 11.
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Appendix 2.3: Possible fragmentation pathway for the enaminone 19a. This pathway is 
characteristic for the enaminones 19a-n and major fragments are included in the experimental data. 
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Appendix 2.4: 300MHz COSY NMR of the E- and Z- isomers of 3-(n-butylamino)-4-
(tetrahydropyran-2-yloxy)but-2-enal 19n.
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Appendix 2.5: Possible fragmentation pathway for the furan 5a. This pathway is characteristic for 
the furans and major fragments are included in the experimental data. 
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Appendix 2.6: 50MHz 13C and 200MHz 1H NMR of N,N-diethyl-furan-3-amine 5l, and EIMS 
fragmentation data. 
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Appendix 2.7: 50MHz 13C and 200MHz 1H NMR of N-(n-butyl)-N-(5-methylfuran-3-yl)acetamide 
21g, and EIMS fragmentation data. 
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Appendix 2.8: 1H NMR, 13C NMR and GC-MS of a mixture of diastereoisomers of 1-((2R/S,4S,5S)-
3’,4’-dimethyl-5’-phenyl-2’-((tetrahydro-2H-pyran-2’’-yloxy)methyl)oxazolidin-2-yl)propan-2-one 19p
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Appendix 2.9: 300MHz 1H COSY NMR of C(2’’) isomers of 1-((2R/S,4S,5S)-3’,4’-dimethyl-5’-
phenyl-2’-((tetrahydro-2H-pyran-2’’-yloxy)methyl)oxazolidin-2-yl)propan-2-one…(19p). 
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Appendix 2.10: Top; 300MHz 1H NMR of 19q, 1-((2R/S,4S,5R)-3,4-dimethyl-5-phenyl-2-
((tetrahydro-2H-pyran-2-yloxy)methyl)oxazolidin-2-yl)propan-2-one. Bottom; 1H NMR and GC-MS 
data of the cyclization mixture showing the 5q-THP intermediate at 16.59 min with a characteristic m/z  
85 THP fragment ion but no molecular ion.  Two sets of  1H signals can be seen in 5q-THP and are due 
to C(2’)-diastereoisomers at the THP group.  
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Chapter 3 
Diels-Alder Reactions of 3-Furylamines: Appendices  
Appendix 3.1: 200 MHz 1H NMR homo-decoupling experiments of 4a.
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Appendix 3.2: 500 MHz 1H/125 MHz 13C HMBC NMR spectrum of 4a and 125MHz 13C NMR of 
4a with peak labels. 
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Appendix 3.3: GC traces for the GC-MS analysis of the crude D-A reaction mixture between 5a and 
MAC in DCM at –78 to 0ºC (top) and 4ºC (bottom). 
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Appendix 3.4: 200MHz 1H and 50 MHz 13C NMR of 4b, and 300 MHz 1H/75 MHz 13C HMQC 
NMR analysis. GC-MS data for 4b is also shown. 
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Appendix 3.5: A summary of bond distances and the X-ray crystal CIF file is shown for 4b. The 
atom numbering produced in the CIF file used to describe the X-ray crystal data of 4b is slightly different 
from that discussed throughout chapter 3 and alternate numbering used in the crystal structure data of 
exo-methyl 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate 4b is shown below.  
 
O
O
OO
C1
C4
C3
C2
O1
C7C5
C6
O2
O3
O4
C9
C8
Bond distances are listed and are close to distances quoted by Allen et al. [88]  
 
Atom 
1 Atom 2 Exp. (Å) Lit. d[88] (Å) Closest functional group   
O2  C1  1.434(2) 1.429 Csp2-O(2) (C)2-CH-O-C  
O2  C4  1.451(2) 1.452 Csp2-O(2) (C)3-C-O-C  
O4  C8  1.337(2) 1.336 Csp2-O(2) C-C(=O)-O-C  
O4  C9  1.440(2) 1.448 Csp3-O(2) C-C(=O)-O-CH3
O3  C8  1.201(2)  1.196 Csp2=O(1) C-C(=O)-O-C  
O1  C2  1.200(2) 1.211 Csp2=O(1) (C)2-C=O cyclohexanone
C8  C5  1.497(2) 1.497 Csp3-Csp3 C-C(=O)(-OC) acyclic esters 
C5  C6  1.541(2) 1.535 Csp3-Csp3 C-C cyclohexane 
C5  C4  1.564(2) 1.556 Csp3-Csp3 (C)3-C-CH-(C)2
C4  C3  1.537(3) 1.535 Csp3-Csp3 C-C cyclohexane 
C2  C3  1.507(3) 1.509 Csp3-Csp3 C2-C=O  C6+ rings 
C2  C1 1.517(3)  1.514 Csp3-Csp3 C2-C=O  cyclopentanone
C6  C1  1.529(3) 1.535 Csp3-Csp3 C-C cyclohexane 
C4  C7  1.502(2)         
X-ray crystal CIF data: 
 
_audit_creation_method           SHELXL-97 
_chemical_name_systematic         
'methyl 1-methyl-5-oxo-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate' 
_chemical_name_common            ? 
_chemical_melting_point          377 
_chemical_formula_moiety         ? 
_chemical_formula_sum            'C9 H12 O4' 
_chemical_formula_weight         184.19 
 
loop_ 
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_atom_type_symbol 
_atom_type_description 
_atom_type_scat_dispersion_real 
_atom_type_scat_dispersion_imag 
_atom_type_scat_source 
C C 0.0033 0.0016 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4' 
H H 0.0000 0.0000 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4' 
O O 0.0106 0.0060 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4' 
 
_symmetry_cell_setting           triclinic 
_symmetry_space_group_name_H-M   'P -1' 
_symmetry_int_tables_number      2 
 
loop_ 
_symmetry_equiv_pos_as_xyz 
'x, y, z' 
'-x, -y, -z' 
 
_cell_length_a                   7.2235(10) 
_cell_length_b                   8.1158(11) 
_cell_length_c                   8.3058(12) 
_cell_angle_alpha                75.273(2) 
_cell_angle_beta                 74.540(3) 
_cell_angle_gamma                86.114(2) 
_cell_volume                     453.89(11) 
_cell_formula_units_Z            2 
_cell_measurement_temperature    293(2) 
_cell_measurement_reflns_used    966 
_cell_measurement_theta_min      2.59 
_cell_measurement_theta_max      26.53 
_exptl_crystal_description       block 
_exptl_crystal_colour            colourless 
_exptl_crystal_size_min          0.10 
_exptl_crystal_size_mid          0.15 
_exptl_crystal_size_max          0.50 
_exptl_crystal_density_meas      ? 
_exptl_crystal_density_diffrn    1.348 
_exptl_crystal_density_method    'not measured' 
_exptl_crystal_F_000             196 
_exptl_absorpt_coefficient_mu    0.106 
_exptl_absorpt_correction_type   none 
_exptl_absorpt_correction_T_min  ? 
_exptl_absorpt_correction_T_max  ? 
_exptl_absorpt_process_details   ? 
 
_exptl_special_details            
;
?
;
_diffrn_ambient_temperature      293(2) 
_diffrn_radiation_probe          x-ray 
_diffrn_radiation_type           MoK\a 
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_diffrn_radiation_wavelength     0.71073 
_diffrn_source                   'sealed tube' 
_diffrn_radiation_monochromator  graphite 
_diffrn_measurement_device_type  'CCD area detector' 
_diffrn_measurement_method       'phi and omega scans' 
_diffrn_detector_area_resol_mean ? 
_diffrn_standards_number         ? 
_diffrn_standards_interval_count ? 
_diffrn_standards_interval_time  ? 
_diffrn_standards_decay_%        ? 
_diffrn_reflns_number            2428 
_diffrn_reflns_av_R_equivalents  0.0587 
_diffrn_reflns_av_sigmaI/netI    0.0477 
_diffrn_reflns_limit_h_min       -8 
_diffrn_reflns_limit_h_max       8 
_diffrn_reflns_limit_k_min       -9 
_diffrn_reflns_limit_k_max       9 
_diffrn_reflns_limit_l_min       -6 
_diffrn_reflns_limit_l_max       9 
_diffrn_reflns_theta_min         2.59 
_diffrn_reflns_theta_max         25.00 
_reflns_number_total             1583 
_reflns_number_gt                1311 
_reflns_threshold_expression     >2sigma(I) 
 
_computing_data_collection       'Bruker SMART' 
_computing_cell_refinement       'Bruker SMART' 
_computing_data_reduction        'Bruker SAINT' 
_computing_structure_solution    'Bruker SHELXTL' 
_computing_structure_refinement  'Bruker SHELXTL' 
_computing_molecular_graphics    'Bruker SHELXTL' 
_computing_publication_material  'Bruker SHELXTL' 
 
_refine_special_details           
;
Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and 
 goodness of fit S are based on F^2^, conventional R-factors R are based 
 on F, with F set to zero for negative F^2^. The threshold expression of 
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and is 
 not relevant to the choice of reflections for refinement.  R-factors based 
 on F^2^ are statistically about twice as large as those based on F, and R- 
 factors based on ALL data will be even larger. 
;
_refine_ls_structure_factor_coef Fsqd 
_refine_ls_matrix_type           full 
_refine_ls_weighting_scheme      calc 
_refine_ls_weighting_details      
'calc w=1/[\s^2^(Fo^2^)+(0.0803P)^2^+0.0000P] where P=(Fo^2^+2Fc^2^)/3' 
_atom_sites_solution_primary     direct 
_atom_sites_solution_secondary   difmap 
_atom_sites_solution_hydrogens   geom 
_refine_ls_hydrogen_treatment    mixed 
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_refine_ls_extinction_method     SHELXL 
_refine_ls_extinction_coef       0.027(11) 
_refine_ls_extinction_expression Fc^*^=kFc[1+0.001xFc^2^\l^3^/sin(2\q)]^-1/4^ 
_refine_ls_number_reflns         1583 
_refine_ls_number_parameters     121 
_refine_ls_number_restraints     0 
_refine_ls_R_factor_all          0.0605 
_refine_ls_R_factor_gt           0.0529 
_refine_ls_wR_factor_ref         0.1414 
_refine_ls_wR_factor_gt          0.1351 
_refine_ls_goodness_of_fit_ref   1.029 
_refine_ls_restrained_S_all      1.029 
_refine_ls_shift/su_max          0.000 
_refine_ls_shift/su_mean         0.000 
 
loop_ 
_atom_site_label 
_atom_site_type_symbol 
_atom_site_fract_x 
_atom_site_fract_y 
_atom_site_fract_z 
_atom_site_U_iso_or_equiv 
_atom_site_adp_type 
_atom_site_occupancy 
_atom_site_symmetry_multiplicity 
_atom_site_calc_flag 
_atom_site_refinement_flags 
_atom_site_disorder_assembly 
_atom_site_disorder_group 
O2 O 0.19794(18) 0.38773(15) 0.55710(16) 0.0517(4) Uani 1 1 d . . . 
O4 O 0.38542(18) -0.05322(15) 0.85346(18) 0.0534(4) Uani 1 1 d . . . 
O3 O 0.56481(18) 0.14141(16) 0.6395(2) 0.0661(5) Uani 1 1 d . . . 
O1 O -0.0597(2) 0.63082(19) 0.8229(2) 0.0745(5) Uani 1 1 d . . . 
C8 C 0.4233(3) 0.1057(2) 0.7566(2) 0.0433(5) Uani 1 1 d . . . 
C5 C 0.2674(2) 0.2268(2) 0.8108(2) 0.0420(5) Uani 1 1 d . . . 
H5 H 0.2048 0.1872 0.9340 0.050 Uiso 1 1 calc R . . 
C4 C 0.1155(2) 0.2493(2) 0.7034(2) 0.0441(5) Uani 1 1 d . . . 
C2 C 0.0159(3) 0.5143(2) 0.7655(3) 0.0535(5) Uani 1 1 d . . . 
C6 C 0.3393(3) 0.4110(2) 0.7698(3) 0.0517(5) Uani 1 1 d . . . 
H6A H 0.3166 0.4517 0.8736 0.062 Uiso 1 1 calc R . . 
H6B H 0.4752 0.4204 0.7116 0.062 Uiso 1 1 calc R . . 
C1 C 0.2175(3) 0.5081(2) 0.6514(3) 0.0534(6) Uani 1 1 d . . . 
H1 H 0.2697 0.6190 0.5797 0.064 Uiso 1 1 calc R . . 
C3 C -0.0607(3) 0.3378(3) 0.7960(3) 0.0548(6) Uani 1 1 d . . . 
H3A H -0.1677 0.3399 0.7455 0.066 Uiso 1 1 calc R . . 
H3B H -0.1007 0.2827 0.9180 0.066 Uiso 1 1 calc R . . 
C9 C 0.5214(3) -0.1813(2) 0.8048(3) 0.0661(6) Uani 1 1 d . . . 
H9A H 0.5110 -0.1996 0.6978 0.099 Uiso 1 1 calc R . . 
H9B H 0.4947 -0.2858 0.8927 0.099 Uiso 1 1 calc R . . 
H9C H 0.6491 -0.1440 0.7914 0.099 Uiso 1 1 calc R . . 
C7 C 0.0747(3) 0.0988(3) 0.6438(3) 0.0617(6) Uani 1 1 d . . . 
H7A H -0.0190 0.1300 0.5782 0.093 Uiso 1 1 calc R . . 
H7B H 0.0260 0.0066 0.7420 0.093 Uiso 1 1 calc R . . 
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H7C H 0.1910 0.0638 0.5730 0.093 Uiso 1 1 calc R . . 
 
loop_ 
_atom_site_aniso_label 
_atom_site_aniso_U_11 
_atom_site_aniso_U_22 
_atom_site_aniso_U_33 
_atom_site_aniso_U_23 
_atom_site_aniso_U_13 
_atom_site_aniso_U_12 
O2 0.0640(9) 0.0463(8) 0.0371(7) -0.0041(6) -0.0065(6) 0.0027(6) 
O4 0.0530(8) 0.0389(7) 0.0575(9) 0.0014(6) -0.0089(6) 0.0001(6) 
O3 0.0521(9) 0.0488(8) 0.0749(11) -0.0019(8) 0.0092(8) 0.0001(6) 
O1 0.0941(12) 0.0626(10) 0.0627(10) -0.0207(8) -0.0162(9) 0.0324(8) 
C8 0.0427(10) 0.0392(10) 0.0446(11) -0.0034(8) -0.0108(9) -0.0045(8) 
C5 0.0431(10) 0.0404(10) 0.0380(10) -0.0052(8) -0.0059(8) -0.0049(8) 
C4 0.0420(10) 0.0414(10) 0.0430(11) -0.0043(8) -0.0066(8) -0.0016(8) 
C2 0.0675(13) 0.0479(11) 0.0400(10) -0.0065(9) -0.0136(9) 0.0178(9) 
C6 0.0514(11) 0.0436(11) 0.0585(13) -0.0142(9) -0.0088(9) -0.0042(8) 
C1 0.0681(13) 0.0331(9) 0.0492(12) -0.0047(9) -0.0033(10) -0.0007(8) 
C3 0.0453(11) 0.0601(12) 0.0513(12) -0.0063(10) -0.0077(9) 0.0053(9) 
C9 0.0725(15) 0.0417(11) 0.0772(16) -0.0050(11) -0.0190(12) 0.0094(10) 
C7 0.0574(13) 0.0582(12) 0.0780(16) -0.0238(12) -0.0247(11) -0.0023(10) 
 
_geom_special_details             
;
All esds (except the esd in the dihedral angle between two l.s. planes) 
 are estimated using the full covariance matrix.  The cell esds are taken 
 into account individually in the estimation of esds in distances, angles 
 and torsion angles; correlations between esds in cell parameters are only 
 used when they are defined by crystal symmetry.  An approximate (isotropic) 
 treatment of cell esds is used for estimating esds involving l.s. planes. 
;
loop_ 
_geom_bond_atom_site_label_1 
_geom_bond_atom_site_label_2 
_geom_bond_distance 
_geom_bond_site_symmetry_2 
_geom_bond_publ_flag 
O2 C1 1.434(2) . ? 
O2 C4 1.451(2) . ? 
O4 C8 1.337(2) . ? 
O4 C9 1.440(2) . ? 
O3 C8 1.201(2) . ? 
O1 C2 1.200(2) . ? 
C8 C5 1.497(2) . ? 
C5 C6 1.541(2) . ? 
C5 C4 1.564(2) . ? 
C5 H5 0.9800 . ? 
C4 C7 1.502(2) . ? 
C4 C3 1.537(3) . ? 
C2 C3 1.507(3) . ? 
Diels-Alder Reactions of 3-Furylamines: Appendices 
333 
C2 C1 1.517(3) . ? 
C6 C1 1.529(3) . ? 
C6 H6A 0.9700 . ? 
C6 H6B 0.9700 . ? 
C1 H1 0.9800 . ? 
C3 H3A 0.9700 . ? 
C3 H3B 0.9700 . ? 
C9 H9A 0.9600 . ? 
C9 H9B 0.9600 . ? 
C9 H9C 0.9600 . ? 
C7 H7A 0.9600 . ? 
C7 H7B 0.9600 . ? 
C7 H7C 0.9600 . ? 
 
loop_ 
_geom_angle_atom_site_label_1 
_geom_angle_atom_site_label_2 
_geom_angle_atom_site_label_3 
_geom_angle 
_geom_angle_site_symmetry_1 
_geom_angle_site_symmetry_3 
_geom_angle_publ_flag 
C1 O2 C4 97.76(12) . . ? 
C8 O4 C9 115.88(15) . . ? 
O3 C8 O4 122.49(17) . . ? 
O3 C8 C5 125.88(16) . . ? 
O4 C8 C5 111.62(15) . . ? 
C8 C5 C6 113.02(14) . . ? 
C8 C5 C4 111.56(15) . . ? 
C6 C5 C4 101.42(14) . . ? 
C8 C5 H5 110.2 . . ? 
C6 C5 H5 110.2 . . ? 
C4 C5 H5 110.2 . . ? 
O2 C4 C7 110.56(16) . . ? 
O2 C4 C3 100.89(14) . . ? 
C7 C4 C3 116.02(15) . . ? 
O2 C4 C5 101.76(12) . . ? 
C7 C4 C5 117.86(15) . . ? 
C3 C4 C5 107.50(16) . . ? 
O1 C2 C3 128.85(19) . . ? 
O1 C2 C1 127.6(2) . . ? 
C3 C2 C1 103.49(15) . . ? 
C1 C6 C5 102.15(14) . . ? 
C1 C6 H6A 111.3 . . ? 
C5 C6 H6A 111.3 . . ? 
C1 C6 H6B 111.3 . . ? 
C5 C6 H6B 111.3 . . ? 
H6A C6 H6B 109.2 . . ? 
O2 C1 C2 102.40(15) . . ? 
O2 C1 C6 102.75(14) . . ? 
C2 C1 C6 106.17(17) . . ? 
O2 C1 H1 114.7 . . ? 
C2 C1 H1 114.7 . . ? 
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C6 C1 H1 114.7 . . ? 
C2 C3 C4 101.62(15) . . ? 
C2 C3 H3A 111.4 . . ? 
C4 C3 H3A 111.4 . . ? 
C2 C3 H3B 111.4 . . ? 
C4 C3 H3B 111.4 . . ? 
H3A C3 H3B 109.3 . . ? 
O4 C9 H9A 109.5 . . ? 
O4 C9 H9B 109.5 . . ? 
H9A C9 H9B 109.5 . . ? 
O4 C9 H9C 109.5 . . ? 
H9A C9 H9C 109.5 . . ? 
H9B C9 H9C 109.5 . . ? 
C4 C7 H7A 109.5 . . ? 
C4 C7 H7B 109.5 . . ? 
H7A C7 H7B 109.5 . . ? 
C4 C7 H7C 109.5 . . ? 
H7A C7 H7C 109.5 . . ? 
H7B C7 H7C 109.5 . . ? 
 
loop_ 
_geom_torsion_atom_site_label_1 
_geom_torsion_atom_site_label_2 
_geom_torsion_atom_site_label_3 
_geom_torsion_atom_site_label_4 
_geom_torsion 
_geom_torsion_site_symmetry_1 
_geom_torsion_site_symmetry_2 
_geom_torsion_site_symmetry_3 
_geom_torsion_site_symmetry_4 
_geom_torsion_publ_flag 
C9 O4 C8 O3 -2.4(3) . . . . ? 
C9 O4 C8 C5 176.40(16) . . . . ? 
O3 C8 C5 C6 -28.6(3) . . . . ? 
O4 C8 C5 C6 152.70(16) . . . . ? 
O3 C8 C5 C4 85.0(2) . . . . ? 
O4 C8 C5 C4 -93.77(17) . . . . ? 
C1 O2 C4 C7 179.27(15) . . . . ? 
C1 O2 C4 C3 55.95(16) . . . . ? 
C1 O2 C4 C5 -54.72(15) . . . . ? 
C8 C5 C4 O2 -88.23(15) . . . . ? 
C6 C5 C4 O2 32.35(16) . . . . ? 
C8 C5 C4 C7 32.8(2) . . . . ? 
C6 C5 C4 C7 153.41(16) . . . . ? 
C8 C5 C4 C3 166.23(14) . . . . ? 
C6 C5 C4 C3 -73.19(17) . . . . ? 
C8 C5 C6 C1 120.65(16) . . . . ? 
C4 C5 C6 C1 1.10(17) . . . . ? 
C4 O2 C1 C2 -53.79(16) . . . . ? 
C4 O2 C1 C6 56.21(16) . . . . ? 
O1 C2 C1 O2 -152.25(19) . . . . ? 
C3 C2 C1 O2 30.56(19) . . . . ? 
O1 C2 C1 C6 100.3(2) . . . . ? 
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C3 C2 C1 C6 -76.84(18) . . . . ? 
C5 C6 C1 O2 -34.87(17) . . . . ? 
C5 C6 C1 C2 72.28(17) . . . . ? 
O1 C2 C3 C4 -173.5(2) . . . . ? 
C1 C2 C3 C4 3.7(2) . . . . ? 
O2 C4 C3 C2 -36.26(18) . . . . ? 
C7 C4 C3 C2 -155.72(18) . . . . ? 
C5 C4 C3 C2 69.90(17) . . . . ? 
 
_diffrn_measured_fraction_theta_max 0.986 
_diffrn_reflns_theta_full        25.00 
_diffrn_measured_fraction_theta_full 0.986 
_refine_diff_density_max         0.244 
_refine_diff_density_min         -0.202 
_refine_diff_density_rms         0.049 
_chemical_compound_source        'Produced Synthetically' 
_exptl_crystal_recrystallization_method Ether 
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Appendix 3.6: 200 MHz 1H NMR and 50 MHz 13C NMR spectra of 26 with GC-MS data. 
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Appendix 3.7: GC traces for the GC-MS analysis of the crude D-A reaction mixture between 5a and 
MAC in H2O at 2ºC (top) and 25ºC (bottom). 
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Appendix 3.8: GC traces for the GC-MS analysis of the crude D-A reaction mixture between 5b and 
MAC in H2O (top), 3.0 M LiCl (second from top), 0.1 M CH3COOH (second from bottom) and 
DIMCARB (bottom) at 25ºC. 
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Appendix 3.9: GC-MS data for the crude D-A reaction between 5p and MAC in DCM. 
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Appendix 3.10: 300 MHz COSY NMR analysis for 28-endo with assignments for the major 
diastereoisomer. The 75 MHz 13C NMR for 28-endo in CDCl3 and the hydrochloride salt of 28-endo in 
D2O is also shown. 
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Appendix 3.11: 300 MHz 1H/ 75 MHz 13C HMBC NMR of 28-endo with 1H expansions. 
 
Chapter 3: Appendices 
342 
Appendix 3.12: 300 MHz 1H COSY NMR analysis of 29 with structure assignments for the major 
isomer. The GC-MS data for 29 is also shown.  
 
Diels-Alder Reactions of 3-Furylamines: Appendices 
343 
Appendix 3.13: 75 MHz 13C NMR Analysis and 300 MHz 1H/ 75 MHz 13C HMBC NMR analysis 
of 29. 1H expansions are also shown. 
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Appendix 3.14: 300 MHz 1H/75 MHz 13C HMQC NMR, 300 MHz COSY NMR and 300 MHz 
1H/75 MHz 13C HMBC NMR spectra of the pure isomer (1S,2S,4S,5S)-29.HClO4. DEPT 135 data is also 
shown. 
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Appendix 3.15: A summary of bond distances and the X-ray crystal CIF file is shown for 
(1S,2S,4S,5S)-29.HClO4. The atom numbering produced in the CIF file used to describe the X-ray crystal 
data is slightly different from that used throughout the discussion in Chapter 3 and alternate numbering 
used in the crystal structure data of  (1S,2S,4S,5S)-methyl- 5-(N-((1S,2S)-1-hydroxy-1-phenylpropan-2-
yl)-N-methylamino)-1-methyl-7-oxa-bicyclo[2.2.1]heptane-2-carboxylate perchlorate salt (1S,2S,4S,5S)-
29.HClO4 is shown below.  
 
O
N
OO
C1
C4
C3
C2
C7
C5
C6
O1
O7
O8
C9
C8
OH
H
H
C10
C15
C17
C18
O2
C14
C13
C12
C11
C16
C20
Cl
O
O
O
O O3O4
O6
O5
Cl1
Atom 1 Atom 2 Exp. d (Å) Lit. d[88] (Å) Closest functional group   
O6  Cl1  1.418(5) 1.414 Cl-O ClO4-
O5  Cl1  1.393(5) 
Cl1  O3  1.389(4)     
Cl1  O4  1.430(4) 
O2  C10  1.416(5) 1.432 Csp3-O(2) C2-CH-OH
O1  C4  1.429(5) 1.429 Csp2-O(2) (C)2-CH-O-C  
O1  C1  1.464(5) 1.452 Csp2-O(2) (C)3-C-O-C  
N1  C17  1.503(5) 1.502 Csp3-N(4) C3-NH+
N1  C5  1.513(5) 
N1  C9  1.521(5)     
C3  C4  1.526(6) 1.535 Csp3-Csp3 C-C cyclohexane
C3  C2  1.526(6) 1.535 Csp3-Csp3 C-C cyclohexane
C11 C12  1.374(6) 1.380 Car=Car H-C=C-H aromatic 
C11 C16  1.394(6) 1.397 Car=Car C-C=C-C aromatic 
C12 C13  1.384(7)   
C15 C14  1.381(9)   
C16 C15  1.389(7) 
C13 C14  1.371(9) 
C11 C10  1.507(6) 1.510 Csp3-Car C-CH2-Car
C5  C4  1.539(5) 1.535 Csp3-Csp3 C-C cyclohexane
C5  C6  1.545(5) 1.543 Csp3-Csp3 C-C cyclopentane
C1  C6 1.531(5) 1.535 Csp3-Csp3 C-C cyclohexane
C1  C2  1.545(5) 1.543 Csp3-Csp3 C-C cyclopentane
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C2  C7  1.506(6) 1.497 Csp3-Csp3 C-C(=O)(-OC) acyclic esters
C10 C9  1.537(6) 1.542 Csp3-Csp3 C2-CH-CH-C2
C9  C18  1.526(6) 1.524 Csp3-Csp3 C2-CH-CH3
C7  O8  1.198(5) 1.196 Csp2=O(1) C-C(=O)-O-C  
C7  O7  1.324(5) 1.336 Csp2-O(2) C-C(=O)-O-C  
O7  C8  1.451(5) 1.448 Csp3-O(2) C-C(=O)-O-CH3
C1  C20  1.487(6) 
X-ray crystal CIF data: 
 
_audit_creation_method            SHELXL-97 
_chemical_name_systematic 
;
?
;
_chemical_name_common             ? 
_chemical_melting_point           ? 
_chemical_formula_moiety          ? 
_chemical_formula_sum 
 'C19 H28 Cl N O8' 
_chemical_formula_weight          433.87 
 
loop_ 
 _atom_type_symbol 
 _atom_type_description 
 _atom_type_scat_dispersion_real 
 _atom_type_scat_dispersion_imag 
 _atom_type_scat_source 
 'C'  'C'   0.0181   0.0091 
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4' 
 'H'  'H'   0.0000   0.0000 
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4' 
 'N'  'N'   0.0311   0.0180 
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4' 
 'O'  'O'   0.0492   0.0322 
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4' 
 'Cl'  'Cl'   0.3639   0.7018 
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4' 
 
_symmetry_cell_setting            'orthorhombic' 
_symmetry_space_group_name_H-M    P212121 
 
loop_ 
 _symmetry_equiv_pos_as_xyz 
 'x, y, z' 
 '-x+1/2, -y, z+1/2' 
 'x+1/2, -y+1/2, -z' 
 '-x, y+1/2, -z+1/2' 
 
_cell_length_a                    8.511(2) 
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_cell_length_b                    15.356(5) 
_cell_length_c                    15.839(3) 
_cell_angle_alpha                 90.00 
_cell_angle_beta                  90.00 
_cell_angle_gamma                 90.00 
_cell_volume                      2070.1(9) 
_cell_formula_units_Z             4 
_cell_measurement_temperature     293(2) 
_cell_measurement_reflns_used     25 
_cell_measurement_theta_min       15 
_cell_measurement_theta_max       25 
 
_exptl_crystal_description        'plate' 
_exptl_crystal_colour             'colourless' 
_exptl_crystal_size_max           0.2 
_exptl_crystal_size_mid           0.1 
_exptl_crystal_size_min           0.02 
_exptl_crystal_density_meas       ? 
_exptl_crystal_density_diffrn     1.392 
_exptl_crystal_density_method     'not measured' 
_exptl_crystal_F_000              920 
_exptl_absorpt_coefficient_mu     2.043 
_exptl_absorpt_correction_type    'analytical' 
_exptl_absorpt_correction_T_min   0.7624 
_exptl_absorpt_correction_T_max   0.9604 
_exptl_absorpt_process_details    'WingX' 
 
_exptl_special_details 
;
?
;
_diffrn_ambient_temperature       293(2) 
_diffrn_radiation_wavelength      1.54180 
_diffrn_radiation_type            CuK\a 
_diffrn_radiation_source          'fine-focus sealed tube' 
 'audit_creation_method           'WinGX-Routine XCAD4' 
_audit_creation_date             2004-08-30 
_diffrn_radiation_monochromator  graphite 
_diffrn_radiation_probe          x-ray 
_diffrn_source                   'Enraf Nonius FR590' 
_diffrn_detector                 'scintillation LiI' 
_diffrn_detector_dtime           1.195 
_diffrn_measurement_device       '\k-geometry diffractometer' 
_diffrn_measurement_device_type  'Enraf Nonius CAD4' 
_diffrn_measurement_method       'non-profiled omega/2theta scans' 
_diffrn_standards_number         3 
_diffrn_standards_interval_time  160 
_diffrn_standards_decay_%         1 
_diffrn_reflns_number             2462 
_diffrn_reflns_av_R_equivalents   0.0230 
_diffrn_reflns_av_sigmaI/netI     0.0313 
_diffrn_reflns_limit_h_min        -1 
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_diffrn_reflns_limit_h_max        9 
_diffrn_reflns_limit_k_min        -18 
_diffrn_reflns_limit_k_max        0 
_diffrn_reflns_limit_l_min        -1 
_diffrn_reflns_limit_l_max        18 
_diffrn_reflns_theta_min          4.01 
_diffrn_reflns_theta_max          64.92 
_reflns_number_total              2365 
_reflns_number_gt                 2006 
_reflns_threshold_expression      >2sigma(I) 
 
_computing_data_collection        ? 
_computing_cell_refinement        ? 
_computing_data_reduction         ? 
_computing_structure_solution     ? 
_computing_structure_refinement   'SHELXL-97 (Sheldrick, 1997)' 
_computing_molecular_graphics     ? 
_computing_publication_material   ? 
 
_refine_special_details 
;
Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and 
 goodness of fit S are based on F^2^, conventional R-factors R are based 
 on F, with F set to zero for negative F^2^. The threshold expression of 
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and is 
 not relevant to the choice of reflections for refinement.  R-factors based 
 on F^2^ are statistically about twice as large as those based on F, and R- 
 factors based on ALL data will be even larger. 
;
_refine_ls_structure_factor_coef  Fsqd 
_refine_ls_matrix_type            full 
_refine_ls_weighting_scheme       calc 
_refine_ls_weighting_details 
 'calc w=1/[\s^2^(Fo^2^)+(0.0878P)^2^+0.2825P] where P=(Fo^2^+2Fc^2^)/3' 
_atom_sites_solution_primary      direct 
_atom_sites_solution_secondary    difmap 
_atom_sites_solution_hydrogens    geom 
_refine_ls_hydrogen_treatment     mixed 
_refine_ls_extinction_method      SHELXL 
_refine_ls_extinction_coef        0.0011(3) 
_refine_ls_extinction_expression 
 'Fc^*^=kFc[1+0.001xFc^2^\l^3^/sin(2\q)]^-1/4^' 
_refine_ls_abs_structure_details 
 'Flack H D (1983), Acta Cryst. A39, 876-881' 
_refine_ls_abs_structure_Flack    0.00(3) 
_refine_ls_number_reflns          2365 
_refine_ls_number_parameters      275 
_refine_ls_number_restraints      0 
_refine_ls_R_factor_all           0.0608 
_refine_ls_R_factor_gt            0.0496 
_refine_ls_wR_factor_ref          0.1371 
_refine_ls_wR_factor_gt           0.1271 
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_refine_ls_goodness_of_fit_ref    1.071 
_refine_ls_restrained_S_all       1.071 
_refine_ls_shift/su_max           0.000 
_refine_ls_shift/su_mean          0.000 
 
loop_ 
 _atom_site_label 
 _atom_site_type_symbol 
 _atom_site_fract_x 
 _atom_site_fract_y 
 _atom_site_fract_z 
 _atom_site_U_iso_or_equiv 
 _atom_site_adp_type 
 _atom_site_occupancy 
 _atom_site_symmetry_multiplicity 
 _atom_site_calc_flag 
 _atom_site_refinement_flags 
 _atom_site_disorder_assembly 
 _atom_site_disorder_group 
H1 H 0.316(5) -0.039(2) 0.125(2) 0.032(10) Uiso 1 1 d . . . 
O6 O 0.9119(7) 0.7454(3) 0.1749(4) 0.133(2) Uani 1 1 d . . . 
O5 O 0.7120(9) 0.7727(4) 0.0797(3) 0.135(2) Uani 1 1 d . . . 
Cl1 Cl 0.77073(15) 0.71368(7) 0.13861(7) 0.0568(3) Uani 1 1 d . . . 
O2 O 0.5625(4) -0.0230(2) 0.14945(19) 0.0482(8) Uani 1 1 d . . . 
O1 O -0.1188(3) 0.00263(19) 0.1100(2) 0.0489(8) Uani 1 1 d . . . 
N1 N 0.2753(4) -0.0757(2) 0.1633(2) 0.0364(7) Uani 1 1 d . . . 
C3 C 0.0923(5) -0.0022(3) 0.0182(2) 0.0449(10) Uani 1 1 d . . . 
H3A H 0.0469 -0.0153 -0.0365 0.054 Uiso 1 1 calc R . . 
H3B H 0.2041 -0.0145 0.0168 0.054 Uiso 1 1 calc R . . 
C11 C 0.6446(5) -0.0379(3) 0.2962(3) 0.0411(9) Uani 1 1 d . . . 
C5 C 0.1045(5) -0.0496(2) 0.1716(2) 0.0359(9) Uani 1 1 d . . . 
H5 H 0.0537 -0.0877 0.2131 0.043 Uiso 1 1 calc R . . 
C1 C -0.0275(5) 0.0810(2) 0.1292(3) 0.0413(9) Uani 1 1 d . . . 
C6 C 0.0805(5) 0.0461(2) 0.1987(2) 0.0376(9) Uani 1 1 d . . . 
H6A H 0.0309 0.0499 0.2537 0.045 Uiso 1 1 calc R . . 
H6B H 0.1795 0.0775 0.2000 0.045 Uiso 1 1 calc R . . 
C2 C 0.0600(5) 0.0918(3) 0.0444(2) 0.0423(10) Uani 1 1 d . . . 
H2A H -0.0137 0.1168 0.0035 0.051 Uiso 1 1 calc R . . 
C16 C 0.6335(6) 0.0486(3) 0.3224(3) 0.0516(11) Uani 1 1 d . . . 
H16 H 0.5604 0.0857 0.2977 0.062 Uiso 1 1 calc R . . 
C10 C 0.5438(5) -0.0712(3) 0.2250(2) 0.0396(9) Uani 1 1 d . . . 
H10 H 0.5712 -0.1321 0.2139 0.048 Uiso 1 1 calc R . . 
C9 C 0.3674(5) -0.0657(3) 0.2450(2) 0.0376(9) Uani 1 1 d . . . 
H9 H 0.3461 -0.0074 0.2675 0.045 Uiso 1 1 calc R . . 
C17 C 0.2890(6) -0.1647(3) 0.1247(3) 0.0561(12) Uani 1 1 d . . . 
H17A H 0.2276 -0.2053 0.1568 0.084 Uiso 1 1 calc R . . 
H17B H 0.3971 -0.1826 0.1249 0.084 Uiso 1 1 calc R . . 
H17C H 0.2511 -0.1631 0.0676 0.084 Uiso 1 1 calc R . . 
C18 C 0.3180(6) -0.1319(4) 0.3117(3) 0.0663(15) Uani 1 1 d . . . 
H18A H 0.2072 -0.1268 0.3219 0.099 Uiso 1 1 calc R . . 
H18B H 0.3743 -0.1210 0.3631 0.099 Uiso 1 1 calc R . . 
H18C H 0.3413 -0.1896 0.2920 0.099 Uiso 1 1 calc R . . 
C4 C 0.0104(5) -0.0525(3) 0.0887(3) 0.0448(10) Uani 1 1 d . . . 
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H4 H -0.0213 -0.1115 0.0722 0.054 Uiso 1 1 calc R . . 
C12 C 0.7538(6) -0.0913(3) 0.3336(3) 0.0596(12) Uani 1 1 d . . . 
H12 H 0.7612 -0.1492 0.3169 0.072 Uiso 1 1 calc R . . 
C15 C 0.7323(7) 0.0789(3) 0.3857(3) 0.0678(15) Uani 1 1 d . . . 
H15 H 0.7241 0.1363 0.4036 0.081 Uiso 1 1 calc R . . 
O4 O 0.6607(7) 0.7060(3) 0.2064(3) 0.1081(17) Uani 1 1 d . . . 
C7 C 0.1989(5) 0.1522(3) 0.0511(3) 0.0451(10) Uani 1 1 d . . . 
O3 O 0.7961(8) 0.6309(3) 0.1061(3) 0.1153(18) Uani 1 1 d . . . 
C13 C 0.8529(7) -0.0600(5) 0.3959(3) 0.0757(17) Uani 1 1 d . . . 
H13 H 0.9271 -0.0968 0.4201 0.091 Uiso 1 1 calc R . . 
C14 C 0.8426(8) 0.0248(5) 0.4223(3) 0.0797(18) Uani 1 1 d . . . 
H14 H 0.9089 0.0457 0.4644 0.096 Uiso 1 1 calc R . . 
O7 O 0.3300(3) 0.11242(19) 0.0742(2) 0.0519(8) Uani 1 1 d . . . 
O8 O 0.1917(5) 0.2295(2) 0.0413(3) 0.0805(12) Uani 1 1 d . . . 
C20 C -0.1280(5) 0.1562(3) 0.1533(3) 0.0569(12) Uani 1 1 d . . . 
H20A H -0.1838 0.1768 0.1045 0.085 Uiso 1 1 calc R . . 
H20B H -0.0632 0.2022 0.1752 0.085 Uiso 1 1 calc R . . 
H20C H -0.2018 0.1383 0.1957 0.085 Uiso 1 1 calc R . . 
C8 C 0.4631(6) 0.1685(3) 0.0924(4) 0.0676(14) Uani 1 1 d . . . 
H8A H 0.4838 0.2050 0.0444 0.101 Uiso 1 1 calc R . . 
H8C H 0.5538 0.1334 0.1041 0.101 Uiso 1 1 calc R . . 
H8B H 0.4396 0.2041 0.1405 0.101 Uiso 1 1 calc R . . 
H2 H 0.654(6) -0.021(3) 0.140(3) 0.044(13) Uiso 1 1 d . . . 
 
loop_ 
 _atom_site_aniso_label 
 _atom_site_aniso_U_11 
 _atom_site_aniso_U_22 
 _atom_site_aniso_U_33 
 _atom_site_aniso_U_23 
 _atom_site_aniso_U_13 
 _atom_site_aniso_U_12 
O6 0.101(4) 0.122(4) 0.176(5) 0.005(4) -0.045(4) -0.048(3) 
O5 0.160(5) 0.139(4) 0.108(3) 0.054(3) 0.002(4) 0.056(5) 
Cl1 0.0621(7) 0.0525(6) 0.0558(6) 0.0003(5) -0.0008(6) 0.0028(6) 
O2 0.0289(15) 0.075(2) 0.0408(16) 0.0139(14) 0.0022(14) 0.0021(15) 
O1 0.0240(12) 0.0548(17) 0.0679(19) 0.0041(15) -0.0046(15) -0.0073(13) 
N1 0.0294(16) 0.0357(15) 0.0442(17) -0.0017(14) -0.0012(16) -0.0034(14) 
C3 0.037(2) 0.060(2) 0.038(2) -0.0075(19) -0.0068(19) -0.009(2) 
C11 0.030(2) 0.050(2) 0.043(2) 0.0109(19) 0.0024(19) -0.0026(18) 
C5 0.0283(18) 0.0365(19) 0.0430(19) 0.0028(17) 0.0045(17) -0.0058(17) 
C1 0.0258(19) 0.047(2) 0.051(2) 0.0052(19) -0.0017(19) -0.0046(17) 
C6 0.028(2) 0.046(2) 0.0379(18) 0.0003(17) 0.0008(17) 0.0027(17) 
C2 0.033(2) 0.053(2) 0.041(2) 0.0082(18) -0.0088(19) -0.002(2) 
C16 0.051(3) 0.053(2) 0.051(2) 0.004(2) 0.002(2) -0.011(2) 
C10 0.032(2) 0.043(2) 0.044(2) 0.0036(17) -0.0013(18) 0.0046(18) 
C9 0.034(2) 0.0405(19) 0.0382(19) 0.0080(17) -0.0004(18) -0.0035(17) 
C17 0.055(3) 0.045(2) 0.069(3) -0.017(2) -0.006(3) 0.007(2) 
C18 0.049(3) 0.089(3) 0.060(3) 0.036(3) -0.004(3) -0.015(3) 
C4 0.033(2) 0.050(2) 0.051(2) -0.007(2) -0.008(2) -0.0073(19) 
C12 0.047(3) 0.073(3) 0.059(3) 0.018(2) -0.010(2) 0.005(2) 
C15 0.079(4) 0.071(3) 0.053(3) -0.005(2) 0.007(3) -0.034(3) 
O4 0.124(4) 0.095(3) 0.105(3) -0.004(3) 0.046(3) -0.015(3) 
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C7 0.039(2) 0.055(3) 0.041(2) 0.0111(18) 0.003(2) -0.005(2) 
O3 0.141(5) 0.086(3) 0.119(3) -0.043(3) -0.012(4) 0.024(3) 
C13 0.053(3) 0.116(5) 0.059(3) 0.030(3) -0.016(3) -0.004(3) 
C14 0.070(4) 0.119(5) 0.050(3) 0.011(3) -0.010(3) -0.042(4) 
O7 0.0281(14) 0.0512(17) 0.076(2) 0.0118(16) -0.0077(16) -0.0079(13) 
O8 0.065(2) 0.0485(19) 0.128(3) 0.028(2) -0.022(3) -0.0075(19) 
C20 0.037(2) 0.055(2) 0.078(3) 0.002(2) 0.004(3) 0.014(2) 
C8 0.038(2) 0.065(3) 0.100(4) 0.007(3) 0.000(3) -0.023(2) 
 
_geom_special_details 
;
All esds (except the esd in the dihedral angle between two l.s. planes) 
 are estimated using the full covariance matrix.  The cell esds are taken 
 into account individually in the estimation of esds in distances, angles 
 and torsion angles; correlations between esds in cell parameters are only 
 used when they are defined by crystal symmetry.  An approximate (isotropic) 
 treatment of cell esds is used for estimating esds involving l.s. planes. 
;
loop_ 
 _geom_bond_atom_site_label_1 
 _geom_bond_atom_site_label_2 
 _geom_bond_distance 
 _geom_bond_site_symmetry_2 
 _geom_bond_publ_flag 
O6 Cl1 1.418(5) . ? 
O5 Cl1 1.393(5) . ? 
Cl1 O3 1.389(4) . ? 
Cl1 O4 1.430(4) . ? 
O2 C10 1.416(5) . ? 
O2 H2 0.79(5) . ? 
O1 C4 1.429(5) . ? 
O1 C1 1.464(5) . ? 
N1 C17 1.503(5) . ? 
N1 C5 1.513(5) . ? 
N1 C9 1.521(5) . ? 
N1 H1 0.90(4) . ? 
C3 C4 1.526(6) . ? 
C3 C2 1.526(6) . ? 
C3 H3A 0.9700 . ? 
C3 H3B 0.9700 . ? 
C11 C12 1.374(6) . ? 
C11 C16 1.394(6) . ? 
C11 C10 1.507(6) . ? 
C5 C4 1.539(5) . ? 
C5 C6 1.545(5) . ? 
C5 H5 0.9800 . ? 
C1 C20 1.487(6) . ? 
C1 C6 1.531(5) . ? 
C1 C2 1.545(5) . ? 
C6 H6A 0.9700 . ? 
C6 H6B 0.9700 . ? 
C2 C7 1.506(6) . ? 
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C2 H2A 0.9800 . ? 
C16 C15 1.389(7) . ? 
C16 H16 0.9300 . ? 
C10 C9 1.537(6) . ? 
C10 H10 0.9800 . ? 
C9 C18 1.526(6) . ? 
C9 H9 0.9800 . ? 
C17 H17A 0.9600 . ? 
C17 H17B 0.9600 . ? 
C17 H17C 0.9600 . ? 
C18 H18A 0.9600 . ? 
C18 H18B 0.9600 . ? 
C18 H18C 0.9600 . ? 
C4 H4 0.9800 . ? 
C12 C13 1.384(7) . ? 
C12 H12 0.9300 . ? 
C15 C14 1.381(9) . ? 
C15 H15 0.9300 . ? 
C7 O8 1.198(5) . ? 
C7 O7 1.324(5) . ? 
C13 C14 1.371(9) . ? 
C13 H13 0.9300 . ? 
C14 H14 0.9300 . ? 
O7 C8 1.451(5) . ? 
C20 H20A 0.9600 . ? 
C20 H20B 0.9600 . ? 
C20 H20C 0.9600 . ? 
C8 H8A 0.9600 . ? 
C8 H8C 0.9600 . ? 
C8 H8B 0.9600 . ? 
 
loop_ 
 _geom_angle_atom_site_label_1 
 _geom_angle_atom_site_label_2 
 _geom_angle_atom_site_label_3 
 _geom_angle 
 _geom_angle_site_symmetry_1 
 _geom_angle_site_symmetry_3 
 _geom_angle_publ_flag 
O3 Cl1 O5 113.8(4) . . ? 
O3 Cl1 O6 109.5(4) . . ? 
O5 Cl1 O6 110.6(4) . . ? 
O3 Cl1 O4 107.7(3) . . ? 
O5 Cl1 O4 108.8(4) . . ? 
O6 Cl1 O4 106.2(4) . . ? 
C10 O2 H2 107(4) . . ? 
C4 O1 C1 97.3(3) . . ? 
C17 N1 C5 110.5(3) . . ? 
C17 N1 C9 113.5(3) . . ? 
C5 N1 C9 113.2(3) . . ? 
C17 N1 H1 106(2) . . ? 
C5 N1 H1 105(3) . . ? 
C9 N1 H1 108(2) . . ? 
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C4 C3 C2 101.4(3) . . ? 
C4 C3 H3A 111.5 . . ? 
C2 C3 H3A 111.5 . . ? 
C4 C3 H3B 111.5 . . ? 
C2 C3 H3B 111.5 . . ? 
H3A C3 H3B 109.3 . . ? 
C12 C11 C16 119.1(4) . . ? 
C12 C11 C10 120.4(4) . . ? 
C16 C11 C10 120.5(4) . . ? 
N1 C5 C4 114.7(3) . . ? 
N1 C5 C6 113.8(3) . . ? 
C4 C5 C6 101.3(3) . . ? 
N1 C5 H5 108.9 . . ? 
C4 C5 H5 108.9 . . ? 
C6 C5 H5 108.9 . . ? 
O1 C1 C20 112.8(3) . . ? 
O1 C1 C6 100.4(3) . . ? 
C20 C1 C6 115.6(4) . . ? 
O1 C1 C2 99.4(3) . . ? 
C20 C1 C2 114.6(4) . . ? 
C6 C1 C2 111.9(3) . . ? 
C1 C6 C5 102.3(3) . . ? 
C1 C6 H6A 111.3 . . ? 
C5 C6 H6A 111.3 . . ? 
C1 C6 H6B 111.3 . . ? 
C5 C6 H6B 111.3 . . ? 
H6A C6 H6B 109.2 . . ? 
C7 C2 C3 117.4(4) . . ? 
C7 C2 C1 112.5(3) . . ? 
C3 C2 C1 102.8(3) . . ? 
C7 C2 H2A 107.9 . . ? 
C3 C2 H2A 107.9 . . ? 
C1 C2 H2A 107.9 . . ? 
C15 C16 C11 119.5(5) . . ? 
C15 C16 H16 120.2 . . ? 
C11 C16 H16 120.2 . . ? 
O2 C10 C11 113.0(3) . . ? 
O2 C10 C9 104.8(3) . . ? 
C11 C10 C9 112.5(3) . . ? 
O2 C10 H10 108.8 . . ? 
C11 C10 H10 108.8 . . ? 
C9 C10 H10 108.8 . . ? 
N1 C9 C18 112.3(3) . . ? 
N1 C9 C10 108.8(3) . . ? 
C18 C9 C10 112.1(4) . . ? 
N1 C9 H9 107.8 . . ? 
C18 C9 H9 107.8 . . ? 
C10 C9 H9 107.8 . . ? 
N1 C17 H17A 109.5 . . ? 
N1 C17 H17B 109.5 . . ? 
H17A C17 H17B 109.5 . . ? 
N1 C17 H17C 109.5 . . ? 
H17A C17 H17C 109.5 . . ? 
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H17B C17 H17C 109.5 . . ? 
C9 C18 H18A 109.5 . . ? 
C9 C18 H18B 109.5 . . ? 
H18A C18 H18B 109.5 . . ? 
C9 C18 H18C 109.5 . . ? 
H18A C18 H18C 109.5 . . ? 
H18B C18 H18C 109.5 . . ? 
O1 C4 C3 102.9(3) . . ? 
O1 C4 C5 100.5(3) . . ? 
C3 C4 C5 111.8(3) . . ? 
O1 C4 H4 113.5 . . ? 
C3 C4 H4 113.5 . . ? 
C5 C4 H4 113.5 . . ? 
C11 C12 C13 120.8(5) . . ? 
C11 C12 H12 119.6 . . ? 
C13 C12 H12 119.6 . . ? 
C14 C15 C16 120.9(5) . . ? 
C14 C15 H15 119.5 . . ? 
C16 C15 H15 119.5 . . ? 
O8 C7 O7 122.4(4) . . ? 
O8 C7 C2 124.1(5) . . ? 
O7 C7 C2 113.4(3) . . ? 
C14 C13 C12 120.5(6) . . ? 
C14 C13 H13 119.7 . . ? 
C12 C13 H13 119.7 . . ? 
C13 C14 C15 119.1(5) . . ? 
C13 C14 H14 120.4 . . ? 
C15 C14 H14 120.4 . . ? 
C7 O7 C8 116.0(3) . . ? 
C1 C20 H20A 109.5 . . ? 
C1 C20 H20B 109.5 . . ? 
H20A C20 H20B 109.5 . . ? 
C1 C20 H20C 109.5 . . ? 
H20A C20 H20C 109.5 . . ? 
H20B C20 H20C 109.5 . . ? 
O7 C8 H8A 109.5 . . ? 
O7 C8 H8C 109.5 . . ? 
H8A C8 H8C 109.5 . . ? 
O7 C8 H8B 109.5 . . ? 
H8A C8 H8B 109.5 . . ? 
H8C C8 H8B 109.5 . . ? 
 
loop_ 
 _geom_torsion_atom_site_label_1 
 _geom_torsion_atom_site_label_2 
 _geom_torsion_atom_site_label_3 
 _geom_torsion_atom_site_label_4 
 _geom_torsion 
 _geom_torsion_site_symmetry_1 
 _geom_torsion_site_symmetry_2 
 _geom_torsion_site_symmetry_3 
 _geom_torsion_site_symmetry_4 
 _geom_torsion_publ_flag 
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C17 N1 C5 C4 -55.6(4) . . . . ? 
C9 N1 C5 C4 175.8(3) . . . . ? 
C17 N1 C5 C6 -171.6(3) . . . . ? 
C9 N1 C5 C6 59.8(4) . . . . ? 
C4 O1 C1 C20 178.8(4) . . . . ? 
C4 O1 C1 C6 -57.6(3) . . . . ? 
C4 O1 C1 C2 57.0(3) . . . . ? 
O1 C1 C6 C5 32.8(3) . . . . ? 
C20 C1 C6 C5 154.4(3) . . . . ? 
C2 C1 C6 C5 -71.9(4) . . . . ? 
N1 C5 C6 C1 125.6(3) . . . . ? 
C4 C5 C6 C1 2.1(4) . . . . ? 
C4 C3 C2 C7 127.3(4) . . . . ? 
C4 C3 C2 C1 3.3(4) . . . . ? 
O1 C1 C2 C7 -163.7(3) . . . . ? 
C20 C1 C2 C7 75.9(5) . . . . ? 
C6 C1 C2 C7 -58.3(5) . . . . ? 
O1 C1 C2 C3 -36.5(4) . . . . ? 
C20 C1 C2 C3 -156.9(4) . . . . ? 
C6 C1 C2 C3 68.9(4) . . . . ? 
C12 C11 C16 C15 -0.1(6) . . . . ? 
C10 C11 C16 C15 -177.2(4) . . . . ? 
C12 C11 C10 O2 -120.5(4) . . . . ? 
C16 C11 C10 O2 56.6(5) . . . . ? 
C12 C11 C10 C9 121.0(4) . . . . ? 
C16 C11 C10 C9 -61.9(5) . . . . ? 
C17 N1 C9 C18 -57.6(5) . . . . ? 
C5 N1 C9 C18 69.5(4) . . . . ? 
C17 N1 C9 C10 67.1(4) . . . . ? 
C5 N1 C9 C10 -165.9(3) . . . . ? 
O2 C10 C9 N1 41.0(4) . . . . ? 
C11 C10 C9 N1 164.2(3) . . . . ? 
O2 C10 C9 C18 165.8(4) . . . . ? 
C11 C10 C9 C18 -71.0(5) . . . . ? 
C1 O1 C4 C3 -56.4(3) . . . . ? 
C1 O1 C4 C5 59.1(3) . . . . ? 
C2 C3 C4 O1 32.3(4) . . . . ? 
C2 C3 C4 C5 -74.8(4) . . . . ? 
N1 C5 C4 O1 -160.2(3) . . . . ? 
C6 C5 C4 O1 -37.3(3) . . . . ? 
N1 C5 C4 C3 -51.6(5) . . . . ? 
C6 C5 C4 C3 71.3(4) . . . . ? 
C16 C11 C12 C13 -0.7(7) . . . . ? 
C10 C11 C12 C13 176.4(4) . . . . ? 
C11 C16 C15 C14 0.7(7) . . . . ? 
C3 C2 C7 O8 152.6(5) . . . . ? 
C1 C2 C7 O8 -88.5(5) . . . . ? 
C3 C2 C7 O7 -31.5(5) . . . . ? 
C1 C2 C7 O7 87.5(5) . . . . ? 
C11 C12 C13 C14 0.9(8) . . . . ? 
C12 C13 C14 C15 -0.3(8) . . . . ? 
C16 C15 C14 C13 -0.5(8) . . . . ? 
O8 C7 O7 C8 3.7(7) . . . . ? 
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C2 C7 O7 C8 -172.4(4) . . . . ? 
 
_diffrn_measured_fraction_theta_max    1.000 
_diffrn_reflns_theta_full              64.92 
_diffrn_measured_fraction_theta_full   1.000 
_refine_diff_density_max    0.341 
_refine_diff_density_min   -0.257 
_refine_diff_density_rms    0.050 
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Appendix 3.16: GC-MS data for the crude D-A reaction between 5q and MAC in DCM. 
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Appendix 3.17: GC-MS data for the crude D-A reaction between 5p and MAC in H2O with 
ultrasonic irradiation. 
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Appendix 3.18: GC-MS data for the crude D-A reaction between 5q and MAC in H2O and 3.0 M 
LiCl with ultrasonic irradiation. 
 
360 
Chapter 4 
Studies Toward the Synthesis of Ring A: Appendices  
Appendix 4.1: 300 MHz 1H/75 MHz 13C HMQC NMR and DEPT 135 NMR analysis of 31.
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Appendix 4.2: 300 MHz 1H COSY NMR of 32 and the GC-MS analysis for the crude reaction of 4a
with LHMDS in THF (-78°C to -45°C over 2 h) to give 32 in 56%. The  EI-MS spectrum of 32 (tR =
12:21 min) is shown below. 
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Appendix 4.3: GC-MS analysis of the crude desilylation mixture of 31 using TBAF which shows 
the formation of 32 as a minor component. 
 
O
O
O
32
O
O
TBDMSO
O
O
31
TBAF
DCM, 25°C, 1.5 h
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Appendix 4.4: 300 MHz 1H/75 MHz 13C HMQC and DEPT 135 NMR data of 33 with 13C
assignments. 
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Appendix 4.5: 300 MHz 1H/75 MHz 13C HMBC and DEPT 135 NMR of 3 with structural 
assignments. 
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Appendix 4.6: 300 MHz 1H COSY NMR of a 2:1 mixture of 3 and C(5)-epi-3. 13C NMR data is also 
shown. 
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Appendix 4.7: GC-MS for a fraction collected from the FCC purification of 2 on SiO2 (8:1, 
pentane:EtOAc) shows a mixture of 2 and C(5)-epi-2 due to C(5) epimerization on the stationary phase. 
The C(5)-epi-2 isomer at tR = 13:29 min was verified by EI-MS showing almost identical fragmentation 
to 2, however no molecular ion was observed for C(5)-epi-2.
O
OMeO
OO
O
OMeO
OO
+
2 C(5)-epi-2
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Appendix 4.8: 300 MHz 1H COSY NMR of 2 with structural assignments. 
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Appendix 4.9: 300 MHz 1H/75 MHz 13C HMBC and DEPT 135 NMR of 2 with structural 
assignments. 
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Appendix 4.10: 300 MHz 1H COSY NMR analysis of 1.0:0.7 ratio of cis:trans 34 with assignments 
for the trans-34 isomer shown.  
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Appendix 4.11: 13C NMR of a 1.0:0.3 mixture of cis:trans 34 with assignments for the major cis-34 
isomer. DEPT 135 NMR data is also included but shows only distinguishable signals for the major cis-34
isomer. 
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Studies Towards the -Lactone Ring C of (1): Appendices  
Appendix 5.1: GC-MS of the crude esterification mixture using 36 and crotonyl chloride with TEA. 
EI-MS of the product 35 (tR = 16:52 min) is shown. The GC trace of an attempted LDA lactone closure 
of 35 is shown at the bottom. 
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Appendix 5.2: 200 MHz 1H NMR analysis of 36 with structural assignments. 
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Appendix 5.3: GC-MS analysis of the crude aldol product 8 (tR = 10:63 min).  
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Appendix 5.4: 75 MHz 13C and DEPT 135 NMR data of 8 with 13C assignments. 
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Appendix 5.5: 300 MHz 1H/75 MHz 13C HMBC NMR of 7 with 1H structural assignments. 
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Appendix 5.6: 300 MHz 1H COSY NMR of 7 with structural assignments. 
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Appendix 5.7: FCC of the crude mixture of 7 led to isomerization to the ,-unsaturated 37. EI-MS 
spectra of 37 is also shown. 
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Appendix 5.8: 300 MHz 1H/75 MHz 13C HMQC and DEPT 135 NMR of 37 with structural 
assignments. 
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Appendix 5.9: 300 MHz 1H COSY NMR of 6 with structural assignments. 
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Appendix 5.10: 300 MHz 1H/75 MHz 13C HMQC NMR of 37 with structural assignments. 
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Appendix 5.11: 300 MHz 1H/75 MHz 13C HMQC and DEPT 135 NMR of 38 with structural 
assignments. 
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Chapter 6 
Experimental Procedures and Methodology 
Appendix 6.1: Characterisation data for 3-furylamines and intermediates 19, 4 and 21. 
 
4-Morpholino-5-(tetrahydropyran-2-yloxy)pent-3-en-2-one (19a)
1H NMR (200MHz, CDCl3):  5.29 (d, 1H, J = 11.9Hz), 5.20 (s, 1H), 4.71 (d, 1H, J = 11.9Hz), 
4.68 (m, 1H), 3.85 (m, 1H), 3.73 (t, 4H, J  = 5.0Hz), 3.55 (m, 1H), 3.35 (m, 4H), 2.1 (s, 3H), 1.9 – 1.4, 
(m, 6H). 13C NMR (200MHz, CDCl3):  195.9, 158.8, 100.0, 98.2, 66.6, 63.5, 60.8, 47.0, 32.3, 31.0, 
25.5, 20.2.  MS m/z (relative intensity) 269 (M+ 3.1), 210 (3.8), 186 (10.8), 185 (100), 184 (38.5), 170 
(15.4), 169 (16.2), 168 (27.7), 167 (12.3), 166 (3.8), 157 (4.6), 156 (51.5), 154 (7.7), 152 (15.4), 150 
(6.2), 143 (7.7), 142 (89.2), 140 (3.8), 138 (6.9), 137 (4.6), 136 (3.1), 127 (11.5), 126 (60.0), 124 (9.2), 
114 (9.2), 112 (9.2), 110 (9.2), 109 (11.5), 108 (3.8), 98 (4.6), 97 (7.7), 96 (6.9), 92 (4.6), 86 (16.2), 85 
(37.7), 84 (13.1), 83 (8.5), 82 (6.2), 81 (3.8), 80 (3.8), 70 (4.6), 69 (4.6), 68 (6.2), 67 (14.6), 57 (11.5), 56 
(7.7), 55 (14.6), 54 (5.4), 43 (25.4), 42 (5.4), 41 (15.4). 
 
4-(5-Methylfuran-3-yl)morpholine (5a)
IR (neat) 3140(w), 2960 (s), 2918 (s), 2855(s), 2820 (s), 2760 (m), 1755 (m), 1681 (s), 1621 (s), 
1555 (m), 1451 (s), 1397 (s), 1379 (s), 1359 (m), 1332 (m), 1302 (m), 1258 (s), 1228 (m), 1178 (m), 
1161 (m) and 1116 cm-1 (s).  1H NMR (200MHz, CDCl3):  6.82 (s, 1H), 5.86 (s, 1H), 3.81 (m, 4H), 2.87 
(m, 4H), 2.22 (s, 3H). 13C NMR (200MHz, CDCl3):  152.5, 141.7, 123.9, 100.2, 66.6, 50.8, 14.0. MS 
m/z (relative intensity) 169 (18.5), 168 (56.2), 167 (M+ 77.9), 166 (5.6), 154 (3.2), 153 (7.6), 152 (12.0), 
139 (4.4), 138 (10.4), 137 (6.4), 136 (8.4), 125 (3.2), 124 (8.4), 122 (8.0), 112 (7.2), 111 (33.7), 110 
(83.1), 109 (100), 108 (12.0), 97 (2.4), 96 (4.0), 95 (4.0), 94 (6.4), 84 (4.0), 83 (4.0), 82 (10.8), 81 (15.3), 
80 (16.1), 79 (4.0), 73 (2.8), 72 (2.4), 70 (4.4), 69 (4.4), 68 (4.0), 67 (6.0), 66 (4.8), 65 (3.2), 59 (2.4), 58 
(2.4), 57 (5.2), 56 (4.4), 55 (8.8), 54 (8.4), 53 (8.4), 52 (3.2), 51 (3.6), 45 (9.2), 44 (49.0), 43 (14.5), 42 
(9.6), 41 (17.7).; HRMS calc. for C9H14NO2 168.1025, found 168.1019. 
 
4-Diethylamino-5-(tetrahydropyran-2-yloxy)pent-3-en-2-one (19b)
1H NMR (200MHz, CDCl3):  5.10 (d, 1H, J = 11.3Hz), 4.94 (s, 1H), 4.67 (m, 1H), 4.58 (d, 1H, 
J = 11.3Hz), 3.75 (m, 1H), 3.40 (m, 1H), 3.21 (quartet, 4H, J = 7.4Hz), 1.93 (s, 3H), 1.72 - 1.28 (m, 6H), 
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1.05 (t, 6H, J = 7.0Hz). 13C NMR (200MHz, CDCl3):  194.1, 157.4, 99.5, 95.2, 62.6, 60.7, 43.8, 31.8, 
30.5, 25.2, 19.6, 12.7. MS m/z (relative intensity) 255 (M+ 7.7), 226 (3.8), 212 (3.8), 196 (10.8), 172 
(10.8), 171 (100), 170 (57.7), 157 (2.3), 156 (27.7), 155 (26.9), 154 (41.5), 153 (12.3), 152 (2.3), 143 
(7.7), 142 (99.0), 140 (16.9), 139 (3.8), 138 (32.3), 136 (9.2), 129 (7.7), 128 (90.8), 127 (3.1), 126 (29.2), 
125 (4.6), 124 (13.1), 114 (4.6), 113 (9.2), 112 (99.0), 111 (9.2), 110 (36.9), 98 (12.3), 97 (16.9), 96 
(15.4), 86 (6.2), 85 (53.8), 84 (28.5), 83 (15.4), 82 (13.8), 81 (4.6), 80 (2.3), 74 (4.6), 72 (23.8), 71 (3.8), 
70 (18.5), 69 (6.2), 68 (10.8), 67 (15.4), 58 (6.2), 57 (12.3), 56 (13.8), 55 (13.8), 54 (6.9), 53 (3.1), 44 
(6.9), 43 (32.3), 42 (16.2), 41 (19.2) 
 
N,N-Diethyl-5-methylfuran-3-amine (5b)
IR (neat) 3142 (w), 2972 (s), 2933 (s), 2872 (m), 2825 (m), 1755 (m), 1622 (s), 1553 (m), 1447 
(s), 1376 (s), 1283 (m), 1183 (m) and 1111 cm-1(s). 1H NMR (200MHz, CDCl3):  6.75 (s, 1H), 5.83 (s. 
1H), 3.03 (quartet, 4H, J = 7.2Hz), 2.22 (s, 3H), 1.08 (t, 6H, J = 7.2Hz). 13C NMR (200MHz, CDCl3): 
 151.9, 139.5, 123.5, 100.8, 45.1, 14.0, 11.7. MS m/z (relative intensity) 154 (7.7), 153 (M+ 72.3), 139 
(9.2), 138 (100), 124 (5.4), 111 (3.8), 110 (41.5), 109 (7.7), 108 (6.9), 96 (3.8), 95 (2.3), 83 (4.6), 82 
(6.9), 81 (3.8), 80 (5.4), 68 (7.7), 67 (4.6), 66 (4.6), 56 (4.6), 55 (3.1), 54 (2.3), 53 (3.8), 43 (6.9), 41 
(4.6).; HRMS calc. for C9H16NO 154.1232, found 154.1229. 
 
4-(Diisopropylamino)-5-(tetrahydropyran-2-yloxy)pent-3-en-2-one (19c)
1H NMR (200MHz, CDCl3):  5.30 (d, 1H, J = 11.5Hz), 5.20 (s, 1H), 4.74 (m. 1H), 4.61 (d, 1H, 
J = 11.5Hz), 3.95 (septet, 2H, J = 6.9Hz), 3.81 (m, 1H), 3.49 (m, 1H), 2.01 (s, 3H), 1.82 – 1.35 (m, 6H), 
1.25 (d, 6H, J = 7.0Hz), 1.23 (d, 6H, 7.0Hz). 13C NMR (200MHz, CDCl3):  193.7, 156.7, 99.7, 98.3, 
63.0, 61.7, 48.1, 32.3, 30.8, 25.4, 20.4, 19.8. MS m/z (relative intensity) 283 (M+ 2.8), 254 (1.0), 241 
(2.3), 240 (15.9), 244 (1.0), 210 (1.0), 200 (3.3), 199 (27.6), 198 (5.6), 184 (15.9), 183 (3.7), 182 (9.3), 
181 (3.3), 170 (3.3), 168 (4.7), 166 (4.2), 157 (9.8), 156 (100), 142 (4.2), 141 (2.3), 140 (21.0), 139 (1.9), 
138 (7.9), 126 (7.5), 125 (2.3), 124 (9.3), 115 (2.8), 114 (40.2), 112 (2.3), 110 (2.3), 100 (5.1), 99 (2.8), 
98 (25.7), 97 (8.4), 96 (9.3), 86 (4.2), 85 (53.3), 84 (25.2), 83 (4.7), 82 (4.7), 81 (2.3), 72 (9.8), 71 (3.7), 
70 (3.7), 68 (4.2), 67 (8.4), 58 (3.7), 57 (8.4), 56 (2.8), 55 (8.4), 54 (2.3), 44 (3.7), 43 (30.8), 42 (8.4), 41 
(15.9). 
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N,N-Diisopropyl-5-methylfuran-3-amine (5c)
IR (neat) 2971 (s), 2932 (m), 2873 (m), 1750 (w), 1619 (s), 1546 (m), 1513 (w), 1456 (m), 1381 
(m), 1364 (m), 1328 (w), 1305 (m), 1271 (m), 1181 (m) and 1115 cm-1(s). 1H NMR (200MHz, CDCl3): 
6.88 (s, 1H), 5.88 (s, 1H), 3.40 (septet, 2H, J = 6.6Hz), 2.22 (s, 3H), 1.11 (d, 12H, J = 6.8Hz). 13C NMR 
(200MHz, CDCl3):  150.8, 134.9, 129.0, 104.5, 48.6, 21.1, 14.0. MS m/z (relative intensity) 182 (7.7), 
181 (M+ 45.4), 167 (10.0), 166 (61.5), 139 (1.5), 138 (9.2), 125 (12.3), 124 (100), 123 (7.7), 122 (10.8), 
110 (2.3), 109 (2.3), 108 (7.7), 106 (3.8), 97 (2.3), 96 (10.0), 95 (2.3), 94 (4.6), 84 (2.3), 83 (3.8), 82 
(10.8), 81 (6.9), 80 (4.6), 79 (4.6), 69 (1.5), 68 (8.4), 67 (2.3), 66 (4.6), 55 (3.8), 54 (2.3), 53 (5.4), 44 
(3.8), 43 (13.1), 42 (5.4).; HRMS calc. for C11H20NO 182.1545, found 182.1541. 
 
4-(Pyrrolidin-1-yl)-5-(tetrahydropyran-2-yloxy)pent-3-en-2-one (19d)
1H NMR (200MHz, CDCl3):  5.14 (d, 1H, J = 10.9Hz), 4.93 (s, 1H), 4.76 (m, 1H), 4.75 (d, 1H, 
J = 10.9Hz), 3.89 (m, 1H), 3.58 (m, 2H), 3.53 (m, 1H), 3.18 (m, 2H), 2.04 (s, 3H), 1.90 (m, 4H), 1.80 – 
1.39 (m, 6H).  13C NMR (200MHz, CDCl3):  194.5, 156.8, 100.1, 96.5, 63.1, 62.8, 48.2, 31.9, 30.8, 
25.6, 24.9, 20.0. MS m/z (relative intensity) 254 (2.3), 253 (M+ 15.4), 224 (6.2), 210 (2.3), 194 (10.0), 
170 (10.0), 169 (100), 168 (97.7), 154 (30), 153 (33.8), 152 (45.4), 151 (50.0), 150 (30.8), 141 (6.2), 140 
(70.0), 138 (14.6), 136 (17.7), 134 (6.2), 127 (6.2), 126 (61.5), 124 (12.3), 123 (16.9), 122 (6.2), 112 
(6.2), 111 (33.1), 110 (70.8), 109 (6.2), 108 (6.2), 85 (16.9), 84 (16.2), 83 (19.2), 82 (6.2), 81 (6.9), 80 
(6.2), 72 (5.4), 71 (7.7), 70 (53.8), 69 (5.4), 68 (10.8), 67 (10.8), 57 (6.9), 56 (3.8), 55 (16.9), 54 (6.9), 53 
(4.6), 43 (23.8), 42 (5.4), 41 (17.7) 
 
1-(5-Methylfuran-3-yl)pyrrolidine (5d)
IR (neat) 3139 (w), 3106 (w), 2967 (s), 2919 (s), 2875 (s), 2814 (s), 1625 (s), 1557 (m), 1459 
(m), 1402 (s), 1358 (m), 1327 (m), 1168 (m), 1152 (m) and 1106 cm-1(s). 1H NMR (200MHz, CDCl3): 
6.72 (s, 1H), 5.80 (s, 1H), 3.01 (m, 4H), 2.22 (s, 3H), 1.93 (m, 4H). 13C NMR (200MHz, CDCl3): 
 152.0, 139.7, 121.6, 100.6, 50.5, 24.9, 14.0. MS m/z (relative intensity) 152 (10.8), 151 (M+ 100), 150 
(89.2), 149 (3.1), 148 (3.1), 136 (7.7), 123 (10.8), 122 (20.0), 120 (2.3), 110 (2.3), 109 (6.2), 108 (33.8), 
106 (2.3), 96 (4.6), 95 (16.2), 94 (13.1), 93 (2.3), 82 (2.3), 81 (8.5), 80 (10.8), 79 (2.3), 70 (3.1), 68 (9.2), 
67 (7.7), 66 (4.6), 65 (2.3), 55 (4.6), 54 (3.1), 53 (8.5), 52 (3.1), 51 (3.1), 43 (6.2), 41 (12.3).; HRMS 
calc. for C9H14NO 152.1075, found 152.1070. 
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4-Dibenzylamino-5-(tetrahydropyran-2-yloxy)pent-3-en-2-one (19e)
1H NMR (200MHz, CDCl3):  7.40 - 7.07 (m, 10H), 5.28 (d, 1H, J = 11.5Hz), 5.20 (s, 1H), 4.87 
(d, 1H, J = 11.5Hz), 4.74 (m, 1H), 4.49 (AB quartet, 4H, J = 5.7Hz), 3.78 (m, 1H), 3.44 (m, 1H), 1.95 (s, 
3H), 1.76 – 1.30 (m, 6H). 13C NMR (200MHz, CDCl3):  195.6, 158.8, 136.7, 128.9, 127.6, 127.0, 99.9, 
97.8, 63.1, 61.1, 52.8, 32.4, 30.8, 25.5, 19.9. MS m/z (relative intensity) 379 (M+ 0.5), 336 (0.5), 296 
(2.3), 295 (13.1), 294 (6.2), 288 (4.6), 280 (1.5), 279 (2.3), 278 (5.4), 277 (4.6), 276 (1.5), 262 (1.5), 252 
(3.1), 236 (3.8), 234 (3.1), 232 (1.5), 205 (10.8), 204 (78.5), 189 (1.5), 188 (16.2), 186 (7.7), 162 (10.8), 
160 (1.5), 158 (1.5), 146 (4.6), 144 (5.4), 143 (1.5), 132 (1.5), 117 (2.3), 115 (1.5), 106 (1.5), 105 (1.5), 
104 (2.3), 92 (16.2), 91 (100), 85 (26.2), 67 (3.8), 65 (6.2), 57 (3.8), 55 (2.3), 43 (5.4), 41 (3.8) 
 
N,N-Dibenzyl-5-methylfuran-3-amine (5e)
IR (neat) 3057 (m), 3026 (m), 2937 (m), 2920 (m), 2882 (m), 2844 (m), 1623 (s), 1493 (s), 1454 
(s), 1395 (m), 1371 (m), 1352 (m), 1224 (m), 1161 (m), 1134 (m), 1101 (m) and 1080 cm-1(m). 1H NMR 
(200MHz, CDCl3):  7.50 – 7.10, (m, 10H), 6.68 (s, 1H), 5.87 (s, 1H), 4.20 (s, 4H), 2.21, (s, 3H). 13C
NMR (200MHz, CDCl3):  151.8, 140.9, 138.9, 128.6, 127.9, 127.2, 123.5, 100.8, 56.1, 14.1. MS m/z 
(relative intensity) 278 (15.4), 277 (M+ 71.5), 276 (20.0), 186 (50.8), 185 (2.3), 184 (3.8), 170 (3.8), 168 
(1.5), 167 (6.9), 159 (5.4), 158 (33.8), 157 (3.1), 156 (3.1), 144 (14.6), 143 (9.2), 142 (2.3), 130 (2.3), 
129 (3.8), 128 (2.3), 117 (3.1), 116 (3.1), 115 (4.6), 108 (3.1), 104 (2.3), 92 (8.5), 91 (100), 90 (3.8), 89 
(5.4), 77 (2.3), 65 (14.6), 53 (1.5), 51 (1.5), 43 (5.4).; HRMS calc. for C19H20NO 278.1545, found 
278.1538. 
 
4,4’-Ethylenediiminobis[5-(tetrahydropyran-2-yloxy)pent-3-en-2-one]  (19f)
1H NMR (200MHz, CDCl3):  5.12 (s, 2H), 4.58 (m, 2H), 4.23 (d, 2H, J = 13.2Hz), 3.92 (d, 2H, 
J = 13.2Hz), 3.75 (m, 2H), 3.47 (m, 2H), 3.41 (m, 4H), 1.97 (s, 6H), 1.85 – 1.35 (m, 12H). 13C NMR 
(200MHz, CDCl3):  196.9, 160.1, 97.9, 95.2, 65.0, 62.3, 43.7, 30.3, 29.3, 25.2, 19.2. MS m/z (relative 
intensity) 424 (M+ 1), 381 (1.5), 340 (2.3), 323 (2.3), 322 (3.5), 267 (2.3), 257 (1.5), 256 (11.5), 255 
(1.5), 240 (2.3), 239 (6.9), 238 (3.8), 226 (4.6), 225 (33.1), 221 (2.3), 220 (2.3), 213 (6.9), 212 (5.4), 209 
(6.2), 207 (10.8), 201 (2.3), 200 (16.9), 197 (3.8), 196 (1.5), 195 (6.2), 183 (2.3), 182 (4.6), 181 (3.1), 
179 (1.5), 165 (3.1), 152 (2.3), 151 (1.5), 142 (15.4), 141 (59.2), 140 (3.8), 130 (3.1), 129 (41.5), 128 
(79.2), 127 (4.6), 126 (13.1), 125 (42.3), 124 (4.6), 123 (8.5), 117 (3.8), 116 (66.9), 115 (4.6), 114 (3.8), 
113 (4.6), 112 (9.2), 111 (12.3), 110 (12.3), 100 (11.5), 99 (3.8), 98 (16.2), 97 (3.8), 96 (6.2), 86 (12.3), 
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85 (100), 84 (9.2), 83 (6.9), 82 (16.9), 71 (3.1), 70 (4.6), 69 (3.1), 68 (6.2), 67 (20.0), 57 (17.7), 56 (3.8), 
55 (11.5), 43 (23.1), 41 (14.6) 
 
N,N’-Bis(5-methylfuran-3-yl)ethylenediamine (5f)
MS m/z (relative intensity) 221 (13.1), 220 (M+ 77.7), 191 (10.7), 190 (56.9), 182 (2.3), 178 
(3.4), 177 (17.7), 176 (3.8), 175 (6.2), 174 (10.7), 172 (3.1), 162 (6.9), 161 (3.1), 160 (3.8), 149 (9.2), 
148 (60.0), 147 (100), 146 (7.7), 134 (5.4), 133 (5.4), 132 (6.2), 124 (3.1), 120 (5.4), 119 (5.4), 118 (8.5), 
117 (3.1), 111 (13.1), 110 (25.4), 109 (6.2), 108 (7.7), 106 (3.1), 105 (2.3), 103 (2.3), 98 (3.1), 96 (3.1), 
91 (5.4), 89 (4.6), 85 (2.3), 83 (3.8), 81 (3.8), 80 (4.6), 79 (3.8), 78 (2.3), 77 (4.6), 69 (2.3), 68 (5.4), 67 
(2.3), 66 (4.6), 65 (4.6), 63 (3.1), 53 (7.7), 52 (2.1), 51 (3.8), 44 (14.6), 43 (20.8), 42 (3.8), 41 (5.4) 
 
N.N’-Ethylenebis[N-(5-methylfuran-3-yl)acetamide] (21f)
IR (neat) 3414 (w), 3167 (w), 3127 (s), 3104 (s), 2985 (m), 2947 (s), 2915 (s), 2853 (w), 1667 
(s), 1613 (s), 1556 (m), 1431 (s), 1397 (s), 1296 (s), 1263 (m), 1237 (s), 1203 (m), 1186 (m) and 1128 
cm-1(s). 1H NMR (200MHz, CDCl3):  7.41 (s, 2H), 5.98 (s, 2H), 3.69 (s, 4H), 2.28 (s, 6H), 1.91 (s, 6H). 
13C NMR (200MHz, CDCl3):  171.7, 153.0, 137.5, 130.3, 105.8, 46.7, 22.5, 14.0. MS m/z (relative 
intensity) 305 (1.5), 304 (M+ 10.0), 262 (3.1), 246 (1.5), 245 (13.8), 219 (3.1), 166 (15.4), 165 (40.0), 
153 (2.3), 140 (3.1), 139 (33.8), 124 (12.3), 123 (46.9), 122 (3.8), 111 (10.8), 110 (100), 109 (8.5), 108 
(10.8), 98 (1.5), 97 (22.3), 82 (3.1), 81 (2.3), 80 (9.2), 68 (3.1), 67 (2.3), 66 (2.3), 55 (2.3), 53 (2.3), 43 
(25.4), 41 (3.1).; HRMS calc. for C16H20N2O4Na 327.1321, found 327.1317. 
 
4-n-Butylamino-5-(tetrahydropyran-2-yloxy)pent-3-en-2-one (19g)
1H NMR (200MHz, CDCl3):  5.15 (s, 1H), 4.65 (m, 1H), 4.30 (d, 1H, J = 13.4Hz), 4.00 (d, 1H, 
J = 13.4Hz), 3.80 (m, 1H), 3.52 (m, 1H), 3.25 (AB quartet, 2H, J= 6.4Hz), 2.05 (s, 1H), 1.87-1.49 (m, 
8H), 1.40 (sextet, 2H, J = 7.3Hz), 0.91 (t, 3H, J= 7.1Hz ). 13C NMR (200MHz, CDCl3):  196.4, 161.1, 
98.1, 93.6, 64.9, 62.3, 42.7, 32.5, 30.5, 29.3, 25.5, 20.1, 19.2, 13.9. MS m/z (relative intensity) 255 (M+
5.7), 212 (2.5), 198 (2.0), 182 (9.3), 172 (10.6), 171 (100), 170 (39.0), 156 (29.3), 155 (15.4), 154 (26.0), 
142 (27.6), 141 (6.5), 140 (77.2), 138 (7.7), 129 (7.3), 128 (51.2), 126 (12.2), 124 (14.6), 115 (4.9), 114 
(52.0), 113 (91.9), 112 (30.1), 111 (9.8), 110 (23.6), 100 (8.9), 99 (9.8), 98 (88.6), 97 (20.3), 96, (12.2), 
86 (8.1), 85 (81.3), 84 (69.1), 83 (8.9), 82 (10.6), 81 (4.1), 80 (2.8), 72 (8.1), 71 (11.4), 70 (50.0), 69 
(7.0), 68 (10.6), 67 (22.4), 58 (13.0), 57 (33.0), 56 (7.3), 55 (17.1), 54 (5.7), 44 (4.1), 43 (38.2), 42 (9.8), 
41 (31.9) 
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N-(n-Butyl)-5-methylfuran-3-amine (5g)
MS m/z (relative intensity) 154 (4.8), 153 (M+ 43.7), 138 (4.0), 124 (4.8), 111(42.1), 110 (100), 
97 (17.5), 96 (7.1), 84 (3.2), 83 (7.9), 82 (7.1), 81 (3.2), 80 (5.6), 70 (3.2), 69 (3.2), 68 (14.3), 67 (4.8), 
66 (3.2), 55 (6.3), 54 (2.4), 53 (4.8), 43 (11.1), 42 (3.2), 41 (11.1) 
 
N-(n-Butyl)-N-(5-methylfuran-3-yl)acetamide (21g)
IR (neat) 3322 (w), 3109 (w), 2959 (s), 2932 (s), 2873 (m), 1722 (w), 1666 (s), 1615 (s), 1548 
(w), 1408 (s), 1367 (s), 1302 (s), 1228 (s), 1180 (w) and 1133 cm-1(m). 1H NMR (200MHz, CDCl3): 
 7.17 (s, 1H), 5.85 (s, 1H), 3.49 (t, 2H, J = 7.7Hz), 2.23 (s, 3H), 1.89 (s, 3H), 1.40 (m, 2H,),  1.25 
(sextet, 2H, J = 7.3Hz), 0.83 (t, 3H, J = 7.3Hz). 13C NMR (200MHz, CDCl3):  171.0, 153.0, 136.6, 
130.4, 106.0, 48.4, 30.1, 22.5, 20.0, 13.9, 13.8. MS m/z (relative intensity) 196 (4.0), 195 (M+ 33.3), 180 
(6.3), 152 (61.1), 151 (11.1), 139 (4.8), 138 (7.9), 136 (5.5), 125 (3.2), 124 (20.6), 123 (4.8), 111 (44.4), 
110 (100), 98 (5.6), 97 (53.2), 83 (4.0), 82 (4.0), 80 (6.3), 68 (6.3), 55 (3.2), 54 (4.0), 43 (23.0).; HRMS 
calc. for C11H18NO2 196.1337, found 196.1334. 
 
4-Cyclohexylamino-5-(tetrahydropyran-2-yloxy)pent-3-en-2-one (19h)
1H NMR (200MHz, CDCl3):  5.15 (s, 1H), 4.68 (m, 1H), 4.35 (d, 1H, J = 13.2Hz), 4.02 (d, 1H, 
J = 13.2Hz), 3.85 (m, 1H), 3.55 (m, 1H), 3.45 (m, 1H), 2.04 (s, 1H), 1.95 – 1.15 (m, 16H). 13C NMR 
(200MHz, CDCl3):  196.1, 159.9, 98.1, 93.4, 64.8, 62.2, 51.6, 34.4, 34.3, 30.5, 29.3, 25.4, 24.6, 19.1. 
MS m/z (relative intensity) 282 (1.0), 281 (M+ 5.4), 238 (1.5), 208 (3.8), 198 (9.2), 197 (56.9), 196 
(16.2), 182 (16.2), 181 (48.5), 180 (12.3), 179 (8.5), 168 (6.9), 167 (3.8), 166 (28.5), 164 (6.9), 162 (3.1), 
154 (12.3), 152 (1.5), 150 (2.3), 139 (6.2), 138 (50.8), 137 (6.9), 136 (45.4), 126 (6.2), 124 (13.8), 123 
(2.3), 122 (3.1), 116 (9.5), 115 (14.6), 114 (77.7), 110 (4.6), 108 (4.6), 102 (2.3), 101 (6.2), 100 (100), 99 
(6.2), 98 (26.9), 97 (12.3), 96 (6.2), 95 (1.5), 94 (6.2), 86 (3.8), 85 (46.2), 84 (43.1), 83 (14.6), 82 (8.5), 
81 (7.7), 80 (4.6), 79 (3.8), 74 (3.1), 72 (3.8), 71 (6.2), 70 (4.6), 68 (5.4), 67 (18.5), 58 (18.5), 57 (12.3), 
56 (6.2), 55 (29.2), 54 (4.6), 53 (3.8), 43 (20.0), 42 (3.8), 41 (21.5) 
 
N-Cyclohexyl-5-methylfuran-3-amine (5h)
MS m/z (relative intensity) 180 (11.5), 179 (M+ 100), 178 (5.4), 164 (6.9), 151 (1.5), 150 (15.4), 
138 (4.6), 137 (10.0), 136 (56.9), 134 (3.1), 124 (9.2), 123 (6.9), 122 (5.4), 120 (2.3), 118 (3.1), 117 
(3.1), 110 (15.4), 109 (1.5), 108 (21.5), 107 (1.5), 106 (3.1), 98 (45.4), 97 (69.2), 96 (4.6), 95 (2.3), 94 
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(19.2), 93 (12.3), 91 (2.3), 83 (3.1), 82 (4.6), 81 (4.6), 80 (11.5), 79 (3.1), 70 (3.1), 69 (6.9), 68 (15.4), 67 
(5.4), 66 (3.1), 56 (2.3), 55 (13.1), 54 (3.8), 53 (6.2), 43 (13.1), 41 (14.6) 
 
N-Cyclohexyl-N-(5-methylfuran-2-yl)acetamide (21h)
IR (neat) 3105 (w), 2930 (s), 2856 (s), 1726 (w), 1660 (s), 1614 (s), 1544 (m), 1451 (m), 1399 
(s), 1375 (s), 1345 (m), 1313 (s), 1283 (m), 1245 (m) and 1132 cm-1(m). 1H NMR (200MHz, CDCl3): 
7.10 (s, 1H), 5.78 (s, 1H), 4.43 (tt, 1H, J = 11.9Hz, J = 3.8Hz), 2.26 (s, 3H), 1.85 (s, 3H), 1.80 – 0.75 (m, 
10H). 13C NMR (200MHz, CDCl3):  170.9, 152.7, 138.1, 126.6, 108.1, 52.9, 31.3, 25.7, 25.5, 23.1, 13.9. 
MS m/z (relative intensity) 222 (3.1), 221 (M+ 20.8), 206 (2.3), 179 (4.6), 178 (20.0), 164 (1.5), 150 
(3.8), 141 (4.6), 140 (55.4), 139 (22.3), 137 (3.1), 136 (16.9), 134 (2.3), 124 (10.0), 123 (2.3), 122 (1.5), 
110 (2.3) , 108 (6.9), 98 (23.8), 97 (100), 96 (2.3), 94 (4.6), 93 (2.3), 83 (2.3), 82 (1.5), 81 (3.1), 
80 (4.6), 79 (2.3), 69 (3.1), 68 (4.6), 67 (3.8), 66 (1.5), 55 (10.0), 54 (2.3), 53 (4.6), 43 (16.9), 41 (8.5).; 
HRMS calc. for C13H19NO2Na 244.1314, found 244.1311. 
 
5-Morpholino-6-(tetrahydropyran-2-yloxy)hex-4-en-3-one (19i)
1H NMR (200MHz, CDCl3):  5.33 (d, 1H, J = 12.1Hz), 5.19 (s, 1H), 4.71 (m, 1H), 4.66 (d, 1H, 
J = 12.1Hz), 3.85 (m, 1H), 3.73 (t, 4H, J = 4.9Hz), 3.50 (m, 1H), 3.34 (m, 4H), 2.35 (quartet, 2H, 7.3Hz), 
1.90 – 1.35 (m, 6H), 1.05 (t, 3H, 7.3Hz). 13C NMR (200MHz, CDCl3):  199.2, 158.5, 100.1, 97.8, 66.6, 
63.5, 61.1, 47.0, 37.8, 31.0, 25.5, 20.2, 9.5. MS m/z (relative intensity) 283 (M+ 2.3), 254 (2.3), 224 (3.1), 
200 (9.2), 199 (82.3), 198 (36.2), 183 (8.5), 182 (15.4), 181 (6.9), 171 (9.2), 170 (100), 168 (5.4), 166 
(5.4), 154 (8.5), 152 (12.3), 143 (8.5), 142 (90.8), 140 (6.2), 127 (12.3), 126 (25.4), 124 (8.5), 123 (4.6), 
114 (8.5), 112 (10.0), 98 (2.3), 97 (3.8), 96 (4.6), 95 (3.8), 94 (3.8), 86 (11.5), 85 (36.2), 84 (7.7), 83 
(5.4), 82 (3.8), 70 (3.8), 69 (3.1), 68 (3.8), 67 (14.6), 57 (29.2), 56 (6.9), 55 (13.1), 54 (3.8), 43 (8.5), 41 
(13.8) 
 
4-(5-Ethylfuran-3-yl)morpholine (5i).
IR (neat) 3136 (w), 2968 (s), 2855 (s), 2821 (m), 1703 (w), 1618 (s), 1551 (w), 1451 (m), 1399 
(m), 1378 (m), 1359 (w), 1257 (s), 1161 (m) and 1117 cm-1(s). 1H NMR (200MHz, CDCl3):  6.83 (s, 
1H), 5.86 (s, 1H), 3.80 (m, 4H), 2.89 (m, 4H), 2.56 (quartet, 2H, J = 7.5Hz), 1.19 (t, 3H, J = 7.5Hz). 13C
NMR (200MHz, CDCl3):  158.1, 141.5, 123.8, 98.7, 66.7, 50.8, 21.8, 12.1. MS m/z (relative intensity) 
182 (12.3), 181 (M+ 97.7), 180 (4.2), 166 (19.2), 152 (13.1), 150 (9.2), 138 (3.8), 136 (3.1), 125 (6.2), 
124 (34.6), 123 (100), 122 (20.0), 109 (6.2), 108 (52.3), 96 (4.6), 95 (7.7), 94 (14.6), 81 (3.8), 80 (9.2), 
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79 (3.1), 67 (6.2), 66 (4.6), 65 (4.6), 57 (3.8), 55 (3.1), 54 (3.8), 53 (7.7), 42 (2.3), 41 (7.7).; HRMS calc. 
for C10H16NO2 182.1181, found 182.1176. 
 
5-Diethylamino-6-(tetrahydro-2-yloxy)hex-4-ene-3-one (19j)
1H NMR (200MHz, CDCl3): 5.31 (d, 1H, J = 11.2Hz), 5.07 (s, 1H), 4.81 (m, 1H), 4.68 (d, 1H, J 
= 11.2Hz), 3.85 (m, 1H), 3.55 (m, 1H), 3.34 (quartet, 4H, J = 7.3Hz), 2.34 (quartet, 2H, J = 7.3Hz), 1.90 
– 1.40 (m, 6H), 1.18 (t, 6H, 7.3Hz), 1.07 (t, 3H, J = 7.3Hz). 13C NMR (200MHz, CDCl3):  198.2, 157.5, 
100.2, 95.1, 63.3, 61.5, 44.1, 37.8, 30.9, 25.6, 20.1, 13.1, 10.0. MS m/z (relative intensity) 269 (M+ 3.1), 
240 (2.3), 210 (4.6), 186 (6.2), 185 (56.2), 184 (31.5), 170 (3.8), 169 (10.0), 168 (16.2), 167 (6.9), 157 
(9.2), 156 (100), 154 (5.4), 152 (10.0), 150 (2.3), 140 (20.0), 138 (11.5), 129 (2.9), 128 (83.1), 126 (6.9), 
124 (6.9), 113 (6.9), 112 (31.5), 111 (6.9), 110 (13.8), 100 (9.2), 98 (6.9), 97 (3.1), 96 (6.9), 86 (3.8), 85 
(32.3), 84 (7.7), 83 (5.4), 82 (5.4), 72 (11.5), 70 (7.7), 69 (2.3), 68 (5.4), 67 (10.0), 58 (3.8), 57 (26.2), 56 
(8.5), 55 (8.5), 54 (3.8), 44 (3.1), 43 (6.2), 42 (8.5), 41 (11.5). 
 
N,N,5-Triethylfuran-3-amine (5j)
IR (neat) 3142 (w), 2971 (s), 2935 (s), 2874 (s), 1755 (m), 1702 (w), 1618 (s), 1550 (m), 1519 
(w), 1462 (s), 1402 (s), 1374 (s), 1277 (m), 1179 (s) and 1113 cm-`1(s). 1H NMR (200MHz, CDCl3): 
 6.76 (s, 1H), 5.83 (s, 1H), 3.03 (quartet, 4H, J = 7.1Hz), 2.57 (quartet, 2H, J = 7.5Hz), 1.21 (t, 3H, 
7.5Hz), 1.08 (t, 6H, J = 7.1Hz). 13C NMR (200MHz, CDCl3):  157.6, 138.3, 123.4, 99.1, 45.1, 21.9, 
12.1, 11.7. MS m/z (relative intensity) 168 (6.9), 167 (M+ 52.3), 153 (12.3), 152 (100), 138 (5.4), 125 
(3.1), 124 (31.5), 123 (3.8), 122 (3.8), 110 (2.3), 109 (2.3), 108 (6.9), 96 (4.6), 95 (5.4), 94 (3.8), 82 
(6.2), 81 (4.6), 80 (6.2), 79 (2.3), 68 (2.3), 67 (4.6), 66 (2.3), 57 (4.6), 56 (5.4), 55 (3.8), 54 (2.3), 53 
(5.4), 43 (2.3), 41 (4.6).; HRMS calc. for C10H18NO 168.1388, found 168.1385. 
 
5-(n-Butylamino)-6-(tetrahydropyran-2-yloxy)hex-4-en-3-one (19k)
1H NMR (200MHz, CDCl3): 5.16 (s, 1H), 4.65 (m, 1H), 4.31 (d, 1H, J = 13.4Hz), 4.01 (d, 1H, J 
= 13.4Hz), 3.80 (m, 1H), 3.50 (m, 1H), 3.24 (quartet, 2H, J = 6.6Hz), 2.28 (quartet, 2H, J = 7.5Hz), 1.90 
– 1.50 (m, 8H), 1.40 (septet, 2H, J = 8.1Hz), 1.07 (t, 3H, J = 7.5Hz), 0.90 (t, 3H, 7.3Hz). 13C NMR 
(200MHz, CDCl3):  200.1, 161.1, 98.1, 92.6, 65.0, 62.8, 42.7, 35.2, 32.4, 30.5, 25.4, 20.1, 19.2, 13.8, 
10.0. MS m/z (relative intensity) 269 (M+ 1.9), 212 (1.9), 196 (3.3), 186 (6.1), 185 (46.7), 184 (23.4), 169 
(7.0), 168 (12.6), 167 (4.7), 157 (10.3), 156 (100), 155 (4.2), 154 (35.5), 142 (7.9), 140 (14.0), 138 
(10.7), 129 (4.7), 128 (45.8), 127 (37.4), 126 (4.7), 125 (5.6), 124 (12.6), 114 (3.7), 113 (4.7), 112 (17.8), 
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111 (7.9), 110 (8.4), 100 (4.2), 99 (5.6), 98 (72.9), 97 (5.6), 96 (9.3), 95 (3.7), 86 (4.7), 85 (49.5), 84 
(21.0), 83 (9.3), 82 (8.4), 81 (2.3), 72 (7.5), 71 (7.5), 70 (28.5), 69 (7.0), 68 (7.5), 67 (17.8), 58 (3.7), 57 
(39.3), 56 (7.9), 55 (22.4), 54 (6.1), 53 (4.2), 43 (11.2), 42 (6.1), 41 (23.4) 
 
N-(n-Butyl)-5-ethylfuran-3-amine  (5k)
MS m/z (relative intensity) 168 (6.2), 167 (M+ 52.3), 152 (6.2), 138 (6.2), 126 (3.1), 125 (41.5), 
124 (100), 111 (13.1), 110 (6.9), 108 (6.9), 97 (3.1), 96 (18.5), 95 (2.3), 83 (3.1), 82 (11.5), 81 (6.2), 80 
(7.7), 68 (5.4), 67 (5.4), 66 (2.3), 57 (6.2), 55 (4.6), 53 (4.6), 41 (7.7) 
 
N-(n-Butyl)-N-(5-ethylfuran-3-yl)acetamide (21k)
IR (neat) 3109 (w), 2960 (s), 2933 (s), 2874 (s), 1761 (w), 1664 (s), 1611 (s), 1543 (w), 1406 (s), 
1301 (m), 1227 (m) and 1136 cm-1(m). 1H NMR (200MHz, CDCl3):  7.20 (s, 1H), 5.86 (s, 1H), 3.51 (t, 
2H, J = 7.1Hz), 2.60 (quartet, 2H, J = 7.5Hz), 1.92 (s, 3H), 1.43 (quintet, 2H, J = 7.5Hz), 1.24 (septet, 
2H, J = 7.0Hz), 1.20 (t, 3H, 7.5Hz), 0.86 (t, 3H, 7.1Hz). 13C NMR (200MHz, CDCl3): d 171.0, 158.7, 
136.6, 130.3, 104.4, 48.4, 30.2, 22.5, 21.7, 20.0, 14.0, 11.9. 
MS m/z (relative intensity) 210 (4.6), 209 (M+ 30.8), 194 (5.4), 180 (7.7), 167 (3.8), 166 (6.2), 153 
(10.0), 152 (52.3), 150 (4.6), 139 (3.8), 138 (23.1), 137 (5.4), 125 (35.4), 124 (100), 112 (3.8), 111 
(30.8), 110 (6.2), 108 (6.9), 97 (23.1), 96 (10.0), 94 (3.8), 82 (6.2), 81 (3.8), 80 (6.2), 68 (3.1), 67 (3.1), 
57 (9.2), 55 (3.8), 53 (3.8), 43 (16.9), 41 (7.7).; HRMS calc. for C12H19NO2Na 232.1313, found 
132.1310. 
 
3-Morpholino-4-(tetrahydropyran-2-yloxy)but-2-enal (19l)
1H NMR (200MHz, CDCl3): 9.70 (d, 1H, J = 8.1Hz), 5.28 (d, 1H, J = 8.1Hz), 4.64 (m, 1H), 
4.62 (AB quartet, 2H, 7.0Hz), 3.80 (m, 1H), 3.71 (m, 4H), 3.50 (m, 4H), 1.95 – 1.6 (m, 9H). 13C NMR 
(200MHz, CDCl3):  188.2, 160.6, 104.5, 98.2, 66.5, 63.1, 59.6, 47.1, 30.6, 25.3, 19.7.  MS m/z (relative 
intensity) 255 (M+ 2.3), 226 (2.3), 196 (3.1), 172 (7.7), 171 (100), 170 (43.8), 156 (2.3), 155 (26.2), 154 
(45.4), 153 (16.2), 152 (6.2), 143 (3.1), 142 (25.4), 140 (7.7), 138 (22.3), 136 (9.2), 127 (15.4), 126 
(45.4), 125 (3.1), 124 (16.2), 123 (2.3), 122 (3.8), 114 (3.8), 113 (9.2), 112 (23.8), 111 (3.1), 110 (8.5), 
108 (5.4), 106 (1.5), 100 (1.5), 99 (2.3), 98 (6.2), 97 (11.5), 96 (18.5), 95 (26.2), 94 (12.3), 87 (4.6), 86 
(16.9), 85 (45.4), 84 (12.3), 83 (9.2), 82 (11.5), 81 (4.6), 80 (3.8), 72 (3.1), 71 (3.8), 70 (10.0), 69 (15.4), 
68 (13.1), 67 (26.2), 66 (2.3), 65 (1.5), 58 (3.8), 57 (21.5), 56 (16.9), 55 (30.0), 54 (12.3), 53 (6.2), 52 
(2.3), 45 (6.2), 44 (4.6), 43 (19.2), 42 (19.2), 41 (42.3). 
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4-(Furan-3-yl)morpholine (5l)
IR (neat) 3454 (w), 3145 (w), 2960 (m), 2915 (m), 2895 (m), 2856 (m), 2823 (m), 1596 (s), 1508 
(w), 1452 (m), 1393 (m), 1381 (m), 1359 (w), 1330 (m), 1303 (w), 1272 (m), 1251 (s), 1211 (w), 1182 
(w), 1160 (m) and 1119 cm-1(s). 1H NMR (200MHz, CDCl3): 7.32 (m, 1H), 7.00 (m, 1H), 6.28 (m, 1H), 
3.84 (m, 4H), 2.94 (m, 4H). 13C NMR (200MHz, CDCl3): 143.4, 141.3, 126.1, 104.0, 66.5, 50.7. MS 
m/z (relative intensity) 154 (3.1), 153 (M+ 40.0), 138 (6.2), 124 (5.4), 122 (9.2), 97 (2.3), 96 (10.8), 95 
(100), 94 (28.5), 69 (2.3), 68 (5.4), 67 (14.6), 66 (5.4), 65 (2.3), 55 (2.3), 54 (6.1), 53 (6.1), 52 (6.1), 45 
(2.3), 44 (1.5), 43 (5.4), 42 (7.7), 41 (21.5).; HREIMS calc. C8H11NO2 153.0790, Found 153.0786. 
 
3-Diethylamino-4-(tetrahydropyran-2-yloxy)but-2-enal (19m)
1H NMR (200MHz, CDCl3): 9.62 (d, 1H, J = 8.3Hz), 5.24 (d, 1H, J = 8.3Hz), 4.66 (m, 1H), 
4.58 (s, 2H), 3.80 (m, 1H), 3.53 (m, 1H), 3.32 (quartet, 4H, J = 7.0Hz), 1.90 – 1.40 (m, 8H), 1.18 (t, 6H, J 
= 7.1Hz). 13C NMR (200MHz, CDCl3): 187.5, 159.7, 102.8, 98.1, 62.7, 59.8, 44.4, 30.5, 25.4, 19.5, 
12.8. MS m/z (relative intensity) 241 (M+ 1.0), 212 (1.0), 208 (1.5), 207 (5.4), 182 (1.5), 158 (3.1), 157 
(8.5), 156 (27.7), 147 (1.5), 142 (4.6), 141 (17.7), 140 (30.0), 139 (3.1), 138 (3.1), 129 (6.2), 128 (75.4), 
126 (10.0), 125 (2.3), 124 (23.1), 122 (7.7), 114 (3.1), 113 (13.1), 112 (52.3), 110 (13.8), 108 (2.3), 105 
(1.5), 100 (6.2), 99 (3.8), 98 (17.7), 97 (6.2), 96 (13.8), 95 (2.3), 94 (3.8), 86 (8.5), 85 (87.7), 84 (33.1), 
83 (19.2), 82 (17.7), 81 (3.8), 80 (3.1), 74 (3.8), 73 (10.0), 72 (19.2), 71 (19.2), 70 (55.4), 69 (23.8), 68 
(19.2), 67 (27.7), 58 (20.8), 57 (56.9), 56 (41.5), 55 (43.8), 54 (21.5), 53 (7.7), 45 (3.8), 44 (27.7), 43 
(53.8), 42 (64.6), 41 (100). 
 
N,N-Diethylfuran-3-amine (5m)
IR (neat) 3148 (w), 2972 (s), 2934 (m), 2873 (m), 2831 (m), 1599 (s), 1508 (w), 1450 (m), 1378 
(m), 1341 (m), 1274 (m), 1194 (w), 1165 (s), 1118 (w) and 1066 cm-1(m). 1H NMR (200MHz, CDCl3): 
7.25 (m, 1H), 6.90 (m, 1H), 6.20 (m, 1H), 3.05 (quartet, 4H, J = 7.0Hz), 1.08 (t, 6H, J = 7.1Hz). 13C
NMR (200MHz, CDCl3):  142.6, 138.8, 125.5, 104.4, 45.2, 11.6. MS m/z (relative intensity) 140 (3.8), 
139 (M+ 43.8), 125 (7.7), 124 (100), 110 (3.1), 109 (2.3), 108 (3.1), 97 (3.1), 96 (53.8), 95 (9.2), 94 
(14.6), 82 (6.2), 81 (4.6), 80 (4.6), 70 (2.3), 69 (4.6), 68 (14.6), 67 (8.5), 66 (4.6), 65 (3.1), 56 (7.7), 55 
(7.7), 54 (18.5), 53 (13.1), 52 (12.3), 51 (1.5), 43 (2.1), 42 (13.8), 41 (30.0).;EIMS: Calc C8H13NO 
139.0997, Found 139.0994. 
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3-(n-Butylamino)-4-(tetrahydropyran –2-yloxy)but-2-enal (19n)
1H NMR (200MHz, CDCl3): E) 9.37 (d, 1H, J = 6.8Hz), 5.01 (d, 1H, J = 6.8), 4.77 (AB quartet, 
1H, J = 19.8Hz, C = 15.5Hz), 4.67 (AB quartet, 1H, J = 19.8Hz, C = 15.5Hz), 4.63 (m, 1H), 3.17 (AB 
quartet, 2H, J = 5.3Hz), 0.92 (m, 3H) ; Z) 9.03 (d, 1H, J = 2.6Hz), 5.15 (d, 1H, J = 2.6Hz), 4.66 (m, 1H), 
4.34 (d, 1H, J = 13.9Hz, C = 54.9Hz), 4.07 (d, 1H, J = 13.9Hz, C = 54.9Hz), 3.10 (AB quartet, 2H), 0.80 
(m, 3H)  ; E + Z) 3.81 (m, 1H), 3.56 (m, 1H), 1.9 – 1.5 (m, 6H), 1.41 (quintet, 2H, J = 7.1Hz). 13C NMR 
(200MHz, CDCl3):  186.9, 185.4, 162.9, 161.6, 99.7, 98.2, 94.5, 64.3, 63.4, 62.3, 43.0, 42.8, 32.3, 30.6, 
30.4, 30.3, 25.4, 25.2, 20.3, 20.1, 20.0, 19.1. MS m/z (relative intensity) 241 (M+ 1.0), 168 (1.5), 158 
(3.1), 151 (26.9), 156 (13.1), 141 (6.2), 140 (10.0), 128 (3.8), 127 (1.5), 126 (22.3), 124 (3.1), 115 (3.8), 
114 (7.7), 113 (10.8), 112 (10.8), 111 (1.5), 110 (8.5), 101 (2.3), 100 (31.5), 99 (31.5), 98 (38.5), 97 
(7.7), 96 (9.2), 87 (2.3), 86 (11.5), 85 (87.7), 84 (28.5), 83 (11.5), 82 (9.2), 73 (3.1), 72 (6.9), 71 (33.1), 
70 (73.8), 69 (13.8), 68 (13.1), 67 (28.5), 58 (8.5), 57 (58.5), 56 (23.1), 55 (27.7), 54 (15.4), 53 (5.4), 52 
(1.5), 51 (1.5), 49 (3.1), 44 (9.2), 43 (40), 42 (13.1), 41 (100). 
 
N-(n-Butyl)furan-3-amine (5n)
MS m/z (relative intensity) 140 (3.1), 139 (M+ 27.7), 124 (1.5), 110 (4.6), 97 (18.5), 96 (100), 94 
(2.3), 83 (4.6), 80 (3.1), 69 (4.6), 68 (5.4), 67 (2.3), 55 (3.1), 54 (7.7), 53 (2.3), 52 (3.1), 42 (3.8), 41 
(13.8). 
 
N-(n-Butyl)-N-(furan-3-yl)acetamide (21n)
IR (neat) 3482 (w), 3317 (w), 3131 (w), 2959 (m), 2933 (m), 2873 (m), 1751 (w), 1722 (w), 
1663 (s), 1592 (m), 1509 (w), 1439 (m), 1403 (s), 1378 (m), 1368 (m), 1303 (m), 1256 (w), 1223 (m), 
1115(w). 1H NMR (200MHz, CDCl3): 7.37 (m, 1H), 7.35 (m, 1H), 6.26 (m, 1H), 3.51 (t, 2H, J = 
7.1Hz), 1.88 (s, 3H), 1.43 (quintet, 2H, J = 8.1Hz), 1.25 (sextet, 2H, J = 7.1Hz), 0.87 (t, 3H, 7.1Hz). 13C
NMR (200MHz, CDCl3):  170.9, 143.5, 138.5, 129.9, 110.1, 48.4, 30.0, 22.4, 19.9, 13.9. MS m/z 
(relative intensity) 182 (1.0), 181 (M+ 10), 166 (3.1), 153 (3.8), 152 (26.2), 139 (4.6), 138 (5.4), 125 
(3.1), 124 (3.1), 111 (5.4), 110 (8.5), 98 (2.3), 97 (32.3), 96 (100), 95 (3.1), 94 (3.8), 83 (12.3), 80 (1.5), 
69 (2.3), 68 (3.1), 67 (3.8), 55 (3.1), 54 (3.8), 53 (2.3), 52 (1.5), 43 (31.5), 42 (3.8), 41 (12.3).; HRESMS: 
calc C10H15NO2Na 204.1001, Found 204.0991. 
 
